(Name, Telephone, E-mail and/or Facsimile number
and Address of Company Contact Person)
Securities for which there is a reporting obligation
pursuant to Section 15(d) of the Act:
The number of outstanding shares of each of the
issuer’s classes of capital or common stock as of August 15, 2022 were 66,854,583 Class A ordinary shares, par value $0.0005
per share and 12,245,100 Class B ordinary shares, par value $0.0005 per share.
Indicate by check mark if the registrant is a
well-known seasoned issuer, as defined in Rule 405 of the Securities Act.
If this report is an annual or transition report,
indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act
of 1934.
Indicate by check mark whether the registrant
(1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months
(or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements
for the past 90 days.
Indicate by check mark whether the registrant
has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405
of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of “accelerated filer and large accelerated
filer” in Rule 12b-2 of the Exchange Act.
If an emerging growth company that prepares its
financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition
period for complying with any new or revised financial accounting standards† provided pursuant to Section 13(a) of the Exchange
Act. ☐
Indicate by check mark whether the registrant
has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial
reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or
issued its audit report. ☐
Indicate by check mark which basis of accounting
the registrant has used to prepare the financial statements included in this filing:
If “Other” has been checked in response
to the previous question, indicate by check mark which financial statement item the registrant has elected to follow: Item 17 ☐ Item
18 ☐
If this is an annual report, indicate by check
mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
Unless otherwise indicated or the context otherwise
requires in this annual report:
This annual report on Form 20-F
contains forward-looking statements that reflect our current expectations and views of future events. These statements are made under
the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. You can identify these forward-looking
statements by terminology such as “may,” “will,” “expect,” “anticipate,” “aim,”
“estimate,” “intend,” “plan,” “believe,” “is/are likely to,” “potential,”
“continue” or other similar expressions. We have based these forward-looking statements largely on our current expectations
and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business
strategy and financial needs. These forward-looking statements include, but are not limited to:
We would like to caution you
not to place undue reliance on these forward-looking statements and you should read these statements in conjunction with the risk factors
disclosed in “Item 3. Key Information—D. Key Information—Risk Factors.” Those risks are not exhaustive. We operate
in an evolving environment. New risks emerge from time to time and it is impossible for our management to predict all risk factors, nor
can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual
results to differ from those contained in any forward-looking statement. We do not undertake any obligation to update or revise the forward-looking
statements except as required under applicable law. You should read this annual report and the documents that we reference in this annual
report completely and with the understanding that our actual future results may be materially different from what we expect.
PART I
ITEM
1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS
Not applicable.
ITEM
2. OFFER STATISTICS AND EXPECTED TIMETABLE
Not applicable.
ITEM
3. KEY INFORMATION
A.
[Reserved]
B.
Capitalization and indebtedness.
Not applicable.
C.
Reasons for the offer and use of proceeds.
Not applicable.
D.
Risk factors.
An investment in our ordinary
shares involves a high degree of risk. You should carefully consider the risks and uncertainties described below together with all other
information contained in this annual report, including the matters discussed under the headings “Forward-Looking Statements”
and “Operating and Financial Review and Prospects” before you decide to invest in our ordinary shares. We are
a holding company with substantial operations in China and are subject to a legal and regulatory environment that in many respects differs
from the United States. If any of the following risks, or any other risks and uncertainties that are not presently foreseeable to us,
actually occur, our business, financial condition, results of operations, liquidity and our future growth prospects could be materially
and adversely affected.
Summary of Risk Factors
Investing in our company
involves significant risks. You should carefully consider all of the information in this annual report before making an investment in
our company. These risks include but not limited to the following:
Risk factors relating to our business include
but not limited to the following:
| ● | We
face risks related to nature disasters (whether or not caused by climate change), unusually adverse weather conditions, pandemic outbreaks,
in particular, the current coronavirus pandemic, terrorist acts and global political events. See more detailed discussion of this risk
factor on page 5 of
this annual report. |
| ● | Our
failure to compete effectively could adversely affect our market share, revenues and growth prospects. See more detailed discussion
of this risk factor on page 6 of this annual report. |
| ● | Any
disruption in the supply chain of suppliers for and our dietary supplement products and our e-commerce solutions services could adversely
impact our ability to produce products and deliver services. See more detailed discussion of this risk factor on page 7
of this annual report. |
| ● | We
are dependent on certain key personnel and loss of these key personnel could have a material adverse effect on our business, financial
condition and results of operations. See more detailed discussion of this risk factor on page 7 of this annual report. |
| ● | If
we fail to increase our brands’ recognition, we may face difficulty in obtaining new customers. See more detailed discussion of
this risk factor on page 7 of this annual report. |
| ● | If
we are unable to provide superior user experience, we may not be able to maintain or grow our user base or keep our users highly engaged.
See more detailed discussion of this risk factor on
page 7 of this annual report. |
| ● | If
we fail to renew our Food Production License and registration of our nutraceutical and dietary supplements products, we may receive fines
or even sanctions which may prohibit us from production. See more detailed discussion of this risk factor on page 8
of this annual report. |
| ● | Developments in China’s automotive industry will impact our automobile
sales business’s net revenues and future growth, including government regulations and policies. See more detailed discussion of
this risk factor on page 9 of this annual report. |
Risk factors relating to doing business in China
include but not limited to the following:
| |
● |
Although the audit report included in this annual report is prepared by an auditor who are currently inspected by the Public Company Accounting Oversight Board (the “PCAOB”), there is no guarantee that future audit reports will be prepared by auditors inspected by the PCAOB and, as such, in the future investors may be deprived of the benefits of such inspection. Furthermore, trading in our securities may be prohibited under the Holding Foreign Companies Accountable Act (the “HFCA Act”) if the SEC subsequently determines our audit work is performed by auditors that the PCAOB is unable to inspect or investigate completely, and as a result, U.S. national securities exchanges, such as Nasdaq, may determine to delist our securities. Furthermore, on June 22, 2021, the U.S. Senate passed the Accelerating Holding Foreign Companies Accountable Act, which, if enacted, would amend the HFCA Act and require the SEC to prohibit an issuer’s securities from trading on any U.S. stock exchanges if its auditor is not subject to PCAOB inspections for two consecutive years instead of three. See more detailed discussion of this risk factor on page 11 of this annual report. |
| |
|
|
| |
● |
Our business is subject to
certain PRC laws and regulations. There are uncertainties regarding the interpretation and enforcement of PRC laws, rules and
regulations. The uncertainty in the PRC legal system may make it difficult for us to predict the outcome of any disputes that we may
be involved in. See more detailed discussion of this risk factor on page 12 of this annual report. |
| |
● |
In light of recent events indicating greater oversight by the Cyberspace Administration of China, or CAC, over data security, we are subject to a variety of laws and other obligations regarding cybersecurity and data protection, and any failure to comply with applicable laws and obligations could have a material and adverse effect on our business, our listing on Nasdaq, financial condition and results of operations. See more detailed discussion of this risk factor on page 13 of this annual report. |
| |
|
|
| |
● |
The approval of the China Securities Regulatory Commission, or the CSRC, may be required in connection with an offering under PRC rules, regulations, or policies, and, if required, we cannot predict whether or how soon we will be able to obtain such approval. As a result, both you and us fact uncertainty about future actions by the PRC government that could significantly affect our business, our listing on Nasdaq, financial condition and results of operations. See more detailed discussion of this risk factor on page 14 of this annual report. |
| |
|
|
| |
● |
The PRC government has significant authority to intervene or influence the China operations of an offshore holding company, such as ours, at any time. The PRC government may exert more control over offerings conducted overseas and/or foreign investment in China-based issuers. If the PRC government exerts more oversight and control over offerings that are conducted overseas and/or foreign investment in China-based issuers and we were to be subject to such oversight and control, it may result in a material adverse change to our business operations, significantly limit or completely hinder our ability to offer or continue to offer securities to investors, and cause the ordinary shares to significantly decline in value or become worthless. See more detailed discussion of this risk factor on page 15 of this annual report. |
| |
● |
Our subsidiaries, main operations and assets are located in the PRC. Shareholders may not be accorded the same rights and protection that would be accorded under the US law. In addition, it would be difficult to enforce a U.S. judgment against our PRC subsidiaries and our officers and directors. See more detailed discussion of this risk factor on page 12 of this annual report. |
| |
● |
It may be difficult for overseas shareholders and/or regulators to conduct investigation or collect evidence within China. See more detailed discussion of this risk factor on page 16 of this annual report. |
| |
● |
Our results and financial conditions are highly susceptible to changes in the PRC’s political, economic and social conditions as our revenue is currently wholly derived from our operations in the PRC. See more detailed discussion of this risk factor on page 17 of this annual report. |
| |
● |
PRC regulations relating to the establishment of offshore special purpose companies by PRC residents may subject our PRC resident beneficial owners or our PRC subsidiary to liability or penalties, limit our ability to inject capital into our PRC subsidiary, limit our PRC subsidiary’s ability to increase their registered capital or distribute profits to us, or may otherwise adversely affect us. See more detailed discussion of this risk factor on page 16 of this annual report. |
| |
● |
PRC regulation of loans and direct investment by offshore holding companies to PRC entities may delay or prevent us from using the proceeds from the offerings of any securities to make loans or additional capital contributions to our PRC operating subsidiaries. See more detailed discussion of this risk factor on page 19 of this annual report. |
| |
● |
Uncertainty in the interpretation of PRC tax regulations may have a negative impact on our business operations, our acquisition or restructuring strategy or the value of our investment in it. See more detailed discussion of this risk factor on page 18 of this annual report. |
| |
● |
Currency fluctuations and restrictions on currency exchange may adversely affect our business, including limiting our ability to convert RMB into foreign currencies and, if RMB were to decline in value, reducing our revenues and profits in U.S. dollar terms. See more detailed discussion of this risk factor on page 19 of this annual report. |
| |
● |
We are subject to the risks relating to the restrictions on paying dividends or making other payments to us by our subsidiaries in China. See more detailed discussion of this risk factor on page 20 of this annual report. |
Risk factors relating to our Ordinary Shares include
but not limited to the following:
| |
● |
Our Memorandum and
Articles of Association afford less protection to our shareholders and may discourage claims and limit shareholders’ ability
to bring claims. See more detailed discussion of this risk factor on page 21 of this annual report. |
| |
● |
Certain judgments obtained against us by our shareholders may not be enforceable. See more detailed discussion of this risk factor on page 21 of this annual report. |
| |
● |
We are an emerging growth company within the meaning of the Securities Act and may take advantage of certain reduced reporting requirements. See more detailed discussion of this risk factor on page 22 of this annual report. |
| |
● |
We qualify as a foreign private issuer and, as a result, we are not subject to U.S. proxy rules and are subject to Exchange Act reporting obligations that permit less detailed and less frequent reporting than that of a U.S. domestic public company. See more detailed discussion of this risk factor on page 22 of this annual report. |
| |
● |
As a foreign private issuer, we are permitted to adopt certain home country practices in relation to corporate governance matters that differ significantly from Nasdaq corporate governance listing standards. See more detailed discussion of this risk factor on page 23 of this annual report. |
| |
● |
There can be no assurance that we will not be a passive foreign investment company, or PFIC, for U.S. federal income tax purposes for any taxable year, which could result in adverse U.S. federal income tax consequences to U.S. holders of our ordinary shares. See more detailed discussion of this risk factor on page 23 of this annual report. |
| |
● |
We may be exposed to potential risks relating to our internal controls over financial reporting. See more detailed discussion of this risk factor on page 25 of this annual report. |
| |
● |
The relative lack of public company experience of our management team may put us at a competitive disadvantage. See more detailed discussion of this risk factor on page 25 of this annual report. |
| |
● |
Our ordinary shares are very thinly traded, and there can be no assurance that there will be an active market for our ordinary shares in the future. See more detailed discussion of this risk factor on page 25 of this annual report. |
Risks related to Our Business
We face risks related to nature disasters
(whether or not caused by climate change), unusually adverse weather conditions, pandemic outbreaks, in particular, the current coronavirus
pandemic, terrorist acts and global political events, all of which could result in adverse effects to our business and financial performance.
The occurrence of one or more
natural disasters, such as hurricanes, fires, floods and earthquakes (whether or not caused by climate change), unusually adverse weather
conditions, pandemic outbreaks, terrorist acts or disruptive global political events, could adversely affect our operations and financial
performance.
On March 11, 2020, the World
Health Organization declared the outbreak of COVID-19 a global pandemic. Many businesses and social activities in China and other countries
and regions have been disrupted, including those of our business partners, customers and employees. This global outbreak has also caused
volatilities in and damage to the global financial markets. Such disruption and the potential slowdown of the world’s economy in
2020 and beyond could have a material adverse effect on our results of operations and financial condition.
In particular, the Chinese
government took a number of actions in order to contain the spread of COVID-19, including mandatory quarantine requirements, shutdown
of schools, travel restrictions, prohibition of public gatherings, temporary closure of office buildings and facilities and postponed
resumption of business operations. More specifically, the COVID-19 has negatively affected our business and operations in many
ways, including the plump closures of experience stores, diving sales in our distribution channels of dietary supplement products, and
shut down of production facilities for a period of approximately three months in 2020. And due to the continual impact of COVID-19 to
our experience stores, we closed certain stores in 2021. Since early 2022, there has been a recurrence of COVID-19 outbreaks in certain
provinces of China, including Shanghai, Beijing, Jiangsu, Yunnan, Liaoning and Fujian, due to the Delta and Omicron variants. As a result,
similar emergency measures such as lockdown and mass testing policies have been implemented to contain further spread of COVID-19. More
than 80% of the company’s suppliers and customers have experienced lockdowns in different levels. At least 30% of the company’s
revenue was affected due to the constant spread of COVID-19 which increased costs and expenses. COVID-19 prevents people from gathering
and has a great impact on the company’s travel authorized stores. Although the company invested a lot to maintain these specialty
stores, there are still more than 7 stores closed this year. The lockdown also has a certain impact on e-commerce sales, mainly due to
the impact of logistics and express delivery.
Many of the quarantine measures
within China have been relaxed as of the date of this annual report, however, relaxation of restrictions on economic and social activities
may lead to new cases. There have been occasional outbreaks of COVID-19 in various cities in China, and the Chinese government may again
take measures to keep COVID-19 in check. In addition, the longer-term trajectory of COVID-19, both in terms of scope and intensity of
the pandemic in China, together with its impact on the industry and the broader economy are still difficult to assess or predict and face
significant uncertainties that will be difficult to quantify. If there is not a material recovery in the COVID-19 situation, or the situation
further deteriorates in China, our business, results of operations and financial condition could be materially and adversely affected.
While the potential downturn brought by and the duration of the COVID-19 outbreak is difficult to assess or predict and the full impact
of the virus on our operations will depend on many factors beyond our control. Our business, results of operations, financial condition
and prospects could be materially adversely affected to the extent that COVID-19 persists in China or harms the Chinese and global economy
in general.
We may not effectively manage our growth, which could materially
harm our business.
We expect that our business
will continue to grow, which may place a significant strain on our management, personnel, systems and resources. We must continue to improve
our operational and financial systems and managerial controls and procedures, and we will need to continue to expand, train and manage
our technology and workforce. We must also maintain close coordination among our compliance, accounting, finance, marketing and sales
organizations. We cannot assure you that we will manage our growth effectively. If we fail to do so, our business could be materially
harmed.
Our continued growth will
require an increased investment by us in technology, facilities, personnel and financial and management systems and controls. It also
will require expansion of our procedures for monitoring and assuring our compliance with applicable regulations, and we will need to integrate,
train and manage a growing employee base. The expansion of our existing businesses, any expansion into new businesses and the resulting
growth of our employee base will increase our need for internal audit and monitoring processes that are more extensive and broader in
scope than those we have historically required. Further, unless our growth results in an increase in our revenues that is proportionate
to the increase in our costs associated with this growth, our operating margins and profitability will be adversely affected.
We operate in a highly competitive industry.
Our failure to compete effectively could adversely affect our market share, revenues and growth prospects.
The P.R.C. dietary supplement
industry is large. Participants include specialty retailers, supermarkets, drugstores, mass merchants, on-line merchants, mail-order companies
and a variety of other smaller participants. We believe that the market is also highly sensitive to the introduction of new products,
which may rapidly capture a significant share of the market. We also compete for sales with heavily advertised national brands manufactured
by large food companies, as well as other retailers. In addition, as some products become more mainstream, we experience increased price
competition for those products as more participants enter the market. Our manufacturing operations compete with other manufacturers of
third-party dietary supplements. We may not be able to compete effectively and our attempt to do so may require us to reduce our prices,
which may result in lower margins. Failure to effectively compete could adversely affect our market share, revenues and growth prospects.
An increase in the price and shortage of supply of key raw materials
of our dietary supplement products could adversely affect our business.
Our dietary supplement products
are composed of certain key raw materials. If the prices of these raw materials were to increase significantly, it could result in a significant
increase in our production. Raw material prices may increase in the future and we may not be able to pass on such increases to our customers.
A significant increase in the price of raw materials that cannot be passed on to customers could have a material adverse effect on our
results of operations and financial condition. In addition, if we no longer are able to obtain products from one or more of our suppliers
on terms reasonable to us or at all, our revenues could suffer. Events such as the threat of political or social unrest, or the perceived
threat thereof, may also have a significant impact on raw material prices and transportation costs for our products. In addition, the
interruption in supply of certain key raw materials essential to the manufacturing of our products may have an adverse impact on our suppliers’
ability to provide us with the necessary products needed to maintain our customer relationships and an adequate level of sales.
Any disruption in the supply chain of suppliers
for and our dietary supplement products and our e-commerce solutions services could adversely impact our ability to produce products and
deliver services.
As to the dietary supplement
products we manufacture and the services we provided, we must manage our supply chain for raw materials and delivery of dietary supplement
our products. Our top five suppliers provided approximately 61.85% of the sourcing of the supplies for our business for the
year ended March 31, 2022.
A significant disruption to our distribution
network or to the timely receipt of inventory could adversely impact sales or increase our transportation costs, which would decrease
our profits.
We rely on our ability to
replenish depleted inventory in our stores through deliveries to our distribution centers from vendors and then from the distribution
centers or direct ship vendors to our stores by various means of transportation, including shipments by sea and truck. Unexpected delays
in those deliveries or increases in transportation costs (including through increased fuel costs) could significantly decrease our ability
to make sales and earn profits.
We are dependent on certain key personnel
and loss of these key personnel could have a material adverse effect on our business, financial condition and results of operations.
Our success is, to a certain
extent, attributable to the management, sales and marketing, and research and development expertise of key personnel. We are dependent
upon the services of experienced personal and technicians, there can be no assurance that we will be able to recruit and retain qualified
management team and skillful labor, due to labor market competition. The loss of these officers could have a material adverse
effect upon our business, financial condition, and results of operations.
We may not be able to hire and retain qualified
personnel to support our growth and if we are unable to retain or hire these personnel in the future, our ability to improve our products
and implement our business objectives could be adversely affected.
We must attract, recruit and
retain a sizeable workforce of technically competent employees. Competition for senior management and personnel in the PRC is intense
and the pool of qualified candidates in the PRC is very limited. We may not be able to retain the services of our senior executives or
personnel, or attract and retain high-quality senior executives or personnel in the future. This failure could materially and adversely
affect our future growth and financial condition.
If we fail to increase our brands’ recognition, we may
face difficulty in obtaining new customers.
Although our brand of “Happiness”
is well-recognized in the dietary supplement industry, we still believe that maintaining and enhancing our brand recognition in a cost-effective
manner outside of that market is critical to achieving widespread acceptance of our current and future products and services and is an
important element in our effort to increase our customer base. We are also working to promote our brands of “Happy Buy” and
“Taochejun” in the e-commerce solutions and automobile sales industries, respectively. Successful promotion of our brand will
depend largely on our ability to maintain a sizeable and active customer base, our marketing efforts and ability to provide reliable and
useful products and services at competitive prices. Brand promotion activities may not yield increased revenue, and even if they do, any
increased revenue may not offset the expenses we will incur in building our brand. If we fail to successfully promote and maintain our
brands, or if we incur substantial expenses in an unsuccessful attempt to promote and maintain our brand, we may fail to attract enough
new customers or retain our existing customers to the extent necessary to realize a sufficient return on our brand-building efforts, in
which case our business, operating results and financial condition, would be materially adversely affected.
If
we are unable to provide superior user experience, we may not be able to maintain or grow our customer base or keep our customers highly
engaged. As a result, our revenues, profitability and business prospects may be materially and adversely affected.
The
success of our business largely depends on our ability to provide superior user experience in order to maintain and grow our user base
and keep our customers highly engaged on our online platform, which in turn depends on a variety of factors. These factors include our
ability to continue to offer attractive and relevant content in engaging formats, source quality merchants to respond to user demands
and preferences, maintain the quality of our products and services, provide reliable and user-friendly features for our users to browse
for content and products, and provide high-quality customer service. If our users are not satisfied with our content, products or services,
or our platform is severely interrupted or otherwise fail to meet our users’ requests, our reputation and user loyalty could be
adversely affected.
In
addition, if users cannot obtain satisfactory customer services after they purchase products with us, our brand and user loyalty may be
adversely affected. Any negative publicity or poor feedback regarding our customer service may harm our brand and reputation and in turn
cause us to lose users and market share.
As
a result, if we are unable to continue to maintain our user experience and provide high-quality customer service, we may not be able to
retain or attract users or keep them highly engaged with the content and products we offer on our platform, which may have a material
adverse effect on our business, financial condition and results of operations.
If our dietary supplement products do not
have the effects intended or cause undesirable side effects, our business may suffer.
Although many of the ingredients
in our current dietary supplement products are vitamins, minerals, and other substances for which there is a long history of human consumption,
they also contain innovative ingredients or combinations of ingredients. While we believe that all of these products and the combinations
of ingredients in them are safe when taken as directed, the products could have certain undesirable side effects if not taken as directed
or if taken by a consumer who has certain medical conditions. In addition, these products may not have the effect intended if they are
not taken in accordance with certain instructions, which include certain dietary restrictions. Furthermore, there can be no assurance
that any of the products, even when used as directed, will have the effects intended or will not have harmful side effects in an unforeseen
way or on an unforeseen cohort. If any of our products or products we develop or commercialize in the future are shown to be harmful or
generate negative publicity from perceived harmful effects, our business, financial condition, results of operations, and prospects could
be harmed significantly.
Our dietary supplement business is subject
to inherent risks relating to product liability and personal injury claims.
As a manufacturer of dietary
supplement products designed for human consumption, we are subject to product liability claims if the use of our products is alleged to
have resulted in injury. Our products consist of minerals, herbs and other ingredients that are classified as foods or dietary supplements
and are not subject to pre-market regulatory approval in the United States. Our products could contain contaminated substances, and some
of our products contain ingredients that do not have long histories of human consumption. Previously unknown adverse reactions resulting
from human consumption of these ingredients could occur. We may also be obligated to recall affected products. If we are found liable
for product liability claims, we could be required to pay substantial monetary damages. Furthermore, even if we successfully defend ourselves
against this type of claim, we could be required to spend significant management, financial and other resources, which could disrupt our
business, and our reputation as well as our brand name may also suffer. We, like many other similar companies in China, do not carry product
liability insurance. As a result, any imposition of product liability could materially harm our business, financial condition and results
of operations. In addition, we do not have any business interruption insurance due to the limited coverage of any available business interruption
insurance in China, and as a result, any business disruption or natural disaster could severely disrupt our business and operations and
significantly decrease our revenue and profitability.
If we fail to renew our Food Production
License and registration of our nutraceutical and dietary supplements products, we may receive fines or even sanctions which may prohibit
us from production.
The Food Safety Law of PRC,
which was amended on April 24, 2015 and became effective on October 1 2015, requires the producers and business operators of dietary supplements
to obtain licensing and to carry out production and operation in accordance with food safety standards. On February 26, 2016, the State
Food and Drug Administration (the “CFDA”) promulgated the Administrative Measures for the Registration and Record-filing of
Dietary Supplements which became effective on July 1, 2016. In accordance with the Administrative Measures for the Registration and Record-filing
of Dietary Supplements, dietary supplements that use raw materials other than those included in the catalogue of raw materials for dietary
supplements shall be registered with CFDA. Furthermore, dietary supplements whose raw materials used have been included in the catalogue
of raw materials for dietary supplements shall be subject to record-filing. Under the laws and regulations on nutraceutical and dietary
supplements, we have obtained Food Production License in December 2017 from Nanping Food and Drug Administration and the registration
or record-filing of each nutraceutical and dietary supplements product that we produced. We have been closely monitoring the status of
all the permits and applied for renewal before the relevant certificate expired. The failure to renew the relevant licenses and/or registrations
may subject us to fines or sanctions which will have negative impact on our production.
The fluctuation and seasonality of tourism
in China could adversely affect the sales of our experience stores for our dietary supplement products.
We
launched the experience store model to stimulate our sales in 2017. As of March 31, 2022, we had 10 experience stores in Xiamen,
Mount Wuyi, Quzhou, Chaozhou, Guilin and other tourism sites in China, respectively.
Experience stores are all located in famous scenery areas in China. Such stores are targeted to tourists, and will be the
focus of our growth in the future. The sales of our experience stores could be affected by the fluctuation and seasonality of
tourism in China. The strict quarantine rule and travel restrictions enforced by PRC government and local governments enforced in
2020 due to the outbreak of COVID-19 have negatively affected the volume of tourists in the cities where our experience stores are
located. Although of the quarantine measures within China have been relaxed as of the date of this annual report, there has been
occasional outbreaks of COVID-19 in various cities in China, and the Chinese government may again take measures to keep COVID-19 in
check, which places uncertainty on our sales of our experience stores.
Our
customers of automobile sale business and e-commerce business use third-party payment service providers to make payments on our platforms.
If these payment services are restricted or curtailed in any way or become unavailable to us or our users for any reason, our business
may be materially and adversely affected.
Our
customers of automobile sale business and e-commerce business make payments through a variety of methods, including payment through our
third-party online payment service partners, such as Weixin Pay, Paypal and Alipay. We may also be subject to fraud, user data leakage
and other illegal activities in connection with the various payment methods we offer. In addition, our business depends on the billing,
payment and escrow systems of the third-party payment service providers to maintain accurate records of payments of sales proceeds by
users and collect such payments. If the quality, utility, convenience or attractiveness of these payment processing and escrow services
declines, or if we have to change the pattern of using these payment services for any reason, the attractiveness of our platform could
be materially and adversely affected.
Business
involving online payment services is subject to a number of risks that could materially and adversely affect third-party online payment
service providers’ ability to provide payment processing and escrow services to us, including:
| ● | dissatisfaction
with these online payment services or decreased use of their services by users and merchants; |
| ● | increasing
competition, including from other established Chinese internet companies, payment service providers and companies engaged in other financial
technology services; |
| ● | changes
to rules or practices applicable to payment systems that link to third-party online payment service providers; |
| ● | breach
of users’ personal information and concerns over the use and security of information collected from buyers; |
| ● | service
outages, system failures or failures to effectively scale the system to handle large and growing transaction volumes; |
| ● | increasing
costs to third-party online payment service providers, including fees charged by banks to process transactions through online payment
channels, which would also increase our costs of revenues; and |
| ● | failure
to manage funds accurately or loss of funds, whether due to employee fraud, security breaches, technical errors or otherwise. |
Certain
commercial banks in China impose limits on the amounts that may be transferred by automated payment from users’ bank accounts to
their linked accounts with third-party online payment services. We cannot predict whether these and any additional restrictions that could
be put in place would have a material adverse effect on our platform. We may also be subject to various rules, regulations and requirements,
regulatory or otherwise, governing electronic fund transfers and online payment, which could change or be reinterpreted to make it difficult
or impossible for us to comply with.
In
addition, we cannot assure you that we will be successful to enter into and maintain amicable relationships with online payment service
providers. Identifying, negotiating and maintaining relationships with these providers require significant time and resources. They could
choose to terminate their relationships with us or propose terms that we cannot accept. In addition, these service providers may not perform
as expected under our agreements with them, and we may have disagreements or disputes with such payment service providers, any of which
could adversely affect our brand and reputation as well as our business operations.
Developments in China’s automotive
industry will impact our automobile sales business’s net revenues and future growth, the prospects of which are subject to many
uncertainties, including PRC government regulations and policies.
Developments in China’s
automotive industry will impact our automobile sales business’s net revenues and future growth. The prospects of China’s automotive
industry are subject to many uncertainties, including those relating to general economic conditions in China, the urbanization rate of
China’s population and the cost of automobiles. In addition, government policies may have a considerable impact on the growth of
the automotive industry in China. For example, in an effort to alleviate traffic congestion and improve air quality, a number of cities,
including Beijing, Shanghai, Guangzhou, Tianjin, Harbin, and Hangzhou, have issued regulations to limit the number of new passenger car
plates issued each year starting from 2010. In 2018, Beijing local government extended for another year existing restrictions on private
vehicle use, which greatly reduced the number of automobiles on the road. On the bright side, both central and local governments in China
have adopted a series of favorable policies targeted at new energy vehicle manufacturers. For example, on January 29, 2019, the PRC Development
and Reformation Commission released a national development plan that launched a new energy public transportation vehicle subsidy plan
and reinforced the existing battery infrastructure development. Such regulatory developments, as well as other uncertainties, may affect
the growth prospects of China’s automotive industry, and in turn reduce consumer demand for automobiles. If automakers, auto dealers
or automotive service providers reduce their marketing expenditures as a result, our business, financial condition and results of operations
could be materially and adversely affected.
Our automobile sales business is subject
to risks related to the overall automotive industry ecosystem, including consumer demand, consumption habits, global supply chain challenges
and other macroeconomic issues.
Decreasing consumer demand
could adversely affect the market for automobile purchases and, as a result, adversely affect our automobile sales business. Consumer
purchases of new and used automobiles generally decline during recessionary periods and other periods in which disposable income is adversely
affected. Purchases of new and used automobiles are typically discretionary for consumers and have been, and may continue to be, affected
by negative trends in the economy, including the rising cost of energy and gasoline, the limited availability and increasing cost of credit,
reductions in business and consumer confidence, stock market volatility, and increased unemployment. Further, in recent years the automotive
market has experienced rapid changes in technology and consumer demands. Self-driving technology, ride sharing, transportation networks,
and other fundamental changes in transportation could impact consumer demand for the purchase of automobiles. A reduction in the number
of automobiles purchased by consumers could adversely affect automakers and auto dealers and lead to a reduction in their spending on
our services. In addition, our automobile sales business may be negatively affected by challenges to the overall automotive industry ecosystem,
including global supply chain challenges and other macroeconomic issues such as the recent trade tension between China and the United
States. The occurrence of any of the foregoing could materially and adversely affect our business, results of operations, and financial
condition.
In addition, our automobile
sales business is focused on third and fourth tier cities in China mainly due to the increasing consumer demand of neighborhood electric
vehicles, or “NEVs”, lower initial investment costs, more affordable lease and less marketing costs. If there is a negative
trend in the economy, consumer demand in third and fourth tier cities would decrease and thereby adversely affect our operations and financial
conditions.
Our success depends on our ability to protect
our intellectual property. However, we may not be able to adequately protect our intellectual property rights, and any failure to protect
our intellectual property rights could adversely affect our revenues and competitive position.
Our success depends on our
ability to obtain and maintain patent protection for products developed utilizing our technologies, in the PRC and in other countries,
and to enforce these patents. There is no assurance that any of our existing and future patents will be held valid and enforceable against
third-party infringement or that our products will not infringe any third-party patent or intellectual property. Although we have filed
additional patent applications with the Patent Administration Department of the PRC, there is no assurance that they will be granted.
We have invested significant
resources to develop our own intellectual property and acquire licenses to use and distribute the intellectual property of others. A failure
to maintain or protect these rights could harm our business. In addition, any unauthorized use of our intellectual property by third parties
may adversely affect our current and future revenues and our reputation.
The validity, enforceability and scope of protection
available under intellectual property laws in the PRC are uncertain and still evolving. Implementation and enforcement of PRC intellectual
property-related laws have historically been deficient and ineffective. Accordingly, protection of intellectual property rights in the
PRC may not be as effective as in the United States or other western countries. Furthermore, policing unauthorized use of proprietary
technology is difficult and expensive, and we may need to resort to litigation to enforce or defend patents issued to us or our other
intellectual property or to determine the enforceability, scope and validity of our proprietary rights or those of others. Such litigation
and an adverse determination in any such litigation, if any, could result in substantial costs and diversion of resources and management
attention.
Risks Related to Doing Business in China
Although the audit report included in this annual report is prepared
by an auditor who are currently inspected by the Public Company Accounting Oversight Board (the “PCAOB”), there is no guarantee
that future audit reports will be prepared by auditors inspected by the PCAOB and, as such, in the future investors may be deprived of
the benefits of such inspection. Furthermore, trading in our securities may be prohibited under the Holding Foreign Companies Accountable
Act (the “HFCA Act”) if the SEC subsequently determines our audit work is performed by auditors that the PCAOB is unable to
inspect or investigate completely, and as a result, U.S. national securities exchanges, such as Nasdaq, may determine to delist our securities.
Furthermore, on June 22, 2021, the U.S. Senate passed the Accelerating Holding Foreign Companies Accountable Act, which, if enacted, would
amend the HFCA Act and require the SEC to prohibit an issuer’s securities from trading on any U.S. stock exchanges if its auditor
is not subject to PCAOB inspections for two consecutive years instead of three.
As an auditor of companies that are registered with the SEC and publicly
traded in the United States and a firm registered with the PCAOB, our auditor is required under the laws of the United States to undergo
regular inspections by the PCAOB to assess their compliance with the laws of the United States and professional standards.
Although we operate substantially in mainland China, a jurisdiction
where the PCAOB is currently unable to conduct inspections without the approval of the Chinese government authorities, our auditor, TPS
Thayer LLC, the independent registered public accounting firm that issues the audit report included elsewhere in this annual report, is
subject to laws in the United States pursuant to which the PCAOB conducts regular inspections to assess our auditor’s compliance
with the applicable professional standards. Inspections of other auditors conducted by the PCAOB outside mainland China have at times
identified deficiencies in those auditors’ audit procedures and quality control procedures, which may be addressed as part of the
inspection process to improve future audit quality. The lack of PCAOB inspections of audit work undertaken in mainland China prevents
the PCAOB from regularly evaluating auditors’ audits and their quality control procedures. As a result, if there is any component
of our auditor’s work papers become located in mainland China in the future, such work papers will not be subject to inspection
by the PCAOB. As a result, investors would be deprived of such PCAOB inspections, which could result in limitations or restrictions to
our access of the U.S. capital markets.
As part of a continued regulatory focus in the United States on access
to audit and other information currently protected by national law, in particular mainland China’s, in June 2019, a bipartisan group
of lawmakers introduced bills in both houses of the U.S. Congress which, if passed, would require the SEC to maintain a list of issuers
for which PCAOB is not able to inspect or investigate the audit work performed by a foreign public accounting firm completely. The proposed
Ensuring Quality Information and Transparency for Abroad-Based Listings on our Exchanges (“EQUITABLE”) Act prescribes increased
disclosure requirements for these issuers and, beginning in 2025, the delisting from U.S. national securities exchanges such as Nasdaq
of issuers included on the SEC’s list for three consecutive years. It is unclear if this proposed legislation will be enacted. Furthermore,
there have been recent deliberations within the U.S. government regarding potentially limiting or restricting China-based companies from
accessing U.S. capital markets. On May 20, 2020, the U.S. Senate passed the Holding Foreign Companies Accountable Act (the “HFCA
Act”), which includes requirements for the SEC to identify issuers whose audit work is performed by auditors that the PCAOB is unable
to inspect or investigate completely because of a restriction imposed by a non-U.S. authority in the auditor’s local jurisdiction.
The U.S. House of Representatives passed the HFCA Act on December 2, 2020, and the HFCA Act was signed into law on December 18, 2020.
Additionally, in July 2020, the U.S. President’s Working Group on Financial Markets issued recommendations for actions that can
be taken by the executive branch, the SEC, the PCAOB or other federal agencies and department with respect to Chinese companies listed
on U.S. stock exchanges and their audit firms, in an effort to protect investors in the United States. In response, on November 23, 2020,
the SEC issued guidance highlighting certain risks (and their implications to U.S. investors) associated with investments in China-based
issuers and summarizing enhanced disclosures the SEC recommends China-based issuers make regarding such risks. On March 24, 2021, the
SEC adopted interim final rules relating to the implementation of certain disclosure and documentation requirements of the HFCA Act. We
will be required to comply with these rules if the SEC identifies us as having a “non-inspection” year (as defined in the
interim final rules) under a process to be subsequently established by the SEC. The SEC is assessing how to implement other requirements
of the HFCA Act, including the listing and trading prohibition requirements described above. Under the HFCA Act, our securities may be
prohibited from trading on Nasdaq or other U.S. stock exchanges if our auditor is not inspected by the PCAOB for three consecutive years,
and this ultimately could result in our Ordinary Shares being delisted. Furthermore, on June 22, 2021, the U.S. Senate passed the Accelerating
Holding Foreign Companies Accountable Act (“HFCAA”), which, if enacted, would amend the HFCA Act and require the SEC to prohibit
an issuer’s securities from trading on any U.S. stock exchanges if its auditor is not subject to PCAOB inspections for two consecutive
years instead of three. On September 22, 2021, the PCAOB adopted a final rule implementing the HFCAA, which provides a framework for the
PCAOB to use when determining, as contemplated under the HFCAA, whether the Board is unable to inspect or investigate completely registered
public accounting firms located in a foreign jurisdiction because of a position taken by one or more authorities in that jurisdiction.
On November 5, 2021, the SEC approved the PCAOB’s Rule 6100, Board Determinations Under the Holding Foreign Companies Accountable
Act. On December 2, 2021, the SEC issued amendments to finalize rules implementing the submission and disclosure requirements in the HFCA
Act. The rules apply to registrants that the SEC identifies as having filed an annual report with an audit report issued by a registered
public accounting firm that is located in a foreign jurisdiction and that PCAOB is unable to inspect or investigate completely because
of a position taken by an authority in foreign jurisdictions. On December 16, 2021, SEC announced that the PCAOB designated China and
Hong Kong as the jurisdictions where the PCAOB is not allowed to conduct full and complete audit inspections as mandated under the HFCA
Act.
While we understand that there has been dialogue among the CSRC, the
SEC and the PCAOB regarding the inspection of PCAOB-registered accounting firms in China, there can be no assurance that we will be able
to comply with requirements imposed by U.S. regulators. Delisting of our Ordinary Shares would force holders of our Ordinary Shares to
sell their shares. The market price of our Ordinary Shares could be adversely affected as a result of anticipated negative impacts of
these executive or legislative actions upon, as well as negative investor sentiment towards, companies with significant operations in
China that are listed in the United States, regardless of whether these executive or legislative actions are implemented and regardless
of our actual operating performance.
Our independent registered public accounting firm issued an audit opinion
on the financial statements incorporated by reference in this annual report filed with the SEC. As an auditor of companies that are traded
publicly in the United States and a firm registered with the PCAOB, our auditor is required by the laws of the United States to undergo
regular inspections by the PCAOB. Our auditor is located in Sugar Land, Texas, not mainland China or Hong Kong. Furthermore, our auditor
is not among the auditor firms listed on an HFCAA Determination List, which includes all of the auditor firms that the PCAOB is not able
to inspect. Recent developments with respect to audits of companies of which the major operations are in China, such as us, create uncertainty
about the ability of our auditor to fully cooperate with the PCAOB’s request for audit work papers without the approval of the Chinese
authorities. As a result, our investors may be deprived of the benefits of PCAOB’s oversight of our auditors through such inspections.
Should the PCAOB be unable to fully conduct inspections of our auditors’
work papers due to a position taken by one or more authorities in the foreign jurisdiction, it will make it more difficult to evaluate
the effectiveness of our auditor’s audit procedures or quality control procedures. Investors may consequently lose confidence in
our reported financial information and procedures and the quality of our financial statements, which would adversely affect the market
price of our Ordinary Shares.
Our subsidiaries, main operations and assets
are located in the PRC. Shareholders may not be accorded the same rights and protection that would be accorded under the US law. In addition,
it would be difficult to enforce a U.S. judgment against our PRC subsidiaries and our officers and directors.
We are a holding company and
all of our operations and assets are held in overseas subsidiaries. Our PRC subsidiaries, Fujian Happiness, Happiness Nanping, and Shunchang
Happiness were established in the PRC, and their main operations and assets are located in the PRC. Our PRC subsidiaries, main operations
and assets are therefore subject to the relevant laws and regulations of the PRC. In addition, a majority of our officers and directors
are non-residents of the United States and substantially all their assets are located outside the United States. As a result, it could
be more difficult for investors to effect service of process in the United States, or to enforce a judgment obtained in the United States
against any of our PRC subsidiaries or any of these persons.
Our business is subject to certain PRC laws
and regulations. There are uncertainties regarding the interpretation and enforcement of PRC laws, rules and regulations. The uncertainty
in the PRC legal system may make it difficult for us to predict the outcome of any disputes that we may be involved in.
The PRC legal system is based
on the PRC Constitution and is made up of written laws, regulations, circulars and directives. The PRC government is still in the process
of developing its legal system, so as to meet the needs of investors and to encourage foreign investment. As the PRC economy is generally
developing at a relative faster pace than its legal system, some degree of uncertainty exists in connection with whether and how existing
laws and regulations will apply to certain events or circumstances.
Some of the laws and regulations,
and the interpretation, implementation and enforcement thereof, are still subject to policy changes. There is no assurance that the introduction
of new laws, changes to existing laws and the interpretation or application thereof or the delays in obtaining approvals from the relevant
authorities will not have an adverse impact on our PRC subsidiaries’ business, financial performance and prospects.
Further, precedents on the
interpretation, implementation and enforcement of the PRC laws and regulations are limited, and unlike other common law countries such
as the United States, decisions on precedent cases are not binding on lower courts. As such, the outcome of dispute resolutions may not
be consistent or predictable as in the other more developed jurisdictions and it may be difficult to obtain swift or equitable enforcement
of the laws in the PRC, or obtain enforcement of judgment by a court of another jurisdiction.
In addition, the PRC government
has recently announced its plans to enhance its regulatory oversight of Chinese companies listing overseas. The “Opinions on Intensifying
Crack Down on Illegal Securities Activities” issued on July 6, 2021 called for:
| ● | tightening
oversight of data security, cross-border data flow and administration of classified information, as well as amendments to relevant regulation
to specify responsibilities of overseas listed Chinese companies with respect to data security and information security; |
| ● | enhanced
oversight of overseas listed companies as well as overseas equity fundraising and listing by Chinese companies; and |
| ● | extraterritorial
application of China’s securities laws. |
As the Opinions on Intensifying
Crack Down on Illegal Securities Activities were recently issued, there are great uncertainties with respect to the interpretation and
implementation thereof. The Chinese government may promulgate relevant laws, rules and regulations that may impose additional and significant
obligations and liabilities on overseas listed Chinese companies regarding data security, cross-border data flow, and compliance with
China’s securities laws. It is uncertain whether or how these new laws, rules and regulations and the interpretation and implementation
thereof may affect us, but among other things, our ability and the ability of our subsidiaries to obtain external financing through the
issuance of equity securities overseas could be negatively affected.
In light of recent events indicating greater
oversight by the Cyberspace Administration of China, or CAC, over data security, we are subject to a variety of laws and other obligations
regarding cybersecurity and data protection, and any failure to comply with applicable laws and obligations could have a material and
adverse effect on our business, our listing on Nasdaq, financial condition and results of operations.
We are subject to PRC laws
relating to the collection, use, sharing, retention, security, and transfer of confidential and private information, such as personal
information and other data. Our compliance obligations include those relating to the Data Protection Act (As revised) of the Cayman Islands
and the relevant PRC laws in this regard. These PRC laws apply not only to third-party transactions, but also to transfers of information
between us and our subsidiaries, and among us, our subsidiaries, and other parties with which we have commercial relations. These laws
continue to develop, and the PRC government may adopt other rules and restrictions in the future. Non-compliance could result in penalties
or other significant legal liabilities.
Pursuant to the PRC Cybersecurity
Law, which was promulgated by the Standing Committee of the National People’s Congress on November 7, 2016 and took effect on June
1, 2017, personal information and important data collected and generated by a critical information infrastructure operator in the course
of its operations in China must be stored in China, and if a critical information infrastructure operator purchases internet products
and services that affects or may affect national security, it should be subject to cybersecurity review by the CAC. Due to the lack of
further interpretations, the exact scope of “critical information infrastructure operator” remains unclear. On December 28,
2021, the CAC and other relevant PRC governmental authorities jointly promulgated the Cybersecurity Review Measures (the “new Cybersecurity
Review Measures”) to replace the original Cybersecurity Review Measures. The new Cybersecurity Review Measures took effect on February
15, 2022. Pursuant to the new Cybersecurity Review Measures, if critical information infrastructure operators purchase network products
and services, or network platform operators conduct data processing activities that affect or may affect national security, they will
be subject to cybersecurity review. A network platform operator holding more than one million users/users’ individual information
also shall be subject to cybersecurity review before listing abroad. The cybersecurity review will evaluate, among others, the risk of
critical information infrastructure, core data, important data, or a large amount of personal information being influenced, controlled
or maliciously used by foreign governments and network information security risk in connection with the overseas listing. As of today, we have not received any inquiry, notice, warning, or
sanctions regarding our corporate structure from the CSRC, CAC or any other PRC governmental agency. As of today,
we have not received any inquiry, notice, warning, or sanctions regarding our corporate structure from the CSRC, CAC or any other PRC
governmental agency. As advised by our PRC counsel, Allbright Law Offices, we are unlikely to be subject to cybersecurity review, because:
(i) we have not received any notice from governmental agency to treat us as an operator of critical information infrastructure, and (ii)
we have not received any notice from governmental agency to treat us as an online platform operator who possesses personal information
of more than one million users. In addition, we currently do not have over one million users’ personal information and do not anticipate
to collect over one million users’ personal information in the foreseeable future. If we ever became subject to the cybersecurity
review of CAC in the future as the applicable rules, regulations, policies or the interpretation thereof change, during such review, we
may be required to suspend our operation or experience other disruptions to our operations. Cybersecurity review could also result in
negative publicity with respect to our company and diversion of our managerial and financial resources.
Furthermore, if we were found
to be in violation of applicable laws and regulations in China during such review, we could be subject to administrative penalties, such
as warnings, fines, or service suspension. Therefore, cybersecurity review could materially and adversely affect our business, financial
condition, and results of operations.
In addition, the PRC Data
Security Law, which was promulgated by the Standing Committee of the National People’s Congress on June 10, 2021 and took effect
on September 1, 2021, requires data collection to be conducted in a legitimate and proper manner, and stipulates that, for the purpose
of data protection, data processing activities must be conducted based on data classification and hierarchical protection system for data
security. As the Data Security Law was recently promulgated, we may be required to make further adjustments to our business practices
to comply with this law. If our data processing activities were found to be not in compliance with this law, we could be ordered to make
corrections, and under certain serious circumstances, such as severe data divulgence, we could be subject to penalties, including the
revocation of our business licenses or other permits. Furthermore, the recently issued Opinions on Strictly Cracking Down Illegal Securities
Activities in Accordance with the Law require (i) speeding up the revision of the provisions on strengthening the confidentiality and
archives management relating to overseas issuance and listing of securities and (ii) improving the laws and regulations relating to data
security, cross-border data flow, and management of confidential information. As there remain uncertainties regarding the further interpretation
and implementation of those laws and regulations, we cannot assure you that we will be compliant such new regulations in all respects,
and we may be ordered to rectify and terminate any actions that are deemed illegal by the regulatory authorities and become subject to
fines and other sanctions. As a result, we may be required to suspend our relevant e-commerce businesses, including our internet information
and advertising services, and automobile sale business, shut down our website and online platform, take down our operating application,
or face other penalties, which may materially and adversely affect our business, financial condition, and results of operations.
On August 20, 2021, the Standing
Committee of the National People’s Congress of China promulgated the Personal Information Protection Law of the PRC, or the PIPL,
which took effect in November 2021. As the first systematic and comprehensive law specifically for the protection of personal information
in the PRC, the PIPL provides, among others, that (i) an individual’s consent shall be obtained to use sensitive personal information,
such as biometric characteristics and individual location tracking, (ii) personal information operators using sensitive personal information
shall notify individuals of the necessity of such use and impact on the individual’s rights, and (iii) where personal information
operators reject an individual’s request to exercise his or her rights, the individual may file a lawsuit with a People’s
Court. As uncertainties remain regarding the interpretation and implementation of the PIPL, we cannot assure you that we will comply with
the PIPL in all respects, we may become subject to fines and/or other penalties which may have material adverse effect on our business,
operations and financial condition.
While we take measures to
comply with all applicable data privacy and protection laws and regulations, we cannot guarantee the effectiveness of the measures undertaken
by us and our business partners. However, compliance with any additional laws could be expensive, and may place restrictions on our business
operations and the manner in which we interact with our users. In addition, any failure to comply with applicable cybersecurity, privacy,
and data protection laws and regulations could result in proceedings against us by government authorities or others, including notification
for rectification, confiscation of illegal earnings, fines, or other penalties and legal liabilities against us, which could materially
and adversely affect our business, financial condition, and results of operations, and the value of our ordinary shares. In addition,
any negative publicity on our website or platform’s safety or privacy protection mechanism and policy could harm our public image
and reputation and materially and adversely affect our business, financial condition, and results of operations.
The approval of the China Securities Regulatory
Commission, or the CSRC, may be required in connection with an offering under PRC rules, regulations, or policies, and, if required, we
cannot predict whether or how soon we will be able to obtain such approval. As a result, both you and us fact uncertainty about future
actions by the PRC government that could significantly affect our business, our listing on Nasdaq, financial condition and results of
operations.
On August 8, 2006, six PRC
regulatory agencies, including the MOFCOM, the State-Owned Assets Supervision and Administration Commission, or the SASAC, the SAT, the
State Administration for Industry and Commerce, or the SAIC, the CSRC, and the State Administration of Foreign Exchange, or the SAFE,
jointly adopted the Regulations on Mergers and Acquisitions of Domestic Enterprises by Foreign Investors, or the M&A Rules, which
came into effect on September 8, 2006 and were amended on June 22, 2009. The M&A Rules include, among other things, provisions that
purport to require that an offshore special purpose vehicle that is controlled by PRC domestic companies or individuals and that has been
formed for the purpose of an overseas listing of securities through acquisitions of PRC domestic companies or assets to obtain the approval
of the CSRC prior to the listing and trading of such special purpose vehicle’s securities on an overseas stock exchange. On September
21, 2006, the CSRC published on its official website procedures regarding its approval of overseas listings by special purpose vehicles.
However, substantial uncertainty remains regarding the scope and applicability of the M&A Rules to offshore special purpose vehicles.
While
the application of the M&A Rules remains unclear, we believe, based on the advice of our PRC legal counsel ,
that the CSRC approval is not required for the listing and trading our ordinary shares on the Nasdaq Capital Market because Happiness
Nanping, or our WFOE was incorporated as a foreign-invested enterprise by means of foreign direct investments rather than by merger with
or acquisition of any PRC domestic companies as defined under the M&A Rules. There can be no assurance that the relevant PRC government
agencies, including the CSRC, would reach the same conclusion as our PRC legal counsel. If the CSRC or other PRC regulatory body subsequently
determines that we need to obtain the CSRC’s approval for our offering or if the CSRC or any other PRC government authorities promulgates
any interpretation or implements rules that would require us to obtain CSRC or other governmental approvals for our offering, we may face
adverse actions or sanctions by the CSRC or other PRC regulatory agencies. In any such event, these regulatory agencies may impose fines
and penalties on our operations in China, limit our operating privileges in China, delay or restrict the repatriation of the proceeds
from our offerings into the PRC, restrictions on or prohibition of the payments or remittance of dividends by our subsidiaries in China,
or other actions that could have a material and adverse effect on our business, reputation, financial condition, results of operations,
prospects, as well as the trading price of the Ordinary Shares. The CSRC or other PRC regulatory agencies may also take actions requiring
us, or making it advisable for us, to halt our offering before settlement and delivery of the Ordinary Shares that we are offering. Consequently,
if you engage in market trading or other activities in anticipation of and prior to settlement and delivery, you would be doing so at
the risk that the settlement and delivery may not occur. In addition, if the CSRC or other regulatory agencies later promulgate new rules
or explanations requiring us to obtain their approvals for our offering, we may be unable to obtain waivers of such approval requirements.
Any uncertainties or negative publicity regarding such approval requirements could materially and adversely affect the trading price of
our Ordinary Shares.
As of the date of this annual
report, we and our subsidiaries, (1) are not required to obtain permissions from any PRC authorities to list or trade our Ordinary Shares
in foreign stock exchanges, (2) are not subject to permission requirements from the CSRC, CAC or any other entity that is required to
approve of our PRC subsidiaries’ operations, and (3) have not received or were denied such permissions by any PRC authorities. Nevertheless,
the General Office of the Central Committee of the Communist Party of China and the General Office of the State Council jointly issued
the “Opinions on Severely Cracking Down on Illegal Securities Activities According to Law,” or the Opinions, which were made
available to the public on July 6, 2021. The Opinions emphasized the need to strengthen the administration over illegal securities activities,
and the need to strengthen the supervision over overseas listings by Chinese companies. Given the current PRC regulatory environment,
it is uncertain when and whether we or our PRC subsidiaries, will be required to obtain permission from the PRC government to list on
U.S. exchanges in the future, and even when such permission is obtained, whether it will be denied or rescinded. We have been closely
monitoring regulatory developments in China regarding any necessary approvals from the CSRC or other PRC governmental authorities required
for overseas listings. As of the date of this annual report, we have not received any inquiry, notice, warning, sanctions or regulatory
objection to this offering from the CSRC or other PRC governmental authorities. However, there remains significant uncertainty as to the
enactment, interpretation and implementation of regulatory requirements related to overseas securities offerings and other capital markets
activities.
Furthermore, on December 24,
2021, the China Securities Regulatory Commission, or the CSRC, issued Provisions of the State Council on the Administration of Overseas
Securities Offering and Listing by Domestic Companies (Draft for Comments) (the “Administration Provisions”), and the Provisions
of the State Council on the Administration of Overseas Securities Offering and Listing by Domestic Companies (Draft for Comments) (the
“Measures”), which are now open for public comments. The Administration Provisions and Measures for overseas listings lay
out specific requirements for filing documents and include unified regulation management, strengthening regulatory coordination, and cross-border
regulatory cooperation. Domestic companies seeking to list abroad must carry out relevant security screening procedures if their businesses
involve such supervision. Companies endangering national security are among those off-limits for overseas listings. According to Relevant
Officials of the CSRC Answered Reporter Questions (“CSRC Answers”), after the Administration Provisions and Measures are implemented
upon completion of public consultation and due legislative procedures, the CSRC will formulate and issue guidance for filing procedures
to further specify the details of filing administration and ensure that market entities could refer to clear guidelines for filing, which
means it still takes time to make the Administration Provisions and Measures into effect. As the Administration Provisions and Measures
have not yet come into effect, we are currently unaffected. However, according to CSRC Answers, new initial public offerings and refinancing
by existent overseas listed Chinese companies will be required to go through the filing process; other existent overseas listed companies
will be allowed sufficient transition period to complete their filing procedure, which means we will certainly go through the filing process
in the future.
The PRC government has significant authority
to intervene or influence the China operations of an offshore holding company, such as ours, at any time. The PRC government may exert
more control over offerings conducted overseas and/or foreign investment in China-based issuers. If the PRC government exerts more oversight
and control over offerings that are conducted overseas and/or foreign investment in China-based issuers and we were to be subject to such
oversight and control, it may result in a material adverse change to our business operations, significantly limit or completely hinder
our ability to offer or continue to offer securities to investors, and cause the ordinary shares to significantly decline in value or
become worthless.
Our business, prospects, financial
condition, and results of operations may be influenced to a significant degree by political, economic, and social conditions in China
generally. The PRC government has significant authority to intervene or influence the China operations of an offshore holding company
at any time, which could result in a material adverse change to our operations and the value of the ordinary shares.
Furthermore, given recent
statements by the Chinese government indicating an intent to exert more oversight and control over offerings that are conducted overseas,
although we are currently not required to obtain permission from any of the PRC federal or local government and has not received any denial
to list on the U.S. exchange, it is uncertain whether or when we might be required to obtain permission from the PRC government to list
on U.S. exchanges in the future. Even if such permission is obtained, it is uncertain whether it will be later denied or rescinded, which
could significantly limit or completely hinder our ability to offer or continue to offer our securities to investors and result in a material
adverse change to our business operations, and damage our reputation, therefore, cause the value of our shares to significantly decline
or be worthless.
We have limited insurance coverage for our
operations in China.
The insurance industry in
China is still at an early stage of development. Insurance companies in China offer limited insurance products. We have determined that
the risks of disruption or liability from our business, the loss or damage to our property, including our facilities, equipment and office
furniture, the cost of insuring for these risks, and the difficulties associated with acquiring such insurance on commercially reasonable
terms make it impractical for us to have such insurance. As a result, we do not have any business liability, disruption, litigation or
property insurance coverage for our operations in China except for insurance on some company owned vehicles. Any uninsured occurrence
of loss or damage to property, or litigation or business disruption may result in the incurrence of substantial costs and the diversion
of resources, which could have an adverse effect on our operating results.
It may be difficult for overseas shareholders
and/or regulators to conduct investigation or collect evidence within China.
Shareholder claims or regulatory
investigation that are common in the United States generally are difficult to pursue as a matter of law or practicality in China. For
example, in China, there are significant legal and other obstacles to providing information needed for regulatory investigations or litigation
initiated outside China. Although the authorities in China may establish a regulatory cooperation mechanism with the securities regulatory
authorities of another country or region to implement cross-border supervision and administration, such cooperation with the securities
regulatory authorities in the Unities States may not be efficient in the absence of mutual and practical cooperation mechanism. Furthermore,
according to Article 177 of the PRC Securities Law, or Article 177, which became effective in March 2020, no
overseas securities regulator is allowed to directly conduct investigation or evidence collection activities within the territory of the
PRC. While detailed interpretation of or implementation rules under Article 177 have yet to be promulgated, the inability
for an overseas securities regulator to directly conduct investigation or evidence collection activities within China may further increase
difficulties faced by you in protecting your interests.
Our principal business operation
is conducted in the PRC. In the event that the U.S. regulators carry out investigation on us and there is a need to conduct investigation
or collect evidence within the territory of the PRC, the U.S. regulators may not be able to carry out such investigation or evidence collection
directly in the PRC under the PRC laws. The U.S. regulators may consider cross-border cooperation with securities regulatory authority
of the PRC by way of judicial assistance, diplomatic channels or regulatory cooperation mechanism established with the securities regulatory
authority of the PRC.
PRC regulations relating to the establishment
of offshore special purpose companies by PRC residents may subject our PRC resident beneficial owners or our PRC subsidiary to liability
or penalties, limit our ability to inject capital into our PRC subsidiary, limit our PRC subsidiary’s ability to increase their
registered capital or distribute profits to us, or may otherwise adversely affect us.
In July 2014, SAFE promulgated
the Circular on Relevant Issues Concerning Foreign Exchange Control on Domestic Residents’ Offshore Investment and Financing and
Roundtrip Investment Through Special Purpose Vehicles, or SAFE Circular 37, to replace the Notice on Relevant Issues Concerning Foreign
Exchange Administration for Domestic Residents’ Financing and Roundtrip Investment Through Offshore Special Purpose Vehicles, or
SAFE Circular 75, which ceased to be effective upon the promulgation of SAFE Circular 37. SAFE Circular 37 requires PRC residents (including
PRC individuals and PRC corporate entities) to register with SAFE or its local branches in connection with their direct or indirect offshore
investment activities. SAFE Circular 37 is applicable to our shareholders who are PRC residents and may be applicable to any offshore
acquisitions that we make in the future.
Under SAFE Circular 37, PRC
residents who make, or have prior to the implementation of SAFE Circular 37 made, direct or indirect investments in offshore SPVs will
be required to register such investments with the SAFE or its local branches. In addition, any PRC resident who is a direct or indirect
shareholder of a SPV is required to update its filed registration with the local branch of SAFE with respect to that SPV, to reflect any
material change. Moreover, any subsidiary of such SPV in China is required to urge the PRC resident shareholders to update their registration
with the local branch of SAFE. If any PRC shareholder of such SPV fails to make the required registration or to update the previously
filed registration, the subsidiary of such SPV in China may be prohibited from distributing its profits or the proceeds from any capital
reduction, share transfer or liquidation to the SPV, and the SPV may also be prohibited from making additional capital contributions into
its subsidiary in China. On February 13, 2015, the SAFE promulgated a Notice on Further Simplifying and Improving Foreign Exchange Administration
Policy on Direct Investment, or SAFE Notice 13, which became effective on June 1, 2015. Under SAFE Notice 13, applications for foreign
exchange registration of inbound foreign direct investments and outbound overseas direct investments, including those required under SAFE
Circular 37, will be filed with qualified banks instead of the SAFE. The qualified banks will directly examine the applications and accept
registrations under the supervision of the SAFE.
We cannot assure you that
all of our shareholders that may be subject to SAFE regulations have completed all necessary registrations with the local SAFE branch
or qualified banks as required by SAFE Circular 37, and we cannot assure you that these individuals may continue to make required filings
or updates in a timely manner, or at all. We can provide no assurance that we are or will in the future continue to be informed of identities
of all PRC residents holding direct or indirect interest in our company. Any failure or inability by such individuals to comply with the
SAFE regulations may subject us to fines or legal sanctions, such as restrictions on our cross-border investment activities or our PRC
subsidiary’s ability to distribute dividends to, or obtain foreign exchange-denominated loans from, our company or prevent us from
making distributions or paying dividends. As a result, our business operations and our ability to make distributions to you could be materially
and adversely affected.
Furthermore, as these foreign
exchange regulations are still relatively new and their interpretation and implementation has been constantly evolving, it is unclear
how these regulations, and any future regulation concerning offshore or cross-border transactions, will be interpreted, amended and implemented
by the relevant government authorities. For example, we may be subject to a more stringent review and approval process with respect to
our foreign exchange activities, such as remittance of dividends and foreign-currency-denominated borrowings, which may adversely affect
our financial condition and results of operations. In addition, if we decide to acquire a PRC domestic company, we cannot assure you that
we or the owners of such company, as the case may be, will be able to obtain the necessary approvals or complete the necessary filings
and registrations required by the foreign exchange regulations. This may restrict our ability to implement our acquisition strategy and
could adversely affect our business and prospects.
Our results and financial conditions are
highly susceptible to changes in the PRC’s political, economic and social conditions as our revenue is currently wholly derived
from our operations in the PRC.
Since 1978, the PRC government
has undertaken various reforms of its economic systems. Such reforms have resulted in economic growth for the PRC in the last three decades.
However, many of the reforms are unprecedented or experimental, and are expected to be refined and modified from time to time. Other political,
economic and social factors may also lead to further readjustment of the reform measures. This refinement and adjustment process may consequently
have a material impact on our operations in the PRC or a material adverse impact on our financial performance. Our results and financial
condition may be adversely affected by changes in the PRC’s political, economic and social conditions and by changes in policies
of the PRC government or changes in laws, regulations or the interpretation or implementation thereof. The outbreak of COVID-19 heightens
the possibility of unpredictable change and accelerates such changes in the PRC’s political, economic, and social conditions. Our
sales of nutraceutical and dietary supplement are highly relevant to the local tourism, which is already and will be subject to unpredictable
changes for an unforeseeable period under restrict travel rules promulgated by local governments.
We may rely on dividends and other distributions on equity paid
by our PRC subsidiaries to fund any cash and financing requirements we may have, and any limitation on the ability of our PRC subsidiaries
to make payments to us could have a material and adverse effect on our ability to conduct our business.
We rely principally on dividends
and other distributions on equity from our PRC Subsidiary for our cash requirements, including for services of any debt we may incur.
Our PRC subsidiary’s
ability to distribute dividends is based upon its distributable earnings. Current PRC regulations permit our PRC subsidiary to pay dividends
to its respective shareholders only out of their accumulated profits, if any, determined in accordance with PRC accounting standards and
regulations. In addition, our PRC Subsidiary is required to set aside at least 10% of its after-tax profits each year, if any, to fund
a statutory reserve until such reserve reaches 50% of its registered capital. These reserves are not distributable as cash dividends.
If our PRC operating subsidiary incur debt on their own behalf in the future, the instruments governing the debt may restrict their ability
to pay dividends or make other payments to us. Any limitation on the ability of our PRC subsidiary to distribute dividends or other payments
to their respective shareholders could materially and adversely limit our ability to grow, make investments or acquisitions that could
be beneficial to our businesses, pay dividends or otherwise fund and conduct our business.
In addition, the Enterprise
Income Tax Law and its implementation rules provide that a withholding tax rate of up to 10% will be applicable to dividends payable by
Chinese companies to non-PRC-resident enterprises unless otherwise exempted or reduced according to treaties or arrangements between the
PRC central government and governments of other countries or regions where the non-PRC resident enterprises are incorporated.
We may be subject to a significant withholding
tax should equity transfers by our non-resident enterprises be determined to have been done without a reasonable business purpose.
In December 2009, the State
Administration of Tax in China issued a circular on strengthening the management of proceeds from equity transfers by non-resident enterprises
and requires foreign entities to report indirect sales of resident enterprises. If the existence of the overseas intermediary holding
company is disregarded due to lack of reasonable business purpose or substance, gains on such sale are subject to PRC withholding tax.
Due to limited guidance and implementation history of the circular, significant judgment is required in determining the existence of a
reasonable business purpose by considering multiple factors, such as the form and substance of the arrangement, time of establishment
of the foreign entity, relationship between each step of the arrangement, relationship between each component of the arrangement, implementation
of the arrangement and the changes in the financial position of all parties involved in the transaction. Although we believe that our
transactions during all the periods presented would be determined to have reasonable business purposes, should this not be the case, we
would be subject to a significant withholding tax that could materially and adversely impact our financial position, results of operations
and cash flows.
Uncertainty in the interpretation of PRC
tax regulations may have a negative impact on our business operations, our acquisition or restructuring strategy or the value of our investment
in it.
Pursuant to the Notice on
Strengthening Administration of Enterprise Income Tax for Share Transfers by Non-PRC Resident Enterprises, or SAT Circular 698, issued
by the State Administration of Taxation in December 2009, with retroactive effect from January 1, 2008, where a non-resident enterprise
transfers the equity interests of a PRC resident enterprise indirectly by disposition of the equity interests of an overseas non-public
holding company, or an Indirect Transfer, and such overseas holding company is located in a tax jurisdiction that: (i) has an effective
tax rate of less than 12.5% or (ii) does not impose income tax on foreign income of its residents, the non-resident enterprise, being
the transferor, must report to the competent tax authority of the PRC resident enterprise this Indirect Transfer. Using a “substance
over form” principle, the PRC tax authority may disregard the existence of the overseas holding company if it lacks a reasonable
commercial purpose and was established for the purpose of reducing, avoiding or deferring PRC tax. As a result, gains derived from such
Indirect Transfer may be subject to PRC withholding tax at a rate of up to 10%. SAT Circular 698 also provides that, where a non-PRC resident
enterprise transfers its equity interests in a PRC resident enterprise to its related parties at a price lower than fair market value,
the relevant tax authority has the power to make a reasonable adjustment to the taxable income of the transaction.
On March 28, 2011, the State
Administration of Taxation released SAT Public Notice (2011) No. 24, or SAT Public Notice 24, to clarify several issues related to Circular
698. SAT Public Notice 24 became effective on April 1, 2011. According to SAT Public Notice 24, the term “effective tax rate”
refers to the effective tax rate on the gain derived from disposition of the equity interests of an overseas holding company; and the
term “does not impose income tax” refers to the cases where the gain derived from disposition of the equity interests of an
overseas holding company is not subject to income tax in the country/region where the overseas holding company is a resident.
There is uncertainty as to
the application of SAT Circular 698. For example, while the term “Indirect Transfer” is not clearly defined, it is understood
that the relevant PRC tax authorities have jurisdiction regarding requests for information over a wide range of foreign entities having
no direct contact with China. Moreover, the relevant authority has not yet promulgated any formal provisions or made any formal declaration
as to the process and format for reporting an Indirect Transfer to the competent tax authority of the relevant PRC resident enterprise.
In addition, there are no formal declarations with regard to how to determine whether a foreign investor has adopted an abusive arrangement
in order to reduce, avoid or defer PRC tax. SAT Circular 698 may be determined by the tax authorities to be applicable to previous investments
by non-resident investors in its company, if any of such transactions were determined by the tax authorities to lack reasonable commercial
purpose. As a result, we and our existing non-resident investors may be at risk of being taxed under SAT Circular 698 and may be required
to expend valuable resources to comply with SAT Circular 698 or to establish that we should not be taxed under SAT Circular 698, which
may have a material adverse effect on our financial condition and results of operations or such non-resident investors’ investments
in us. We have conducted and may conduct transactions involving our corporate structure. We cannot assure you that the PRC tax authorities
will not, at their discretion, adjust any capital gains and impose tax return filing obligations on us or require us to provide assistance
for the investigation of PRC tax authorities with respect thereto. Any PRC tax imposed on a transfer of our shares or any adjustment of
such gains would cause us to incur additional costs and may have a negative impact on the value of your investment in us.
PRC regulation of loans and direct investment
by offshore holding companies to PRC entities may delay or prevent us from using the proceeds from the offerings of any securities to
make loans or additional capital contributions to our PRC operating subsidiaries.
As an offshore holding company,
our ability to make loans or additional capital contributions to our PRC operating subsidiaries is subject to PRC regulations and approvals.
These regulations and approvals may delay or prevent us from using the proceeds we received in the past or will receive in the future
from the offerings of securities to make loans or additional capital contributions to our PRC operating subsidiaries, and impair our ability
to fund and expand our business which may adversely affect our business, financial condition and result of operations.
In 2008, the SAFE promulgated
the Circular on the Relevant Operating Issues Concerning the Improvement of the Administration of the Payment and Settlement of Foreign
Currency Capital of Foreign-Invested Enterprises, or SAFE Circular 142, which used to regulate the conversion by foreign-invested enterprises
of foreign currency into Renminbi by restricting the usage of converted Renminbi. On April 8, 2015, the SAFE promulgated the Circular
on Reforming the Management Approach Regarding the Foreign Exchange Capital Settlement of Foreign-Invested Enterprises, or SAFE Circular
19. SAFE Circular 19 took effect as of June 1, 2015 and superseded SAFE Circular 142 on the same date. SAFE Circular 19 launched a nationwide
reform of the administration of the settlement of the foreign exchange capitals of foreign-invested enterprises and allows foreign-invested
enterprises to settle their foreign exchange capital at their discretion, but continues to prohibit foreign-invested enterprises from
using the Renminbi fund converted from their foreign exchange capitals for expenditures beyond their business scopes. On June 15, 2016,
the SAFE promulgated the Circular on Reforming and Standardizing the Administrative Provisions on Capital Account Foreign Exchange, or
SAFE Circular 16. SAFE Circular 19 and SAFE Circular 16 continue to prohibit foreign-invested enterprises from, among other things, using
RMB fund converted from its foreign exchange capitals for expenditure beyond its business scope, investment and financing (except for
guarantee products issued by banks), providing loans to non-affiliated enterprises or constructing or purchasing real estate not for self-use.
SAFE Circular 19 and SAFE Circular 16 may significantly limit our ability to transfer to and use in China the net proceeds from our initial
public offering, which may adversely affect our business, financial condition and results of operations.
Currency fluctuations and restrictions on
currency exchange may adversely affect our business, including limiting our ability to convert RMB into foreign currencies and, if RMB
were to decline in value, reducing our revenues and profits in U.S. dollar terms.
Our reporting currency is
the U.S. dollar and our operations in China use RMB as functional currencies. The majority of our revenues derived and expenses incurred
are in Chinese RMB with a relatively small amount in U.S. dollars. We are subject to the effects of exchange rate fluctuations with respect
to any of these currencies. For example, the value of the RMB depends to a large extent on Chinese government policies and China’s
domestic and international economic and political developments, as well as supply and demand in the local market. Starting July 2005,
the Chinese government changed its policy of pegging the value of the RMB to the U.S. dollar. Under the new policy, the RMB has fluctuated
within a narrow and managed band against a basket of certain foreign currencies. It is possible that the Chinese government will adopt
a more flexible currency policy, which could result in more significant fluctuations of the RMB against the U.S. dollar.
The income statements of our
China operations are translated into U.S. dollars at the average exchange rates in each applicable period. To the extent the U.S. dollar
strengthens against foreign currencies, the translation of these foreign currency-denominated transactions results in reduced revenues,
operating expenses and net income for our non-U.S. operations. Similarly, to the extent the U.S. dollar weakens against foreign currencies,
the translation of RMB denominated transactions results in increased revenues, operating expenses and net income for our non-U.S. operations.
We are also exposed to foreign exchange rate fluctuations as we convert the financial statements of our non-U.S. subsidiaries into U.S.
dollars in consolidation. If there is a change in foreign currency exchange rates, the conversion of the non-U.S. subsidiaries’
financial statements will similarly be affected.
We have not entered into agreements
or purchased instruments to hedge our exchange rate risks, although we may do so in the future. The availability and effectiveness of
any hedging transaction may be limited and we may not be able to successfully hedge our exchange rate risks.
Although Chinese governmental
policies were introduced in 1996 to allow the convertibility of RMB into foreign currency for current account items, conversion of RMB
into foreign exchange for most of the capital items, such as foreign direct investment, loans or securities, requires the approval of
the State Administration of Foreign Exchange, or SAFE. These approvals, however, do not guarantee the availability of foreign currency.
We cannot be sure that we will be able to obtain all required conversion approvals for our operations or that Chinese regulatory authorities
will not impose greater restrictions on the convertibility of RMB in the future. Because a significant amount of our future revenues are
in the form of RMB, our inability to obtain the requisite approvals or any future restrictions on currency exchanges could limit our ability
to utilize revenue generated in RMB to fund our business activities outside China, or to repay non-RMB-denominated obligations, including
our debt obligations, which would have a material adverse effect on our financial condition and results of operations.
We are subject to risks relating to the
restrictions on paying dividends or making other payments to us by our subsidiaries in China.
We are a holding company and
do not have any assets or conduct any business operations in China other than our investments in our subsidiaries in China. As a result,
if our non-China operations require cash from China, we would depend on dividend payments from our subsidiaries in China. We cannot make
any assurance that we can continue to receive payments from our subsidiaries in China. In addition, under Chinese law, our subsidiaries
are only allowed to pay dividends to us out of their distributable earnings, if any, as determined in accordance with Chinese accounting
standards and regulations. Moreover, our Chinese subsidiaries are required to set aside at least 10% of their respective after-tax profit
each year, if any, to fund certain mandated reserve funds, unless these reserves have reached 50% of their registered capital. These reserve
funds are not payable or distributable as cash dividends. For Chinese subsidiaries with after-tax profits for the periods presented, the
difference between after-tax profits as calculated under PRC accounting standards and U.S. GAAP relates primarily to share-based compensation
expenses and intangible assets amortization expenses, which are not pushed down to our subsidiaries under PRC accounting standards. In
addition, under the EIT Law and its implementing Rules, dividends generated from our PRC subsidiaries after January 1, 2008 and payable
to their immediate holding company incorporated in Hong Kong generally will be subject to a withholding tax rate of 10% (unless the PRC
tax authorities determine that our Hong Kong subsidiary is a resident enterprise). If certain conditions and requirements under the Arrangement
between the Mainland of China and the Hong Kong Special Administrative Region for the Avoidance of Double Taxation and the Prevention
of Fiscal Evasion with respect to Taxes on Income entered into between Hong Kong and the PRC and other related PRC laws and regulations
are met, the withholding rate could be reduced to 5%.
The Chinese government also
imposes controls on the convertibility of RMB into foreign currencies and the remittance of currency out of China in certain cases. We
have experienced and may continue to experience difficulties in completing the administrative procedures necessary to obtain and remit
foreign currency. If we or any of our subsidiaries are unable to receive substantially all of the economic benefits from our operations
through these contractual or dividend arrangements, we may be unable to effectively finance our operations or pay dividends on our ordinary
shares.
The PRC Labor Contract Law and its implementing
rules may adversely affect our business and results of operations.
The PRC Labor Contract Law
became effective and was implemented on January 1, 2008. The PRC Labor Contract Law has reinforced the protection for employees who, under
the PRC Labor Contract Law, have the right, among others, to have written labor contracts, to enter into labor contracts with no fixed
terms under certain circumstances, to receive overtime wages and to terminate or alter terms in labor contracts. Furthermore, the PRC
Labor Contract Law establishes additional restrictions and increases the costs involved with dismissing employees. As the PRC Labor Contract
Law is relatively new, there remains significant uncertainty as to its interpretation and application by the PRC Government. In the event
that we decide to significantly reduce our workforce, the PRC Labor Contract Law could adversely affect our ability to do so in a timely
and cost-effective manner, and our results of operations could be adversely affected. In addition, for employees whose contracts include
non-competition terms, the Labor Contract Law requires us to pay monthly compensation after such employment is terminated, which will
increase our operating expenses.
Risks Related to Our Ordinary Shares
Our Memorandum and Articles of Association
afford less protection to our shareholders and may discourage claims and limit shareholders’ ability to bring claims.
Our shareholders could have
more difficulty protecting their interests than would shareholders of a corporation incorporated in a jurisdiction of the United States.
As a Cayman Islands company, we are governed by our memorandum and articles of association and Cayman Islands Companies Law (as amended).
The provisions of the Cayman Islands Companies Act, which applies to us, differs in some material respects from laws generally applicable
to U.S. corporations and shareholders, including the provisions relating to shareholder lawsuits.
Our amended and restated memorandum
and articles of association contain a provision by virtue of which we and our shareholders waive any claim or right of action
that they have, both individually and on our behalf, against any director or officer in relation to any action or failure to take action
by such director or officer, except in respect of any fraud or dishonesty of such director or officer. Class actions and derivative actions
generally are available to shareholders under Delaware law for, among other things, breach of fiduciary duty, corporate waste and actions
not taken in accordance with applicable law. In such actions, the court has discretion to permit the winning party to recover attorneys’
fees incurred in connection with such action. Although this provision does not preclude our shareholders to bring federal securities claims
against us, it may be difficult or impossible for our shareholders to bring an action against us or against any director or officer in
the United States in the event that our shareholders believe that their rights have been infringed under the United States federal securities
laws or otherwise. Even if the Shareholder are successful in bringing an action of this kind, the laws of the Cayman Islands and of China
may render you unable to enforce a judgment against our assets or the assets of our directors and officers.
As a result of these differences,
investors could have more difficulty protecting their interests than would shareholders of a corporation incorporated in the United States.
Certain judgments obtained against us by
our shareholders may not be enforceable.
We are a Cayman Islands company
and substantially all of our assets are located outside of the United States. Substantially all of our current operations are conducted
in China. In addition, most of our current directors and officers are nationals and residents of countries other than the United States.
Substantially all of the assets of these persons are located outside the United States. As a result, it may be difficult or impossible
for you to bring an action against us or against these individuals in the United States in the event that you believe that your rights
have been infringed under the U.S. federal securities laws or otherwise. Even if you are successful in bringing an action of this kind,
the laws of the Cayman Islands and of China may render you unable to enforce a judgment against our assets or the assets of our directors
and officers.
We are an emerging growth company within
the meaning of the Securities Act and may take advantage of certain reduced reporting requirements.
We are an “emerging
growth company,” as defined in the JOBS Act, and we may take advantage of certain exemptions from requirements applicable to
other public companies that are not emerging growth companies, including, most significantly, not being required to comply with the auditor
attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002 for so long as we remain an emerging growth company. As a result,
if we elect not to comply with such auditor attestation requirements, our investors may not have access to certain information they may
deem important.
The JOBS Act also
provides that an emerging growth company does not need to comply with any new or revised financial accounting standards until such date
that a private company is otherwise required to comply with such new or revised accounting standards. We do not plan to “opt out”
of such exemptions afforded to an emerging growth company. As a result of this election, our financial statements may not be comparable
to companies that comply with public company effective data.
We qualify as a foreign private issuer and,
as a result, we are not subject to U.S. proxy rules and are subject to Exchange Act reporting obligations that permit less detailed
and less frequent reporting than that of a U.S. domestic public company.
We report under the Exchange
Act as a non-U.S. company with foreign private issuer status. Because we qualify as a foreign private issuer under the Exchange
Act, we are exempt from certain provisions of the Exchange Act that are applicable to U.S. domestic public companies, including
(i) the sections of the Exchange Act regulating the solicitation of proxies, consents or authorizations in respect of a security
registered under the Exchange Act; (ii) the sections of the Exchange Act requiring insiders to file public reports of their
stock ownership and trading activities and liability for insiders who profit from trades made in a short period of time; and (iii) the
rules under the Exchange Act requiring the filing with the SEC of quarterly reports on Form 10-Q containing unaudited financial
and other specified information, or current reports on Form 8-K upon the occurrence of specified significant events. In addition, our
officers, directors and principal shareholders are exempt from the reporting and “short-swing” profit recovery provisions
of Section 16 of the Exchange Act and the rules thereunder. Therefore, our shareholders may not know on a timely basis when our officers,
directors and principal shareholders purchase or sell our ordinary shares. In addition, foreign private issuers are not required to file
their annual report on Form 20-F within four months after the end of each fiscal year, while U.S. domestic issuers that are accelerated
filers are required to file their annual report on Form 10-K within 75 days after the end of each fiscal year. Foreign private issuers
also are exempt from Regulation Fair Disclosure, aimed at preventing issuers from making selective disclosures of material information.
As a result of the above, you may not have the same protections afforded to shareholders of companies that are not foreign private issuers.
If we lose our status as a
foreign private issuer, we would be required to comply with the Exchange Act reporting and other requirements applicable to
U.S. domestic issuers, which are more detailed and extensive than the requirements for foreign private issuers. We may also be required
to make changes in our corporate governance practices in accordance with various SEC and Nasdaq rules. The regulatory and compliance costs
to us under U.S. securities laws if we are required to comply with the reporting requirements applicable to a U.S. domestic issuer may
be significantly higher than the cost we would incur as a foreign private issuer. As a result, we expect that a loss of foreign private
issuer status would increase our legal and financial compliance costs and would make some activities highly time consuming and costly.
We also expect that if we were required to comply with the rules and regulations applicable to U.S. domestic issuers, it would make it
more difficult and expensive for us to obtain and maintain directors’ and officers’ liability insurance, and we may be required
to accept reduced coverage or incur substantially higher costs to obtain coverage. These rules and regulations could also make it more
difficult for us to attract and retain qualified members of our board of directors.
As a foreign private
issuer, we are permitted to adopt certain home country practices in relation to corporate governance matters that differ significantly
from Nasdaq corporate governance listing standards. These practices may afford less protection to shareholders than they would enjoy if
we complied fully with corporate governance listing standards.
As a foreign private issuer,
we are permitted to take advantage of certain provisions in the Nasdaq rules that allow us to follow our home country law for certain
governance matters. Certain corporate governance practices in our home country, the Cayman Islands, may differ significantly from corporate
governance listing standards. We choose to follow home country practice with respect to our corporate governance, therefore, our shareholders
may be afforded less protection than they would otherwise enjoy under the Nasdaq corporate governance listing standards applicable to
U.S. domestic issuers. See Item 16G “Corporate Governance”.
There can be no
assurance that we will not be a passive foreign investment company, or PFIC, for U.S. federal income tax purposes for any taxable year,
which could result in adverse U.S. federal income tax consequences to U.S. holders of our ordinary shares.
A non-U.S. corporation will
be a PFIC for any taxable year if either (1) at least 75% of its gross income for such year consists of certain types of “passive”
income; or (2) at least 50% of the value of its assets (based on an average of the quarterly values of the assets) during such year is
attributable to assets that produce passive income or are held for the production of passive income (the “asset test”). Based
on our current and expected income and assets (taking into account the expected cash proceeds and our market capitalization), we do not
presently expect to be a PFIC for the current taxable year or the foreseeable future. However, no assurance can be given in this regard
because the determination of whether we are or will become a PFIC is a fact-intensive inquiry made on an annual basis that depends, in
part, upon the composition of our income and assets. In addition, there can be no assurance that the Internal Revenue Service, or IRS,
will agree with our conclusion or that the IRS would not successfully challenge our position. Fluctuations in the market price of our
ordinary shares may cause us to become a PFIC for the current or subsequent taxable years because the value of our assets for the purpose
of the asset test may be determined by reference to the market price of our ordinary shares. The composition of our income and assets
may also be affected by how, and how quickly, we use our liquid assets and the cash raised in our initial public offering. If we were
to be or become a PFIC for any taxable year during which a U.S. Holder holds our ordinary shares, certain adverse U.S. federal income
tax consequences could apply to such U.S. Holder. See “Taxation— Passive Foreign Investment Company Consequences.”
The economic substance
legislation of the Cayman Islands may adversely impact the Company or its operations.
The Cayman Islands, together
with several other non-European Union jurisdictions, have introduced legislation aimed at addressing concerns raised by the Council of
the European Union as to offshore structures engaged in certain activities which attract profits without real economic activity. With
effect from January 1, 2019, the International Tax Co-operation (Economic Substance) Law, 2018 (the “ES Law”) and issued
related Regulations and Guidance Notes came into force in the Cayman Islands introducing certain economic substance requirements for
“relevant entities” which are engaged in certain “relevant activities,” which in the case of exempted companies
incorporated before January 1, 2019, will apply in respect of financial years commencing July 1, 2019, onwards. A “relevant
entity” includes an exempted company incorporated in the Cayman Islands; however, it does not include an entity that is tax resident
outside the Cayman Islands. Accordingly, for so long as the Company is a tax resident outside the Cayman Islands, it is not required
to satisfy the economic substance test. Although it is presently anticipated that the ES Law will have little material impact on the
Company or its operations, as the legislation is new and remains subject to further clarification and interpretation it is not currently
possible to ascertain the precise impact of these legislative changes on the Company.
We may be exposed to liabilities under
the Foreign Corrupt Practices Act, and any determination that we violated the Foreign Corrupt Practices Act or Chinese anti-corruption
law could have a material adverse effect on our business.
We are subject to the Foreign
Corrupt Practice Act, or FCPA, and other laws that prohibit improper payments or offers of payments to foreign governments and their
officials and political parties by U.S. persons and issuers as defined by the statute for the purpose of obtaining or retaining business.
Chinese anti-corruption law also strictly prohibits bribery of government officials. We have operations, agreements with third parties
and make sales in China, where corruption may occur. Our activities in China create the risk of unauthorized payments or offers of payments
by one of the employees, consultants, sales agents or distributors of our Company, even though these parties are not always subject to
our control. It is our policy to implement safeguards to prevent these practices by our employees. However, our existing safeguards and
any future improvements may prove to be less than effective, and the employees, consultants, sales agents or distributors of our Company
may engage in conduct for which we might be held responsible.
Violations of the FCPA or
other anti-corruption laws may result in severe criminal or civil sanctions, and we may be subject to other liabilities, which could
negatively affect our business, operating results and financial condition. In addition, the United States government may seek to hold
our Company liable for successor liability FCPA violations committed by companies in which we invest or that we acquire.
We rely on internal models to manage risk,
to provide accounting estimates and to make other business decisions. Our results could be adversely affected if those models do not
provide reliable estimates or predictions of future activity.
We rely heavily on internal
models in making a variety of decisions crucial to the successful operation of our business, including the allowance for doubtful accounts
and other accounting estimates. It is therefore important that our models are accurate, and any failure in this regard could have a material
adverse effect on our results. Models are inherently imperfect predictors of actual results because they are based on historical data
available to us and our assumptions about factors such as credit demand, payment rates, default rates, delinquency rates and other factors
that may overstate or understate future experience. Our models could produce unreliable results for a number of reasons, including the
limitations of historical data to predict results due to unprecedented events or circumstances, invalid or incorrect assumptions underlying
the models, the need for adjustments in response to rapid changes in economic and health conditions. In particular, models are less dependable
when the economic environment is outside of historical experience, as has been the case recently.
The relative lack of public company experience
of our management team may put us at a competitive disadvantage.
Our management team lacks
U.S. public company experience, which could impair our ability to comply with legal and regulatory requirements such as those imposed
by the Sarbanes-Oxley Act. Our senior management does not have experience managing a U.S. publicly traded company and lacks knowledge
about the Sarbanes-Oxley Act. Such responsibilities include complying with federal securities laws and making required disclosures on
a timely basis. Our senior management are unable to implement programs and policies in an effective and timely manner or that adequately
respond to the increased legal, regulatory and reporting requirements associated with being a U.S. publicly traded company. Our failure
to comply with all applicable requirements could lead to the imposition of fines and penalties, distract our management from attending
to the management and growth of our business, result in a loss of investor confidence in our financial reports and have an adverse effect
on our business and stock price.
We may be exposed to potential risks relating to our internal
controls over financial reporting.
As directed by Section 404 of the Sarbanes-Oxley
Act of 2002 or SOX 404, the SEC adopted rules requiring public companies to include a report of management on the company’s internal
controls over financial reporting in their annual reports. Under current law, the auditor attestation will not be required as long as
our filing status remains as a smaller reporting company, but we may cease to be a smaller reporting company in future years, in which
case we will be subject to the auditor attestation requirement. We were subject to management report for the fiscal year ended March
31, 2022, and a report of our management for the 2022 fiscal year is included under Item 15 of this annual report concluding that, as
of March 31, 2022, our internal controls over financial reporting were not effective. If we cannot remediate the material weakness identified
in a timely manner, investors and others may lose confidence in the reliability of our financial statements, which could adversely affect
the price of our ordinary shares.
Our ordinary shares are very thinly traded,
and there can be no assurance that there will be an active market for our ordinary shares in the future.
Our ordinary shares are very
thinly traded, and the price if traded may not reflect our value. There can be no assurance that there will be an active market for our
ordinary shares in the future. The market liquidity will be dependent on the perception of our operating business and any steps that
our management might take to bring us to the awareness of investors. There can be no assurance given that there will be any awareness
generated. Consequently, investors may not be able to liquidate their investment or liquidate it at a price that reflects the value of
the business. If a more active market should develop, the price may be highly volatile. Because there may be a low price for our ordinary
shares, many brokerage firms may not be willing to effect transactions in the securities. Even if an investor finds a broker willing
to effect a transaction in our ordinary shares, the combination of brokerage commissions, transfer fees, taxes, if any, and any other
selling costs may exceed the selling price. Further, many lending institutions will not permit the use of such ordinary shares as collateral
for any loans.
You may not receive dividends or other
distributions on our ordinary shares and you may not receive any value for them, if it is illegal or impractical to make them available
to you.
Under Cayman Islands law,
we may only pay dividends out of our profits or share premium account subject to our ability to pay our debts as they fall due in the
ordinary course of our business. Our ability to pay dividends will therefore depend on our ability to generate sufficient profits. On
July 31, 2020, the Board of the Company declared a special cash dividend of $0.015 per Ordinary Shares. The dividend, equal to $375,000
in the aggregate, was fully paid on August 17, 2020. However, we cannot give any assurance that we will declare dividends of any amounts,
at any rate or at all in the future. Future dividends, if any, will be paid at the discretion of our board of directors, subject to requirements
under Cayman Islands law and our memorandum and articles of association, as amended and restated from time to time, and will depend upon
our future operations and earnings, capital expenditure requirements, general financial conditions, legal and contractual restrictions
and other factors that our board of directors may deem relevant.
We may be subject to penny stock regulations and restrictions
and you may have difficulty selling our ordinary shares.
The SEC has adopted regulations
which generally define so-called “penny stocks” to be an equity security that has a market price less than $5.00 per share
or an exercise price of less than $5.00 per share, subject to certain exemptions. If our ordinary shares become a “penny stock”,
we may become subject to Rule 15g-9 under the Exchange Act, or the “Penny Stock Rule”. This rule imposes additional sales
practice requirements on broker-dealers that sell such securities to persons other than established customers and “accredited investors”
(generally, individuals with a net worth in excess of $1,000,000 or annual incomes exceeding $200,000, or $300,000 together with their
spouses). For transactions covered by Rule 15g-9, a broker-dealer must make a special suitability determination for the purchaser and
have received the purchaser’s written consent to the transaction prior to sale. As a result, this rule may affect the ability of
broker-dealers to sell our securities and may affect the ability of purchasers to sell any of our securities in the secondary market.
For any transaction involving
a penny stock, unless exempt, the rules require delivery, prior to any transaction in a penny stock, of a disclosure schedule prepared
by the SEC relating to the penny stock market. Disclosure is also required to be made about sales commissions payable to both the broker-dealer
and the registered representative and current quotations for the securities. Finally, monthly statements are required to be sent disclosing
recent price information for the penny stock held in the account and information on the limited market in penny stock.
There can be no assurance
that our ordinary shares will qualify for exemption from the Penny Stock Rule. In any event, even if our ordinary shares were exempt
from the Penny Stock Rule, we would remain subject to Section 15(b)(6) of the Exchange Act, which gives the SEC the authority to restrict
any person from participating in a distribution of penny stock, if the SEC finds that such a restriction would be in the public interest.
| ITEM 4. |
INFORMATION
ON THE COMPANY |
| |
A. |
History
and development of the company. |
We were formed under the
name of “Happiness Biotech Group Limited” on February 9, 2018, under the laws of the Cayman Islands. In October 2022, we
changed the name from “Happiness Biotech Group Limited” to “Happiness Development Group Limited.” Our registered
office is at Harnes Fiduciary (Cayman) Limited, with its offices located at 4th Floor, Harbour Place, 103 South Church Street,
P.O. Box 10240, Grand Cayman, KY1-1002M Cayman Islands. Our principal executive offices are located at No. 11, Dongjiao East Road, Shuangxi,
Shunchang, Nanping City, Fujian Province, People’s Republic of China. Our telephone number at that address is + 86-0599-782-8808.
Our company website is http://www.fjxfl.com.
Happiness Development is
the sole shareholder of Happiness Hong Kong, incorporated in Hong Kong on March 5, 2018, which is the sole shareholder of Happiness Nanping.
Happiness Nanping was incorporated on June 1, 2018 under the laws of the People’s Republic of China, as a wholly-owned subsidiary
of Happiness Hong Kong and a wholly foreign-owned entity under the PRC laws. Neither Happiness Development, Happiness Hong Kong nor Happiness
Nanping is currently engaged in any active business other than acting as holding companies. We conduct our business mainly through Fujian
Happiness, a wholly-owned subsidiary of Happiness Nanping and incorporated on November 19, 2004 under the PRC laws. Fujian Happiness
holds all of the equity or ownership of Shunchang Happiness Nutraceutical Co., Ltd (“Shunchang Happiness”). Through Fujian
Happiness and Shunchang Happiness, the Company is a biotech company that specializes in research, development, production and selling
of nutraceutical and dietary supplements made of Ganoderma spore powder and others mainly in China.
On October 25, 2019, our
ordinary shares commenced trading on Nasdaq under the symbol “HAPP.”
On July 17, 2020, Happy Buy
(Fujian) Internet Technology Co., Limited, or “Happy Buy”, was incorporated under the laws of People’s Republic of
China and is a wholly owned subsidiary of Happiness Nanping. Happy Buy was incorporated in order to develop our e-commerce business.
Our e-commerce business focuses on providing e-commerce solutions and services for small and medium-sized enterprises. Our mission for
the e-commerce business is to enable small and medium-sized enterprises to fully leverage the power of e-commerce to grow rapidly.
On April 27, 2021, Taochejun
(Fujian) Auto Sales Co., Limited, “Taochejun”, was incorporated under the laws of People’s Republic of China and 51%
of it is owned by Happiness Nanping. We launched this B2B (Business-to-Business) platform for sales of automobiles. Our automobile sales
business was formerly under the brand name of “Happy Auto”, and was rebranded to “Taochejun” in June 2021. Taochejun
mainly focuses on building a network among car dealers in China to offer better overall sales experience and services to purchasers,
and to streamline the automotive industry transaction. China is one of the world’s largest automobile markets, both in terms of
demand and supply. Through Taochejun, we plan to utilize our dealer network to distribute the inventories and used cars from large 4S
stores, online car hailing platforms and car makers to third and fourth tier cities, which serves as a great solution to the over-supply
issues in first tier cities. Meanwhile, new energy vehicles will also be one of Taochejun’s focuses. At present, electric vehicles
are mostly concentrated in the first tier cities. In the future, we believe that new energy vehicles will start to popularize in lower
tier cities and car makers will spend more resources on developing these markets.
On October 14, 2021, Happiness
Development and its wholly-owned subsidiary, Fujian Happiness, acquired 70% of the equity interest in Fujian Shennong Jiagu Development
Co., Ltd. (“Fujian Shennong”) to further strengthen the Company’s industrial integration. The acquisition of Fujian
Shennong closed on November 22, 2021.
On March 4, 2022, Happiness
Development and its wholly-owned subsidiary, Fujian Happiness, acquired 100% of the equity interest in Fuzhou Hekangyuan Trading Co.,
Ltd. (“Hekangyuan”) to further strengthen the distribution network of the Company.
The Company is subject to
the informational requirements of the Securities Exchange Act of 1934, as amended, and will file reports, registration statements and
other information with the SEC. The Company’s reports, registration statements and other information can be inspected on the SEC’s
website at www.sec.gov and such information can also be inspected and copies ordered at the public reference facilities maintained by
the SEC at the following location: 100 F Street NE, Washington, D.C. 20549. You may also visit us at http://www.fjxfl.com. However, information
contained on our website does not constitute a part of this annual report.
Our business currently has
three revenue streams: nutraceutical and dietary supplements business, e-commerce business and automobile sale business. We are an innovative
nutraceutical and dietary supplements producer focused on the research, development, manufacturing, marketing and sales of a variety
of products made from Chinese herbal and animal extracts in China. We conduct our business through our wholly-owned subsidiaries, mainly
Fujian Happiness. Founded in 2004, Fujian Happiness focuses on providing nutraceutical solutions made from Chinese herbal extracts. During
the outbreak of COVID-19 in China, we have produced portable hand sanitizer and daily protective masks to supplement our herbal extracts
sales but they are not our main products. We believe enhanced consumer awareness and demand for nutraceutical and dietary supplements,
rising health care costs, aging populations, coupled with our effective sales have been the primary reasons for our growth throughout
our 17 years of operating history.
We are one of the leading
companies in Fujian Province specializing in research, development, manufacturing, and marketing of nutraceutical and dietary supplements
authorized by Nutraceutical Association of Fujian Province. Our products are mainly made of Lucidum spore powder (also known as Ganoderma
spore powder or Ganoderma Lucidum spore powder), Cordyceps mycelia, Ejiao, other traditional Chinese herbal and animal extracts, vitamins,
minerals and amino acids. Our brand, “Happiness”, is a well-known trademark in Fujian Province and well-recognized in the
nutraceutical industry in China. Headquartered in Fuzhou, the provincial capital of Fujian Province, and Nanping, our products are sold
throughout China. In February 2020, we set up four production lines to produce portable hand sanitizer and daily protective masks to
supplement our herbal extracts sales to combat the spreading of COVID-19 in China. The production lines ceased in August 2020.
In addition, we started two
new revenue streams in the year ended March 31, 2021. We engaged in e-commerce business via Happy Buy in September 2020. Our e-commerce
platform “Happy Buy” mainly focuses on providing small and middle size business with professional product marketing and e-commerce
agency operation services. We also provide e-commerce solutions, internet information and advertising service to the small online stores
or small manufactures in China in fiscal year ended March 31, 2021, leveraging our resources and experiences in marketing and in the
e-commerce industry to provide efficient solutions to promote and sell products of our customers.
We began our automobile sale
in November 2020. Our automobile sales platform “Happy Auto”, which later upgraded to “Taochejun”, focuses
on empowering the automotive supply chain by building a network to connect different car dealers and offer better overall sales experience
and services to purchasers, and to streamline the automotive industry transaction.
Products and Services
Nutraceutical and dietary supplements
Currently we market and sell
approximately 23 kinds of nutraceutical and dietary supplements products through over 100 distributors in 20 different provinces
and 10 experience stores in China. We categorize our products into six groups: Lucidum spore powder products, Cordyceps mycelia
products, Ejiao solution products, vitamins and dietary supplements products, American ginseng products, and others. For the years ended
March 31, 2022, 2021, and 2020, our sales from Lucidum spore powder products, Cordyceps mycelia products and Ejiao solution products,
approximately amounted 16.65%, 18.7%, and 66.6% of our gross sales, respectively.
As in Administrative Measures
for Nutraceutical Products promulgated by National Health Commission of PRC, nutraceutical and dietary supplements products are a category
of food targeted to specific population with general health benefits for daily wellness. Nutraceutical and dietary supplements products
are not intended to treat any specific diseases and must not cause any acute, subacute or chronic harm to the human body. With the requirements
of nutraceutical and dietary supplements being met and approved by the CFDA, the predecessor of the NMPA, under regulations for nutraceutical
and dietary supplements, herbal and animal extracts used as both nourishment food and traditional Chinese medicine can be included into
raw materials of nutraceutical and dietary supplements products.
We mainly use herbal and
animal extracts as raw materials of our Lucidum spore powder products, Cordyceps mycelia products, Ejiao solution products and others.
These herbal and animal extracts have been used as both daily nourishment food and traditional Chinese medicine in China for a long time.
Approved by CFDA under regulations for nutraceutical and dietary supplements, 32 kinds of our products are nutraceutical and dietary
supplements products labeled with “Blue Caps.” All our products are produced in compliance with the regulations of food industry.
In February 2020, we began
the production of disinfectants for combatting the COVID-19 pandemic, including 75% alcohol disinfectant and hand sanitizer, after obtaining
the Sanitation License of Disinfection Product Manufacture (the “Sanitation License”) issued by Fujian Provincial Health
Commission. The production of disinfectants ceased in August 2020 and we do not anticipate to resume the production in any near future.
Automobile Sales
In November 2020, the Company
began its automobile sales business. The Company has entered into agreements with automobile companies to purchase cars and obtain authorization
to distribute the cars in different cities in China including Xiamen, Zhangzhou and Hangzhou. The Company utilizes its online platform
of “Taochejun” on WeChat, as a WeChat Mini Program (微信小程序), to link comprehensive automobile
trade and resource providers, and provide vehicle source solutions for automobile dealers. It can display and sell the car source of
the resource business alliance on the platform, and also help the comprehensive auto trade to solve its own car source demand.
Ecommerce
Online Stores
In 2020, the Company has
begun the online store business on several different platforms. The Company focuses on providing e-commerce overall services, internet
promotion, agency operations, supply chain resources and logistics services for all types of enterprises. The company's main business
forms are community group buying and cross-border e-commerce. The company has a delivery and optimization department, a procurement department,
and a live streaming team, and has established a comprehensive business support center and management team.
Internet Information and Advertising Service
In 2021, the Company began
to provide internet information and advertising service to small online stores or small manufacturers in China.
Suppliers
We
consider our suppliers whose sales to us accounted for more than 10% of our overall purchases in any given period to be our major suppliers
of such period. We have two such vendors of our advertising services during fiscal years ended March 31, 2022. These top 2 vendors accounted
for approximately 19.62% and 18.35% of our overall purchases and our top 5 vendors accounted for 61.85% of our overall purchases, respectively.
We purchase other types of
raw materials for our dietary supplements products and engage services from a variety of suppliers at the market price. We believe these
types of raw materials and services are widely available, and therefore if we were unable to purchase from our primary suppliers, we
do not expect we would face difficulties in locating another supplier at substantially the same price. We have stable access to all the
raw materials and services necessary for our operation. We believe our relationships with our suppliers are strong.
Sales and Marketing
As for our nutraceutical
and dietary supplements products, we currently have two sales models, namely traditional distribution model and experience store model.
The main way we sell our
dietary supplements products is through regional distributors and large-scale chain drugstores, malls and supermarkets. In selecting
our regional distributors, we consider factors including capital strength, network coverage, marketing ability and etc. We are responsible
for the training of distributors and their sales consultants. Our regional distributors focus on expanding sales network, distributing
and promoting our products. Regional distributors directly sell our products to customers in retail sales terminals through their sales
consultants after receiving training on marketing and basic information of our products. These consultants are not licensed medical professionals
and not required to be licensed. At the sales terminals, customers can receive information on the efficacy and usage of our products
provided by the sales consultants. Sales terminals are one of the main conduits through which we market our marketing and sales activities.
Our customers of dietary
supplements products also include well-known chain drugstores, malls and supermarkets. Customers who fall under this category tend to
have established cross-regional sales networks, strong sales capabilities, well-recognized brands and good reputation among the consumers.
We tend to establish direct business partnership with this type of customers. We provide marketing plan, sales support, personnel training
and after sales services to them.
The
aforementioned two kinds of customers are together referred to as the traditional distribution model. Through our efforts for the past
16 years, we have successfully built our traditional distribution channel, as well as established a leading sales system in the industry.
As of March 31, 2022, we had over 100 distributors with more than 20,000 sales terminals in 20 different provinces in China, and
established close business relationships with them. With our expansive
sales network and quality after-sales service, we have effectively promoted our sales and enhanced our brand image.
Traditional sales model face
challenges when consumers start to demand high quality individualized health services. In 2017, we started to open experience stores
to stimulate our sales. We enter into experience store agreements with participating distributors, who own and operate retail stores
in popular tourist sites. Pursuant to such agreements, we provide consulting services to the distributors with respect to store site
selection, equipment purchase, store decoration and design. As part of such agreement, we will coach the distributor to design a high-tech
exhibition store of approximately 2,000 square meters (approximately 21,500 square feet). Further, we provide professional trainings
to sales consultants employed by these exclusive distributors, so that these consultants are able to provide individualized nutrition
tips to consumers. We also provide training to the personnel employed by the distributors so that such personnel are able to function
as commentators to give in-depth presentation of the origin, tradition and history of our products in the background of the tourist sites.
The key difference between
sales terminals operated by traditional distributors and the experience stores are that we provide more support to them and the experience
stores are located in tourist sites where the sales consultants gave in-depth presentation of the origin, tradition and history of our
products and as a result, the price at such stores are higher than those sold in the sales terminals operated by traditional distributors.
The experience stores are presented by the tourists’ sites operators as part of its cultural offerings. The tourists are guided
to enjoy a presentation of traditional Chinese herb culture offered by the distributors in the experience store. At the end of the presentation,
the tourists are led to the counters and be presented with our products. We estimate about 50% of the tourists visited our experience
stores will purchase our products in such stores.
As
of March 31, 2022, we had 10 exclusive distributors in Xiamen, Chaozhou, Guilin and other touristic cities in China, with a customer
conversion rate of approximately 50%.
Our e-commerce solutions
services aim to offer IT and advertising services to the small to medium sized businesses, assisting them to reach target customers via
social media. Happy Buy, through its subsidiaries, uses domestic plus cross-border platforms, establishes internal front desk, middle
desk, back-office systems and departments, forming a commercial closed loop, which greatly reduces the marketing costs and improving
marketing efficiency. It also links factories, logistics, brands and sales together to provide an overall e-commerce solution for the
small and middle-sized businesses.
Our automobile sales platform
Taochejun commits to develop more sales channels for car dealers in the future to connect the upstream and downstream channel network
of automobile distribution. Currently, we have developed a WeChat Mini Program for Taochejun, on which we provide car dealers with real
and high-quality car sources as well as safe and efficient transaction services.
Competition
We compete with other top-tier
dietary supplement producers in China. Many of our competitors also manufacture and sell products similar to ours. Furthermore, many
of these companies entered into the market earlier than us, and thus they are more established than we are and have significantly greater
financial, technical, marketing and other resources than we presently possess. Some of our competitors have greater name recognition
and a larger customer base. Those competitors may be able to respond more quickly to new opportunities, market changes or changes of
customer preferences, and may be able to undertake more extensive promotional activities, offer more attractive terms to distributors,
and adopt more aggressive pricing policies.
Some of our competitors,
including Shouxiangu Pharmaceutical Co., Ltd. and Xianzhilou Biotechnology Co., Ltd., also sell dietary supplement products made of Lucidum
spores. Some of our competitors are high-profile and large-scale companies along with some companies that have huge production and storage
capacity to influence the market price. Despite that, we believe we are well positioned to compete in this fast-developing market with
our diversified product portfolio, proven research and development and in-licensing capabilities, established sales and marketing network
and management experiences.
Since we started our e-commerce
business and automobile sale in 2020, which are both highly competitive and rapidly evolving industries in China, we are making great
efforts to improve our competitiveness in both industries and attempting new business models to distinguish us from our competitors.
Trademarks, Copyrights, Patents and Domain
Names
We regard our trademarks,
domain names, know-how, proprietary technologies and similar intellectual property as critical to our success, and we rely on trademark
and trade secret law and confidentiality and invention assignment with our employees and others to protect our proprietary rights.
Trademark
“Happiness” is
a Well-Known Trademark and well recognized by consumers in Southeastern China. “Happiness” was registered as a Well-Known
Trademark in China by State Administration of Industry and Commerce of PRC in 2010 and Famous Brand in Fujian by Fujian Administration
of Industry and Commerce in 2007. Our brand is also widely recognized in the nutraceutical industry in China as one of the most famous
brands. It is especially recognized in Fujian Province where it was originated and provinces nearby, such as Zhejiang, Jiangsu and Guangdong.
Patent
We
rely on our in-house research and development team to upgrade current products and invent new products. We were granted an award of “Outstanding
Research and Development Companies” by Nanping Intellectual Property Office on October 16, 2017. We currently have 20 employees
dedicated to research and development.
Domain Names
Our intellectual property
includes our domain names of http://www.fjxfl.com., and https://www.happgo.net/.
Sources and Availability of Raw Materials
Property,
Plant and Equipment
There is no private land
ownership in China. Individuals and entities are permitted to acquire land use rights for specific purposes. We were granted land use
rights for our facilities in Nanping. Following is a list of our properties, all of which we own the land use rights to:
| No. |
|
Property |
|
Duration of Land
Use Rights(1) |
|
Space
(m2) |
|
|
Ground
Floor
Area (m2) |
|
| 1 |
|
No. 134 Freight Yard Road, Shuangxi, Shunchang |
|
January 30, 2016 -
January 29, 2066 |
|
|
12,120 |
|
|
|
16,038.22 |
|
| 2 |
|
No. 11 Dongjiao East Road, Shuangxi, Shunchang |
|
May 12, 2006 -
May 11, 2056 |
|
|
17,600 |
|
|
|
9,520.4 |
(2) |
| (1) |
We have the option to renew these land use rights agreements
with the government. |
| (2) |
The certificate of the real estate is under processing. |
Our headquarters and manufacturing
facility is located at No.11 Dongjiao East Road, Shuangxi, Shunchang, Naping City, Fujian Province, PRC and No.134 Feight Yard Road,
Shuangxi, Shuangchang, Nanping City, Fujian Province, PRC. At these locations, we have a variety of heavy equipment required to customize
the products and laboratory equipment for research and development. None of our properties are encumbered by debt, and we are not aware
of any environmental concerns or limitations on the use of our properties for the purposes we currently use them or intend to use them
in the future.
In addition, our cooperation
partners lease spaces from different real estate entities for our experience stores. Currently, the average lease term for flagship stores
is five years and for the general stores is three years.
Research and Development
Nutraceutical and Dietary Supplements Products
We
rely on our in-house research and development team to upgrade current products and invent new products. We were granted an award of “Outstanding
Research and Development Companies” by Nanping Intellectual Property Office on October 16, 2017. We currently have 20 employees
dedicated to research and development and we hold a total of 18 patents as of the date of this report.
Mr. Xuezhu Wang and Mr. Zongwei
Zhang, our key technician, both have over twenty-six years of experiences in the nutraceutical industry. They lead our research team in
the process of applying patents for the Company. Dr. Junsheng Fu joined the company as a consultant in June 2018 to assist our technical
manager Yujing Zheng, who has over fourteen years of experiences in the food manufacturing industry, to rebuild our Research and Development
team. Dr. Fu holds Doctorate degree in Microbiology from Fujian Agriculture and Forestry University, and is currently as a
professor at the same University. He established our general research and development strategy to use modern technology to improve the
production process and continue developing newly advanced products to meet the highest quality standards. We believe that our research
and development team holds a leading position in the nutraceutical and dietary supplements industry. We will continue to sharpen our advantages
and expect to develop new advanced products in the foreseeable future. A detailed development process of our new products is as following:
| |
● |
Start-up of a project:
feasibility study on the formula, production process and technical requirements of the new product; |
| |
● |
Lab test of the formula
and production process on small scale; |
| |
● |
Pilot production test of
the formula and production process on medium scale; |
| |
● |
Make further modification
on the formula and production process of the new product based on the results of lab test and pilot test to meet current technical
requirements and quality standards of nutraceutical and diet supplements; |
| |
● |
Assessment on safety and
general health benefits of the new product: the assessment covers hygienic testing, toxicological testing and functional testing
on safety, stability and health benefits of the products. The assessment reports are required and reviewed by CFDA to make sure the
product can not cause any acute, subacute or chronic harm to the human body. We mainly rely on third party assessment agencies authorized
by CFDA to perform the assessment of the safety, stability and general health benefits of the new products. |
| |
● |
Submit the materials to
CFDA for registration or record-filing process of the new product (for a detailed discussion on the materials needed, see section
“Regulation”); |
| |
● |
Approved by CFDA and get
the official approval and “Blue Cap” label of the new product: CFDA shall review the materials for registration or record-filing
and perform on-site verification of the production process to confirm whether the products meet the requirements of nutraceutical
and dietary supplements products. With the requirements of nutraceutical and dietary supplements being met, CFDA will issue the official
approvals of the products to the manufacturers. |
Hygienic testing of nutraceutical
and dietary supplements products includes various trials on the functional ingredients of the products to assess whether the products
meet the hygienic requirements for nutraceutical and dietary supplements products and whether the products contain ingredients harmful
to human body, such as Lead, Arsenic and Mercury. Toxicological testing of nutraceutical and dietary supplements products includes experiments
on the ingredients to ensure the product must not cause any acute, subacute or chronic harm to the human body. In the condition of the
hygienic testing and toxicological testing being qualified, functional testing provide assessments to verify the specified functions
of the products. Functional testing includes experiments on animals or human beings (if necessary) for the specific functions of the
products. According to the Technical Standards for Testing &Assessment of Health Food promulgated by National Health Commission of
PRC, functions of these nutraceutical and dietary supplements products must be covered by the 27 kinds of general health benefits listed
in the standard, such as boosting the immune system, improvement of sleep etc.
Insurance
As required by laws and regulations
in China, we participate in various employee social security plans that are organized by municipal and provincial governments, including
housing, pension, medical insurance and unemployment insurance programs. The Company is required under Chinese law to make contributions
to employee benefit plans at specified percentages of the salaries, bonuses and certain allowances of our employees, up to a maximum
amount specified by the local government from time to time. We have contributed to the basic and minimum social insurance plan. While
we believe we have made adequate provision of such outstanding amounts of contributions to such plans in our financial statements, any
failure to make sufficient payments to such plans would be in violation of applicable PRC laws and regulations and, if we are found to
be in violation of such laws and regulations, we could be required to make up the contributions for such plans as well as to pay late
fees and fines.
Seasonality
The sale of nutraceutical
and dietary supplements product is slightly subject to seasonal changes, usually sales is higher in winter time due to traditional Chinese
dietary culture. In addition, there are peak and low season period for various attractions with experience stores, which may lead to
volatility of sales for different stores.
There is no seasonality impact
to the business of automobile sales, online store or internet information and advertising services.
Employees
We
currently have 218 full-time employees. We have employment
contracts with all of our employees in China in accordance with relevant PRC laws. Our employees are not represented by a labor organization
or covered by a collective bargaining agreement. We have not experienced any work stoppages.
We have contributed to the
basic and minimum social insurance plan. While we believe we have made adequate provision of such outstanding amounts of contributions
to such plans in our financial statements, any failure to make sufficient payments to such plans would be in violation of applicable
PRC laws and regulations and, if we are found to be in violation of such laws and regulations, we could be required to make up the contributions
for such plans as well as to pay late fees and fines.
Management, Culture and Training
We are guided by a philosophy
that recognizes customer service and the importance of delivering optimal performance, allowing us to identify and reward teams that
meet our high performance standards.
We provide professional trainings
to sales consultants employed by these exclusive distributors, so that these consultants are able to provide individualized nutrition
tips to consumers. We also provide training to the personnel employed by the distributors so that such personnel are able to function
as commentators to give in-depth presentation of the origin, tradition and history of our products in the background of the tourist sites.
We also provide all employees with appropriate workplace safety training.
Competitive Advantage
We believe our principal competitive strengths
of our dietary supplements products are as follows:
Recognized Brand Name
“Happiness” is
a Well-Known Trademark and well recognized by consumers in Southeastern China. “Happiness” was registered as a Well-Known
Trademark in China by State Administration of Industry and Commerce of PRC in 2010 and Famous Brand in Fujian by Fujian Administration
of Industry and Commerce in 2016. Our brand is also widely recognized in the nutraceutical industry in China as one of the most famous
brands. It is especially recognized in Fujian Province where it was originated and provinces nearby, such as Zhejiang, Jiangsu and Guangdong.
Provider of a Wide Range of Nutraceutical
and Dietary Supplements Products
We are a nutraceutical manufacturer
producing a wide range of nutraceutical and dietary supplements products. We make products from ingredients such as Lucidum spore powder,
Cordyceps mycelia, Ejiao, vitamins and minerals, American ginseng, and others. A broad product portfolio allows us to attract consumers
with different preferences and to gain competitive advantages in our products.
Strong Research and Development Capability
We have established a strong
research and development team (“R&D Team”) of 14 talented researchers as of the date of this annual report. Our R&D
Team has demonstrated its success of developing new products and technologies that lend us an edge over our major competitors. Our R&D
Team has developed several products that were successfully launched with positive consumer feedback, including melatonin tablets, calcium
tablets, ginseng tea powders, and supplemental tablets with immune-boosting efficacy. Further, we cooperate with Fujian Agriculture and
Forestry University and Academy of Chinese Medical Sciences on product research. We believe that our research and development capabilities,
in addition to our partnership with scientific research institutions, allow us to provide steady pipeline of innovative dietary supplement
solutions that fulfill our customers’ needs.
Experienced and accomplished leadership team
with a proven track record.
We
have an experienced management team. For example, Mr. Xuezhu Wang, our Chairman of the Board, has over twenty-five years of experiences
in the dietary supplement industry. Mr. Zongwei Zhang, our key technician, have over twenty-five years of experience in the nutraceutical
industry. We believe that our leadership team is well-positioned
to lead us through clinical development, regulatory approval and commercialization of our product candidates. Collectively, our management
team has extensive experience in the research and development, manufacturing, and commercialization of nutraceutical and dietary supplement
products. Experienced in managing fast-growing enterprises, our entrepreneurial management team takes the initiative to adapt our business
strategies to market, industry and therapeutic trends. Our management team has successfully established a steady product pipeline and
built an integrated research and development, production, sales and marketing infrastructure. Our success in product development and
branding reflects the experiences that our management team has in their areas of expertise and their in-depth knowledge of the regulatory
framework in China.
For our e-commerce business,
we compete primarily on the basis of the following factors: (i) our ability to attract, incubate and empower high-quality key opinion
leaders, or KOLs, in growing numbers; (ii) our strong network with small and middle size business in China; (iv) the superiors shopping
experience on our platform; (v) pricing of products sold on our platform; (vi) our ability to attract and retain merchants;
and (vii) product quality and selection.
For our automobile sale business,
we believe our primary competitive advantages are: (i) the internet-based and digitized sales model empowered the resource car dealers
and comprehensive auto trade, fully improving the operation efficiency of the industry; (ii) the strong relationship with resourceful
car dealers and (iv) the standardized service process, including car hailing services and potentially financing and insurance services.
Licenses, Permits and Government Regulations
License
Dietary Supplement Production License and Official Approvals
In China, food and nutritious
supplement manufacturers are required to comply with the certain quality control, safety requirement and obtain “Food Production
License” from CFDA for full compliance with the safety requirements set forth in Food Safety Law of People’s Republic of China.
Besides, each nutraceutical product is required to obtain the official approval of manufacturing from CFDA, which is the commonly known
as the “Blue Caps”. Currently 23 of our products are approved by CFDA. The approvals of our main products are listed in the
below chart.
| No. |
|
Product
Name |
|
Code |
|
Expiration
Date |
|
Owner |
| 1 |
|
“Happiness” Lucidum Spore Powder Capsule |
|
No.346(1998) |
|
not applicable |
|
Fujian Happiness |
| 2 |
|
“Daguangrong” Cordyceps Mycelia Oral Liquid |
|
No.220(1997) |
|
not applicable |
|
Shunchang Happiness |
| 3 |
|
“Happiness” Ejiao Astragalus Oral Liquid |
|
G20040107 |
|
not applicable |
|
Fujian Happiness |
| 4 |
|
“Happiness” Iron and Zinc Amino Acids Oral
Liquid |
|
G20060704 |
|
8/13/2025 |
|
Fujian Happiness |
| 5 |
|
“Happiness” American Ginseng Capsule |
|
G20050572 |
|
7/8/2025 |
|
Fujian Happiness |
| 6 |
|
Lishi Jinjin Qingzhi Capsule |
|
No.0288(2003) |
|
not applicable |
|
Fujian Happiness |
| 7 |
|
“Happiness” Fenglingbao Capsule |
|
No.0064(2003) |
|
not applicable |
|
Fujian Happiness |
| 8 |
|
“Happiness” American Ginseng Original Grain
Tea bag |
|
No.0291(2003) |
|
not applicable |
|
Fujian Happiness |
| 9 |
|
“Happiness” American Ginseng Oral Liquid |
|
G20040182 |
|
not applicable |
|
Shunchang Happiness |
| 10 |
|
“Happiness” Taurine Zinc Oral Liquid |
|
G20120537 |
|
1/6/2025 |
|
Fujian Happiness |
| 11 |
|
“Happiness” Spirulina Tablets |
|
G20050573 |
|
8/13/2025 |
|
Fujian Happiness |
| 12 |
|
“Happiness” Sleeping Capsule |
|
No.0198(2002) |
|
not applicable |
|
Fujian Happiness |
| 13 |
|
“Happiness” Tablets |
|
G20140404 |
|
5/22/2026 |
|
Fujian Happiness |
| 14 |
|
“Happiness” American Ginseng Chicken Essence
Tonic |
|
G20040889 |
|
not applicable |
|
Fujian Happiness |
| 15 |
|
“Happiness” Calcium Iron Zinc Multidimensional
Oral Liquid (pregnant type) |
|
G20100149 |
|
6/2/2022
(under renewal)
|
|
Fujian Happiness |
| 16 |
|
“Happiness” Little Pigeon Oral Liquid |
|
No.0487(1998) |
|
not applicable |
|
Fujian Happiness |
| 17 |
|
“Happiness” Ginseng Taurine Drink |
|
G20140393 |
|
8/22/2026 |
|
Fujian
Happiness |
| 18 |
|
“Happiness” Fish Oil Vitamin E Soft Capsule |
|
G20100155 |
|
9/4/2024 |
|
Fujian
Happiness |
| 19 |
|
“Happiness” Vitamin E Soft Capsule |
|
G20090458 |
|
6/1/2022
(under renewal) |
|
Fujian
Happiness |
| 20 |
|
“Happiness” Calcium Tablets |
|
G202035000761 |
|
not applicable |
|
Fujian Happiness |
| 21 |
|
“Happiness” Selenium tablets |
|
G201935001306 |
|
not applicable |
|
Fujian Happiness |
| 22 |
|
“Happiness” Calcium Oral Liquid |
|
G201935000766 |
|
not applicable |
|
Fujian Happiness |
| 23 |
|
“Happiness” Coenzyme Q10 Capsule |
|
G202135100829 |
|
not applicable |
|
Fujian Happiness |
According
to CFDA regulations, “Blue Caps” approvals granted prior to July 1, 2005 do not have any expiration date, “Blue Caps”
approvals obtained after July 1, 2005 have a term of 5 years and maybe renewed. Our research and development team monitors the approval
status of our products. For all of our products that require approval renewal, we have already submitted to CFDA the renewal applications,
which are currently under review. Pending the renewal applications,
as long as the renewal requests have been filed with CFDA, we are still permitted to sell these products despite their approvals expired.
PRC Laws and Regulations Relating to Our Business
Registration and Approval of Dietary Supplements
Pursuant to the Food Safety
Law of PRC, which was amended on April 24, 2015 and became effective on October 1, 2015, the producers and business operators of
dietary supplements shall obtain licensing and shall carry out production and operation in accordance with food safety standards.
On February 26, 2016, CFDA
promulgated the Administrative Measures for the Registration and Record-filing of Dietary Supplements which became effective on July 1, 2016.
In accordance with the Administrative Measures for the Registration and Record-filing of Dietary Supplements, dietary supplements that
use raw materials other than those included in the catalogue of raw materials for dietary supplements shall be registered with CFDA.
To apply for the registration,
the applicant shall submit the following materials:
| |
● |
The application form for
registration and written legal liability undertaking that the applicant shall be responsible for the truthfulness of the application
material; |
| |
● |
Photocopies of the supporting
documents on the registration of the registration applicant; |
| |
● |
The research and development
reports of the dietary supplement, covering the research and development personnel, research and development time, development processes,
validation data for tests at and above the level of intermediate pilot experiments, Non-catalogue Raw Materials, demonstration reports
and relevant scientific bases for the safety, health benefits and quality controllability of the dietary supplements, product technical
requirements determined in a comprehensive manner according to the research and development results; |
| |
● |
Materials on the formula
of the dietary supplement, including the names and dosage of raw materials and auxiliary materials, production processes and quality
standards; where necessary, the bases for use of certain raw materials, descriptions on the parts used, certificates of inspection
conformity, variety appraisal reports, etc. shall also be provided in accordance with relevant provisions; |
| |
● |
Materials on the production
process of the dietary supplement, covering the diagram and descriptions of the production processes, key process control points
and descriptions; |
| |
● |
Materials on the assessment
of the safety and health benefits of the dietary supplement, covering assessment materials on the safety and health benefits tests
of Non-catalogue Raw Materials and the dietary supplements, assessment materials on the consumption of the dietary supplement by
human beings, testing reports on the effective ingredients or symbolic ingredients, hygiene, stability, strain identification, strain
virulence, etc. of the dietary supplement, as well as testing reports involving stimulants, ingredients of illegal substances; |
| |
● |
The types, names, relevant
standards, etc. concerning the packaging materials in direct contact with the dietary supplement; |
| |
● |
Labels and instruction
manual sample texts of the dietary supplement, and search materials proving that the generic names in the name of the dietary supplement
are not the same as the names of any registered drug; |
| |
● |
Samples of the dietary
supplement in three minimum sales packages; and |
| |
● |
Other materials related
to the assessment of the registration of the dietary supplement. |
The CFDA shall send all application
materials to the Assessment Agency within three c upon acceptance of the application. The Assessment Agency shall organize assessment
experts to examine application materials, organize Verification Agency to conduct on-site verification according to actual needs, and
organize the inspection agency to carry out review inspection. The Assessment Agency shall put forward the suggestions on the supplement
that the said product is scientific and safe, and has the claimed health benefits, that production processes of the said product are
reasonable, feasible and controllable in terms of quality, and that the technical requirements and inspection methods of the said product
are scientific and rational. After making comprehensive assessment conclusions and suggestions, the Assessment Agency shall submit the
same to the CFDA within five business days. The CFDA shall examine the legality, standardization and integrity of assessment procedures
and conclusions and suggestions within 20 business days upon acceptance of the comprehensive assessment conclusions and suggestions on
the dietary supplement, and make a decision to register or not to register the said product.
In the event the registrant
of a dietary supplement transfers relevant technology, the transferee shall submit a new application for registration of the dietary
supplement under the guidance of the transferor, and the technical requirements, etc. of the dietary supplement shall remain consistent
with the original application materials. In addition to the application materials for registration, the transferee shall also submit
the notarized transfer contract. Where pertinent requirements are met, the CFDA will issue a new registration certificate of the dietary
supplement to the transferee upon verification, and deregister the dietary supplement registration of the transferor.
Where the registration certificate
of a dietary supplement that has already been manufactured for sale needs to be renewed upon expiry, the registrant of the dietary supplement
shall apply for renewal six months prior to the expiry. The food and drug administration that receives an application for renewal of
the registration of a dietary supplement shall make a decision on whether to approve the renewal application prior to the expiry of the
registration certificate of the dietary supplement. The failure of the food and drug administration to make a decision within the prescribed
time period shall be deemed as approval of renewal. Where renewal of registration is approved, a new registration certificate of dietary
supplement shall be issued, and the original registration certificate of dietary supplement shall be deregistered at the same time.
Record-filing of Dietary Supplements
Pursuant to the Administrative
Measures for the Registration and Record-filing of Dietary Supplement, dietary supplements whose raw materials used have been included
in the catalogue of raw materials for dietary supplements shall be subject to record-filing.
To apply for the record-filing
of a dietary supplement, a record-filing party shall submit the following materials:
| |
● |
The record-filing and registration
form for the dietary supplements, and written legal liability undertaking that the record-filing party shall be responsible for the
truthfulness of the materials submitted; |
| |
● |
Photocopies of the supporting
documents on the registration of the record-filing party; |
| |
● |
Materials on the formula
of the dietary supplement, including the names and dosage of raw materials and auxiliary materials, production processes and quality
standards; where necessary, the bases for use of certain raw materials, descriptions on the parts used, certificates of inspection
conformity, variety appraisal reports, etc. shall also be provided in accordance with relevant provisions; |
| |
● |
Materials on the production
process of the dietary supplement, covering the diagram and descriptions of the production processes, key process control points
and descriptions; |
| |
● |
Materials on the assessment
of the safety and health care functions of the dietary supplement, covering assessment materials on the safety and health benefits
tests of Non-catalogue Raw Materials and the dietary supplement, assessment materials on the consumption of the dietary supplements
by human beings, testing reports on the effective ingredients or symbolic ingredients, hygiene, stability, strain identification,
strain virulence, etc. of the dietary supplements, as well as testing reports involving stimulants, ingredients of illegal substances; |
| |
● |
The types, names, relevant
standards, etc. concerning the packaging materials in direct contact with the dietary supplement; |
| |
● |
Labels and instruction
manual sample texts of the dietary supplement, and search materials proving that the generic names in the name of the dietary supplement
are not the same as the names of any registered drug; |
| |
● |
Materials on the technical
requirements of the dietary supplement; |
| |
● |
An all-item inspection
report issued by a duly qualified inspection agency that the dietary supplement meets product technical requirements; and |
| |
● |
Other materials demonstrating
the safety and health benefits of the dietary supplement. |
Upon receipt of record-filing
materials, CFDA shall process record-filing on the spot if such materials meet relevant requirements; and, where the record-filing materials
fail to meet the relevant requirements, the food and drug administration shall inform the record-filing party concerned to make all necessary
corrections/submit all necessary supplementary materials at one time.
Under the above laws and
regulations, we have obtained Food Production License in December 2017 from Nanping Food and Drug Administration, and we also have obtained
the registration and record-filing of dietary supplements that we produced.
Safety Standards relating to Dietary Supplements
Pursuant to the Food Safety
Law of PRC, which was amended on April 24, 2015 and became effective on October 1, 2015, the producers and business operators of dietary
supplements shall obtain licensing and shall carry out production and operation in accordance with food safety standards. According to
‘National Food Safety Standards: Nutraceutical Food’ (GB 16740-2014) by National Health Commission of PRC (formerly known
as National Health and Family Planning Commission of PRC), dietary supplements shall meet the standard in the aspect of raw materials,
physical-chemical properties, provisions on the quantitative limits of polluting substances, mycotoxin, and microorganisms, as well as
food additives and nutrient supplement. According to the Administrative Measures for the Registration and Record-filing of Dietary Supplements,
which became effective on July 1, 2016, to apply for the registration of dietary supplements, the applicant shall submit the research
and development reports, materials on the formula of the dietary supplement, relevant standards concerning the packaging materials and
other materials relating to the registration which are sufficient to prove the dietary supplement meets the standard provided by law
and National Food Safety Standards. Under the laws and regulations on nutraceutical and dietary supplements, we have obtained the registration
or record-filing of each nutraceutical and dietary supplements product that we produced and all of the products we produced meet the
food safety standards.
Packages of Dietary Supplement
In accordance with the Administrative
Measures for the Registration and Record-filing of Dietary Supplement, the labels and texts of the instruction manuals of dietary supplement
shall cover the name, raw materials and auxiliary materials of the said product, its effective ingredients or symbolic ingredients and
the contents thereof, the suitable and unsuitable groups, health care functions, consumption volume and methods, specifications, storage
methods and shelf life of the said product, precautions and other relevant contents, as well as relevant formula bases and descriptions,
etc. The labels and the main contents of the instruction manuals, of a dietary supplement shall not involve any disease prevention or
treatment function, and shall include the statement that “This product is not a substitute for medication”.
Key Differences between Regulations on Dietary Supplements and
on traditional Chinese Medicine
According to the Food Safety
Law of PRC, the producers and business operators of dietary supplements shall obtain Food Production License. Pursuant to the Administrative
Measures for the Registration and Record-filing of Dietary Supplements, dietary supplements that use raw materials other than those included
in the catalogue of raw materials for dietary supplements shall be registered with CFDA. Furthermore, dietary supplements whose raw materials
used have been included in the catalogue of raw materials for dietary supplements shall be subject to record-filing. Under the laws and
regulations on nutraceutical and dietary supplements, we have obtained Food Production License in 2017 from Nanping Food and Drug Administration
and the registration or record-filing of each nutraceutical and dietary supplements product that we produced, and there is no need to
apply for additional permits from Nanping Food and Drug Administration in order to manufacture or sell our products.
According to the Food Safety
Law of PRC, the State encourages enterprises engaging in food production and operation to meet the requirements of good manufacturing
practice (“GMP”), and thus the GMP we obtained in 2005 does not need to be renewed.
According to the Law of the
PRC on traditional Chinese Medicine, the traditional Chinese medicine is the umbrella term for the medicine of all ethnic groups in China;
it is a medicine system with a long history and unique theoretical and technical methods. The State encourages the exchanges, mutual
enhancement and coordinated development of the traditional Chinese medicine and Western medicine. In China, nutraceutical industry belongs
to food manufacturing industry and is subject to laws and regulations pertaining to the food manufacturing industry, while traditional
Chinese medicine products are subject to various PRC laws and regulations pertaining to the pharmaceutical industry.
The Law of the PRC on the
Administration of Pharmaceuticals provides the basic legal framework for the administration of the production and sale of pharmaceuticals
in China and covers the manufacturing, distribution, packaging, pricing and advertising of pharmaceutical products. A pharmaceutical
manufacturer, including a traditional Chinese Medicine products manufacturer, must obtain a pharmaceutical manufacturing permit from
the CFDA’s relevant provincial branch. This permit is valid for five years and is renewable for an additional five-year period
upon its expiration.
In addition, a pharmaceutical
manufacturer, including a traditional Chinese Medicine products manufacturer, must meet the GMP standards for each of its production facilities
in China for each form of pharmaceutical product it produces. GMP standards include staff qualifications, production premises and facilities,
equipment, raw materials, environmental hygiene, production management, quality assurance and customer complaint administration. Furthermore,
the staff qualifications set quality standards that the manufacturer should have an adequate number of management and operation personnel
with the necessary qualifications. Premises, facilities and equipment must aim to minimize the risk of contamination, cross-contamination
and permit effective cleaning operation and maintenance. As a part of quality management system, quality assurance system should be established
by manufacturers, and integrated document system is required to ensure system effective operation. A reporting and supervising management
system for drug adverse reactions are required by customer complaint administration and a person should be designated responsible for
handling the complaints and deciding the measures to be taken; all complaint, investigation information shall be informed to a qualified
person. If a manufacturer meets the GMP standards, the CFDA will issue to the manufacturer a GMP certificate with a five-year validity
period. The New GMP Standards became effective on March 1, 2011 and pharmaceutical manufacturers (except manufacturers of injectable,
blood products or vaccines, which have a three-year grace period) had a five-year grace period to upgrade existing facilities to comply
with the new standards.
Manufacturers and vendors
of defective products in the PRC may incur liability for losses and injuries caused by such products. Under the General Principles of
the Civil Laws of the PRC, which became effective on January 1, 1987 and were amended on August 27, 2009, manufacturers or retailers
of defective products that cause property damage or physical injury to any person will be subject to civil liability.
In 1993, the General Principles
of the PRC Civil Law were supplemented by the Product Quality Law of the PRC (as amended in 2000 and 2009) and the Law of the PRC on
the Protection of the Rights and Interests of Consumers (as amended in 2009), which were enacted to protect the legitimate rights and
interests of end-users and consumers and to strengthen the supervision and control of the quality of products. If our products are defective
and cause any personal injuries or damage to assets, our customers have the right to claim compensation from us.
Regulations on E-commerce
On August 31, 2018, the Standing
Committee of the National People’s Congress (the “SCNPC”) promulgated the PRC E-Commerce Law, or the E-Commerce Law,
which became effective on January 1, 2019. The E-Commerce Law establishes the regulatory framework for the e-commerce sector in the PRC
for the first time by laying out certain requirements on e-commerce operators, including e-commerce platform operators like us. Pursuant
to the E-Commerce Law, e-commerce platform operators are required to (i) take necessary actions or report to relevant competent government
authorities when such operators notice any illegal production or services provided by merchants on the e-commerce platforms; (ii) verify
the identity of the business operators on the platforms; (iii) provide identity and tax related information of merchants to local branches
of State Administration of Market Regulation and tax bureaus; or (iv) record and preserve goods and service information and transaction
information on the e-commerce platform. The E-Commerce Law also specifically stipulates that e-commerce platform operators shall not
impose unreasonable restrictions or conditions on the transactions of their business operators on the platforms. According to the E-Commerce
Law, failures to comply with these requirements may subject the e-commerce platform operators to administrative penalties, fines and/or
suspension of business. In addition, for goods and services provided via e-commerce platforms and pertinent to the life and health of
consumers, e-commerce platform operators shall bear relevant responsibilities, which may give rise to civil or criminal liabilities if
the consumers suffered damages due to the e-commerce platform operators’ failure to duly verify the qualifications or the licenses
of the business operators on the platforms or to duly perform their safety protection obligations as required by the E-Commerce Law.
Moreover, the E-Commerce
Law imposes a requirement on operators of e-commerce platforms to assist in tax collection with respect to income generated by sellers
from transactions conducted on e-commerce platforms, including among others, submitting to the tax authority information on the identities
of sellers on e-commerce platforms and other information relating to tax payment. Failure to comply with the requirement may result in
operators of e-commerce platform being subject to fines and, in severe circumstances, suspension of business operations of e-commerce
platforms.
On January 26, 2014, the
State Administration for Industry and Commerce, which is the predecessor of the SAMR, promulgated the Administrative Measures for Online
Trading, or the Online Trading Measures, which became effective on March 15, 2014, to regulate all operating activities for product sales
and services provision via the internet (including mobile internet). It stipulates the obligations of online product operators and services
providers and certain special requirements applicable to third-party platform operators. On March 15, 2021, the SAMR promulgated the
revised vision of the Online Trading Measures, which took into effect on May 1, 2021. The revision makes further provisions with regard
to emerging models of online trading (such as online social networking and online live streaming), consumer rights protection, personal
information protection, etc. It also imposes new obligations on the e-commerce platform operators, such as verifying and registering
the identity of trading parties on the platform either that are required to registered with SAMR or that are exempted from such registration,
regular reporting of prescribed information of trading parties on the platform to the relevant branch of SAMR, establishing a system
of inspection and monitoring of information on the goods sold or services provided on the platform.
Regulations on Consumer Protection
On October 31, 1993, the
Standing Committee of the National People’s Congress, or SCNPC, promulgated the Law on the Protection of Rights and Interests of
Consumers, or the Consumer Protection Law, which was amended on August 27, 2009 and October 25, 2013. Pursuant to the Consumer Protection
Law, the business operators must ensure that the commodities they sell satisfy the safety requirements, provide consumers with authentic
information, and guarantee the quality, function, term of use of the commodities. Failure to comply with the Consumer Protection Law
may subject business operators to liabilities such as refund, returns, repairs, and payment of damages. If business operators infringe
the legal rights and interests of consumers, they may be subject to criminal liabilities. The amended Consumer Protection Law launched
in October 2013 further enhances consumer protection and intensifies the obligations imposed on online trading platform and business
operators.
The Tort Liability Law, which
was promulgated by the SCNPC on December 26, 2009 and became effective on July 1, 2010, provides that if an online services provider
is aware that an online user is engaged in infringing activities, such as selling counterfeit products through its internet services,
but fails to take necessary measures, it shall be held jointly liable. If the online service provider receives any notice from the infringed
party on any infringing activities, the online service provider shall take necessary measures, including removing, blocking and unlinking
the infringing content, in a timely manner. Otherwise, it shall be held jointly liable with the relevant online user.
On May 31, 2010, the SAIC
(the predecessor of the State Administration of Market Regulation) adopted the Interim Administrative Measures for the Online Commodities
Trading and Relevant Services. According to these measures, enterprises or other operators which engage in online commodities trading
and other services that have been registered with SAIC or its local branches must make the information available to the public in their
business licenses, either through physical copies or electronic links. Operators that provide platform services for online trading shall
review the identities of companies or individuals that apply for provision of commodities and services through online trading platform,
conclude agreements with the aforesaid parties as well as establish relevant internal rules to provide necessary and reliable transaction
environment and transaction service, and maintain order of online trading.
On January 26, 2014, the
SAIC promulgated the Administrative Measure for the Online Trading, or the Online Trading Measures, which became effective as of March
15, 2014 and replaced the above measures. The online trading platform operators are obligated to examine the legal status of the third-party
merchants and make the information such third-party merchants available to the public through business licenses, either through displaying
the information specified in their business licenses or electronic links to their business licenses. The online trading platform operators
must distinguish between their own products and those of third-party merchants on the platform, as applicable. Subsequent to the Online
Trading Measures, the SAIC issued the Guidelines for the Performance of Social Responsibilities by Online Trading Platform Operators
on May 28, 2014 to regulate online product trading and the relevant services, guide online trading platform operators to actively perform
social responsibilities, protect the lawful rights and interests of consumers and business operators and promote the sustainable and
healthy development of online economy. These guidelines aim at enhancing the social responsibilities of online trading platforms.
On January 6, 2017, the SAIC
promulgated the Interim Measures for 7-day Unconditional Return of Online Purchased Goods, which was effective as of March 15, 2017.
Under such measures, customers are entitled to return goods without cause, subject to certain exceptions. For example, these measures
shall not apply to customized goods, newspapers or periodicals, perishable goods, audio-visual products, computer software and other
digital products, products downloaded from the internet or products whose packages have been opened by customers. Online trading platform
operators should guide and supervise the merchants who use the platform to perform the duties of “7-day Unconditional Return,”
conduct inspections, and provide technical support.
Regulations on Advertising
On October 27, 1994, the
SCNPC promulgated the Advertising Law, which was amended on April 24, 2015. Under the Advertising Law, advertisers refer to any legal
persons, economic organizations or individuals that, directly or through agents, design, produce and publish advertisements to promote
products or services. Advertisement operators refer to those legal persons, economic organizations or individuals consigned to provide
advertisement content design, production and agency services. Advertisement publishers refers to those legal persons or other economic
organizations that publish advertisements for the advertisers or for those advertisement operators which are consigned by the advertisers.
An advertisement should present distinct and clear descriptions of the product’s function, place of origin, quality, price, manufacturer,
validity period, warranties or the contents, forms, quality, price or promises of the services offered. False advertising that may mislead
consumers and compromise legal rights and interests of consumers shall subject the advertiser to civil liabilities. Where the advertising
operator or advertising publisher is unable to provide the real name, address or valid contact information of the advertiser, the consumers
may require the advertising operator or advertising publisher make compensation in advance. For false advertisements of goods or services
other than those stipulated in the preceding paragraph which caused harm to consumers, where the advertising operator, advertising publisher
and advertising spokesperson knew or should have known the falsity yet still provided design, production, agency or publishing services,
or provide recommendation or endorsement, they shall bear joint and several liability with the advertiser.
On July 4, 2016, the SAIC
promulgated the Interim Measures for the Administration of Internet Advertising, or the Internet Advertising Measures, which became effective
as of on September 1, 2016. The Internet Advertising Measures set forth further compliance requirements for online advertising business
in addition to those in the Advertising Law. Pursuant to the Internet Advertising Measures, Internet Advertising refers to the commercial
advertising for direct or indirect marketing goods or services in the form of text, image, audio, video, or others means through websites,
webpages, internet apps, or other internet media. Major additional compliance requirements are: (i) advertisements must be identifiable
and marked with the word “advertisement,” enabling consumers to distinguish them from non-advertisement content; (ii) publishing
advertisements on the Internet through a pop-up page or in other forms shall provide a prominently marked “CLOSE” button
to ensure “one-click closure”; (iii) sponsored search results must be clearly distinguished from organic search results;
(iv) it is forbidden to send advertisements or advertisement links by email without the recipient’s permission or induce Internet
users to click on an advertisement in a deceptive manner; and (v) internet information service providers that do not participate in the
operation of internet advertisements should stop publishing illegal advertisements if they know or should know that the advertisements
are illegal.
Regulations on Automobile Sales
Pursuant to the Administrative
Measures on Automobile Sales promulgated by the Ministry of Commerce, or the MOFCOM on April 5, 2017, which became effective on July
1, 2017, automobile suppliers and dealers are required to file with relevant authorities through the information system for the national
automobile circulation operated by the competent commerce department within 90 days after the receipt of a business license. Where there
is any change to the information concerned, automobile suppliers and dealers must update such information within 30 days after such change.
Regulations on the Recall of Defective Automobiles
On October 22, 2012, the
State Council promulgated the Administrative Provisions on Defective Automotive Product Recalls, which became effective on January 1,
2013. The product quality supervision department of the State Council is responsible for the supervision and administration of recalls
of defective automotive products nationwide. Pursuant to the administrative provisions, manufacturers of automobile products are required
to take measures to eliminate defects in products they sell. A manufacturer must recall all defective automobile products. Failure to
recall such products may result in an order to recall the defective products from the quality supervisory authority of the State Council.
If any operator conducting sales, leasing, or repair of vehicles discovers any defect in automobile products, it must cease to sell,
lease or use the defective products and must assist manufacturers in the recall of those products. Manufacturers must recall their products
through publicly available channels and publicly announce the defects. Manufacturers must take measures to eliminate or cure defects,
including rectification, identification, modification, replacement or return of the products. Manufacturers that attempt to conceal defects
or do not recall defective automobile products in accordance with relevant regulations will be subject to penalties, including fines,
forfeiture of any income earned in violation of law and revocation of licenses.
Pursuant to the Implementation
Rules on the Administrative Provisions on Defective Automotive Product Recalls which was promulgated by the QSIQ on November 27, 2015
and became effective on January 1, 2016, if a manufacturer is aware of any potential defect in its automobiles, it must investigate in
a timely manner and report the results of such investigation to the QSIQ. Where any defect is found during the investigations, the manufacturer
must cease to manufacture, sell, or import the relevant automobile products and recall such products in accordance with applicable laws
and regulations.
Policies Relating to Incentives for Electric
Vehicle Charging Infrastructure
On January 11, 2016, the
MOF, the MOST, the MIIT, the NDRC and the National Energy Administration, or the NEA, jointly promulgated the Circular on Incentive Policies
on the Charging Infrastructures of New Energy Vehicles and Strengthening the Promotion and Application of New Energy Vehicles during
the 13th Five-year Plan Period, which became effective on January 1, 2016. Pursuant to such circular, the central finance department
is expected to provide certain local governments with funds and subsidies for the construction and operation of charging facilities and
other relevant charging infrastructure.
On November 29, 2016, the
State Council promulgated Notice on the National Strategic Emerging Industry Plan during the 13th Five-year Plan. The State Council further
encouraged the application of new energy and new energy vehicles, and intended to develop and construct these industries as pillar industries
of the nation. Pursuant to the Notice, municipal governments include Anhui, Henan, and Sichuan Province, released development plans to
promote the development of new energy vehicle industry. These measures range from constructing charging infrastructures to encouraging
expansion of new energy sales market and sales of new energy vehicles.
Certain local governments
have also implemented incentive policies for the construction and operation of charging infrastructure. For example, pursuant to the
Supporting Measures on Encouraging the Development of Charging Infrastructures of the Electric Vehicles in Shanghai, builders of certain
non-self-use charging infrastructure may be eligible for subsidies for up to 30% of its investment cost, and the operator of certain
non-self-use charging infrastructure may be eligible for subsidies calculated based on electricity output.
All the above incentives
are expected to facilitate acceleration of development of public charging infrastructure, which will consequently offer more accessible
and convenient EV charging solutions to purchasers of electric vehicles.
Regulation on Foreign Exchange Control
Foreign exchange in China is primarily regulated
by:
| |
● |
The Foreign Currency Administration
Regulations (1996), as amended on January 14, 1997 and August 5, 2008; and |
| |
● |
The Administration Rules
of the Settlement, Sale and Payment of Foreign Exchange (1996), or the Administration Rules. |
Under the Foreign Currency
Administration Regulations, the Renminbi is convertible for current account items, including the distribution of dividends, interest
payments and trade and service-related foreign exchange transactions. Conversion of Renminbi into foreign currency for capital account
items, such as, loans, investment in securities and repatriation of investments, however, remains subject to the registration of the
SAFE or its local counterparts as required by law. Under the Administration Rules, foreign-invested enterprises may buy, sell and remit
foreign currencies at banks authorized to conduct foreign exchange transactions for settlement of current account transactions after
providing valid commercial documents and, in the case of capital account item transactions, only after registration with the SAFE and,
as the case may be, other relevant PRC government authorities as required by law. Capital investments directed outside of China by foreign-invested
enterprises are also subject to restrictions, which include registration filing with MOFCOM. If the investment is made to the sensitive
countries, districts, or industries, it needs to be approved by MOFCOM.
The value of the Renminbi
against the U.S. dollar and other currencies may fluctuate and is affected by, among other things, changes in China’s political
and economic conditions. The conversion of Renminbi into foreign currencies, including U.S. dollars, has been based on rates set by the
People’s Bank of China. On July 21, 2005, the PRC government changed its policy of pegging the value of the Renminbi to the
U.S. dollar. Under the new policy, the Renminbi will be permitted to fluctuate within a band against a basket of certain foreign
currencies. We receive a significant portion of our revenue in Renminbi, which is not a freely convertible currency. Under our current
structure, our income will be primarily derived from dividend payments from our subsidiaries in China. Even though we may remit the income
from China to anywhere we want, the fluctuation of exchange rate may be a disadvantage to us if Renminbi depreciated.
In November 2012, SAFE promulgated
the Circular of Further Improving and Adjusting Foreign Exchange Administration Policies on Foreign Direct Investment, as amended on
May 4, 2015, which substantially amends and simplifies the current foreign exchange procedure. Pursuant to this circular, the opening
of various special purpose foreign exchange accounts, such as pre-establishment expenses accounts, foreign exchange capital accounts
and guarantee accounts, the reinvestment of Renminbi proceeds derived by foreign investors in China, and remittance of foreign exchange
profits and dividends by a foreign-invested enterprise to its foreign shareholders no longer require the approval or verification of
SAFE, and multiple capital accounts for the same entity may be opened in different provinces, which was not possible previously. In addition,
SAFE promulgated the Provisions on Foreign Exchange Administration over Direct Investment Made by Foreign Investors in China in May 2013,
which specifies that the administration by SAFE or its local branches over direct investment by foreign investors in China must be conducted
by way of registration and banks must process foreign exchange business relating to the direct investment in China based on the registration
information provided by SAFE and its branches. On February 28, 2015, SAFE promulgated the Notice on Further Simplifying and Improving
the Administration of the Foreign Exchange Concerning Direct Investment, or SAFE Notice 13. After SAFE Notice 13 became effective on
June 1, 2015, instead of applying for approvals regarding foreign exchange registrations of foreign direct investment and overseas direct
investment from SAFE, entities and individuals may apply for such foreign exchange registrations from qualified banks. The qualified
banks, under the supervision of SAFE, may directly review the applications and conduct the registration.
On March 30, 2015, SAFE promulgated
the Circular of the SAFE on Reforming the Management Approach regarding the Settlement of Foreign Capital of Foreign-invested Enterprise,
or Circular 19, which expands a pilot reform of the administration of the settlement of the foreign exchange capitals of foreign-invested
enterprises nationwide. Circular 19 came into force and replaced both the Circular of the State Administration of Foreign Exchange on
Issues Relating to the Improvement of Business Operations with Respect to the Administration of Foreign Exchange Capital Payment and
Settlement of Foreign-invested Enterprises, or Circular 142 and the Circular of the State Administration of Foreign Exchange on Issues
concerning the Pilot Reform of the Administrative Approach Regarding the Settlement of the Foreign Exchange Capitals of Foreign-invested
Enterprises in Certain Areas, or Circular 36 on June 1, 2015. Circular 19 allows foreign-invested enterprises established in China whose
main business is investment to use their foreign exchange capitals to make equity investment and removes certain other restrictions under
Circular 142. However, Circular 19 continues to prohibit foreign-invested enterprises from, among other things, using Renminbi fund converted
from its foreign exchange capitals for expenditure beyond its business scope and providing entrusted loans or repaying loans between
non-financial enterprises.
SAFE promulgated the Notice
of the State Administration of Foreign Exchange on Reforming and Standardizing the Foreign Exchange Settlement Management Policy of Capital
Account, or Circular 16, effective in June 2016, which reiterates some of the rules set forth in Circular 19, but compared to Circular
19, Circular 16 provides that discretionary foreign exchange settlement applies to foreign exchange capital, foreign debt offering proceeds
and remitted foreign listing proceeds, and the corresponding Renminbi capital converted from foreign exchange are not restricted from
extending loans to related parties or repaying the intercompany loans (including advances by third parties).
SAFE further promulgated
Notice of the State Administration of Foreign Exchange on Further Facilitating Cross-border Trade and Investment, or Circular 28, effective
from January 2020, which allows all foreign-invested enterprises to make domestic equity investments using their foreign exchange capitals
or Renminbi fund converted from its foreign exchange capitals with limited preconditions. However, there exist substantial uncertainties
with respect to the interpretation and implementation in practice with respect to the Circular 28, Circular 16 and other laws and regulations
related to foreign currency exchange.
Regulation on Foreign Exchange Registration of Offshore Investment
by PRC Residents
SAFE Circular on Relevant
Issues Relating to Domestic Resident’s Investment and Financing and Roundtrip Investment through Special Purpose Vehicles, or SAFE
Circular 37, issued by SAFE and effective on July 4, 2014, regulates foreign exchange matters in relation to the use of special purpose
vehicles, or SPVs, by PRC residents or entities to seek offshore investment and financing and conduct round trip investment in China.
Under SAFE Circular 37, an SPV refers to an offshore entity established or controlled, directly or indirectly, by PRC residents or entities
for the purpose of seeking offshore financing or making offshore investment, using legitimate domestic or offshore assets or interests,
while “round trip investment” refers to the direct investment in China by PRC residents or entities through SPVs, namely,
establishing foreign-invested enterprises to obtain the ownership, control rights and management rights. SAFE Circular 37 requires that,
before making contribution into an SPV, PRC residents or entities are required to complete foreign exchange registration with SAFE or
its local branch. In the event of change of basic information such as the individual shareholder, name, operation term, etc., or if there
is a capital increase, decrease, equity transfer or swap, merge, spin-off or other amendment of the material items, the PRC residents
or entities shall complete foreign exchange alteration registration formality for offshore investment. The SAFE Circular 37 further provides
that option or share-based incentive tool holders of a non-listed SPV can exercise the options or share incentive tools to become a shareholder
of such non-listed SPV, subject to registration with SAFE or its local branch. In addition, according to the procedural guidelines as
attached to SAFE Circular 37, PRC residents or entities are only required to register the SPV directly established or controlled (first
level).
On February 13, 2015, SAFE
further promulgated the Circular on Further Simplifying and Improving the Administration of the Foreign Exchange Concerning Direct Investment,
or SAFE Circular 13, which took effect on June 1, 2015. SAFE Circular 13 has amended SAFE Circular 37 by requiring PRC residents or entities
to register with qualified banks rather than SAFE or its local branch in connection with their establishment or control of an offshore
entity established for the purpose of overseas investment or financing.
Regulation on Dividend Distributions
Our PRC subsidiary, Happiness
Nanping is a wholly foreign-owned enterprise under the PRC law. The principal regulations governing the distribution of dividends paid
by wholly foreign-owned enterprises include:
| |
● |
Corporate Law (1993) as
amended in 2005 and 2013; |
| |
● |
The Wholly Foreign-Owned
Enterprise Law (1986), as amended in 2000; |
| |
● |
The Wholly Foreign-Owned
Enterprise Law Implementation Regulations (1990), as amended in 2001; and |
| |
● |
The Enterprise Income Tax
Law (2007) and its Implementation Regulations (2007). |
Under these regulations,
wholly foreign-owned enterprises in China may pay dividends only out of their accumulated profits, if any, as determined in accordance
with PRC accounting standards and regulations. In addition, an enterprise in China is required to set aside at least 10% of its after-tax
profit based on PRC accounting standards each year to its general reserves until its cumulative total reserve funds reaches 50% of its
registered capital. Our Company’s reserve fund has not yet reached this level. The board of directors of a wholly foreign-owned
enterprise has the discretion to allocate a portion of its after-tax profits to its employee welfare and bonus funds. These reserve funds,
however, may not be distributed as cash dividends.
On March 16, 2007, the
National People’s Congress enacted the Enterprise Income Tax Law, and on December 6, 2007, the State Council issued the Implementation
Regulations on the Enterprise Income Tax Law, both of which became effective on January 1, 2008. Under this law and its implementation
regulations, dividends payable by a foreign-invested enterprise in the PRC to its foreign investor who is a non-resident enterprise will
be subject to a 10% withholding tax, unless any such foreign investor’s jurisdiction of incorporation has a tax treaty with the
PRC that provides for a lower withholding tax rate.
M&A Rules and Regulation on Overseas Listings
On August 8, 2006, six
PRC regulatory agencies, MOFCOM, the State Assets Supervision and Administration Commission, the State Administration for Taxation, the
State Administration for Industry and Commerce, CSRC and SAFE, jointly adopted the Regulation on Mergers and Acquisitions of Domestic
Enterprises by Foreign Investors, or the M&A Rules, which became effective on September 8, 2006, and were later amended on June
22, 2009. The M&A Rules purport, among other things, to require that offshore SPVs that are controlled by PRC companies or individuals
and that have been formed for overseas listing purposes through acquisitions of PRC domestic interests held by such PRC companies or
individuals, obtain the approval of the CSRC prior to publicly listing their securities on an overseas stock exchange.
On July 6, 2021, the relevant
PRC government authorities issued Opinions on Strictly Cracking Down Illegal Securities Activities in Accordance with the Law, or the
Opinions on Security Activities, which calls for the need to strengthen the administration over illegal securities activities and the
supervision on overseas listings by China-based companies and proposed to take effective measures, such as promoting the construction
of relevant regulatory systems to deal with the risks and incidents faced by China-based overseas-listed companies. On December 24, 2021,
the State Council issued a draft Regulations of the State Council on the Administration of Overseas Issuance and Listing of Securities
by Domestic Companies (Draft for Comments), or the Draft Provisions, and the CSRC issued a draft Measures for the Record-Filing of Overseas
Securities Offering and Listing by Domestic Companies (Draft for Comments), or the Draft Administration Measures, for public comments.
Pursuant to these drafts, PRC domestic companies that seek to directly or indirectly offer and list their securities, including overseas,
should file with the CSRC certain required documents. Among the other things, “directly overseas offering and listing by PRC domestic
companies” are defined as overseas offering and listing of the securities of PRC companies limited by shares, and “indirectly
overseas offering and listing by PRC domestic companies” are defined as overseas offering and listing of the securities of offshore-incorporated
companies whose main business operations are in mainland China, based on their onshore equity, assets or similar interests. Specifically,
the examination and determination of an indirect offering and listing will be conducted on a substance-over-form basis, and an offering
and listing shall be considered as an indirect overseas offering and listing by a domestic company if the issuer meets the following
conditions: (i) the operating income, gross profit, total assets, or net assets of the domestic enterprise in the most recent fiscal
year was more than 50% of the relevant line item in the issuer’s audited consolidated financial statement for that year; and (ii)
senior management personnel responsible for business operations and management are mostly PRC citizens or are ordinarily resident in
the PRC, and the main place of business is in the PRC or carried out in the PRC. According to the Draft Administration Measures, the
issuer or its affiliated domestic company, as the case may be, should file with the CSRC for its initial public offering, follow-on offering,
listing of securities in another overseas market, and other equivalent offing activities. Particularly, the issuer should submit the
filing with respect to its initial public offering and listing or listing of securities in another overseas market within three business
days after submitting the application documents for the foregoing transactions and the issuer should submit the filing with respect to
its follow-on offering within three business days after completion of the follow-on offering. Besides, direct or indirect overseas listing
of assets of PRC domestic companies by merger and acquisition, share swap, allocation, or other arrangements through one of a series
of transactions are also subject to filing with the CSRC. Failure to comply with the filing requirements may result in fines to the relevant
domestic companies, suspension of their businesses, revocation of their business licenses and operation permits and fines on the controlling
shareholder and other responsible persons. The Draft Administration Measures also sets forth certain regulatory red lines for overseas
offerings and listings by domestic enterprises. As of the date of this annual report, the Draft Provisions and the Draft Administration
Measures were released for public comment only. There are uncertainties as to whether the Draft Provisions and the Draft Administration
Measures would be further amended, revised or updated. Substantial uncertainties exist with respect to the enactment timetable and final
content of the Draft Provisions and the Draft Administration Measures. As the CSRC may formulate and publish guidelines for filings in
the future, the Draft Administration Measures does not provide for detailed requirements of the substance and form of the filing documents.
In a Q&A released on its official website, the respondent CSRC official indicated that the proposed new filing requirement will start
with new companies and the existing companies seeking to carry out activities like follow-on financing or listing of securities in another
overseas market. As for the filings for the existing companies, the regulator will grant adequate transition period and apply separate
arrangements. The Q&A also addressed the contractual arrangements and pointed out that if relevant domestic laws and regulations
have been observed, companies with compliant variable interest entity structure may seek overseas listing after completion of the CSRC
filings. Nevertheless, it does not specify what qualify as compliant variable interest entity structures and what relevant domestic laws
and regulations are required to be complied with.
On December 27, 2021, the
NDRC and the Ministry of Commerce, jointly issued the 2021 Negative List, which became effective on January 1, 2022. Pursuant to the
2021 Negative List, if a domestic company engaging in the prohibited business stipulated in the 2021 Negative List seeks an overseas
offering and listing, it shall obtain the approval from the competent governmental authorities. Besides, the foreign investors of the
company shall not be involved in the company’s operation and management, and their shareholding percentages shall be subject, mutatis
mutandis, to the relevant regulations on the domestic securities investments by foreign investors. As the 2021 Negative List is relatively
new, there remain substantial uncertainties as to the interpretation and implementation of these new requirements, and it is unclear
as to whether and to what extent listed companies like us will be subject to these new requirements.
On April 2, 2022, the CSRC
published the amended version of the Provisions on Strengthening the Confidentiality and Archives Administration Related to Overseas
Issuance and Listing of Securities (Draft for Comments), or the Draft Amended Provisions on Confidentiality. According to the Draft Amended
Provisions on Confidentiality, (i) domestic companies directly or indirectly listed overseas should obtain the approvals from the competent
governmental authorities and file with secret administration authorities in advance, if such domestic companies intend to provide or
disclose documents or files involving state secrets or government authorities’ secrets to securities companies, securities service
providers or offshore regulators, and (ii) such domestic companies must comply with relevant rules and regulations and follow the applicable
procedures in case of providing or disclosing documents or files, which may cause negative impacts to national interests or public interests
in case of leakage, to securities companies, securities service providers or offshore regulators. Furthermore, the Draft Amended Provisions
on Confidentiality provides that the oversea securities regulatory authorities and relevant competent authorities that intend to conduct
investigations or inspections on domestic companies in relation to their overseas securities issuance and listing-related activities,
will be subject to the cross-border regulatory cooperation mechanism, and the domestic companies involved should file reports to CSRC
or competent authorities in advance before cooperating with such investigations or inspections. As of the date of this annual report,
the Draft Amended Provisions on Confidentiality was released for public comment only. There are substantial uncertainties as to whether
the Draft Amended Provisions on Confidentiality would be further amended, revised or updated.
Restriction on Foreign Ownership
Pursuant to the Foreign Investment
Industries Guidance Catalog (2017 Revision), or the 2017 Catalogue, which was amended by the NDRC and the MOFCOM, and became effective
on July 28, 2017 replacing the Foreign Investment Industries Guidance Catalog (2015 Revision). The 2017 Catalogue classifies the various
industries into three categories: encouraged, restricted and prohibited. Our company’s primary products, nutraceutical products,
are encouraged industries for foreign investors.
The Special Administrative
Measures for Access of Foreign Investment (Foreign Investment Access Negative List) set forth in the 2017 Catalogue was replaced by the
Special Administrative Measures for Access of Foreign Investment (Negative List) (2018 Version), or the 2018 Negative List, promulgated
on June 28, 2018 with effect on July 28, 2018, which imposes the same restriction and prohibition on foreign investors. On June 30, 2019,
the MOFCOM and the NDRC jointly released the Catalog of Industries Encouraging Foreign Investment (2019 Version), or the 2019 Encouraged
Catalog, which became effective on July 30, 2019 and replaced the previous list of the industries in which foreign investment is encouraged
to invest under the 2017 Catalogue, and the Special Administrative Measures for Access of Foreign Investment (Negative List) (2019 Version),
or the 2019 Negative List, which became effective on July 30, 2019 and replaced the 2018 Negative List. On June 23, 2020, the MOFCOM
and the NDRC jointly released the Special Administrative Measures for Access of Foreign Investment (Negative List) (2020 Version), or
the 2020 Negative List, which superseded the 2019 Negative List on July 23, 2020. On December 27, 2021, the NDRC and the MOFCOM jointly
released the Special Administrative Measures for Access of Foreign Investment (Negative List) (2021 Version), or the 2021 Negative List
which came into effect on January 1, 2022 and replaced the 2020 Negative List.
Regulations on Offshore Parent Holding Companies’ Direct
Investment in and Loans to Their PRC Subsidiaries
An offshore company may invest
equity in a PRC company, which will become the PRC subsidiary of the offshore holding company after investment. Such equity investment
is subject to a series of laws and regulations generally applicable to any foreign-invested enterprise in China, which include the Wholly
Foreign Owned Enterprise Law, the Sino-foreign Equity Joint Venture Enterprise Law, the Sino-foreign Contractual Joint Venture Enterprise
Law, all as amended from time to time, and their respective implementing rules; the Tentative Provisions on the Foreign Exchange Registration
Administration of Foreign-Invested Enterprise; and the Notice on Certain Matters Relating to the Change of Registered Capital of Foreign-Invested
Enterprises.
Under the aforesaid laws
and regulations, the increase of the registered capital of a foreign-invested enterprise is subject to the prior approval by or registration
with the original approval authority of its establishment. In addition, the increase of registered capital and total investment amount
shall both be registered with SAIC.
Shareholder loans made by
offshore parent holding companies to their PRC subsidiaries are regarded as foreign debts in China for regulatory purposes, which debts
are subject to a number of PRC laws and regulations, including the PRC Foreign Exchange Administration Regulations, the Interim Measures
on Administration on Foreign Debts, the Tentative Provisions on the Statistics Monitoring of Foreign Debts and its implementation rules,
and the Administration Rules on the Settlement, Sale and Payment of Foreign Exchange.
Under these regulations,
the shareholder loans made by offshore parent holding companies to their PRC subsidiaries shall be registered with SAFE. Furthermore,
the total amount of foreign debts that can be incurred by such PRC subsidiaries, including any shareholder loans, shall not exceed the
difference between the total investment amount and the registered capital amount of the PRC subsidiaries, both of which are subject to
governmental approval.
Regulations on Trademarks
Trademarks are protected
by the PRC Trademark Law adopted in 1982, as subsequently amended, as well as the Implementation Regulations of the PRC Trademark Law
adopted by the State Council in 2002 and 2013. The Trademark Office under the SAIC handles trademark registrations. Trademarks can be
registered for a term of ten years and can be extended for another ten years if requested upon expiration of the first or any renewed
ten-year term. The PRC Trademark Law has adopted a “first-to-file” principle with respect to trademark registration. Where
a trademark for which a registration application has been made is identical or similar to another trademark which has already been registered
or been subject to a preliminary examination and approval for use on the same type of or similar commodities or services, the application
for such trademark registration may be rejected. Any person applying for the registration of a trademark may not prejudice the existing
right first obtained by others, nor may any person register in advance a trademark that has already been used by another party and has
already gained a “sufficient degree of reputation” through such other party’s use. Trademark license agreements must
be filed with the Trademark Office or its regional offices. Meanwhile, we have successfully obtained 38 trademarks.
Regulations on Patents
The PRC Patent Law provides
for patentable inventions, utility models and designs, which must meet three conditions: novelty, inventiveness and practical applicability.
The State Intellectual Property Office is responsible for examining and approving patent applications. A patent is valid for a term of
twenty years in the case of an invention patent and a term of ten years in the case of utility models and designs. We have obtained 18 patents,
all of which we have ownership of, including a number of those that were originally under the ownership of certain individuals affiliated
with our Company through ownership transfer.
PRC Enterprise Income Tax Law and Individual Income Tax Law
Under the Enterprise Income
Tax Law or EIT Law, enterprises are classified as resident enterprises and non-resident enterprises. PRC resident enterprises typically
pay an enterprise income tax at the rate of 25%. An enterprise established outside of the PRC with its “de facto management bodies”
located within the PRC is considered a “resident enterprise,” meaning that it can be treated in a manner similar to a PRC
domestic enterprise for enterprise income tax purposes. The implementation rules of the EIT Law define “de facto management body”
as a managing body that in practice exercises “substantial and overall management and control over the production and operations,
personnel, accounting, and properties” of the enterprise.
The SAT Circular 82
issued by the SAT in April 2009 provides certain specific criteria for determining whether the “de facto management body”
of a PRC-controlled offshore incorporated enterprise is located in China. Pursuant to the SAT Circular 82, a PRC-controlled offshore
incorporated enterprise has its “de facto management body” in China only if all of the following conditions are met: (a) the
senior management and core management departments in charge of its daily operations function have their presence mainly in the PRC; (b) its
financial and human resources decisions are subject to determination or approval by persons or bodies in the PRC; (c) its major
assets, accounting books, company seals, and minutes and files of its board and shareholders’ meetings are located or kept in the
PRC; and (d) more than half of the enterprise’s directors or senior management with voting rights habitually reside in the
PRC. The SAT Bulletin 45, in effect from September 2011, provides more guidance on the implementation of the SAT Circular 82
and provides for procedures and administration details on determining resident status and administration on post-determination matters.
Although the SAT Circular 82 and the SAT Bulletin 45 only apply to offshore enterprises controlled by PRC enterprises or PRC
enterprise groups, not those controlled by PRC individuals or foreign individuals, the determining criteria set forth there may reflect
the SAT’s general position on how the “de facto management body” test should be applied in determining the tax resident
status of offshore enterprises, regardless of whether they are controlled by PRC enterprises or PRC enterprise groups or by PRC or foreign
individuals.
Due to the lack of applicable
legal precedents, it remains unclear how the PRC tax authorities will determine the PRC tax resident treatment of a foreign company controlled
by individuals. We may be classified as a PRC “resident enterprise” for PRC enterprise income tax purposes. Such classification
would likely result in unfavorable tax consequences to us and our non-PRC shareholders and have a material adverse effect on our results
of operations and the value of your investment.
Employment Laws
In accordance with the PRC
National Labor Law, which became effective in January 1995, and the PRC Labor Contract Law, which became effective in January 2008, as
amended subsequently in 2012, employers must execute written labor contracts with full-time employees in order to establish an employment
relationship. All employers must compensate their employees equal to at least the local minimum wage standards. All employers are required
to establish a system for labor safety and sanitation, strictly abide by state rules and standards and provide employees with appropriate
workplace safety training. In addition, employers in China are obliged to pay contributions to the social insurance plan and the housing
fund plan for employees. We have contributed to the basic and minimum social insurance plan. While we believe we have made adequate provision
of such outstanding amounts of contributions to such plans in our financial statements, any failure to make sufficient payments to such
plans would be in violation of applicable PRC laws and regulations and, if we are found to be in violation of such laws and regulations,
we could be required to make up the contributions for such plans as well as to pay late fees and fines.
Taxation
Income Tax
The New Income Tax Law was
promulgated by NPC on March 16, 2007 and came into effect on January 1, 2008. The Chinese domestic enterprises and FIEs are treated equally
on the income tax rate, and the enterprise income tax rate shall be 25%. Enterprise Income Tax law grants preferential tax treatment
to High and New Technology Enterprises (“HNTEs”). Under this preferential tax treatment, HNTEs are entitled to an income
tax rate of 15%, subject to a requirement that they re-apply for HNTE status every three years. In accordance with the New Income Tax
Law and its implementing regulations, the non-resident enterprise which has not set up institutions or establishments in China, or has
set up institutions or establishments but the income has no relationship with such institutions or establishments, it shall pay enterprise
income tax on such income sourced from China, and the income tax rate shall be 20%, subject to reduction as provided by any applicable
double taxation treaty, unless the relevant income is specially exempted from tax under the applicable tax laws, regulations, notices
and decisions which relate to FIEs and their investors.
The enterprises that were
approved and established prior to the promulgation hereof and that, in accordance with the effective tax laws and administrative regulations,
enjoy a special lower tax rate shall, in accordance with the provisions of the State Council, progressively transit to the tax rate specified
herein within 5 years following the implementation hereof. Those enterprises that enjoy a fixed-term tax exemption or tax reduction shall,
in accordance with the provisions of the State Council, continue to enjoy such exemption or reduction after the implementation hereof
until the expiration of the term of such exemption or reduction. However, if an enterprise did not enjoy such preferential treatment
because it has not yet achieved profitability, the term of such preferential treatment shall be calculated from January 1, 2008 until
the expiration of the term of such exemption or reduction.
According to the Notice on
Strengthening Administration of Enterprise Income Tax for Share Transfers by Non-PRC Resident Enterprise (Circular Guoshuihan [2009]
No. 698) implemented on January 1, 2008, except for the purchase and sale of equity through a public securities market, where a foreign
corporate investor indirectly transfers the equity of a PRC resident enterprise by disposing the equity of an overseas holding company
(the “Indirect Transfer”) located in a tax jurisdiction that (i) has an effective tax rate of less than 12.5%, or (ii) does
not tax its residents on their foreign income, the foreign corporate investor shall report the Indirect Transfer to the competent PRC
tax authority within 30 days from the date when the equity transfer agreement was made. In this case, the PRC tax authority will examine
the true nature of the Indirect Transfer. Should it deem the foreign investor to have made the Indirect Transfer without reasonable commercial
purpose and in order to avoid the PRC tax, the PRC tax authority may disregard the existence of the overseas holding company that is
used for tax planning purpose and re-characterize the Indirect Transfer. As a result, gains derived from such Indirect Transfer by the
foreign investor may be subject to the EIT Law.
Value-Added Tax
Pursuant to the Provisional
Regulations on Value-added Tax of PRC, last amended on November 5, 2008 and took effect from January 1, 2009, and its implementation
rules which were revised on December 15, 2008 and took effect from January 1, 2009, all entities or individuals in PRC engaging in the
sale of goods, the provision of processing services, repairs and replacement services, and the import of goods are required to pay value-added
tax (“VAT”). The amount of VAT payable in the sale or import of goods except as otherwise provided by paragraph (2) and paragraph
(3) of Article 2 of the Provisional Regulations on Value-added Tax of PRC. Before May 1, 2018, the applicable VAT rate was 17%,
while after May 1, 2018 and before April 1, 2019, the Company is subject to a VAT rate of 16%. After April 1, 2019, the Company is subject
to a VAT rate of 13% based on the new Chinese tax law.
In November 2011, the Ministry
of Finance (“MOF”) and the State Administration of Tax (“SAT”) promulgated the Pilot Plan for Imposition of Value-Added
Tax to Replace Business Tax (the “Pilot Plan”). Since January 1, 2012, the PRC government has been implementing a pilot program
in certain provinces and municipalities, to levy a 6% VAT on revenue generated from certain kinds of services in lieu of the 5% business
tax. According to the Notice Regarding the Nationwide Implementation of B2V Transformation Pilot Program in respect of Transportation
and Certain Modern Service Industries jointly issued by the MOF and SAT effective from August 1, 2013 (the “B2V Circular 37”),
such policy has been implemented nationwide. In addition, the MOF and SAT released the Notice on Including Railway Transportation and
Postal Services Sectors into the Pilot Scheme on Switching from Business Tax to VAT on December 12, 2013, which further expanded the
scope of taxable services for value-added tax and replaced the B2V Circular 37 as of January 1, 2014.
Business Tax
Pursuant to the Interim Regulation
of the People’s Republic of China on Business Tax (“Business Tax Regulation”) last amended on November 10, 2008 and
took effect from 1 January, 2009, business that provide services (including entertainment business), assign intangible assets or sell
immovable property became liable to business tax at a rate ranging from 3% to 20% of the charges of the services provided, intangible
assets assigned or immovable property sold, as the case may be.
Tax on Dividends from PRC Enterprise with
Foreign Investment
According to the New Income
Tax Law and the Implementation Rules, income such as dividends and profits distribution from the PRC derived from a foreign enterprise
which has no establishment in the PRC is subject to a 10% withholding tax, subject to reduction as provided by any applicable double
taxation treaty.
Stamp Duty
Under the PRC Interim Regulations
on Stamp Duty promulgated by the State Council on August 6, 1988 and amended in January 6, 2011, for building property transfer instruments,
including those in respect of property ownership transfer, the duty rate shall be 0.03% of the amount stated therein; for permits and
certificates relating to rights, including real estate title certificates and land use right certificates, stamp duty shall be levied
on an item basis at an annual rate of RMB5 per item.
Urban Maintenance Tax
Under the PRC Interim Regulations
on Urban Maintenance Tax promulgated by the State Council on February 8, 1985 and amended on January 8, 2011, any taxpayer, whether an
individual or otherwise, of product tax, value-added tax or business tax shall be required to pay urban maintenance tax. The tax rate
shall be 7% for a taxpayer whose domicile is in an urban area, 5% for a taxpayer whose domicile is in a county and a town, and 1% for
a taxpayer whose domicile is not in any urban area or county or town.
Wholly Foreign-Owned Enterprise
WFOE is governed by the Law
of the People’s Republic of China Concerning Enterprises with Sole Foreign Investments, which was promulgated on April 12, 1986
and was subsequently amended on October 31, 2000, and its Implementation Regulations promulgated on December 12, 1990 and was subsequently
amended on April 12, 2001 (together the “Foreign Enterprises Law”).
Procedures for Establishment of a WFOE
The establishment of a WFOE
will have to be approved by Ministry of Commerce (or its delegated authorities) (the “MOC”). If two or more foreign investors
jointly apply for the establishment of a WFOE, a copy of the contract between the parties must also be submitted to MOC (or its delegated
authorities) for its record. A WFOE must also obtain a business license from the State Administration of Industry and Commerce (or its
delegated authorities) before it can commence business.
Nature
A WFOE is a limited liability
company under the Foreign Enterprise Law. It is a legal entity which may independently assume civil obligations, enjoy civil rights and
has the right to own, use and dispose of property. It is required to have a registered capital contributed by the foreign investor(s).
The liability of the foreign investor(s) is limited to the amount of registered capital contributed. The foreign investor may make its
contributions by installments and the registered capital must be contributed within the period as approved by the MOC (or its delegated
authorities) in accordance with relevant regulations.
Profit Distribution
The Foreign Enterprise Law
provides that after payment of taxes, a WFOE must make contributions to a reserve fund and at least 10% of the after-tax profits must
be allocated to the reserve fund. If the accumulative amount of allocated reserve funds reaches 50% of an enterprise’s registered
capital, the WFOE will not be required to make any additional contribution. The WFOE is prohibited from distributing dividends unless
the losses (if any) of previous years have been made up.
In accordance with the Notice
of the Ministry of Finance on the Issue of Handling Financial Issues by Relevant Enterprises after the Implementation of the Company Law
promulgated by the Ministry of Finance on March 15, 2006 and effective April 1, 2006, from January 1, 2006 on, enterprises established
in accordance with the Company Law shall distribute profits pursuant to Article 167 of the Company Law and shall no longer make contributions
to the reserve fund. After an enterprise ceases to make contributions to the reserve fund, it may continue to make contributions to the
employee bonus and welfare fund as decided by the board of directors if the purpose, use conditions, and procedures thereof shall be made
clear, and such funds shall be manage as debts.
Company Law
The establishment and operation
of corporate entities in China is governed by the PRC Company Law, which was promulgated by the Standing Committee of the NPC on December
29, 1993 and became effective on July 1, 1994 (“1993 PRC Company Law”). It was subsequently amended on December 25, 1999,
August 28, 2004, October 27, 2005, December 28, 2013, and October 26, 2018.
The PRC Company Law generally
governs 2 types of companies — limited liability companies and joint stock limited companies. Both types of companies have the status
of legal persons, and the liability of a company to its debtors is limited to the value of assets owned by the company. Liabilities of
shareholders of a limited liability company are limited to the amount of registered capital they have contributed.
The amendments to the PRC
Company Law adopted in October 2005 seek to reform various aspects of the 1993 PRC Company Law and simplify the establishment and operation
of companies incorporated in China by lowering capitalization requirements, increasing shareholder and creditor protection, improving
corporate governance, and relaxing rules regarding the establishment of subsidiaries. Further, the restriction relating to the total investment
of a company in other entities exceeding 50% of its net assets has been removed, the incorporation of one shareholder limited liability
companies in addition to wholly State-owned enterprises is permitted, and the Chinese Company Law shall apply to foreign invested limited
liability companies. Where laws on foreign investment have other stipulations, such stipulations shall apply.
The amendments to the PRC
Company Law adopted in December 2013 took effect on March 1, 2014. These amendments cover three aspects: (a) replacing the paid-up capital
registration system by subscribed capital registration system; (b) relaxing the requirements for registered capital registration; and
(c) streamlining the registration items and requirements for registration documents.
On December 24, 2021, the
Standing Committee of the National People’s Congress issued the Company Law of the People’s Republic of China (Draft for Comments)
(the “Revised Company Law”), which is now open for public comments. The Revised Company Law further stipulates the establishment
and withdrawal of the company, the organizational structure and the capital system of the company, and strengthens the responsibilities
of shareholders and management personnel and Corporate Social Responsibility. Foreign invested projects must also comply with the Company
Law, with exceptions as specified in foreign investment laws.
PRC Laws and Regulations Relating to Foreign
Investment
With respect to the establishment
and operation of wholly foreign-owned projects, or WFOE, the MOFCOM and NDRC, promulgated the Special Administrative Measures for the
Access of Foreign Investment (Negative List) (2021 Version) (the “2021 Negative List”) on December 27, 2021, which became
effective on January 1, 2022. The 2021 Negative List will replace the Special Administrative Measures for the Access of Foreign Investment
(2020 Version) (the “2020 Negative List”) and serve as the main basis for management and guidance for the MOFCOM to manage
and supervise foreign investments. Those industries not set out on the 2021 Negative List shall be classified as industries permitted
for foreign investment. None of our Group’s business activities are listed on the 2021 Negative List, nor on the 2020 Negative List.
Therefore, the Company is able to conduct its business through its wholly owned PRC Subsidiaries without being subject to restrictions
imposed by the foreign investment laws and regulations of the PRC.
The Foreign Investment Law
of the People’s Republic of China (the “Foreign Investment Law”) was adopted by the second meeting of the 13th National
People’s Congress on March 15, 2019, which became effective on January 1, 2020. On December 26,2019, the State Council promulgated
Regulation for Implementing the Foreign Investment Law of the People’s Republic of China (the “Regulation”), which became
effective on January 1, 2020.
The Foreign Investment Law
and the Regulation apply the administrative system of pre-establishment national treatment plus negative list to foreign investment and
clarify the state shall develop a catalogue of industries for encouraging foreign investment to specify the industries, fields, and regions
where foreign investors are encouraged and directed to invest, which refers to the Catalogue of Industries for Guiding Foreign Investment
Industries (amended in 2020) (the “Catalogue”). Specifically, the special administrative measures to be implemented are the
restricted and prohibited industry categories as well as encouraged industry categories having shareholding and executive management requirements
prescribed in the Catalogue (the Special Administrative Measures for the Access of Foreign Investment specified in the Catalogue was replaced
by the 2020 Negative List, and the Catalogue of Industries for Encouraged Foreign Investment specified in the Catalogue was replaced by
the Catalogue of Industries for Encouraged Foreign Investment (2020 Version).
Labor Law
Pursuant to the Labor Law
of the PRC promulgated by Standing Committee of the NPC on July 5, 1994 and was subsequently amended on August 27, 2009, the Labor Contract
Law of the PRC promulgated by Standing Committee of the NPC on June 29, 2007 and was subsequently amended on December 28, 2012 and the
Labor Contract Law Implementation Rules of the PRC promulgated by the State Council on September 18, 2008, companies must enter into employment
contracts with their employees, based on the principles of equality, consent and agreement through consultation. Companies must establish
and effectively implement system of ensuring occupational safety and health, educating employees on occupational safety and health, preventing
work-related accidents and reducing occupational hazards. Companies must also pay for their employees’ social insurance premium.
Social Insurance Law
Employers in China are required
to contribute, on behalf of their employees, to a number of social security funds, including funds for basic pension insurance, unemployment
insurance, basic medical insurance, work-related injury insurance, maternity insurance, and housing provident funds. These payments are
made to local administrative authorities and an employer who fails to contribute may be fined and be ordered to make-up for the missed
contributions. The various laws and regulations that govern the employers’ obligation to contribute to the social security funds
include PRC Social Insurance Law promulgated by the Standing Committee of the NPC on October 28, 2010 and became effective July 1, 2011;
the Interim Regulations on the Collection and Payment of Social Security Funds, which were promulgated by the State Council and became
effective on January 22, 1999; the Interim Measures concerning the Maternity Insurance, which were promulgated by the Ministry of Labor
on December 14, 1994 and became effective on January 1, 1995; the Regulations on Occupational Injury Insurance, which were promulgated
by the State Council on April 27, 2003 and became effective on January 1, 2004 and was amended on December 20, 2010; the Regulations on
Management of the Housing Provident Fund, which were promulgated and became effective on April 3, 1999 and was amended on March 24, 2002.
Where the enterprises fail
to pay the full amount of the social insurance premiums, the relevant department aforesaid has the authority to check and decide on the
amount of social insurance premiums that the enterprises should pay as the supplementary payment. If the enterprises do not pay for the
social insurance premiums after the relevant department has charged the full amount of the supplementary payment, the relevant department
is authorized to either inquire about the deposit account of such enterprises, or apply to the related department at or above the county
level for making the decision of the allocation of social insurance premiums. The relevant department can also inform the bank or other
financial institution to execute the allocation by written notice. If the amount of the deposit account is smaller than the amount of
social insurance premiums required to pay by the enterprises, the enterprises may provide a security and delay the date to pay the social
insurance premiums. If the amount of the deposit account is smaller than the amount of the social insurance premiums needed to pay by
the enterprises, and the enterprises fails to provide a security, the relevant department shall apply to the court for the levying, sealing
and auctioning of the property of such enterprises.
If the enterprises do not
pay the full amount of social insurance premiums as scheduled, the social insurance premium collection institution shall order them to
make the payment or make up the difference within a stipulated period and impose a daily fine equivalent to 0.05% of the overdue payment
from the date on which the payment is overdue. If payment is not made within the stipulated period, the relevant administration department
shall impose a fine from one to three times the amount of overdue payment.
Corporate Information
Our principal executive offices
are located at No. 11, Dongjiao East Road, Shuangxi, Shunchang, Nanping City, Fujian Province, People’s Republic of China,
where we owned the land use rights till 2056.
Our telephone number at that
address is + 86-0599-782-8808. Our company website is http://www.fjxfl.com.
C. Organizational structure
The
chart below presents our corporate structure as of the date
of this report.
D. Property, Plants and Equipment
Information regarding our property, plants and
equipment is described “Item 4. B. Business Overview.”
ITEM
4A. UNRESOLVED STAFF COMMENTS
Not required.
ITEM
5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS
MANAGEMENT’S DISCUSSION AND ANALYSIS
OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The information in this
report contains forward-looking statements. All statements other than statements of historical fact made in this report are forward looking.
In particular, the statements herein regarding industry prospects and future results of operations or financial position are forward-looking
statements. These forward-looking statements can be identified by the use of words such as “believes,” “estimates,”
“could,” “possibly,” “probably,” anticipates,” “projects,” “expects,”
“may,” “will,” or “should” or other variations or similar words. No assurances can be given that the
future results anticipated by the forward-looking statements will be achieved. Forward-looking statements reflect management’s current
expectations and are inherently uncertain. Our actual results may differ significantly from management’s expectations.
The following discussion
and analysis should be read in conjunction with our financial statements, included herewith. This discussion should not be construed to
imply that the results discussed herein will necessarily continue into the future, or that any conclusion reached herein will necessarily
be indicative of actual operating results in the future. Such discussion represents only the best present assessment of our management.
The following discussion
and analysis of our financial condition and results of operations should be read in conjunction with our consolidated financial statements
and related notes that appear in this annual report. In addition to historical consolidated financial information, the following discussion
contains forward-looking statements that reflect our plans, estimates, and beliefs. Our actual results could differ materially from those
discussed in the forward-looking statements. Factors that could cause or contribute to these differences include those discussed below
and elsewhere in this annual report, particularly in “Risk Factors.” All amounts included herein with respect to the fiscal
years ended March 31, 2022, 2021, and 2020 are derived from our audited consolidated financial statements included elsewhere in this annual
report. The audited consolidated financial statements for the fiscal years ended March 31, 2022, 2021, and 2020 have been prepared in
accordance with U.S. Generally Accepted Accounting Principles, or US GAAP.
Overview
Incorporated on February 9,
2018, under the laws of Cayman Islands, Happiness Development currently has three business revenue streams: nutraceutical and dietary
supplements, e-commerce and automobile sales. Happiness conducts its nutraceutical and dietary supplements business in China primarily
through its wholly-owned subsidiary, Fujian Happiness. Founded in 2004, Fujian Happiness aims to make the world healthier and happier
by developing and selling nutraceutical solutions for consumers looking to enhance their daily health performance. We believe enhanced
consumer awareness and demand for our products due to trends such as the global awareness for health, increasing healthcare costs, increasing
aging populations, and increasing needs of nutraceutical, coupled with the effectiveness of our distribution model and authorized experience
store model have been the primary reasons for our success throughout our 17-year operating history.
We are one of the leading
companies in Fujian which specialize in research, development, manufacturing, and marketing of nutraceutical and dietary supplements authorized
by Nutraceutical Association of Fujian Province. Our products are mainly made of Lucidum spore powder, Cordyceps mycelia, Ejiao, vitamins,
minerals, amino acids and others. Headquartered in Fuzhou, the provincial capital of Fujian Province, and Nanping, our products are sold
throughout China.
Our objective is to provide
the high-quality products to our consumers. We seek to accomplish this goal through execution of significant investments in quality control,
scientific personnel, product testing, and self-manufacturing of our products. Our objective is rooted in using quality ingredients from
traceable sources coupled with the continuous control during the manufacturing process of our products. We produce most of the products
by ourselves without any outsource subcontracting.
Currently, we have mainly
two kinds of sales channels for our dietary supplements products, which are traditional distribution channel and experience stores channel.
Traditional distributors including regional distributors and large-scale chain drugstores, malls and supermarkets are our main sales channels
and their sales terminals are the core resources of our marketing network and the main way to achieve sales. For well-known chain drugstores,
malls and supermarkets customers, we tend to establish direct business partnership with them, rather than through our regional distributors.
Experience store model is our new attempt in 2017 to boost our market share and the key point of our development strategy.
As
of the date of this report, we have over 100 distributors and 10 experience stores in 20 different provinces in China for our nutraceutical
and dietary supplements. Meanwhile, we have also built up
our online sales, which also becomes our important distribution channel. We categorize our products into four groups: Healthcare products,
e-commerce products, automobile and Internet information advertising services.
We started our online store
business in September 2020. Our online store platform “Happy Buy” focuses on providing
small and medium-sized enterprises with professional product sales and e-commerce agency operation services. The online store sales have
grown steadily as the live streaming e-commerce industry, a form of online shopping that has developed rapidly in recent years, has been
expanding its market scale in China.
We began our Internet information
advertising services to individuals or small companies who want to get more exposure to expand their market in October 2020. We used our
strength in this industry to provide them the more cost-effective information service.
In November 2020, we engaged
in selling automobiles. Our auto sales platform “Happy Auto”, was later upgraded to “Taochejun”. Taochejun mainly
focuses on building a network among car dealers in China. Currently, it operates an online platform of “Taochejun” on
WeChat, as a WeChat Mini Program (微信小程序), where we and the car dealers can post information of available
automobiles for sale. By utilizing our dealer network, the inventories and used cars from large 4S stores, the cars posted on Taochejun
have competitive selling prices and Taochejun is able to provide services including car hailing in connection with the automobile sales.
We plan to focus on the sales in small cities in China, and on the sales of new energy vehicles.
In summary, we generated a
revenue and had net loss of $89,488,658 and $54,020,081, respectively, for the year ended March 31, 2022, representing an increase of
$18,003,955 and decrease of $54,712,037 respectively, compared with the fiscal year ended March 31, 2021, during which we generated a
revenue and net income of $71,484,703 and $691,956, respectively. We generated a revenue and net income of $71,484,703 and $691,956, respectively,
for the year ended March 31, 2021, representing an increase of 9.9% and decrease of 94.5% respectively, compared with the fiscal year
ended March 31, 2020, during which we generated $65,061,953 and $12,688,035, respectively.
Critical Accounting Policies
We believe it is helpful to
investors to understand the critical accounting policies underlying our financial statements and the following discussion of our company’s
financial condition and results of operations.
Use of Estimates
In
preparing the consolidated financial statements in conformity with US GAAP, management makes estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements
and the reported amounts of revenues and expenses during the reporting period. These estimates are based on information as of the date
of the consolidated financial statements. Significant estimates required to be made by management include, but are not limited
to, the valuation of accounts receivable and related allowance for doubtful accounts, useful lives of property and equipment and intangible
assets, the recoverability of long-lived assets, inventory reserve, allowance for credit losses, goodwill impairment, income taxes related
to realization of deferred tax assets and uncertain tax position, provisions necessary for contingent liabilities and purchase price
allocation in connection with the business combination. The current economic environment has increased the degrees of uncertainty inherent
in those estimates and assumptions, actual results could differ from those estimates.
Accounts Receivable and Allowance for Doubtful Accounts
Accounts receivable are recognized
and carried at original invoiced amount less an estimated allowance for uncollectible accounts. The Company determines the adequacy of
reserves for doubtful accounts based on individual account analysis and historical collection trends. The Company establishes a provision
for doubtful receivables when there is objective evidence that the Company may not be able to collect amounts due. The allowance is based
on management’s best estimates of specific losses on individual exposures, as well as a provision on historical trends of collections.
Based on management of customers’ credit and ongoing relationship, management makes conclusions whether any balances outstanding
at the end of the period will be deemed uncollectible on an individual basis and on aging analysis basis. The provision is recorded against
accounts receivables balances, with a corresponding charge recorded in the consolidated statements of income and comprehensive income.
Delinquent account balances are written-off against the allowance for doubtful accounts after management has determined that the likelihood
of collection is not probable.
Inventories
Inventories are stated at
the lower of cost or net realizable value. Cost of inventories is determined using the weighted-average method. In addition to cost of
raw materials, work in progress and finished goods include direct labor costs and overheads. The Company periodically assesses the recoverability
of all inventories to determine whether adjustments are required to record inventories at the lower of cost or market value. Inventories
that the Company determines to be obsolete or in excess of forecasted usage are reduced to its estimated realizable value based on assumptions
about future demand and market conditions. If actual demand is lower than the forecasted demand, additional inventory write-downs may
be required.
No inventories write-downs
for the year ended March 31, 2022 and 2021.
Value-added Tax
Value-added taxes (“VAT”) collected from customers relating
to product sales and remitted to governmental authorities are presented on a net basis. VAT collected from customers is excluded from
revenue. The Company is generally subject to the VAT for merchandise sales and services performed. Before May 1, 2018, the applicable
VAT rate was 17%, while after May 1, 2018 and before April 1, 2019, the Company is subject to a VAT rate of 16%. After April 1, 2019,
the Company is subject to a VAT rate of 13% based on the new Chinese tax law.
Revenue Recognition
The
Company generates its revenue mainly from sales of healthcare products, automobiles, online store sales and internet information and
advertising services.
The Company allows its customers to return products
within some range. The range was limited to 3% of the customer’s yearly payment amount for the year for online store
business. The transportation fee is borne by the customers in the condition of products return. For the year ended March 31,
2022, products return of all product sales amounted to $66,646, which is within the range.
The Company adopted the new guidance of ASC Topic
606, Revenue from Contracts with Customers (“Topic 606”), which supersedes the revenue recognition requirements
in ASC Topic 605, Revenue Recognition on April 1, 2019.
The core principle of the guidance is that an
entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration
to which the entity expects to be entitled in exchange for those goods or services. Revenue is the transaction price the Company expects
to be entitled to in exchange for the promised services in a contract in the ordinary course of the Company’s activities and is
recorded net of value-added tax (“VAT”). To achieve that core principle, the Company applies the following steps:
Step 1: Identify the contract (s) with a customer
Step 2: Identify the performance obligations in the contract
Step 3: Determine the transaction price
Step 4: Allocate the transaction price to the performance
obligations in the contract
Step 5: Recognize revenue when (or as)
the entity satisfies a performance obligation
The Company generates revenues from providing
transportation services and warehouse storage and management services. No practical expedients were used when adoption ASC 606. Revenue
recognition policies for each type of revenue stream are as follow:
Healthcare products
The Company sells nutraceutical and dietary supplements
to third-party distributors and experience stores. Experience stores are owned by third parties, which are
located in tourist sites where the sales consultants gave in-depth presentation of the origin, tradition and history of the Company’s
products. Tourists are guided to enjoy a presentation of traditional Chinese herb culture offered by the distributors in the experience
store and be presented with the Company’s healthcare products. The Company is a principal for the healthcare product sales as i)
the Company produce or obtain control of the specified goods before transferring to the customers; ii) the Company has the right to determine
the sales price; iii) the Company bears the risk of inventories and collection of consideration. For all sales, the Company requires a
signed contract and sales order, which specifies pricing, quantity and product specifications. Under ASC 606, the Company recognizes revenue
upon the satisfaction of its performance obligation, which is to transfer the control of the promised products to customers in an amount
that reflects the consideration to which the Company expects to be entitled to in exchange for those products, excluding amounts collected
on behalf of third parties (e.g., value-added taxes). The transfer of control of the products is satisfied at a point in time, which is
the delivery of the products to distributors’ or the experience stores’ premises and evidenced by signed acknowledgment. The
selling price, which is specified in the signed sales orders, is fixed. The Company has unconditional right to receive full payment of
the sales price, upon the delivery of the products to distributors or experience stores and the signing of their acknowledgment. Distributors
and experience stores are required to pay under the customary payment terms, which is generally less than six months. According to the
sales agreement, the healthcare product sold cannot be returned after the acknowledgement.
Automobile
The Company sells automobiles in fiscal year 2022.
For all sales, the Company requires a signed contract and sales order, which specifies pricing, quantity and product specifications. The
Company is a principal for the automobiles sales as i) the Company produce or obtain control of the specified goods before transferring
to the customers; ii) the Company has the right to determine the sales price; iii) the Company bears the risk of inventories and collection
of consideration. Under ASC 606, the Company recognizes revenue upon the satisfaction of its performance obligation, which is to transfer
the control of the promised products to customers in an amount that reflects the consideration to which the Company expects to be entitled
to in exchange for those products, excluding amounts collected on behalf of third parties (e.g., value-added taxes). The transfer of control
of the products is satisfied at a point in time, which is the delivery of the products to customers’ premises and evidenced by signed
customer acknowledgment. According to the contract, the automobile sold cannot be returned after the customer acknowledgement. The
selling price, which is specified in the signed sales orders, is fixed. The Company has unconditional right to receive full payment of
the sales price, upon the delivery of the products to customers and the signing of the customer acknowledgment, which is within 3 months
after sales.
Online store
The Company sells various goods through its online
store business in fiscal year 2022. For all sales, the Company requires a sales order generated by the online store platform, which specifies
pricing, quantity and product specifications. The Company is a principal for the online store sales as i) the Company produce or obtain
control of the specified goods before transferring to the customers; ii) the Company has the right to determine the sales price; iii)
the Company bears the risk of inventories and collection of consideration. Under ASC 606, the Company recognizes revenue upon the satisfaction
of its performance obligation, which is to transfer the control of the promised products to customers in an amount that reflects the consideration
to which the Company expects to be entitled to in exchange for those products, excluding amounts collected on behalf of third parties
(e.g., value-added taxes). The transfer of control of the products is satisfied at a point in time, which is the delivery of the products
to customers’ premises and evidenced by signed customer acknowledgment. The selling price, which is specified in the signed sales
orders, is fixed. The Company has unconditional right to receive full payment of the sales price, upon the delivery of the products to
customers and the signing of the customer acknowledgment unless the customers require sales return within 7 days after the acknowledgement.
Customers are required to pay to the third-party platform before the goods were send out and the Company will receive the amount from
the third-party platform after the customer sign off the acceptance form on the platform.
Internet information and advertising service
The Company provides internet information and
advertising service online. For all sales, the Company requires a signed contract and sales order, which specifies the price and service
range. The Company is a principal for the services as i) the Company has the right to determine the sales price; ii) the Company bears
the collection risks; iii) the Company is responsible to the service provided. Under ASC 606, the Company recognizes revenue upon the
satisfaction of its performance obligation, which is to provide specified information and advertising service to customers in an amount
that reflects the consideration to which the Company expects to be entitled to in exchange for those services, excluding amounts collected
on behalf of third parties (e.g., value-added taxes). The information and advertising service provided is satisfied at a point in time,
which is the time when the information and advertising service is performed. No sales return is permitted after the service performed
according to the contract signed. The selling price per click, which is specified in the signed sales orders, is fixed. The Company has
unconditional right to receive full payment of the sales price, upon the completion of the service. Customers are required to pay to the
Company in advance according to the contract.
The Company adopted ASC 606 as of April 1, 2019
using the modified retrospective transition method, the Company recognizes the cumulative effect of initially applying the new revenue
standard as an adjustment to the opening balance of retained earnings; however, no adjustment was required as a result of adopting the
new revenue standard. Results for reporting periods beginning after April 1, 2019 are presented under the new standard. The
comparative information has not been restated and continues to be reported under the historic accounting standards in effect for those
periods. The Company does not expect any impact to its net income from the adoption of ASU 2014-09 on an ongoing basis.
All of the Company’s revenues from
contracts with customers represent products transferred at a point in time as control is transferred to the customer and are generated
in PRC. All of the Company’s revenues are recognized on a gross basis and presented as revenue on the consolidated statements of
operations and comprehensive income/(loss).
The following table presents an overview of our
sales from our product lines for the years ended March 31, 2022, 2021 and 2020:
| | |
For the years ended
March 31, | |
| | |
2022 | | |
2021 | | |
2020 | |
| Healthcare products | |
$ | 30,323,831 | | |
$ | 45,389,702 | | |
$ | 65,061,953 | |
| Online store | |
| 28,014,109 | | |
| 13,473,626 | | |
| - | |
| Internet information and advertising | |
| 10,538,943 | | |
| 9,245,019 | | |
| - | |
| Automobile | |
| 20,611,775 | | |
| 3,376,356 | | |
| - | |
| Revenue | |
$ | 89,488,658 | | |
$ | 71,484,703 | | |
$ | 65,061,953 | |
Income Taxes
The Company accounts for current income taxes
in accordance with the laws of the relevant tax authorities. Deferred income taxes are recognized when temporary differences exist between
the tax bases of assets and liabilities and their reported amounts in the consolidated financial statements. Deferred tax assets and liabilities
are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected
to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the
period including the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount
expected to be realized.
The provisions of ASC 740-10, “Accounting
for Uncertainty in Income Taxes”, prescribe a more-likely-than-not threshold for consolidated financial statement recognition and
measurement of a tax position taken (or expected to be taken) in a tax return. This interpretation also provides guidance on the recognition
of income tax assets and liabilities, classification of current and deferred income tax assets and liabilities, accounting for interest
and penalties associated with tax positions, and related disclosures. The Company does not believe that there was any uncertain tax position
at March 31, 2022 and 2021.
To the extent applicable, the Company records
interest and penalties as a general and administrative expense. All of the tax returns of the Company and its subsidiaries remain subject
to examination by PRC tax authorities for five years from the date of filing.
The Company is subject to Chinese tax laws. We
are not subject to U.S. tax laws and local state tax laws. Our income and our related entities must be computed in accordance with Chinese
and foreign tax laws, as applicable, and we are subject to Chinese tax laws, all of which may be changed in a manner that could adversely
affect the amount of distributions to shareholders. There can be no assurance that Income Tax Laws of China will not be changed in a manner
that adversely affects shareholders. In particular, any such change could increase the amount of tax payable by us, reducing the amount
available to pay dividends to the holders of our ordinary shares.
We are a holding company with no material operations
of our own. We conduct our operations through our subsidiaries in China. As a result, our ability to pay dividends and to finance any
debt we may incur depends upon dividends paid by our subsidiaries. Under applicable PRC regulations, foreign-invested enterprises in China
may pay dividends only out of their accumulated profits, if any, determined in accordance with PRC accounting standards and regulations.
In addition, a foreign-invested enterprise in China is required to set aside at least 10% of its after-tax profit based on PRC accounting
standards each year to its general reserves until the accumulative amount of such reserves reaches 50% of its registered capital. These
reserves are not distributable as cash dividends.
As of March 31, 2022, our PRC subsidiaries had
an aggregate retained earnings of approximately RMB 195.2 million (US$26.04 million) under PRC GAAP. With respect to retained
earnings accrued after such date, our Board of Directors may declare dividends after taking into account our operations, earnings, financial
condition, cash requirements and availability and other factors as it may deem relevant at such time. Any declaration and payment, as
well as the amount, of dividends will be subject to our By-Laws, charter and applicable Chinese and U.S. state and federal laws and regulations,
including the approval from the shareholders of each subsidiary which intends to declare such dividends, if applicable.
Foreign Currency Translation
The Company and its subsidiaries’ principal
country of operations is the PRC. The Company maintained its financial record using the United States dollar (“US dollar”)
as the functional currency, while the subsidiaries of the Company in Hong Kong and mainland China maintained their financial records using
RMB as the functional currencies. The consolidated statements of income and comprehensive income and cash flows denominated in foreign
currency are translated at the average rate of exchange during the reporting period. Assets and liabilities denominated in foreign currencies
at the balance sheet date are translated at the applicable rates of exchange in effect at that date. The equity denominated in the functional
currency is translated at the historical rate of exchange at the time of capital contribution. Because cash flows are translated based
on the average rate of exchange, amounts related to assets and liabilities reported on the consolidated statements of cash flows will
not necessarily agree with changes in the corresponding balances on the consolidated balance sheets. Translation adjustments arising from
the use of different exchange rates from period to period are included as a separate component of accumulated other comprehensive income
(loss) included in consolidated statements of changes in shareholders’ equity. Gains and losses from foreign currency transactions
are included in the consolidated statement of income and comprehensive income.
The value of RMB against US$ and other currencies
may fluctuate and is affected by, among other things, changes in the PRC’s political and economic conditions. Any significant revaluation
of RMB may materially affect the Company’s financial condition in terms of US$ reporting. The following table outlines the currency
exchange rates that were used in creating the consolidated financial statements in this report:
| |
|
March 31,
2022 |
|
March 31,
2021 |
|
March 31,
2020 |
| Period-end spot rate |
|
US$1=RMB 6.3482 |
|
US$1=RMB 6.5713 |
|
US$1=RMB 7.0851 |
| Average rate |
|
US$1=RMB 6.4083 |
|
US$1=RMB 6.7960 |
|
US$1=RMB 6.965 |
A.
Operating Results
Comparison of Fiscal Years Ended March 31, 2022, 2021, and
2020
The following table presents
an overview of our results of operations for the years ended March 31, 2022, 2021 and 2020:
(All amounts, other than percentages, in U.S. dollars)
| | |
For the years ended
March 31, | |
| | |
2022 | | |
2021 | | |
2020 | |
| Revenues | |
$ | 89,488,658 | | |
$ | 71,484,703 | | |
$ | 65,061,953 | |
| Cost of revenues | |
| (85,777,192 | ) | |
| (53,309,102 | ) | |
| (34,642,649 | ) |
| Gross profit | |
| 3,711,466 | | |
| 18,175,601 | | |
| 30,419,304 | |
| | |
| | | |
| | | |
| | |
| Operating expenses: | |
| | | |
| | | |
| | |
| Selling and marketing | |
| 40,476,616 | | |
| 9,958,886 | | |
| 9,179,160 | |
| General and administrative | |
| 9,126,812 | | |
| 5,030,899 | | |
| 3,482,459 | |
| Research and development | |
| 1,684,089 | | |
| 1,660,100 | | |
| 2,358,968 | |
| Goodwill impairment | |
| 10,309,745 | | |
| - | | |
| - | |
| Total operating expenses | |
| 61,597,262 | | |
| 16,649,885 | | |
| 15,020,587 | |
| | |
| | | |
| | | |
| | |
| Operating (loss) income | |
| (57,885,796 | ) | |
| 1,525,716 | | |
| 15,398,717 | |
| | |
| | | |
| | | |
| | |
| Other income (expenses): | |
| | | |
| | | |
| | |
| Interest income | |
| 108,395 | | |
| 131,901 | | |
| 74,929 | |
| Interest expense | |
| (85,993 | ) | |
| (111,799 | ) | |
| (98,086 | ) |
| Other income | |
| 117,086 | | |
| 105,522 | | |
| 156,562 | |
| Total other income | |
| 139,488 | | |
| 125,624 | | |
| 133,405 | |
| | |
| | | |
| | | |
| | |
| (Loss) Income before income taxes | |
| (57,746,308 | ) | |
| 1,651,340 | | |
| 15,532,122 | |
| | |
| | | |
| | | |
| | |
| Income tax (provision) benefit | |
| 3,726,227 | | |
| (959,384 | ) | |
| (2,844,087 | ) |
| | |
| | | |
| | | |
| | |
| Net (loss) income | |
$ | (54,020,081 | ) | |
$ | 691,956 | | |
$ | 12,688,035 | |
Year Ended March 31, 2022 Compared to Year Ended March 31, 2021
Revenues
We generated $89,488,658 in
revenues for the fiscal year ended March 31, 2022, representing an increase of $18,003,955 or 25.19%, as compared with $71,484,703 for
the fiscal year ended March 31, 2021. The increase was primarily due to the increase of the revenues generated from the online stores
and the automobile business.
Our sales of the healthcare
products had dropped down significantly to $30,323,831 during fiscal year 2022 due to the adverse impact of COVID-19 pandemic during 2022.
The new variants of COVID-19 which occurred from time to time in different provinces in Chain have materially negatively impacted the
performance of our experience stores and our customers and suppliers. During the year ended March 31, 2022, we continually
closed 7 experience stores due to their poor performance to avoid further losses. Meanwhile, we tried to upgrade our online business model
to realize the increase orders.
The revenue of our online
store for the fiscal year ended March 31, 2022 increased to $28,014,109 from $13,473,626 for the fiscal year ended March 31, 2021. The
increase was primarily due to the development of the online store business. We obtained more individual customer sales during this year
ended March 31, 2022. In addition, we focused on providing e-commerce solutions and services for small and medium-sized enterprises. As
Chinese young generations are used to making purchase online rather than offline, the online store sales increased within a short period
of time. We will continue to invest in this revenue stream in the next few years.
In October 2020, we began
the information service to individuals or small companies who want to get more online exposure to expand their market and gain more customers.
We used our strength in the e-commerce industry to provide them with the more cost-effective information service. In the year ended March
31, 2022, the information service revenue reached $10,538,943, representing an increase of $1,293,924 or 14%, as compared with $9,245,019
for the fiscal year ended March 31, 2021.
In November 2020, we started
our business of selling automobiles to companies or individual customers. The needs of automobile are still huge in China. We focus on
building a network among car dealers in China. The unit price listed through our platform ranged from $10,396 to $642,702 for different
brands. In the fiscal year ended March 31, 2022, the revenue of selling automobile increased $17,235,419 or 510.47% to $20,611,775 from
$3,376,356 for the fiscal year ended March 31, 2021. The increase was primarily because that the automobiles sales commencing in November
2021 generated only four months income, in contrast to the whole-year of income generated from the automobile business in the year ended
March 31, 2022. We are looking forward to our development in the automobile market and will continue to invest in it.
Cost of Revenues
Total cost of revenues was
$85,777,192 for the fiscal year ended March 31, 2022, representing an increase of $32,468,090 or 60.91%, compared with $53,309,102 for
the fiscal year ended March 31, 2021. The gross margin ratio of us was 4.2% for the fiscal year ended March 31, 2022, representing a decrease
of 21.2%, compared with 25.4% for the fiscal year ended March 31, 2021. The decrease of gross margin ratio was mainly due to the lower
gross margin of the healthcare products stream.
The gross margin ratio of healthcare products was negative 0.7% for
the fiscal year ended March 31, 2022, representing a decrease of 38.6%, compared with 37.9% for the fiscal year ended March 31, 2021.
The decrease was mainly due to the smaller product volume that pushed up the unit costs. Meanwhile, the decrease of high gross margin
products and the discounted sales of raw materials also led to the decrease.
The gross margin ratio of online sale was 7.7% for the fiscal year
ended March 31, 2022. representing an increase of 2.4%, compared with 5.3% for the fiscal year ended March 31, 2021. The increase
was mainly due to the increase of individual customers in the year ended March 31, 2022, which generated higher gross margin than that
of business customers. The online store sales to business customers usually have 3-5% in gross margin rate.
The gross margin ration of information service and selling of automobile
was 14.5% and 1.1% for the fiscal year ended March 31, 2022. As we are newcomer in these two industries, we were trying to get more market
and maintain a good customer base in a short period with a lower gross profit margin.
All the above facts resulted
in the significant drop in the gross profit margin ratio for the fiscal year ended March 31, 2022 compared to the fiscal year ended March
31, 2021.
Selling and Marketing Expenses
We incurred $40,476,616 in
selling and marketing expenses for the fiscal year ended March 31, 2022, representing an increase of $30,517,730 or 306.44%, compared
with $9,958,886 for the fiscal year ended March 31, 2021. The increase was primarily due to increases in higher advertising costs, and
network flow fee
General and Administrative Expenses
We incurred $9,126,812 in general and administrative expenses for the
fiscal year ended March 31, 2022, representing an increase of $4,095,913 or 81.4%, compared with $5,030,899 for the fiscal year ended
March 31, 2021. The increase was primarily attributable to the shared granted to the employees in the year ended March 31, 2022 as well
as the service charges by internet search engine of key words and brand promotion costs for company online sales.
Research and Development Expenses
We incurred $1,684,089 in
research and development expenses for the fiscal year ended March 31, 2022, representing an increase of $23,989 or 1.45%, compared with
$1,660,100 for the fiscal year ended March 31, 2021. The increase was primarily due to the increase of the sophisticated products ,
including the wall-breaking method of Ganoderma lucidum spore and ginseng taurine drink, as a result of more intensive consumer preference
among all market participants.
Goodwill impairment
We incurred $10,309,745 in
goodwill impairment for the fiscal year ended March 31, 2022 and nil for the fiscal year ended March 31, 2021. The increase was primarily
due to continually influence of the COVID-19 pandemic, which led to the dramatic decrease of operating performance in the two newly acquired
entities.
Income from Operations
As a result of the factors described above, our operating loss was
$57,885,796 for the fiscal year ended March 31, 2022, compared with operating income of $1,525,716 for the fiscal year ended March 31,
2021, increased by $44,778,859. The increase was primarily due to the higher advertising fee and network flow fee invested in new business
streams and impairment of long-lived assets.
Interest income
Our interest income of $108,395
for the fiscal year ended March 31, 2022 decreased by $23,506 or 17.82%, compared with interest income of $131,901 for the fiscal year
ended March 31, 2021. The decrease was primarily due to the decrease of our cash.
Interest expense
Our interest expense of $85,993
for the fiscal year ended March 31, 2022 decreased by $25,806 or 23.08%, compared with interest expense of $111,799 for the fiscal year
ended March 31, 2021. The decrease was mainly due to the decrease of the interest rate.
Other Income (Expenses)
Our other income of $117,086
for the fiscal year ended March 31, 2022 increased by $11,564 or 10.96% compared with other income of $105,522 for the fiscal
year ended March 31, 2021. The increase was primarily due to the changes in fair value recognized in profit of contingent assets derived
from the redemption option of transaction agreements.
Income Tax
We incurred income tax benefit
of $3,726,227 for the fiscal year ended March 31, 2022. The income tax provision for the fiscal year ended March 31, 2021 was $959,384.
The change was primary attributable to provision of the deductible temporary difference. Our effective income tax rates for the years
ended March 31, 2022 and 2021 are 17.7% and 22.4%, respectively, mainly due to difference to include tax non-deductible cost for this
reporting period.
Net Income
As a result of the factors described above, our net loss for the fiscal
year ended March 31, 2022 was $54,020,081, representing a decrease of $53,328,125, compared with net income of $691,956 for the fiscal
year ended March 31, 2021 as a result of lower operating profit margin and higher operating expense in 2022.
Foreign Currency Translation
Our consolidated financial
statements are expressed in U.S. dollars but the functional currency of our operating subsidiaries is RMB. Results of operations and cash
flows are translated at average exchange rates during the period, assets and liabilities are translated at the unified exchange rate at
the end of the period and equity is translated at historical exchange rates. Translation adjustments resulting from the process of translating
the financial statements denominated in RMB into U.S. dollars are included in determining comprehensive income. Our foreign currency translation
income for the fiscal year ended March 31, 2022 and 2021 was $2,523,258 and $6,113,570, respectively. The fluctuation was primarily
due to the appreciation or depreciation of RMB against the U.S. dollars for the year ended March 31, 2022 and 2021.
Year Ended March 31, 2021 Compared to Year Ended March 31, 2020
Revenues
We generated $71,484,703 in
revenues for the fiscal year ended March 31, 2021, representing an increase of $6,422,750 or 9.9%, as compared with $65,061,953 for the
fiscal year ended March 31, 2020. The increase was primarily due to the new goods or service provided including online sale, automobile
sale and advertising service in 2021.
Our sales from the healthcare
products had dropped down significantly from $65,061,953 in the fiscal year 2020 to $45,389,702 during the fiscal year 2021 due to the
adverse impact of COVID-19 starting from January 2020. As travelling is restricted in January to March 2020 in China, and continuous spreading
of COVID-19 in different provinces in China, the performance of our experience stores were greatly impaired. During the year ended March
31, 2021, we closed 10 experience stores due to their poor performance to avoid further losses. Meanwhile, we tried to enhance our online
sale model to increase our sales.
In September 2020, we started
our online store sales, the revenue of which for the fiscal year ended March 31, 2021 was $13,473,626. In addition to the online sales,
we also focus on providing e-commerce solutions and services for small and medium-sized enterprises in China. As Chinese young generations
are used to consume online rather than offline, the online store sales got successfully soon. We will continue to invest in this revenue
stream in the next few years.
In October 2020, we began
providing the internet information and advertising service to individuals or small companies whose businesses need exposure online. We
used our strength in the e-commerce industry to provide them the more cost-effective internet information and advertising service. For
the year ended March 31, 2021, the information service revenue reached $9,245,019.
In November 2020, we started
engaging in selling automobiles to companies or individual customers under the brand of “Taochejun”. The demand for automobile
is huge in China. Through Taochejun, we aim to build a network among car dealers in China, especially in the third- and fourth-tier
cities, and provide the purchasers with streamline services relating to the automobile sale. The unit price ranged from $8,000 to $512,066
for different brands of cars. In the fiscal year ended March 31, 2021, the revenue of selling automobile is $3,376,356. We are looking
forward to this market and will continue to invest in it.
Cost of Revenues
Total cost of revenues was
$53,309,102 for the fiscal year ended March 31, 2021, representing an increase of $18,666,453 or 53.9%, compared with $34,642,649 for
the fiscal year ended March 31, 2020. The gross margin ratio of our company was 25.4% for the fiscal year ended March 31, 2021, representing
a decrease of 21.3%, compared with 46.8% for the fiscal year ended March 31, 2020. The decrease of gross margin ratio was mainly due to
the lower gross margin of our new revenue streams.
The gross margin ratio of
healthcare products was 37.9% for the fiscal year ended March 31, 2021, representing a decrease of 8.9%, compared with 46.8% for the fiscal
year ended March 31, 2020. The decrease was mainly due to lower margin of lucidum spore powder raw material products. The gross margin
ratio of other healthcare products was 42.6% for the fiscal year ended March 31, 2021.
The gross margin ratio of
online sell was 5.3% for the fiscal year ended March 31, 2021. This is a normal gross profit margin in this industry as there is less
operating expenses such as the rental expenses.
The gross margin ratio of
information service and selling of automobile was 2.6% and 1.1% for the fiscal year ended March 31, 2021. As we are newcomer in these
two industries and we were trying to grow our scale and retain a good customer base in a short period. Thus, our gross profit margin is
lower.
All the above facts result
in the significant drop in the gross profit margin ratio for the fiscal year ended March 31, 2021 compared to the fiscal year ended March
31, 2020.
Selling and Marketing Expenses
We incurred $9,958,886 in
selling and marketing expenses for the fiscal year ended March 31, 2021, representing an increase of $779,726 or 8.5%, compared with $9,179,160
for the fiscal year ended March 31, 2020. The increase was primarily due to increases in higher advertising costs, and subsidy to our
experience store operators.
General and Administrative Expenses
We incurred $5,030,899 in
general and administrative expenses for the fiscal year ended March 31, 2021, representing an increase of $1,548,440 or 44.5%, compared
with $3,482,459 for the fiscal year ended March 31, 2020. The increase was primarily attributable to the shares granted to our employees
from April 1, 2020 through March 31, 2021, as well as the service charges by internet search engine of key words, brand promotion costs
of the online sales.
Research and Development Expenses
We incurred $1,660,100 in
research and development expenses for the fiscal year ended March 31, 2021, representing a decrease of $698,868 or 29.6%, compared with
$2,358,968 for the fiscal year ended March 31, 2020. The decrease was primarily due to reduce of R&D lab equipment expenses. Our research
and development expenses may increase in the future, for more sophisticated products as a result of more intensive consumer preference
among all market participants.
Income from Operations
As a result of the factors
described above, our operating income was $1,525,716 for the fiscal year ended March 31, 2021, compared with operating income of $15,398,717
for the fiscal year ended March 31, 2020, representing a decrease of $13,873,001 or approximately 90.1%.
Interest income
Our interest income of $131,901
for the fiscal year ended March 31, 2021, compared with interest income of $74,929 for the fiscal year ended March 31, 2020, which was
primarily due to the average cash balance deposit in commercial bank.
Interest expense
Our interest expense of $111,799
for the fiscal year ended March 31, 2021, compared with interest expense of $98,086 for the fiscal year ended March 31, 2020, which was
mainly due to the increase of the interest rate.
Other Income (Expenses)
Our other income of $105,522
for the fiscal year ended March 31, 2021, compared with other income of $156,562 for the fiscal year ended March 31, 2020, which was primarily
government grants of compensation for our research and development efforts.
Income Tax
We incurred income tax expense
of $959,384 for the fiscal year ended March 31, 2021, representing a decrease of $1,884,703 or 66.3%, compared with $2,844,087 for the
fiscal year ended March 31, 2020. The decrease was primary attributable to less total income before corporate income tax for fiscal year
ended March 31, 2021. Our effective income tax rates for the years ended March 31, 2021 and 2020 are 22.4% and 18.3%, respectively, mainly
due to difference to include tax non-deductible cost for this reporting period.
Net Income
As a result of the factors
described above, our net income for the fiscal year ended March 31, 2021 was $691,956, representing a decrease of $11,996,079 or 94.5%,
compared with net income of $12,688,035 for the fiscal year ended March 31, 2020 due to the lower operating profit margin in the year
ended March 31, 2021.
Foreign Currency Translation
Our consolidated financial
statements are expressed in U.S. dollars but the functional currency of our operating subsidiaries is RMB. Results of operations and cash
flows are translated at average exchange rates during the period, assets and liabilities are translated at the unified exchange rate at
the end of the period and equity is translated at historical exchange rates. Translation adjustments resulting from the process of translating
the financial statements denominated in RMB into U.S. dollars are included in determining comprehensive income (loss). Our foreign currency
translation income (loss) for the fiscal year ended March 31, 2021 and 2020 was $6,113,570 and $(3,356,032), respectively. The fluctuation
was primarily due to the appreciation or depreciation of RMB against the U.S. dollars for the year ended March 31, 2021 and 2020.
B.
Liquidity and Capital Resources
The following table presents an overview of cash
flows for the periods indicated:
| | |
For the years ended March 31, | |
| | |
2022 | | |
2021 | | |
2020 | |
| | |
| | |
| | |
| |
| Net cash (used in)/ provided by operating activities | |
$ | (28,134,783 | ) | |
$ | 2,904,466 | | |
$ | 10,777,843 | |
| Net cash used in investing activities | |
| (8,476,879 | ) | |
| (13,222,847 | ) | |
| (1,159,355 | ) |
| Net cash provided by financing activities | |
| 18,830,786 | | |
| 10,672,219 | | |
| 10,404,718 | |
| Effect of exchange rate changes on cash and cash equivalents | |
| 955,755 | | |
| 2,550,149 | ) | |
| (1,169,213 | ) |
| Net (decrease) increase in cash and cash equivalents | |
$ | (16,825,121 | ) | |
$ | 2,903,987 | | |
$ | 18,853,993 | |
As of March 31, 2022, 2021
and 2020, we had cash and cash equivalents of $19,733,631, $36,558,752 and $33,654,765, respectively. We did not have any other short-term
investments. As of March 31, 2022, 2021 and 2020, our current assets were approximately $56.6 million, $95.1 million and $70.0 million,
respectively, and our current liabilities were approximately $17.9 million, $15.1 million and $5.5 million, respectively.
Operating Activities
Net cash used in operating activities for the year ended March 31,
2022 was approximately $28.1 million, which was primarily attributable to a net loss approximately $54.0
million, adjusted for non-cash items for approximately $10.8 million and adjustments for changes in working capital approximately $14.7
million. Net cash provided by operating activities for the year ended March 31, 2021 was approximately $2.9 million, adjusted for non-cash
items for approximately $1.7 million and adjustments for changes in working capital approximately $0.6 million. Net cash generated from
operating activities for the year ended March 31, 2020 was approximately $10.8 million, which was primarily attributable to a net profit
approximately $12.7 million, adjusted for non-cash items for approximately $0.8 million and adjustments for changes in working capital
approximately $2.7 million.
The decrease in the year ended
March 31, 2022 was mainly due to the business expansion for the sales of automobiles and online stores.
Investing Activities
Net cash used in investing activities were $8.5 million, $13.2 million and $1.2 million for the year ended March 31, 2022, 2021 and 2020, respectively. For the year ended March 31, 2022, the decrease was primarily
attributable to the new business acquisition of approximately $6.1 million and the proceeds of disposal of the subsidiaries. For the year
ended March 31, 2021, the increase was primarily attributable to an increase of fixed assets of approximately $2.78 million, the purchase
of software used for management of approximately $1.05 million and deposits paid for business acquisitions for approximately $9.31 million.
For the year ended March 31, 2020, the increase was primarily attributable to an increase of fixed assets of approximately $1.15 million.
Financing Activities
Net cash provided by financing
activities was approximately $10.4 million for the year ended March 31, 2020. It was primarily attributable to capital contributions of
net proceeds $9.3 million from IPO issuance of new ordinary shares. In terms of bank loans, the proceeds from short-term bank borrowings
was approximately $3.1 million and the repayments to short-term bank borrowings was approximately $2.1 million.
Net cash provided by financing activities was approximately
$10.7 million for the year ended March 31, 2021. It was primarily attributable to capital contributions of net proceeds $11.0 million
from issuance of new ordinary shares. In terms of bank loans, the proceeds from short-term bank borrowings was approximately $2.2 million
and the repayments to short-term bank borrowings was approximately $2.1 million. Dividend paid in 2021 was $0.4 million.
Net cash provided by financing
activities was approximately $18.8 million for the year ended March 31, 2022. It was primarily attributable to capital contributions of
net proceeds $18.9 million from issuance of new ordinary shares. In terms of bank loans, the proceeds from short-term bank borrowings
was approximately $2.2 million and the repayments to short-term bank borrowings was approximately $2.3 million. There was no dividend
payment in 2022.
Capital Expenditures
Our capital expenditures consist
primarily of expenditures for the construction of facilities, purchase of fixed assets and intangible assets as a result of our business
growth. Our capital expenditures amounted to $2,407,504, $3,834,578 and $1,159,355 for the years ended March 31, 2022, 2021 and 2020,
respectively.
Related
Party Transactions
In addition to the executive
officer compensation arrangements discussed in “Executive Compensation,” below we describe transactions since April 1,
2016, to which we have been a participant, in which the amount involved in the transactions is material to us or the related party.
No balance of due to related parties as
of March 31, 2022 and 2021.
Future Related Party Transactions
We will apply all rules about
related party transactions as a listing company, and the Corporate Governance Committee of our Board of Directors (consist solely of independent
directors) must approve all related party transactions. All related party transactions will be made or entered into on terms that are
no less favorable to use than can be obtained from unaffiliated third parties. Related party transactions that we have previously entered
into were not approved by independent directors, as we had no independent directors at that time.
Holding Company Structure
We are a holding company with
no material operations of our own. We conduct our operations through our subsidiaries in China. As a result, our ability to pay dividends
and to finance any debt we may incur depends upon dividends paid by our subsidiaries. Under applicable PRC regulations, foreign-invested
enterprises in China may pay dividends only out of their accumulated profits, if any, determined in accordance with PRC accounting standards
and regulations. In addition, a foreign-invested enterprise in China is required to set aside at least 10% of its after-tax profit based
on PRC accounting standards each year to its general reserves until the accumulative amount of such reserves reaches 50% of its registered
capital. These reserves are not distributable as cash dividends. The board of directors of a foreign-invested enterprise has the discretion
to allocate a portion of its after-tax profits to staff welfare and bonus funds, which may not be distributed to equity owners except
in the event of liquidation. Under PRC law, RMB is currently convertible into U.S. Dollars under a company’s “current account,”
which includes dividends, trade and service-related foreign exchange transactions, without prior approval of the State Administration
of Foreign Exchange (SAFE), but is not from a company’s “capital account,” which includes foreign direct investments
and loans, without the prior approval of the SAFE.
As of March 31, 2022,
our PRC subsidiaries had an aggregate retained earnings of approximately RMB 195.2 million (US$26.04 million) under PRC GAAP. With
respect to retained earnings accrued after such date, our Board of Directors may declare dividends after taking into account our
operations, earnings, financial condition, cash requirements and availability and other factors as it may deem relevant at such
time. Any declaration and payment, as well as the amount, of dividends will be subject to our By-Laws, charter and applicable
Chinese and U.S. state and federal laws and regulations, including the approval from the shareholders of each subsidiary which
intends to declare such dividends, if applicable.
C. Research and development, patents, and licenses,
etc.
Please refer to Item 4 Subparagraph B “Information
on the Company—Business Overview—Research and Development”, “Information on the Company—Business Overview—
Trademarks, Copyrights, Patents and Domain Names” and “Information on the Company—Business Overview—Licenses,
Permits and Government Regulations.”
D. Trend Information
Other than as disclosed elsewhere
in this annual report, we are not aware of any trends, uncertainties, demands, commitments or events that are reasonably likely to have
a material effect on our net revenues, income from continuing operations, profitability, liquidity or capital resources, or that would
cause reported financial information not necessarily to be indicative of future operating results or financial condition.
E.
Critical Accounting Estimates
Management makes estimates and assumptions
that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during the reporting period. These estimates are based on information as
of the date of the consolidated financial statements. Significant estimates required to be made by management include, but are not limited
to, the valuation of accounts receivable and related allowance for doubtful accounts, useful lives of property and equipment and intangible
assets, the recoverability of long-lived assets, inventory reserve, goodwill impairment, income taxes related to realization of deferred
tax assets and uncertain tax position, provisions necessary for contingent liabilities and contingent consideration. The current economic
environment has increased the degrees of uncertainty inherent in those estimates and assumptions, actual results could differ from those
estimates.
ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES
A. Directors and Senior Management
Our directors
and executive officers are as follows:
| Name | |
Age | | |
Position |
| Xuezhu Wang | |
| 38 | | |
Chief Executive Officer, Chairman of the Board |
| Jiong Bian | |
| 54 | | |
Chief Financial Officer |
| Wenhui Lin | |
| 59 | | |
Director |
| Zhangshu Huang | |
| 66 | | |
Director |
| Lun Liu | |
| 50 | | |
Director |
| John Levy | |
| 66 | | |
Director |
Below is a summary of the business experience
of each of our executive officers and directors:
Xuezhu Wang
Mr. Xuezhu Wang has been our
Chief Executive Officer since August 28, 2018, and Executive Director since February 9, 2018. He has been the Chief Executive Officer
of Fujian Happiness, our Chinese subsidiary since 2015. As the CEO of Fujian Happiness, he was responsible for procurement and formulating
a cost-effective strategy for purchasing goods and services. Mr. Xuezhu Wang studied the courses of Executive MBA in Peking University
in 2013 and obtained an MBA degree from University of Wales in 2015. Mr. Xuezhu Wang received his college degree from Minjiang University
in 2006.
Jiong Bian
Mr. Jiong Bian has been our
Chief Financial Officer since August 26, 2018. From January 2013 to October 2017, Mr. Bian served as the Chief Financial Officer of CWZ
China Flowers AG, formerly known as XinRuiKe, responsible for managing the China Flowers’ finances, including financial planning,
management of financial risks, record-keeping and financial reporting. From 2008 to 2012, Mr. Bian was a vice president for Viscardi AG.
China Division where he was responsible for introducing Frankfurt stock exchange listing incentives and the company’s scope of service
to local companies, encouraging Chinese companies to have an IPO on the German equity market. From 2005 to 2007, Mr. Bian served as the
Chief Financial Officer for Jiangsu Huadu Tongyi Co. Limited. Mr. Bian obtained a bachelor degree in economics from Shanghai University
of Finance and Economics. He is also a CFA Charter holder in the U.S.
Wenhui Lin
Mr. Wenhui Lin was appointed
as our director on November 13, 2020 and the Vice General Manager since 2007. Mr. Zhang served as the Deputy director of workshop at Shunchang
Fubao Industrial Co., Ltd from March 1991 to March 2007. As the Vice General Manager, his responsibilities included supporting Mr. Xuezhu
Wang to maintain a smooth process of purchase and production. Mr. Lin graduated from Jilin University in pharmaceutical specialty.
Zhangshu Huang
Mr.
Zhangshu Huang was appointed as our director in annual meeting of shareholders for the fiscal year ended March 31, 2021 on October 21,
2021. He currently is a director of the Scientific Research and Disciplinary Construction Division of Yango University in China.
He was a director and professor at School of Economics and Management at Fuzhou
University from January 2016 to December 2017. He served as the executive Dean and a professor at the Business School of Yango University
since January 2017 to May 2020. He has long been engaged in research and studies in topics including Internet economy, e-commerce, data
mining and business intelligence, logistics and supply chain management, and Internet of Things applications. Since 2016, he has undertaken
and participated in scientific research projects with organizations like the National Natural Science Foundation of China, Fujian Development
and Reform Commission’s Soft Science Key Project, and the Fujian Information Industry Soft Science Research Major Project. Mr. Huang
studied in the Department of Computer Science at Xiamen University and graduated in 1982 with a Bachelor’s Degree. He earned a Master’s
Degree in Business Administration at the Business School of Hong Kong Metropolitan University in 2001.
Lun Liu
Mr.
Lun Liu was appointed as our director in annual meeting of shareholders for the fiscal year ended March 31, 2021 on October 21, 2021.
Mr. Lun Liu is the chairman of Beijing Nine Cycle Wealth Investment Management Co., Ltd. Prior to this, Mr. Liu worked as a general manager
at Shaanxi Financial Holding Group from October 2018 to January 2020. He was the deputy general manager at Financial Capital Department
of Fujian Provincial Investment and Development Group from August 2014 to October 2018. Mr. Liu graduated in 1996 from Shihezi University
with a Bachelor’s Degree in Economics and Trade, and in 1999 he earned his Master’s Degree in Economics and Trade from Xinjiang
Agriculture University. Mr. Liu obtained his Doctorate Degree from China Agricultural University in 2004 with a major in Economics and
Trade. He did his post-doctorate studies in Chinese Academy of Social Sciences and Tehua Postdoctoral Research Station from 2004 to 2006.
John F. Levy
John F. Levy has served as our
independent director starting immediately upon the effectiveness of our registration statement on Form F-1. Mr. Levy currently serves
as the chief executive officer and principal consultant for Board Advisory (the “Levy Company”). He has held this role since
May 2005. Mr. Levy is a recognized corporate governance and financial reporting expert with over 30 years of progressive financial, accounting
and business experience; including nine years in public accounting with three national accounting firms and having served as chief financial
officer of both public and private companies for over 13 years. Mr. Levy currently serves on the board of directors of two other public
companies: Applied Minerals, Inc. (since January 2008), whose common stock is quoted on OTC; and Happiness Development Group Ltd. (since
October 2019), which is a company listed on Nasdaq Capital Market. Mr. Levy is a Certified Public Accountant. Mr. Levy is a graduate of
the Wharton School of Business at the University of Pennsylvania, and received his MBA from St. Joseph's University in Philadelphia, Pennsylvania.
Board Diversity
| Board Diversity Matrix |
| Country of Principal Executive Offices: |
China |
| Foreign Private Issuer |
Yes |
| Disclosure Prohibited under Home Country Law |
No |
| Total Number of Directors |
5 |
| |
Female |
Male |
Non-
Binary |
Did Not
Disclose
Gender |
| Part I: Gender Identity |
|
| Directors |
0 |
5 |
0 |
0 |
| Part II: Demographic Background |
|
| Underrepresented Individual in Home Country Jurisdiction |
0 |
| LGBTQ+ |
0 |
| Did Not Disclose Demographic Background |
0 |
Employment Agreements with Senior Management
On August 28, 2018, we entered
into an employment agreement with our CEO, Xuezhu Wang, effective on October 25, 2019. Pursuant to such agreement, he shall receive a
monthly base salary of approximately $2,200, paid in periodic installments in accordance with the Company’s regular payroll practices,
and such compensation is subject to annual review and adjustment by the Board. Mr. Wang is also eligible for bonus, benefits and reasonable
expenses reimbursement. Under this employment agreement, Mr. Wang is employed as our CEO for a term of five years, which automatically
renews for additional one year terms unless previously terminated on three months written notice by either party. We may terminate the
employment for cause, at any time, without notice or remuneration, for certain acts of the executive officer, such as conviction or plea
of guilty to a felony or grossly negligent or dishonest acts to our detriment, or misconduct or a failure to perform agreed duties. In
such case, the executive officer will not be entitled to receive payment of any severance benefits or other amounts by reason of the termination,
and the executive officer’s right to all other benefits will terminate, except as required by any applicable law. We may also terminate
an executive officer’s employment without cause upon one-month advance written notice. In such case of termination by us, we are
required to provide compensation to the executive officer, including (1) a lump sum cash payment equal to 1 months of the Executive’s
base salary as of the date of such termination; (2) a lump sum cash payment equal to a pro-rated amount of his target annual bonus for
the year immediately preceding the termination, if any; (3) payment of premiums for continued health benefits under the Company’s
health plans for 12 months fo1lowing the termination, if any; and (4) immediate vesting of 100% of the then-unvested portion of any outstanding
equity awards held by Mr. Wang.
Employment Agreement with Jiong Bian
On August 26, 2018, we entered
into an employment agreement with our CFO, Mr. Jiong Bian, effective on October 25, 2019. Pursuant to such agreement, he shall receive
a monthly base salary of approximately $3,200, paid in periodic installments in accordance with the Company’s regular payroll practices,
and such compensation is subject to annual review and adjustment by the Board. Mr. Bian is also eligible for bonus, benefits and reasonable
expenses reimbursement. Under this employment agreement, Mr. Bian is employed as our CFO for a term of five years, which automatically
renews for additional one year terms unless previously terminated on three months written notice by either party. We may terminate the
employment for cause, at any time, without notice or remuneration, for certain acts of the executive officer, such as conviction or plea
of guilty to a felony or grossly negligent or dishonest acts to our detriment, or misconduct or a failure to perform agreed duties. In
such case, the executive officer will not be entitled to receive payment of any severance benefits or other amounts by reason of the termination,
and the executive officer’s right to all other benefits will terminate, except as required by any applicable law. We may also terminate
an executive officer’s employment without cause upon one-month advance written notice. In such case of termination by us, we are
required to provide compensation to the executive officer, including (1) a lump sum cash payment equal to 1 months of the Executive’s
base salary as of the date of such termination; (2) a lump sum cash payment equal to a pro-rated amount of his target annual bonus for
the year immediately preceding the termination, if any; (3) payment of premiums for continued health benefits under the Company’s
health plans for 12 months fo1lowing the termination, if any; and (4) immediate vesting of 100% of the then-unvested portion of any outstanding
equity awards held by Mr. Bian.
Mr. Bian may terminate the
employment at any time with a one-month prior written notice to the Company, if (1) there is a material reduction in Mr. Bian’s
authority, duties and responsibilities, or (2) there is a material reduction in Mr. Bian’s annual salary. Upon the Executive’s
termination of the employment due to either of the above reasons, the Company shall provide compensation to the Mr. Bian equivalent to
one month of his base salary that he is entitled to immediately prior to such termination. In addition, Mr. Bian may resign prior to the
expiration of the agreement if such resignation is approved by the Board or an alternative arrangement with respect to the employment
is agreed to by the Board.
B. Compensation
Directors and Executive Compensation
The following table represents
compensation earned by our executive officers in the fiscal year ended March 31, 2022:
| Name and Principal Position | |
Salary ($) | | |
Bonus ($) | | |
Stock Awards ($) | | |
Option Award ($) | | |
Other Compensation ($) | | |
Total ($) | |
| | |
| | |
| | |
| | |
| | |
| | |
| |
| Xuezhu Wang (CEO and Chairman) | |
| 24,507 | | |
| 1,976 | | |
| 27,000 | | |
| - | | |
| - | | |
| 53,483 | |
| Jiong Bian (CFO) | |
| 28,107 | | |
| - | | |
| 5,400 | | |
| - | | |
| - | | |
| 33,507 | |
| Wenhui Lin (Director) | |
| 17,038 | | |
| 1,447 | | |
| 11,150 | | |
| - | | |
| - | | |
| 29,635 | |
| Zhangshu Huang (Director) | |
| - | | |
| - | | |
| 5,400 | | |
| - | | |
| - | | |
| 5,400 | |
| Lun Liu (Director) | |
| - | | |
| - | | |
| 50,640 | | |
| - | | |
| - | | |
| 50,640 | |
| John Levy (Director) | |
| 50,000 | | |
| - | | |
| 2,700 | | |
| - | | |
| - | | |
| 52,700 | |
| Wanhe Zhang (Former Director) | |
| | | |
| | | |
| 11,500 | | |
| | | |
| | | |
| 11,500 | |
| Rui Qiang (Former Director) | |
| | | |
| | | |
| 15,660 | | |
| | | |
| | | |
| 15,660 | |
Grants of Plan Based Awards
From April 1, 2021 through
the date of this annual report, we have issued a total of 1,478,103 Ordinary Shares to employees, directors and consultants.
Pension Benefits
None of the named executives
currently participates in or has account balances in qualified or nonqualified defined benefit plans sponsored by us.
Nonqualified Deferred Compensation
None of the named executives
currently participates in or has account balances in nonqualified defined contribution plans or other deferred compensation plans maintained
by us.
Other than as disclosed above,
we have not entered into any agreements or arrangements with our executive officers or directors, and have not made any agreements to
provide benefits upon termination of employment.
C. Board Practices
Committees of the Board of Directors
We have established an audit
committee, a compensation committee and a nominating and governance committee. Each of the committees of the Board has the composition
and responsibilities described below.
Audit Committee
Zhangshu Huang, Lun Liu and
John Levy are members of our Audit Committee, where John Levy, serves as the chairman. All members of our Audit Committee satisfy the
independence standards promulgated by the SEC and by NASDAQ as such standards apply specifically to members of audit committees.
We have adopted and approved
a charter for the Audit Committee prior to consummation of our initial public offering. In accordance with our Audit Committee Charter,
our Audit Committee performs several functions, including:
| |
● |
evaluates the independence and performance of, and assesses the qualifications of, our independent auditor, and engages such independent auditor; |
| |
● |
approves the plan and fees for the annual audit, quarterly reviews, tax and other audit-related services, and approves in advance any non-audit service to be provided by the independent auditor; |
| |
● |
monitors the independence of the independent auditor and the rotation of partners of the independent auditor on our engagement team as required by law; |
| |
● |
reviews the financial statements to be included in our Annual Report on Form 20-F and Quarterly Reports on Form 6-K and reviews with management and the independent auditors the results of the annual audit and reviews of our quarterly financial statements; |
| |
● |
oversees all aspects our systems of internal accounting control and corporate governance functions on behalf of the board; |
| |
● |
reviews and approves in advance any proposed related-party transactions and report to the full Board on any approved transactions; and |
| |
● |
provides oversight assistance in connection with legal, ethical and risk management compliance programs established by management and the Board, including Sarbanes-Oxley Act implementation, and makes recommendations to the Board regarding corporate governance issues and policy decisions. |
It is determined that John
Levy, possesses accounting or related financial management experience that qualifies him as an “audit committee financial expert”
as defined by the rules and regulations of the SEC.
Compensation Committee
We have established the Compensation
Committee in October 2019. Zhangshu Huang, Lun Liu, and John Levy are members of our Compensation Committee and Zhangshu Huang is the
chairman. All members of our Compensation Committee are qualified as independent under the current definition promulgated by NASDAQ. We
have adopted a charter for the Compensation Committee prior to consummation of this offering. In accordance with the Compensation Committee’s
Charter, the Compensation Committee is responsible for overseeing and making recommendations to the Board regarding the salaries and other
compensation of our executive officers and general employees and providing assistance and recommendations with respect to our compensation
policies and practices.
Nominating and Governance Committee
Zhangshu
Huang, John Levy and Lun Liu are the members of our Nominating and Governance Committee where Lun Liu serves
as the chairman. All members of our Nominating and Governance Committee are qualified as independent under the current definition promulgated
by NASDAQ. The Board of Directors adopted and approved a charter for the Nominating and Governance Committee prior to consummation of
this offering. In accordance with the Nominating and Governance Committee’s Charter, the Nominating and Corporate Governance Committee
is responsible to identify and propose new potential director nominees to the Board of Directors for consideration and review our corporate
governance policies.
Code of Conduct and Ethics
On October 24, 2019, we adopted
a code of conduct and ethics applicable to our directors, officers and employees in accordance with applicable federal securities laws
and NASDAQ rules.
Corporate Governance
Our board of directors has
adopted a code of business conduct and ethics, which is applicable to all of our directors, officers and employees. We will make our code
of business conduct and ethics publicly available on our website prior to the initial closing of this offering.
Insider Trading Policy
On October 24, 2019, our Board
of Directors adopted an insider trading policy that applies to our directors, officers and employees.
Director Independence
In
conformity with Nasdaq’s Corporate Governance Rules, the Company, as a foreign private issuer, has opted not to comply with Nasdaq’s
independence requirements. Accordingly, our Board of Directors has determined that three of our directors, Zhangshu Huang, Lun Liu and
John Levy qualify as independent directors pursuant to the rules of the Nasdaq Marketplace.
D. Employees
As of March 31, 2022, we have
a total of 218 full-time employees, all of whom are located in the PRC. We do not experience any significant seasonal fluctuations in
our number of employees.
None of our employees are
represented by a union. We believe that our relationship with our employees has historically been good and this is expected to continue.
The functional distribution
of our full-time employees as of March 31, 2022 is as follows:
| Function | |
Number | |
| Management | |
| 12 | |
| Sales and marketing | |
| 38 | |
| Research and Development | |
| 20 | |
| Finance and administration | |
| 25 | |
| E-commerce operation and logistics | |
| 123 | |
| | |
| | |
| Total | |
| 218 | |
E. Share Ownership
The following table sets forth
information regarding the beneficial ownership of our ordinary shares as of August 15, 2022:
| |
● |
each person known by us to be the beneficial owner of more than 5% of our outstanding ordinary shares; |
| |
● |
each of our executive officers and directors; and |
| |
● |
all our executive officers and directors as a group. |
The
beneficial ownership of ordinary shares is determined in accordance with the rules of the SEC and generally includes any ordinary shares
over which a person exercises sole or shared voting or investment power. For purposes of the table below, we deem shares subject to options,
warrants or other exercisable or convertible securities that are exercisable or convertible currently or within 60 days of August 15,
2022, to be outstanding and to be beneficially owned by the person holding the options, warrants or other currently exercisable or convertible
securities for the purposes of computing the percentage ownership of that person but we do not treat them as outstanding for the purpose
of computing the percentage ownership of any other person. Unless otherwise indicated below, to our knowledge, all persons named in the
table have sole voting and investment power with respect to their shares, except to the extent authority is shared by spouses under community
property laws.
| | |
Shares
Beneficially Owned (1)(2) | | |
| |
| | |
Class A Ordinary Shares | | |
Class B Ordinary Shares | | |
% of Total
Voting Power | |
| | |
Number | | |
% | | |
Number | | |
% | | |
| |
| Directors and Executive Officers(3): | |
| | |
| | |
| | |
| | |
| |
| Xuezhu Wang, Chief Executive Officer and Chairman of the Board(4) | |
| — | | |
| * | | |
| 12,245,100 | | |
| 100 | % | |
| 78.56 | % |
| Jiong Bian, Chief Financial Officer | |
| 16,200 | | |
| * | | |
| — | | |
| — | | |
| — | |
| Wenhui Lin, Director | |
| 30,327 | | |
| * | | |
| — | | |
| — | | |
| — | |
| Zhangshu Huang, Director | |
| 10,000 | | |
| * | | |
| — | | |
| — | | |
| — | |
| Lun Liu, Director | |
| 10,000 | | |
| * | | |
| — | | |
| — | | |
| — | |
| John Levy, Director | |
| 10,000 | | |
| * | | |
| — | | |
| — | | |
| — | |
| All Directors and Executive Officers | |
| 76,527 | | |
| * | % | |
| 12,245,100 | | |
| 100 | % | |
| 78.58 | % |
| 5% Shareholders: | |
| | | |
| | | |
| | | |
| | | |
| | |
| Happy Group Inc.(4) | |
| — | | |
| — | | |
| 12,045,100 | | |
| 98.37 | % | |
| 77.27 | % |
* less than 1%
| (1) | Beneficial ownership is determined in accordance with the rules of the SEC and includes voting or investment
power with respect to the ordinary shares. All shares represent only ordinary shares held by shareholders as no options are issued or
outstanding. The percentage of shares beneficially owned is based on 66,854,583 Class A ordinary shares and 12,245,100 Class B ordinary
shares outstanding as of August 15, 2022. |
| (2) | Each Class A ordinary share has one (1) vote per share. Each Class B ordinary share has
twenty (20) votes per share. |
| (3) | Unless otherwise noted, the business address for each of our beneficial owners is c/o Happiness Development
Group Limited, NO. 11, Dongjiao East Road, Shuangxi, Shunchang Nanping City, Fujian, China |
| (4) |
Mr. Xuezhu Wang indirectly owns100% of our issued and outstanding Class B ordinary shares through Happy Group Inc., which is wholly owned by Mr. Wang |
ITEM
7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS
A. Major Shareholders
Please refer to Item 6 “Directors,
Senior Management and Employees—E. Share Ownership.”
B. Related Party Transactions
In addition to the executive
officer and director compensation arrangements discussed in “Directors and Executive Compensation,” below we describe transactions
since April 1, 2016, to which we have been a participant, in which the amount involved in the transactions is material to us or the related
party.
From
time to time, we receive cash advances from the related parties. The Company has repaid all related party balance during the year ended
March 31, 2022.
C. Interests of Experts and Counsel
Not applicable.
ITEM 8. FINANCIAL INFORMATION
A. Consolidated Statements and Other Financial
Information
Financial Statements
We have appended consolidated
financial statements filed at the end of this report on 20-F, beginning on page F-1.
Legal Proceedings
We are currently not a party
to any material legal or administrative proceedings. We may from time to time be subject to various legal or administrative claims and
proceedings arising in the ordinary course of business. Litigation or any other legal or administrative proceeding, regardless of the
outcome, is likely to result in substantial cost and diversion of our resources, including our management’s time and attention.
Dividends
On July 31, 2020, the Board
of the Company declared a special cash dividend of $0.015 per Ordinary Shares. The dividend, equal to $375,000 in the aggregate, was fully
paid on August 17, 2020.
B. Significant Changes
Not applicable.
ITEM 9. THE OFFER AND LISTING
A. Offer and Listing Details
Our Class A ordinary shares
are currently trading under the ticker symbol “HAPP.” The shares began trading on October 25, 2019 on the NASDAQ Capital Market.
B. Plan of Distribution
Not applicable.
C. Markets
Our Class A ordinary shares
are currently traded on the NASDAQ Capital Market
D. Selling Shareholders
Not applicable.
E. Dilution
Not applicable.
F. Expenses of the Issue
Not Applicable.
ITEM 10. ADDITIONAL INFORMATION
A. Share Capital
Not applicable.
B. Memorandum and Articles of Association
We are an exempted company
incorporated in Cayman Islands and our affairs are governed by our second amended and restated memorandum and articles of association
and the Cayman Islands Companies Act (2022 Revision) (as amended) (the “Cayman Companies Act”). A Cayman Islands exempted
company:
| ● | is
a company that conducts its business mainly outside the Cayman Islands; |
| |
● |
is prohibited from trading in the Cayman Islands with any person, firm or corporation except in furtherance of the business of the exempted company carried on outside the Cayman Islands (and for this purpose can effect and conclude contracts in the Cayman Islands and exercise in the Cayman Islands all of its powers necessary for the carrying on of its business outside the Cayman Islands); |
| |
● |
does not have to hold an annual general meeting; |
| |
● |
does not have to make its register of members open to inspection by shareholders of that company; |
| |
● |
may obtain an undertaking against the imposition of any future taxation; |
| |
● |
may register by way of continuation in another jurisdiction and be deregistered in the Cayman Islands; |
| |
● |
may register as a limited duration company; and |
| |
● |
may register as a segregated portfolio company. |
The
following description of our memorandum and articles of association, as amended and restated from time to time, are summaries and do not
purport to be complete. Reference is made to our second amended and restated memorandum and articles of association,
effective on October 21, 2021 (respectively, the “Memorandum” and the “Articles”).
All of our issued and outstanding
Ordinary Shares are fully paid and non-assessable. Our Ordinary Shares are issued in registered form, and are issued when registered in
our register of members. Unless and until the directors resolve to issue share certificates, no share certificate shall be issued, and
the records of the shareholdings of each shareholder shall be in uncertified book entry form. Our shareholders who are non-residents of
the Cayman Islands may freely hold and vote their Ordinary Shares. We may not issue shares or warrants to bearer.
On October 21, 2021, we re-classified and re-designated
our Ordinary Shares into Class A Ordinary Shares and Class B Ordinary Shares by filing the amended and restated memorandum and articles
of association with the Cayman Islands Registrar of Companies.
As of the date of this report,
the authorized share capital of the Company is US $50,000 divided into 70,000,000 Class A Ordinary Shares of US $0.0005 par value each
and 20,000,000 Class B Ordinary Shares with a par value of US $0.0005 each. The Articles provide that our authorized share capital is
US$50,000 divided into 70,000,000 Class A Ordinary Shares of US $0.0005 par value each and 20,000,000 Class B Ordinary Shares with a par
value of US $0.0005 each, and 10,000,000 Preferred Shares with a par value of US$0.0005 each. Subject to the provisions of the Cayman
Companies Act and the provisions, if any, of the Articles, and any directions given by any ordinary resolution and the rights attaching
to any class of existing shares, the directors may issue, allot, grant options over or otherwise dispose of shares (including any fractions
of Shares) and other securities of our company at such times, to such persons, for such consideration and on such terms as the directors
may determine. Such authority could be exercised by the directors to allot shares which carry rights and privileges that are preferential
to the rights attaching to Ordinary Shares provided that if such operates to vary the rights of holders of Ordinary Shares then the sanction
of a special resolution of the affected class is required. No share may be issued at a discount except in accordance with the provisions
of the Cayman Companies Act. The directors may refuse to accept any application for shares, and may accept any application in whole or
in part, for any reason or for no reason.
Ordinary Shares
General. The
unissued shares of the Company shall be at the disposal of the Board, under its absolute discretion, at such times and for such consideration
and upon such terms and conditions and for any reason, without limitation, but so that no shares shall be issued at a discount to par
value. Except as otherwise expressly provided in the resolution or resolutions providing for the establishment of any class or series
of preferred shares, no vote of the holders shall be a prerequisite to the issuance of any shares of any class or series of the preferred
shares authorized by and complying with the conditions of the Memorandum and Articles of Association. The board may issue options, warrants,
convertible securities or other similar nature securities.
Dividends. The
holders of our ordinary shares are entitled to such dividends as may be declared by our board of directors. In addition, our
shareholders may by ordinary resolution declare a dividend, but no dividend may exceed the amount recommended by our directors.
Voting Rights. Subject
to any special rights or restrictions as to voting attached to any shares, every shareholder who is present in person and every person
representing a shareholder by proxy shall have one vote for each share of which he or the person represented by proxy is the holder. All
votes at meetings of members shall be by way of poll. In addition, all shareholders holding shares of a particular class are entitled
to vote at a meeting of the holders of that class of shares. Votes may be given either personally or by proxy.
Transfer of Ordinary Shares.
Subject to these Articles, any Member may transfer all or any of his shares by an instrument of transfer in the usual or common form or
in a form prescribed by the NASDAQ or in any other form approved by the Board and may be under hand or, if the transferor or transferee
is a clearing house or a central depository house or its nominee(s), by hand or by machine imprinted signature or by such other manner
of execution as the Board may approve from time to time. Our board of directors may, in its absolute discretion, and without assigning
any reason, refuse to register any transfer of any ordinary share which is not fully paid up or upon which our company has a lien. Our
directors may also decline to register any transfer of any ordinary share unless (a) a fee of such maximum sum as the NASDAQ may
determine to be payable or such lesser sum as the Board may from time to time require is paid to the Company in respect thereof; (b) the
instrument of transfer is in respect of only one class of shares; (c) the instrument of transfer is lodged at the Office or such other
place at which the Register is kept in accordance with the Law or the Registration Office (as the case may be) accompanied by the relevant
share certificate(s) and such other evidence as the Board may reasonably require to show the right of the transferor to make the transfer
(and, if the instrument of transfer is executed by some other person on his behalf, the authority of that person so to do); and (d) if
applicable, the instrument of transfer is duly and properly stamped.
If our directors refuse to
register a transfer they shall, within one months after the date on which the instrument of transfer was lodged, send to each of the transferor
and the transferee notice of such refusal. The registration of transfers may, on fourteen (14) days’ notice being given by
advertisement in an appointed newspaper or any other newspapers or by any other means in accordance with the requirements of the NASDAQ
to that effect, be suspended at such times and for such periods (not exceeding in the whole thirty (30) calendar days in any year) as
our directors may determine.
Winding-Up/Liquidation.
If we are wound up, the shareholders may, subject to the articles and any other sanction required by the Cayman Companies Act, pass a
special resolution voluntarily winding up the company. Upon being appointed, a liquidator may do either or both of the following with
the authority of a special resolution:
(a) divide in specie among
the shareholders the whole or any part of our assets and, for that purpose, to value any assets and to determine how the division shall
be carried out as between the shareholders or different classes of shareholders; and
(b) vest the whole or any
part of the assets in trustees for the benefit of shareholders as the liquidator thinks fit.
The directors have the authority
to present a petition for our winding up to the Grand Court of the Cayman Islands on our behalf without the sanction of a resolution passed
at a general meeting.
Calls on Ordinary Shares
and Forfeiture of Ordinary Shares. Our board of directors may from time to time make calls upon shareholders for any amounts unpaid
on their shares in a notice served to such shareholders at least 14 days prior to the specified time and place of payment. The shares
that have been called upon and remain unpaid on the specified time are subject to forfeiture.
Redemption of Shares.
We may issue shares on terms that are subject to redemption, at our option or at the option of the holders, on such terms and in such
manner as may be determined by our Board of Directors.
Inspection of Books and
Records. The accounting records shall be kept at the office or, at such other place or places as the board decides and shall always
be open to inspection by the directors. No member, non-director, shall have any right of inspecting any accounting record or book or document
of the company except as conferred by the law or authorized by the board or the members in general meeting.
Issuance of Additional
Shares. Our Memorandum and Articles authorize our Board of Directors to issue additional Ordinary Shares from time to time as our
Board of Directors shall determine, to the extent there are available authorized but unissued shares.
Our Memorandum and Articles
also authorizes our Board of Directors to establish from time to time one or more series of preferred shares and to determine, subject
to compliance with the variation of rights of shares provision in the Memorandum and Articles, with respect to any series of preferred
shares, the terms and rights of that series, including:
| |
● |
the designation of the series; |
| |
● |
the number of shares of the series; |
| |
● |
the dividend rights, dividend rates, conversion rights, voting rights; and |
| |
● |
the rights and terms of redemption and liquidation preferences. |
Our Board of Directors may,
issue preferred shares without action by our shareholders to the extent there are authorized but unissued shares available.
General Meetings of Shareholders
and Shareholder Proposals.
As a Cayman Islands exempted
company, we are not obligated by the Cayman Companies Act to call shareholders’ annual general meetings; however, our articles provide
that the Company shall hold a general meeting as an annual general meeting in each year other than the year in which the Articles are
adopted. Any annual general meeting held shall be held at such time and place as may be determined by our board of directors. All general
meetings other than annual general meetings shall be called extraordinary general meetings.
The directors may convene
general meetings whenever they think fit. Upon the written request of shareholders holding 20% or more of the issued share capital of
the Company carrying the right to vote in respect of the matter for which the meeting is requisitioned, any one or more of the directors
shall forthwith proceed to convene a meeting of shareholders. The written request of shareholders to requisition a meeting must state
the objects of the meeting and must be signed by the shareholders requisitioning the meeting. The written request must be lodged at the
principal place of business of the Company (with a copy to the registered office) and may be delivered in counterpart. If our board of
directors do not within 21 calendar days, proceed to convene a meeting of shareholders within a further 21 days, the requisitionists,
or any of them together holding at least half of the total voting rights of all of them may convene the general meeting but any meeting
so convened shall not be held after the expiration of three months after the expiration of the second 21 calendar days.
At least ten (10) clear days’
notice of a meeting shall be given to shareholders entitled to attend and vote at such meeting where such meeting is convened by the directors.
Subject to the Cayman Companies
Act, a general meeting may be convened on shorter notice, if
| |
(a) |
In the case of an annual general meeting, by all the Members entitled to attend and vote thereat; and |
| |
(b) |
In the case of any other meeting, by a majority in number of the Members having the right to attend and vote at the meeting, being a majority together holding not less than ninety-five per cent (95%) in nominal value of the issued shares giving that right. |
The presence of one or more
shareholders entitled to vote, whether in person or represented by proxy or (if a corporation) by its duly appointed representative representing
not less than one-third in nominal value of the total issued voting shares in the Company throughout the meeting, shall constitute a quorum
at a general meeting.
If, within 30 minutes (or
such longer time not exceeding one hour as the chairman of the meeting may determine to wait) from the time appointed for the meeting
a quorum is not present, the meeting, shall stand adjourned to the same day in the next week at the same time and place or to such other
time and place as is determined by the directors and if at the adjourned meeting a quorum is not present within half an hour from the
time appointed for the meeting the meeting shall be dissolved.
The chairman may, with the
consent of a meeting at which a quorum is present, adjourn the meeting. When a meeting is adjourned for fourteen days or more, at least
seven (7) clear days’ notice of the adjourned meeting shall be given specifying the time and place of the adjourned meeting but
it shall not be necessary to specify in such notice the nature of the business to be transacted at the adjourned meeting.
At any general meeting a resolution
put to the vote of the meeting shall be decided by poll by the affirmative vote of the majority of issued shares held by persons present
in person or by proxy at the meeting entitled to vote and each shareholder shall be entitled to one vote in respect of each fully paid
share held. A declaration by the chairman that a resolution has been carried, or carried unanimously, or by a particular majority, or
not carried by a particular majority, or lost, and an entry to that effect made in the minute book of the Company, shall be conclusive
evidence of the facts without proof of the number or proportion of the votes recorded for or against the resolution.
In the case of an equality
of votes, on a poll, the chairman of the meeting at shall be entitled to a second or casting vote in addition to any other votes he may
have.
Register of Members
Under Cayman Islands law,
we must keep a register of members and there should be entered therein:
| |
● |
the names and addresses of the members, a statement of the shares held by each member, and of the amount paid or agreed to be considered as paid, on the shares of each member; |
| |
|
|
| |
● |
the date on which the name of any person was entered on the register as a member; and |
| |
|
|
| |
● |
the date on which any person ceased to be a member. |
Under Cayman Islands law,
the register of members of our Company is prima facie evidence of the matters set out therein (i.e. the register of members will raise
a presumption of fact on the matters referred to above unless rebutted) and a member registered in the register of members is deemed as
a matter of Cayman Islands law to have legal title to the shares as set against its name in the register of members. Once our register
of members has been updated, the shareholders recorded in the register of members are deemed to have legal title to the shares set against
their name.
If the name of any person
is incorrectly entered in, or omitted from, our register of members, or if there is any default or unnecessary delay in entering on the
register the fact of any person having ceased to be a member of our Company, the person or member aggrieved (or any member of our Company
or our Company itself) may apply to the Cayman Islands Grand Court for an order that the register be rectified, and the Court may either
refuse such application or it may, if satisfied of the justice of the case, make an order for the rectification of the register.
Indemnification of Directors and Executive
Officers and Limitation of Liability
Cayman Islands law does not
limit the extent to which a company’s memorandum and articles of association may provide for indemnification of officers and directors,
except to the extent any such provision may be held by the Cayman Islands courts to be contrary to public policy, such as to provide indemnification
against civil fraud or the consequences of committing a crime. Our Memorandum and Articles require us to indemnify our officers and directors
for actions, costs, charges, losses, damages, and expenses (“Indemnified Losses”) incurred in their capacities as such unless
such Indemnified Losses arise from dishonesty or fraud of such directors or officers.
Insofar
as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers or persons controlling
us under the foregoing provisions, we have been informed that in the opinion of the SEC, such indemnification is against public policy
as expressed in the Securities Act and is therefore unenforceable.
Differences in Corporate Law
The Companies Law is derived,
to a large extent, from the older Companies Acts of England, but does not follow recent United Kingdom statutory enactments, and accordingly
there are significant differences between the Companies Law and the current Companies Act of England. In addition, the
Companies Law differs from laws applicable to United States corporations and their shareholders. Set forth below is a summary
of certain significant differences between the provisions of the Companies Law applicable to us and the comparable provisions of the laws
applicable to companies incorporated in the State of Delaware and their shareholders.
Mergers and Similar Arrangements. The
Companies Law permits mergers and consolidations between Cayman Islands companies and between Cayman Islands companies and non-Cayman
Islands companies. For these purposes, (a) “merger” means the merging of two or more constituent companies and
the vesting of their undertaking, property and liabilities in one of such companies as the surviving company and (b) a “consolidation”
means the combination of two or more constituent companies into a consolidated company and the vesting of the undertaking, property and
liabilities of such companies to the consolidated company. In order to effect such a merger or consolidation, the directors
of each constituent company must approve a written plan of merger or consolidation, which must then be authorized by (i) a special resolution
of the shareholders of each constituent company and (ii) such other authorization, if any, as may be specified in such constituent company’s
articles of association. The plan of merger or consolidation must be filed with the Registrar of Companies together with a
declaration as to the solvency of the consolidated or surviving company, a list of the assets and liabilities of each constituent company
and an undertaking that a copy of the certificate of merger or consolidation will be given to the members and creditors of each constituent
company and that notification of the merger will be published in the Cayman Islands Gazette. Dissenting shareholders have the right to
be paid the fair value of their shares (which, if not agreed between the parties, will be determined by the Cayman Islands court) if they
follow the required procedures, subject to certain exceptions. Court approval is not required for a merger or consolidation
effected in compliance with these statutory procedures.
In addition, there are statutory
provisions that facilitate the reconstruction and amalgamation of companies, provided that the arrangement is approved by a majority in
number of each class of shareholders and creditors with whom the arrangement is to be made, and who must, in addition, represent three-fourths
in value of each such class of shareholders or creditors, as the case may be, that are present and voting either in person or by proxy
at a meeting, or meetings, convened for that purpose. The convening of the meetings and subsequently the arrangement must be
sanctioned by the Grand Court of the Cayman Islands. While a dissenting shareholder has the right to express to the court the
view that the transaction ought not to be approved, the court can be expected to approve the arrangement if it determines that:
| |
● |
the statutory provisions as to the required majority vote have been met; |
| |
● |
the shareholders have been fairly represented at the meeting in question and the statutory majority are acting bona fide without coercion of the minority to promote interests adverse to those of the class; |
| |
● |
the arrangement is such that may be reasonably approved by an intelligent and honest man of that class acting in respect of his interest; and |
| |
● |
the arrangement is not one that would more properly be sanctioned under some other provision of the Companies Law. |
When a take-over offer is
made and accepted by holders of 90.0% of the shares affected (within four months after they marking the offer), the offeror may, within
a two-month period commencing on the expiration of such four months period, require the holders of the remaining shares to transfer such
shares on the terms of the offer. An objection can be made to the Grand Court of the Cayman Islands but this is unlikely to
succeed in the case of an offer which has been so approved unless there is evidence of fraud, bad faith or collusion.
If an arrangement and reconstruction
is thus approved, the dissenting shareholder would have no rights comparable to appraisal rights, which would otherwise ordinarily be
available to dissenting shareholders of Delaware corporations, providing rights to receive payment in cash for the judicially determined
value of the shares.
Shareholders’ Suits. In
principle, we will normally be the proper plaintiff to sue for a wrong done to us as a company, and as a general rule a derivative action
may not be brought by a minority shareholder. However, based on English authorities, which would in all likelihood be of persuasive
authority in the Cayman Islands, the Cayman Islands courts can be expected to apply and follow common law principles so that a non-controlling
shareholder may be permitted to commence a class action against the company or a derivative action in the name of the company to challenge
certain acts, including the following:
| |
● |
an act which is ultra vires the company or illegal and is therefore incapable of ratification by the shareholders; |
| |
● |
an act which, although not ultra vires, could only be effected if duly authorized by a resolution with a qualified or special majority (i.e., more than a simple majority) that has not been obtained; and |
| |
● |
an act which constitutes a “fraud on the minority” where the wrongdoers are themselves in control of the company. |
Indemnification of Directors
and Executive Officers and Limitation of Liability. Cayman Islands law does not limit the extent to which a company’s
memorandum and articles of association may provide for indemnification of officers and directors, except to the extent any such provision
may be held by the Cayman Islands courts to be contrary to public policy, such as to provide indemnification against civil fraud or the
consequences of committing a crime.
Our Memorandum and Articles
provide that our directors and officers shall be indemnified against all actions, proceedings, costs, charges, expenses, losses, damages
or liabilities incurred or sustained by such director or officer, other than by reason of such person’s own dishonesty, willful
default or fraud, in or about the conduct of our company’s business or affairs (including as a result of any mistake of judgment)
or in the execution or discharge of his duties, powers, authorities or discretions, including without prejudice to the generality of the
foregoing, any costs, expenses, losses or liabilities incurred by such director or officer in defending (whether successfully or otherwise)
any civil proceedings concerning our company or its affairs in any court whether in the Cayman Islands or elsewhere. This standard
of conduct is generally the same as permitted under the Delaware General Corporation Law for a Delaware corporation. In addition,
we intend to enter into indemnification agreements with our directors and senior executive officers that will provide such persons with
additional indemnification beyond that provided in our Memorandum and Articles.
Insofar as indemnification
for liabilities arising under the Securities Act may be permitted to our directors, officers or persons controlling us under the foregoing
provisions, we have been informed that, in the opinion of the SEC, such indemnification is against public policy as expressed in the Securities
Act and is therefore unenforceable.
Directors’ Fiduciary
Duties. Under Delaware corporate law, a director of a Delaware corporation has a fiduciary duty to the corporation and
its shareholders. This duty has two components: the duty of care and the duty of loyalty. The duty of
care requires that a director act in good faith, with the care that an ordinarily prudent person would exercise under similar circumstances. Under
this duty, a director must inform himself of, and disclose to shareholders, all material information reasonably available regarding a
significant transaction. The duty of loyalty requires that a director act in a manner he or she reasonably believes to be in
the best interests of the corporation. He or she must not use his or her corporate position for personal gain or advantage. This
duty prohibits self-dealing by a director and mandates that the best interest of the corporation and its shareholders take precedence
over any interest possessed by a director, officer or controlling shareholder and not shared by the shareholders generally. In
general, actions of a director are presumed to have been made on an informed basis, in good faith and in the honest belief that the action
taken was in the best interests of the corporation. However, this presumption may be rebutted by evidence of a breach of one
of the fiduciary duties. Should such evidence be presented concerning a transaction by a director, a director must prove the
procedural fairness of the transaction, and that the transaction was of fair value to the corporation.
As a matter of Cayman Islands
law, a director of a Cayman Islands company is in the position of a fiduciary with respect to the company and therefore it is considered
that he owes the following duties to the company—a duty to act bona fide in the best interests of the company, a duty not to make
a profit based on his or her position as director (unless the company permits him to do so) and a duty not to put himself in a position
where the interests of the company conflict with his or her personal interest or his or her duty to a third party. A director
of a Cayman Islands company owes to the company a duty to act with skill and care. It was previously considered that a director
need not exhibit in the performance of his or her duties a greater degree of skill than may reasonably be expected from a person of his
or her knowledge and experience. However, English and Commonwealth courts have moved towards an objective standard with regard
to the required skill and care and these authorities are likely to be followed in the Cayman Islands.
Shareholder Action by Written
Consent. Under the Delaware General Corporation Law, a corporation may eliminate the right of shareholders to act by written
consent by amendment to its certificate of incorporation. As permitted by Cayman Islands law, our Memorandum and Articles provide
that the shareholders may not take any required or permitted action at any annual or extraordinary general meetings of the Company by
written resolution without a meeting.
Shareholder Proposals. Under
the Delaware General Corporation Law, a shareholder has the right to put any proposal before the annual meeting of shareholders, provided
it complies with the notice provisions in the governing documents. A special meeting may be called by the board of directors
or any other person authorized to do so in the governing documents, but shareholders may be precluded from calling special meetings.
Cayman Islands law provides
shareholders with only limited rights to requisition a general meeting, and does not provide shareholders with any right to put any proposal
before a general meeting. However, these rights may be provided in a company’s articles of association.
Our Memorandum and Articles
provide that general meetings shall be convened on the written requisition of one or more of the shareholders entitled to attend and vote
at our general meetings who (together) hold not less than twenty percent (20%) of the issued share capital of the Company as at that date
carries the right of voting at general meetings of the Company, specifying the purpose of the meeting and signed by each of the shareholders
making the requisition. If the directors do not convene such meeting for a date not later than twenty-one clear days’ after the
date of receipt of the written requisition, those shareholders who requested the meeting may convene the general meeting themselves within
three months after the end of such period of twenty-one clear days in which case reasonable expenses incurred by them as a result of the
directors failing to convene a meeting shall be reimbursed by us. Our articles provide no other right to put any proposals before annual
general meetings or extraordinary general meetings. As a Cayman Islands exempted company, we are not obligated by law to call shareholders’
annual general meetings. However, our corporate governance guidelines require us to call such meetings every year. Cumulative Voting. Under
the Delaware General Corporation Law, cumulative voting for elections of directors is not permitted unless the corporation’s certificate
of incorporation specifically provides for it. Cumulative voting potentially facilitates the representation of minority shareholders
on a board of directors since it permits the minority shareholder to cast all the votes to which the shareholder is entitled on a single
director, which increases the shareholder’s voting power with respect to electing such director. There are no prohibitions
in relation to cumulative voting under Cayman Islands law, but Memorandum and Articles do not provide for cumulative voting. As
a result, our shareholders are not afforded any less protections or rights on this issue than shareholders of a Delaware corporation.
Removal of Directors.
Under the Delaware General
Corporation Law, a director of a corporation with a classified board may be removed only for cause with the approval of a majority of
the outstanding shares entitled to vote, unless the certificate of incorporation provides otherwise. Under Cayman Islands law the office
of director shall be vacated, if the director:
| (a) | resigns his office by notice in writing to the company |
| (b) | becomes bankrupt or has a receiving order made against him
or suspends payment or makes an arrangement or composition with his creditors generally; |
| (c) | is found to be or becomes of unsound mind; |
| (d) | without special leave of absence from the Board, is absent
from meetings of the Board for six consecutive months and the Board resolves that his office be vacated; or; |
| (e) | is prohibited from the law from being a Director; or |
| (f) | ceases to be a Director by virtue of any provision of any
Statutes or is removed from office pursuant to these Articles. |
Transactions with Interested
Shareholders. The Delaware General Corporation Law contains a business combination statute applicable to Delaware corporations
whereby, unless the corporation has specifically elected not to be governed by such statute by amendment to its certificate of incorporation,
it is prohibited from engaging in certain business combinations with an “interested shareholder” for three years following
the date that such person becomes an interested shareholder. An interested shareholder generally is a person or a group who
or which owns or owned 15% or more of the target’s outstanding voting stock within the past three years. This has the
effect of limiting the ability of a potential acquirer to make a two-tiered bid for the target in which all shareholders would not be
treated equally. The statute does not apply if, among other things, prior to the date on which such shareholder becomes an
interested shareholder, the board of directors approves either the business combination or the transaction which resulted in the person
becoming an interested shareholder. This encourages any potential acquirer of a Delaware corporation to negotiate the terms
of any acquisition transaction with the target’s board of directors.
Cayman Islands law has no
comparable statute. As a result, we cannot avail ourselves of the types of protections afforded by the Delaware business combination
statute. However, although Cayman Islands law does not regulate transactions between a company and its significant shareholders,
it does provide that such transactions must be entered into bona fide in the best interests of the company for a proper corporate purpose
and not with the effect of constituting a fraud on the minority shareholders.
Dissolution; Winding up. Under
the Delaware General Corporation Law, unless the board of directors approves the proposal to dissolve, dissolution must be approved by
shareholders holding 100% of the total voting power of the corporation. Only if the dissolution is initiated by the board of
directors may it be approved by a simple majority of the corporation’s outstanding shares. Delaware law allows a Delaware
corporation to include in its certificate of incorporation a supermajority voting requirement in connection with dissolutions initiated
by the board of directors. Under Cayman Islands law, a company may be wound up by either an order of the courts of the Cayman
Islands or by a special resolution of its members or, if the company is unable to pay its debts as they fall due, by an ordinary resolution
of its members. The court has authority to order winding up in a number of specified circumstances including where it is, in
the opinion of the court, just and equitable to do so.
Under the Companies Law of
the Cayman Islands, our company may be dissolved, liquidated or wound up voluntarily by a special resolution, or by an ordinary resolution
on the basis that we are unable to pay our debts as they fall due.
Variation of Rights of
Shares. Under the Delaware General Corporation Law, a corporation may vary the rights of a class of shares with the approval
of a majority of the outstanding shares of such class, unless the certificate of incorporation provides otherwise. Under our
Memorandum and Articles, and as permitted by Cayman Islands law, if our share capital is divided into more than one class of shares, we
may vary the rights attached to any class either with the written consent of the holders of two-thirds of the issued shares of that class
or with the sanction of a special resolution passed at a general meeting of the holders of the shares of that class.
Amendment of Governing
Documents. Under the Delaware General Corporation Law, a corporation’s governing documents may be amended with the
approval of a majority of the outstanding shares entitled to vote, unless the certificate of incorporation provides otherwise. Under
Cayman Islands law, our memorandum and articles of association may only be amended by special resolution.
Inspection of Books and
Records. Under the Delaware General Corporation Law, any shareholder of a corporation may for any proper purpose inspect
or make copies of the corporation’s stock ledger, list of shareholders and other books and records.
Holders of our shares
will have no general right under Cayman Islands law to inspect or obtain copies of our list of shareholders or our corporate
records. However, we intend to provide our shareholders with annual reports containing audited financial statements.
Anti-takeover Provisions
in Our Memorandum and Articles of Association. Some provisions of our Memorandum and Articles may discourage, delay or
prevent a change of control of our company or management that shareholders may consider favorable, including a provision that authorizes
our board of directors to issue preference shares in one or more series and to designate the price, rights, preferences, privileges and
restrictions of such preference shares without any further vote or action by our shareholders.
Such shares could be issued
quickly with terms calculated to delay or prevent a change in control of our company or make removal of management more difficult. If
our board of directors decides to issue these preference shares, the price of our ordinary share may fall and the voting and other rights
of the holders of our ordinary shares may be materially and adversely affected.
However, under Cayman Islands
law, our directors may only exercise the rights and powers granted to them under our Memorandum and Articles association for a proper
purpose and for what they believe in good faith to be in the best interests of our company.
Rights of Non-resident
or Foreign Shareholders. There are no limitations imposed by our Memorandum and Articles on the rights of non-resident
or foreign shareholders to hold or exercise voting rights on our shares. In addition, there are no provisions in our Memorandum
and Articles of association governing the ownership threshold above which shareholder ownership must be disclosed.
C. Material Contracts
The following descriptions
of the material provisions of the referenced agreements do not purport to be complete and are subject to, and qualified in their entirety
by reference to the agreements which have been filed as exhibits to this report.
Securities Purchase Agreement relating to the
offering and sale of 1,240,000 Ordinary Shares.
On June 25, 2021, pursuant
to a securities purchase agreement with respect to a registered direct offering pursuant to a shelf takedown under a registration statement
on Form F-3 (Registration No. 333-250026), the company agreed to sell 1,240,000 Ordinary Shares at a per share purchase price of $1.74,
for gross proceeds of $2,157,600, before deducting any estimated offering expenses. The Company intended to use the net proceeds from
the offering for the development of the Company’s auto business under the brand of “Taochejun”, working capital and
other general corporate purposes.
The form of the securities
purchase agreement is filed as Exhibit 1.1 to the Current Report on Form 6-K filed with the Commission on July 1, 2021, and such document
is incorporated herein by reference.
The foregoing is only a brief
description of the material terms of the securities purchase agreement, and does not purport to be a complete description of the rights
and obligations of the parties thereunder and is qualified in its entirety by reference to such exhibit.
Share Purchase Agreement relating to the acquisition
of Fujian Shennong Jiagu Development Co., Ltd. (“Fujian Shennong”)
On January 18, 2021, Fujian
Happiness, a wholly-owned indirect subsidiary of the Company, entered into a letter of intent (the “LOI”) with an equity owner
(the “Seller”) of Fujian Shennong for the purchase of 70% of the equity interest of Fujian Shennong (the “Equity Interests”).
Pursuant to the LOI, Fujian Happiness paid RMB 60 million (approximately US$9.38 million) as an advance to the Seller.
On October 14, 2021, the Company,
its wholly-owned subsidiary, Fujian Happiness, and the Seller entered into a share purchase agreement for the transaction contemplated
in the LOI. The parties agreed that the valuation of all the equity interests of Fujian Shennong is RMB 103 million (approximately $16.1
million). The total consideration to be paid for the Equity Interests are RMB48 million (approximately $7.5 million) in cash and 4,200,000
ordinary shares of the Company (the “Shares”) to be issued to the Seller or his appointees. The Seller will return RMB 12
million (approximately $1.9 million) which was previously paid to him as an advance pursuant to the LOI and the Company issued the Shares
in reliance on the exemptions from registration provided by Section 4(a)(2) under the Securities Act and Regulation D promulgated thereunder.
The closing of the transaction shall take place after all necessary consents and regulatory approvals have been obtained.
According to the share purchase
agreement, in the event that the aggregate net profits of Fujian Shennong in the next three fiscal years are less than RMB 45 million
(approximately $7 million), then Fujian Happiness has the right to request the Seller to purchase back the Equity Interests at the price
RMB 72.1 million (approximately $11.3 million) in cash.
The form of the share purchase
agreement is filed as Exhibit 4.1 to the Current Report on Form 6-K filed with the Commission on October 25, 2021, and such document is
incorporated herein by reference.
The foregoing is only a brief
description of the material terms of the share purchase agreement, and does not purport to be a complete description of the rights and
obligations of the parties thereunder and is qualified in its entirety by reference to such exhibit.
Private Placement of $10 million
On January 20,2022, the Company completed a private placement of 12,500,000
of our Class A Ordinary Shares to certain “non-U.S. Persons” (the “Investors”) as defined in Regulation S of the
Securities Act of 1933, as amended (the “Securities Act”), at a price of $0.80 per ordinary share, which generated total gross
proceeds approximately $10.0 million. Upon closing of this private placement, the Company had 36,523,003 Class A ordinary shares and 12,095,100
Class B ordinary shares issued and outstanding.
The parties to the securities
purchase agreement have each made customary representations, warranties and covenants. The ordinary shares issued in the offering are
exempt from the registration requirements of the Securities Act of 1933, as amended, pursuant to Regulation S promulgated thereunder.
The form of the share purchase
agreement is filed as Exhibit 99.1 to the Current Report on Form 6-K filed with the Commission on January 21, 2022, and such document
is incorporated herein by reference.
The foregoing is only a brief
description of the material terms of the securities purchase agreement, and does not purport to be a complete description of the rights
and obligations of the parties thereunder and is qualified in its entirety by reference to such exhibit.
Share Purchase Agreement relating to the acquisition
of Fuzhou Hekangyuan Trading Co., Ltd. (“Hekangyuan”)
On March 4, 2022, Fujian Happiness,
a wholly-owned indirect subsidiary of the Company, entered into a certain equity transfer agreement with the equity owners (the “Sellers”)
of Fuzhou Hekangyuan Trading Co., Ltd. (“Hekangyuan”) for the purchase of 100% of the equity interest of Hekangyuan (the “Equity
Interests”). The parties agreed that the valuation of all the equity interests of Hekangyuan is $12 million. The total consideration
to be paid for the Equity Interests are $8 million in cash and 10 million Class A ordinary shares of the Company (the “Shares”)
to be issued to the Sellers or their respective appointees. The Company issued the Shares in reliance on the exemptions from registration
provided by Section 4(a)(2) under the Securities Act and Regulation D promulgated thereunder. Upon the completion of the proposed acquisition,
Hekangyuan became a wholly owned subsidiary of Fujian Happiness and an indirect subsidiary of the Company.
According to the equity transfer
agreement, in the event that the aggregate net profits of Hekangyuan in the next three fiscal years are less than $4.5 million, than the
Company has the right to request the Sellers to purchase back the Equity Interests at the price $12 million in cash.
The form of the equity transfer
agreement is filed as Exhibit 4.1 to the Current Report on Form 6-K filed with the Commission on March 7, 2022, and such document is incorporated
herein by reference.
The foregoing is only a brief
description of the material terms of the equity transfer agreement, and does not purport to be a complete description of the rights and
obligations of the parties thereunder and is qualified in its entirety by reference to such exhibit.
Securities Purchase Agreement relating to the
offering and sale of 19,200,000 Class A Ordinary Shares.
On March 10, 2022, pursuant
to a securities purchase agreement with respect to a registered direct offering pursuant to a shelf takedown under a registration statement
on Form F-3 (Registration No. 333-250026), the company agreed to sell 19,200,000 Class A Ordinary Shares at a per share purchase price
of $0.35, for gross proceeds of $6,720,000, before deducting any estimated offering expenses. The closing occurred on March 15, 2022.
The Company intended to use the net proceeds from the offering for the development of the Company’s auto business under the brand
of “Taochejun”, working capital and other general corporate purposes.
The form of the securities
purchase agreement is filed as Exhibit 1.1 to the Current Report on Form 6-K filed with the Commission on March 16, 2022, and such document
is incorporated herein by reference.
The foregoing is only a brief
description of the material terms of the securities purchase agreement, and does not purport to be a complete description of the rights
and obligations of the parties thereunder and is qualified in its entirety by reference to such exhibit.
D. Exchange Controls
Cayman Islands
There are currently no exchange
control regulations in the Cayman Islands applicable to us or our shareholders.
The PRC
General administration of foreign exchange
The principal regulation governing
foreign currency exchange in the PRC is the Administrative Regulations of the PRC on Foreign Exchange (the “Foreign Exchange Regulations”),
which were promulgated on January 29, 1996, became effective on April 1, 1996 and were last amended on August 5, 2008. Under these rules,
Renminbi is generally freely convertible for payments of current account items, such as trade- and service-related foreign exchange transactions
and dividend payments, but not freely convertible for capital account items, such as capital transfer, direct investment, investment in
securities, derivative products or loans unless prior approval by competent authorities for the administration of foreign exchange is
obtained. Under the Foreign Exchange Regulations, foreign-invested enterprises in the PRC may purchase foreign exchange without the approval
of SAFE to pay dividends by providing certain evidentiary documents, including board resolutions, tax certificates, or for trade- and
services-related foreign exchange transactions, by providing commercial documents evidencing such transactions.
Circular No. 75, Circular No. 37 and Circular
No. 13
Circular 37 was released by
SAFE on July 4, 2014 and abolished Circular 75 which had been in effect since November 1, 2005. Pursuant to Circular 37, a PRC resident
should apply to SAFE for foreign exchange registration of overseas investments before it makes any capital contribution to a special purpose
vehicle, or SPV, using his or her legitimate domestic or offshore assets or interests. SPVs are offshore enterprises directly established
or indirectly controlled by domestic residents for the purpose of investment and financing by utilizing domestic or offshore assets or
interests they legally hold. Following any significant change in a registered offshore SPV, such as capital increase, reduction, equity
transfer or swap, consolidation or division involving domestic resident individuals, the domestic individuals shall amend the registration
with SAFE. Where an SPV intends to repatriate funds raised after completion of offshore financing to the PRC, it shall comply with relevant
PRC regulations on foreign investment and foreign debt management. A foreign-invested enterprise established through return investment
shall complete relevant foreign exchange registration formalities in accordance with the prevailing foreign exchange administration regulations
on foreign direct investment and truthfully disclose information on the actual controller of its shareholders.
If any shareholder who is
a PRC resident (as determined by the Circular No. 37) holds any interest in an offshore SPV and fails to fulfil the required foreign exchange
registration with the local SAFE branches, the PRC subsidiaries of that offshore SPV may be prohibited from distributing their profits
and dividends to their offshore parent company or from carrying out other subsequent cross-border foreign exchange activities. The offshore
SPV may also be restricted in its ability to contribute additional capital to its PRC subsidiaries. Where a domestic resident fails to
complete relevant foreign exchange registration as required, fails to truthfully disclose information on the actual controller of the
enterprise involved in the return investment or otherwise makes false statements, the foreign exchange control authority may order them
to take remedial actions, issue a warning, and impose a fine of less than RMB300,000 on an institution or less than RMB50,000 on an individual.
Circular 13 was issued by
SAFE on February 13, 2015 and became effective on June 1, 2015. Pursuant to Circular 13, a domestic resident who makes a capital contribution
to an SPV using his or her legitimate domestic or offshore assets or interests is no longer required to apply to SAFE for foreign exchange
registration of his or her overseas investments. Instead, he or she shall register with a bank in the place where the assets or interests
of the domestic enterprise in which he or she has interests are located if the domestic resident individually seeks to make a capital
contribution to the SPV using his or her legitimate domestic assets or interests; or he or she shall register with a local bank at his
or her permanent residence if the domestic resident individually seeks to make a capital contribution to the SPV using his or her legitimate
offshore assets or interests.
Circular 19 and Circular 16
Circular 19 was promulgated
by SAFE on March 30, 2015 and became effective on June 1, 2015. According to Circular 19, foreign exchange capital of foreign-invested
enterprises shall be granted the benefits of Discretional Foreign Exchange Settlement (“Discretional Foreign Exchange Settlement”).
With Discretional Foreign Exchange Settlement, foreign exchange capital in the capital account of a foreign-invested enterprise for which
the rights and interests of monetary contribution has been confirmed by the local foreign exchange bureau, or for which book-entry registration
of monetary contribution has been completed by the bank, can be settled at the bank based on the actual operational needs of the foreign-invested
enterprise. The allowed Discretional Foreign Exchange Settlement percentage of the foreign exchange capital of a foreign-invested enterprise
has been temporarily set to be 100%. The Renminbi converted from the foreign exchange capital will be kept in a designated account and
if a foreign-invested enterprise needs to make any further payment from such account, it will still need to provide supporting documents
and to complete the review process with its bank.
Furthermore, Circular 19 stipulates
that foreign-invested enterprises shall make bona fide use of their capital for their own needs within their business scopes. The capital
of a foreign-invested enterprise and the Renminbi if obtained from foreign exchange settlement shall not be used for the following purposes:
| |
● |
directly or indirectly used for expenses beyond its business scope or prohibited by relevant laws or regulations; |
| |
|
|
| |
● |
directly or indirectly used for investment in securities unless otherwise provided by relevant laws or regulations; |
| |
|
|
| |
● |
directly or indirectly used for entrusted loan in Renminbi (unless within its permitted scope of business), repayment of inter-company loans (including advances by a third party) or repayment of bank loans in Renminbi that have been sub-lent to a third party; and |
| |
|
|
| |
● |
directly or indirectly used for expenses related to the purchase of real estate that is not for self-use (except for foreign-invested real estate enterprises). |
Circular 16 was issued by
SAFE on June 9, 2016. Pursuant to Circular 16, enterprises registered in the PRC may also convert their foreign debts from foreign currency
to Renminbi on a self-discretionary basis. Circular 16 provides an integrated standard for conversion of foreign exchange capital items
(including but not limited to foreign currency capital and foreign debts) on a self-discretionary basis applicable to all enterprises
registered in the PRC. Circular 16 reiterates the principle that an enterprise’s Renminbi converted from foreign currency-denominated
capital may not be directly or indirectly used for purposes beyond its business scope or purposes prohibited by PRC laws or regulations,
and such converted Renminbi shall not be provided as loans to non-affiliated entities.
Circulars 16 and 19 address
foreign direct investments into the PRC, and stipulate the procedures applicable to foreign exchange settlement. If and when circumstances
require funds to be transferred to our WFOE in the PRC from our offshore entities, then any such transfer would be subject to Circulars
16 and 19.
E. Taxation
The following summary of the
material Cayman Islands, PRC and U.S. tax consequences of an investment in our ordinary shares is based upon laws and relevant interpretations
thereof in effect as of the date hereof, all of which are subject to change, possibly with retroactive effect. This summary is not intended
to be, nor should it be construed as, legal or tax advice and is not exhaustive of all possible tax considerations. This summary also
does not deal with all possible tax consequences relating to an investment in our ordinary shares, such as the tax consequences under
state, local, non-U.S., non-PRC, and non-Cayman Islands tax laws. Investors should consult their own tax advisors with respect to the
tax consequences of the acquisition, ownership and disposition of our ordinary shares.
Cayman Islands Taxation
The Cayman Islands currently
levies no taxes on individuals or corporations based upon profits, income, gains or appreciation and there is no taxation in the nature
of inheritance tax or estate duty. There are no other taxes levied by the Government of the Cayman Islands that are likely to be material
to holders of ordinary shares or ordinary shares. The Cayman Islands is not party to any double tax treaties. There are no exchange control
regulations or currency restrictions in the Cayman Islands.
People’s Republic of China Taxation
Under the EIT Law, an enterprise
established outside the PRC with a “de facto management body” within the PRC is considered a PRC resident enterprise for PRC
enterprise income tax purposes and is generally subject to a uniform 25% enterprise income tax rate on its worldwide income as well as
tax reporting obligations. Under the Implementation Rules, a “de facto management body” is defined as a body that has material
and overall management and control over the manufacturing and business operations, personnel and human resources, finances and properties
of an enterprise. In addition, SAT Circular 82 issued in April 2009 specifies that certain offshore-incorporated enterprises controlled
by PRC enterprises or PRC enterprise groups will be classified as PRC resident enterprises if all of the following conditions are met:
(a) senior management personnel and core management departments in charge of the daily operations of the enterprises have their presence
mainly in the PRC; (b) their financial and human resources decisions are subject to determination or approval by persons or bodies in
the PRC; (c) major assets, accounting books and company seals of the enterprises, and minutes and files of their board’s and
shareholders’ meetings are located or kept in the PRC; and (d) half or more of the enterprises’ directors or senior management
personnel with voting rights habitually reside in the PRC. Further to SAT Circular 82, the SAT issued SAT Bulletin 45, which took effect
in September 2011, to provide more guidance on the implementation of SAT Circular 82. SAT Bulletin 45 provides for procedures and
administration details of determination on PRC resident enterprise status and administration on post-determination matters. If the PRC
tax authorities determine that Happiness Development Group Limited is a PRC resident enterprise for PRC enterprise income tax purposes,
a number of unfavorable PRC tax consequences could follow. For example, Fujian Happiness may be subject to enterprise income tax at a
rate of 25% with respect to its worldwide taxable income. Also, a 10% withholding tax would be imposed on dividends we pay to our non-PRC
enterprise shareholders and with respect to gains derived by our non-PRC enterprise shareholders from transferring our shares or ordinary
shares and potentially a 20% of withholding tax would be imposed on dividends we pay to our non-PRC individual shareholders and with respect
to gains derived by our non-PRC individual shareholders from transferring our shares or ordinary shares.
It is unclear whether, if
we are considered a PRC resident enterprise, holders of our shares or ordinary shares would be able to claim the benefit of income tax
treaties or agreements entered into between China and other countries or areas. See “Risk Factors — Risk Factors Relating
to Doing Business in China — Under the PRC Enterprise Income Tax Law, we may be classified as a PRC resident enterprise for PRC
enterprise income tax purposes. Such classification would likely result in unfavorable tax consequences to us and our non-PRC Shareholders
and have a material adverse effect on our results of operations and the value of your investment”.
The SAT issued SAT Circular
59 together with the Ministry of Finance in April 2009 and SAT Circular 698 in December 2009. Both SAT Circular 59 and SAT Circular 698
became effective retroactively as of January 1, 2008. By promulgating and implementing these two circulars, the PRC tax authorities have
enhanced their scrutiny over the direct or indirect transfer of equity interests in a PRC resident enterprise by a non-PRC resident enterprise.
Under SAT Circular 698, where a non-PRC resident enterprise transfers the equity interests of a PRC resident enterprise indirectly by
disposition of the equity interests of an overseas holding company, and the overseas holding company is located in a tax jurisdiction
that: (1) has an effective tax rate of less than 12.5% or (2) does not impose tax on foreign income of its residents, the non-PRC resident
enterprise, being the transferor, must report to the relevant tax authority of the PRC resident enterprise this Indirect Transfer. Using
a “substance over form” principle, the PRC tax authority may disregard the existence of the overseas holding company if it
lacks a reasonable commercial purpose and was established for the purpose of reducing, avoiding or deferring PRC tax. As a result, gains
derived from such Indirect Transfer may be subject to PRC tax at a rate of up to 10%. Although it appears that SAT Circular 698 was not
intended to apply to share transfers of publicly traded companies, there is uncertainty as to the application of SAT Circular 698 and
we and our non-PRC resident investors may be at risk of being required to file a return and being taxed under SAT Circular 698 and we
may be required to expend valuable resources to comply with SAT Circular 698 or to establish that we should not be taxed under SAT Circular
698. See “Risk Factors — Risk Factors Relating to Doing Business in China — We face uncertainty regarding the PRC tax
reporting obligations and consequences for certain indirect transfers of our operating company’s equity interests. Enhanced scrutiny
over acquisition transactions by the PRC tax authorities may have a negative impact on potential acquisitions we may pursue in the future.”
Pursuant to the Arrangement
between the Mainland China and the Hong Kong Special Administrative Region for the Avoidance of Double Taxation and Tax Evasion on Income,
or the Tax Arrangement, where a Hong Kong resident enterprise which is considered a non-PRC tax resident enterprise directly holds at
least 25% of a PRC enterprise, the withholding tax rate in respect of the payment of dividends by such PRC enterprise to such Hong Kong
resident enterprise is reduced to 5% from a standard rate of 10%, subject to approval of the PRC local tax authority. Pursuant to the
Notice of the State Administration of Taxation on the Issues concerning the Application of the Dividend Clauses of Tax Agreements, or
Circular 81, a resident enterprise of the counter-party to such Tax Arrangement should meet the following conditions, among others, in
order to enjoy the reduced withholding tax under the Tax Arrangement: (i) it must directly own the required percentage of equity interests
and voting rights in such PRC resident enterprise; and (ii) it should directly own such percentage in the PRC resident enterprise anytime
in the 12 months prior to receiving the dividends. Furthermore, the Administrative Measures for Non-Resident Enterprises to Enjoy Treatments
under Tax Treaties (For Trial Implementation), or the Administrative Measures, which became effective in October 2009, requires that the
non-resident enterprises must obtain the approval from the relevant tax authority in order to enjoy the reduced withholding tax rate under
the tax treaties. There are also other conditions for enjoying such reduced withholding tax rate according to other relevant tax rules
and regulations. According to Circular 81, if the relevant tax authorities consider the transactions or arrangements we have are for the
primary purpose of enjoying a favorable tax treatment, the relevant tax authorities may adjust the favorable withholding tax in the future.
United
States Federal Income Taxation
The following is a discussion
of United States federal income tax considerations relating to the acquisition, ownership, and disposition of our ordinary shares by a
U.S. Holder, as defined below, that acquires our ordinary shares and holds our ordinary shares as “capital assets” (generally,
property held for investment) under the United States Internal Revenue Code of 1986, as amended (the “Code”). This discussion
is based upon existing United States federal income tax law, which is subject to differing interpretations or change, possibly with retroactive
effect. No ruling has been sought from the Internal Revenue Service (the “IRS”) with respect to any United States federal
income tax consequences described below, and there can be no assurance that the IRS or a court will not take a contrary position. This
discussion does not address all aspects of United States federal income taxation that may be important to particular investors in light
of their individual circumstances, including investors subject to special tax rules (such as, for example, certain financial institutions,
insurance companies, regulated investment companies, real estate investment trusts, broker-dealers, traders in securities that elect mark-to-market
treatment, partnerships and their partners, tax-exempt organizations (including private foundations)), investors who are not U.S. Holders,
investors that own (directly, indirectly, or constructively) 10% or more of our voting stock, investors that hold their ordinary shares
as part of a straddle, hedge, conversion, constructive sale or other integrated transaction), or investors that have a functional currency
other than the U.S. dollar, all of whom may be subject to tax rules that differ significantly from those summarized below. In addition,
this discussion does not address any tax laws other than the United States federal income tax laws, including any state, local, alternative
minimum tax or non-United States tax considerations, or the Medicare tax. Each potential investor is urged to consult its tax advisor
regarding the United States federal, state, local and non-United States income and other tax considerations of an investment in our ordinary
shares.
General
For purposes of this discussion,
a “U.S. Holder” is a beneficial owner of our ordinary shares that is, for United States federal income tax purposes, (i) an
individual who is a citizen or resident of the United States, (ii) a corporation (or other entity treated as a corporation for United
States federal income tax purposes) created in, or organized under the laws of, the United States or any state thereof or the District
of Columbia, (iii) an estate the income of which is includible in gross income for United States federal income tax purposes regardless
of its source, or (iv) a trust (A) the administration of which is subject to the primary supervision of a United States court and which
has one or more United States persons who have the authority to control all substantial decisions of the trust or (B) that has otherwise
elected to be treated as a United States person under the Code.
If a partnership (or other
entity treated as a partnership for United States federal income tax purposes) is a beneficial owner of our ordinary shares, the tax treatment
of a partner in the partnership will depend upon the status of the partner and the activities of the partnership. Partnerships and partners
of a partnership holding our ordinary shares are urged to consult their tax advisors regarding an investment in our ordinary shares.
The discussion set forth below
is addressed only to U.S. Holders that purchase ordinary shares. Prospective purchasers are urged to consult their own tax advisors about
the application of the U.S. federal income tax rules to their particular circumstances as well as the state, local, foreign and other
tax consequences to them of the purchase, ownership and disposition of our ordinary shares.
Taxation of Dividends and Other Distributions
on our Ordinary Shares
Subject to the passive foreign
investment company rules discussed below, the gross amount of distributions made by us to you with respect to the ordinary shares (including
the amount of any taxes withheld therefrom) will generally be includable in your gross income as dividend income on the date of receipt
by you, but only to the extent that the distribution is paid out of our current or accumulated earnings and profits (as determined under
U.S. federal income tax principles). With respect to corporate U.S. Holders, the dividends will not be eligible for the dividends-received
deduction allowed to corporations in respect of dividends received from other U.S. corporations.
With respect to non-corporate
U.S. Holders, including individual U.S. Holders, dividends will be taxed at the lower capital gains rate applicable to qualified dividend
income, provided that (1) the ordinary shares are readily tradable on an established securities market in the United States, or we are
eligible for the benefits of an approved qualifying income tax treaty with the United States that includes an exchange of information
program, (2) we are not a passive foreign investment company (as discussed below) for either our taxable year in which the dividend is
paid or the preceding taxable year, and (3) certain holding period requirements are met. Because there is no income tax treaty between
the United States and the Cayman Islands, clause (1) above can be satisfied only if the ordinary shares are readily tradable on an established
securities market in the United States. Under U.S. Internal Revenue Service authority, ordinary shares are considered for purpose of clause
(1) above to be readily tradable on an established securities market in the United States if they are listed on Nasdaq. You are urged
to consult your tax advisors regarding the availability of the lower rate for dividends paid with respect to our ordinary shares, including
the effects of any change in law after the date of this report.
To the extent that the amount
of the distribution exceeds our current and accumulated earnings and profits (as determined under U.S. federal income tax principles),
it will be treated first as a tax-free return of your tax basis in your ordinary shares, and to the extent the amount of the distribution
exceeds your tax basis, the excess will be taxed as capital gain. We do not intend to calculate our earnings and profits under U.S. federal
income tax principles. Therefore, a U.S. Holder should expect that a distribution will be treated as a dividend even if that distribution
would otherwise be treated as a non-taxable return of capital or as capital gain under the rules described above.
Taxation of Dispositions of Ordinary Shares
Subject to the passive foreign
investment company rules discussed below, you will recognize taxable gain or loss on any sale, exchange or other taxable disposition of
a share equal to the difference between the amount realized (in U.S. dollars) for the share and your tax basis (in U.S. dollars) in the
ordinary shares. The gain or loss will be capital gain or loss. If you are a non-corporate U.S. Holder, including an individual U.S. Holder,
who has held the ordinary shares for more than one year, you may be eligible for reduced tax rates on any such capital gains. The deductibility
of capital losses is subject to limitations.
Passive Foreign Investment Company Rules
A foreign (i.e., non-U.S.)
corporation will be a PFIC if at least 75% of its gross income in a taxable year of the foreign corporation, including its pro rata share
of the gross income of any corporation in which it is considered to own at least 25% of the shares by value, is passive income. Alternatively,
a foreign corporation will be a PFIC if at least 50% of its assets in a taxable year of the foreign corporation, ordinarily determined
based on fair market value and averaged quarterly over the year, including its pro rata share of the assets of any corporation in which
it is considered to own at least 25% of the shares by value, are held for the production of, or produce, passive income. Passive income
generally includes dividends, interest, rents and royalties (other than certain rents or royalties derived from the active conduct of
a trade or business) and gains from the disposition of passive assets.
Based on the composition of
our assets and the nature of the Company’s income and subsidiaries’ income for our taxable year ended March 31, 2020, we do
not expect to be treated as a PFIC for such year and we do not expect to be one for our taxable year ending March 31, 2021 or become
one in the foreseeable future. Nevertheless, the application of the PFIC rules is subject to ambiguity in several respects and, in addition,
we must make a separate determination each year as to whether we are a PFIC (after the close of each taxable year). Accordingly, we cannot
assure you that we will not be a PFIC for the current or any other taxable year. Moreover, although we do not believe we would be treated
as a PFIC, we have not engaged any U.S. tax advisers to determine our PFIC status. In addition, if a U.S. Holder owned our ordinary shares
at any time prior to our acquisition of Elite, such U.S. Holder may be considered to own stock of a PFIC by virtue of the fact that we
may have been a PFIC during the period prior to our acquisition of Elite, unless such U.S. Holder made either a valid and timely QEF election
or a valid and timely mark-to-market election, in each case as described below.
If we are determined to be
a PFIC for any taxable year (or portion thereof) that is included in the holding period of a U.S. Holder of our shares or redeemable warrants
and, in the case of our shares, the U.S. Holder did not make either a timely qualified electing fund (“QEF”) election for
our first taxable year as a PFIC in which the U.S. Holder held (or was deemed to hold) such shares, a QEF election along with a purging
election, or a mark-to-market election, each as described below, such holder generally will be subject to special rules for regular U.S.
federal income tax purposes with respect to:
| |
● |
any gain recognized by the U.S. Holder on the sale or other disposition of its shares or redeemable warrants; and |
| |
● |
any “excess distribution” made to the U.S. Holder (generally, any distributions to such U.S. Holder during a taxable year of the U.S. Holder that are greater than 125% of the average annual distributions received by such U.S. Holder in respect of the shares or warrants during the three preceding taxable years of such U.S. Holder or, if shorter, such U.S. Holder’s holding period for the shares or warrants). |
Under these rules,
| |
● |
the U.S. Holder’s gain or excess distribution will be allocated ratably over the U.S. Holder’s holding period for the shares or redeemable warrants; |
| |
● |
the amount allocated to the U.S. Holder’s taxable year in which the U.S. Holder recognized the gain or received the excess distribution, or to the period in the U.S. Holder’s holding period before the first day of our first taxable year in which we are a PFIC, will be taxed as ordinary income; |
| |
● |
the amount allocated to other taxable years (or portions thereof) of the U.S. Holder and included in its holding period will be taxed at the highest tax rate in effect for that year and applicable to the U.S. Holder; and |
| |
● |
the interest charge generally applicable to underpayments of tax will be imposed in respect of the tax attributable to each such other taxable year of the U.S. Holder. |
In general, if we are determined
to be a PFIC, a U.S. Holder may avoid the PFIC tax consequences described above in respect to our shares by making a timely QEF election
(or a QEF election along with a purging election, as described below). Pursuant to the QEF election, a U.S. Holder will be required to
include in income its pro rata share of our net capital gains (as long-term capital gain) and other earnings and profits (as ordinary
income), on a current basis, in each case whether or not distributed, in the taxable year of the U.S. Holder in which or with which our
taxable year ends. A U.S. Holder may make a separate election to defer the payment of taxes on undistributed income inclusions under the
QEF rules, but if deferred, any such taxes will be subject to an interest charge.
A U.S. Holder may not make
a QEF election with respect to its redeemable warrants. As a result, if a U.S. Holder sells or otherwise disposes of a redeemable warrant
(other than upon exercise of the redeemable warrant), any gain recognized generally will be subject to the special tax and interest charge
rules treating the gain as an excess distribution, as described above, if we were a PFIC at any time during the period the U.S. Holder
held the redeemable warrants. If a U.S. Holder that exercises such redeemable warrants properly makes a QEF election with respect to the
newly acquired ordinary shares (or has previously made a QEF election with respect to our shares), the QEF election will apply to the
newly acquired ordinary shares, but the adverse tax consequences relating to PFIC shares, adjusted to take into account the current income
inclusions resulting from the QEF election, will continue to apply with respect to such newly acquired ordinary shares (which generally
will be deemed to have a holding period for purposes of the PFIC rules that includes the period the U.S. Holder held the redeemable warrants),
unless the U.S. Holder makes a purging election with respect to such shares. The purging election creates a deemed sale of such shares
at their fair market value. The gain recognized by the purging election will be subject to the special tax and interest charge rules treating
the gain as an excess distribution, as described above. As a result of the purging election, the U.S. Holder will increase the adjusted
tax basis in its ordinary shares acquired upon the exercise of the redeemable warrants by the gain recognized and will also have a new
holding period in such ordinary shares for purposes of the PFIC rules.
The QEF election is made on
a shareholder-by-shareholder basis and, once made, can be revoked only with the consent of the IRS. A U.S. Holder generally makes a QEF
election by attaching a completed IRS Form 8621 (Information Return by a Shareholder of a Passive Foreign Investment Company or Qualified
Electing Fund), including the information provided in a PFIC annual information statement, to a timely filed U.S. federal income tax return
for the taxable year to which the election relates. Retroactive QEF elections generally may be made only by filing a protective statement
with such return and if certain other conditions are met or with the consent of the IRS.
In order to comply with the
requirements of a QEF election, a U.S. Holder must receive certain information from us. Upon request from a U.S. Holder, we will endeavor
to provide to the U.S. Holder no later than 90 days after the request such information as the IRS may require, including a PFIC annual
information statement, in order to enable the U.S. Holder to make and maintain a QEF election. However, there is no assurance that we
will have timely knowledge of our status as a PFIC in the future or of the required information to be provided.
If a U.S. Holder has made
a QEF election with respect to our shares and the special tax and interest charge rules do not apply to such shares (because of a timely
QEF election for our first taxable year as a PFIC in which the U.S. Holder holds (or is deemed to hold) such shares or a QEF election,
along with a purge of the PFIC taint pursuant to a purging election, as described above), any gain recognized on the sale or other taxable
disposition of our shares generally will be taxable as capital gain and no interest charge will be imposed. As discussed above, for regular
U.S. federal income tax purposes, U.S. Holders of a QEF are currently taxed on their pro rata shares of the QEF’s earnings and profits,
whether or not distributed. In such case, a subsequent distribution of such earnings and profits that were previously included in income
generally should not be taxable as a dividend to such U.S. Holders. The adjusted tax basis of a U.S. Holder’s shares in a QEF will
be increased by amounts that are included in income, and decreased by amounts distributed but not taxed as dividends, under the above
rules. Similar basis adjustments apply to property if by reason of holding such property the U.S. Holder is treated under the applicable
attribution rules as owning shares in a QEF.
Although a determination as
to our PFIC status will be made annually, the initial determination that we are a PFIC generally will apply for subsequent years to a
U.S. Holder who held shares or redeemable warrants while we were a PFIC, whether or not we meet the test for PFIC status in those subsequent
years, unless such U.S. Holder made a purging election as described below. A U.S. Holder who makes the QEF election discussed above for
our first taxable year as a PFIC in which the U.S. Holder holds (or is deemed to hold) our shares, however, will not be subject to the
PFIC tax and interest charge rules discussed above in respect to such shares. In addition, such U.S. Holder will not be subject to the
QEF inclusion regime with respect to such shares for any of our taxable years that end within or with a taxable year of the U.S. Holder
and in which we are not a PFIC. On the other hand, if the QEF election is not effective for each of our taxable years in which we are
a PFIC and during which the U.S. Holder holds (or is deemed to hold) our shares, the PFIC rules discussed above will continue to apply
to such shares unless the holder files on a timely filed U.S. income tax return (including extensions) a QEF election and a purging election
to recognize under the rules of Section 1291 of the Code any gain that the U.S. Holder would otherwise recognize if the U.S. Holder had
sold our shares for their fair market value on the “qualification date.” The qualification date is the first day of our tax
year in which we qualify as a QEF with respect to such U.S. Holder. The purging election can only be made if such U.S. Holder held our
ordinary shares on the qualification date. The gain recognized by the purging election will be subject to the special tax and interest
charge rules treating the gain as an excess distribution, as described above. As a result of the purging election, the U.S. Holder will
increase the adjusted tax basis in its ordinary shares by the amount of the gain recognized and will also have a new holding period in
the shares for purposes of the PFIC rules.
If a U.S. Holder did not make
a timely “mark-to-market” election (as described above), and if we were a PFIC at any time during the period such U.S.
Holder held our ordinary shares, then such ordinary shares will continue to be treated as stock of a PFIC with respect to such U.S. Holder
even if we cease to be a PFIC in a future year, unless such U.S. Holder makes a “purging election” for the year we cease to
be a PFIC. A “purging election” creates a deemed sale of such ordinary shares at their fair market value on the last
day of the last year in which we are treated as a PFIC. The gain recognized by the purging election will be subject to the special tax
and interest charge rules treating the gain as an excess distribution, as described above. As a result of the purging election, such U.S.
Holder will have a new tax basis (equal to the fair market value of the ordinary shares on the last day of the last year in which we are
treated as a PFIC) and tax holding period (which new holding period will begin the day after such last day) in such ordinary shares.
As an alternative to the QEF
election, if a U.S. Holder, at the close of its taxable year, owns shares in a PFIC that are treated as marketable stock, the U.S. Holder
may make a mark-to-market election with respect to such shares for such taxable year. If the U.S. Holder makes a valid mark-to-market
election for the first taxable year of the U.S. Holder in which the U.S. Holder holds (or is deemed to hold) our shares and for which
we are determined to be a PFIC, such holder generally will not be subject to the PFIC rules described above in respect to its shares.
Instead, in general, the U.S. Holder will include as ordinary income each year the excess, if any, of the fair market value of its shares
at the end of its taxable year over the adjusted tax basis in its shares. The U.S. Holder also will be allowed to take an ordinary loss
in respect of the excess, if any, of the adjusted tax basis of its shares over the fair market value of its shares at the end of its taxable
year (but only to the extent of the net amount of previously included income as a result of the mark-to-market election). The U.S. Holder’s
adjusted tax basis in its shares will be adjusted to reflect any such income or loss amounts, and any further gain recognized on a sale
or other taxable disposition of the shares will be treated as ordinary income. Currently, a mark-to-market election may not be made with
respect to our redeemable warrants.
The mark-to-market election
is available only for stock that is regularly traded on a national securities exchange that is registered with the Securities and Exchange
Commission, including the NASDAQ Capital Market, or on a foreign exchange or market that the IRS determines has rules sufficient to ensure
that the market price represents a legitimate and sound fair market value. Although our ordinary shares are listed and traded on the NASDAQ
Capital Market, we cannot guarantee that our shares will continue to be listed and traded on the NASDAQ Capital Market. U.S. Holders should
consult their own tax advisors regarding the availability and tax consequences of a mark-to-market election in respect to our shares under
their particular circumstances.
If we are a PFIC and, at any
time, have a foreign subsidiary that is classified as a PFIC, a U.S. Holder generally would be deemed to own a portion of the shares of
such lower-tier PFIC, and generally could incur liability for the deferred tax and interest charge described above if we receive a distribution
from, or dispose of all or part of our interest in, or the U.S. Holder otherwise were deemed to have disposed of an interest in, the lower-tier
PFIC. Upon request, we will endeavor to cause any lower-tier PFIC to provide to a U.S. Holder no later than 90 days after the request
the information that may be required to make or maintain a QEF election with respect to the lower-tier PFIC. However, there is no assurance
that we will have timely knowledge of the status of any such lower-tier PFIC, and we do not plan to make annual determinations or otherwise
notify U.S. Holders of the PFIC status of any such lower-tier PFIC. There also is no assurance that we will be able to cause the lower-tier
PFIC to provide the required information. U.S. Holders are urged to consult their own tax advisors regarding the tax issues raised by
lower-tier PFICs.
A U.S. Holder that owns (or
is deemed to own) shares in a PFIC during any taxable year of the U.S. Holder may have to file an IRS Form 8621 (whether or not a QEF
election or mark-to-market election is or has been made) with such U.S. Holder’s U.S. federal income tax return and provide such
other information as may be required by the U.S. Treasury Department.
The rules dealing with PFICs
and with the QEF and mark-to-market elections are very complex and are affected by various factors in addition to those described above.
Accordingly, U.S. Holders of our shares and redeemable warrants should consult their own tax advisors concerning the application of the
PFIC rules to our shares and redeemable warrants under their particular circumstances.
Non-U.S. Holders
Dividends (including constructive
dividends) paid or deemed paid to a Non-U.S. Holder in respect to our securities generally will not be subject to U.S. federal income
tax, unless the dividends are effectively connected with the Non-U.S. Holder’s conduct of a trade or business within the United
States (and, if required by an applicable income tax treaty, are attributable to a permanent establishment or fixed base that such holder
maintains or maintained in the United States).
In addition, a Non-U.S. Holder
generally will not be subject to U.S. federal income tax on any gain attributable to a sale or other taxable disposition of our securities
unless such gain is effectively connected with its conduct of a trade or business in the United States (and, if required by an applicable
income tax treaty, is attributable to a permanent establishment or fixed base that such holder maintains or maintained in the United States)
or the Non-U.S. Holder is an individual who is present in the United States for 183 days or more in the taxable year of sale or other
disposition and certain other conditions are met (in which case, such gain from U.S. sources generally is subject to U.S. federal income
tax at a 30% rate or a lower applicable tax treaty rate).
Dividends and gains that are
effectively connected with the Non-U.S. Holder’s conduct of a trade or business in the United States (and, if required by an applicable
income tax treaty, are attributable to a permanent establishment or fixed base that such holder maintains or maintained in the United
States) generally will be subject to regular U.S. federal income tax at the same regular U.S. federal income tax rates applicable to a
comparable U.S. Holder and, in the case of a Non-U.S. Holder that is a corporation for U.S. federal income tax purposes, may also be subject
to an additional branch profits tax at a 30% rate or a lower applicable tax treaty rate.
The U.S. federal income tax
treatment of a Non-U.S. Holder’s exercise of redeemable warrants, or the lapse of redeemable warrants held by a Non-U.S. Holder,
generally will correspond to the U.S. federal income tax treatment of the exercise or lapse of redeemable warrants by a U.S. Holder, as
described under “U.S. Holders — Exercise or Lapse of Redeemable Warrants” above.
Backup Withholding and Information Reporting
Dividend payments with respect
to our ordinary shares and proceeds from the sale, exchange or redemption of our ordinary shares may be subject to information reporting
to the U.S. Internal Revenue Service and possible U.S. backup withholding at a current rate of 24%. Backup withholding will not apply,
however, to a U.S. Holder who furnishes a correct taxpayer identification number and makes any other required certification on U.S. Internal
Revenue Service Form W-9 or who is otherwise exempt from backup withholding. U.S. Holders who are required to establish their exempt status
generally must provide such certification on U.S. Internal Revenue Service Form W-9. U.S. Holders are urged to consult their tax advisors
regarding the application of the U.S. information reporting and backup withholding rules.
Backup withholding is not
an additional tax. Amounts withheld as backup withholding may be credited against your U.S. federal income tax liability, and you may
obtain a refund of any excess amounts withheld under the backup withholding rules by filing the appropriate claim for refund with the
U.S. Internal Revenue Service and furnishing any required information. We do not intend to withhold taxes for individual shareholders.
However, transactions effected through certain brokers or other intermediaries may be subject to withholding taxes (including backup withholding),
and such brokers or intermediaries may be required by law to withhold such taxes.
Under the Hiring Incentives
to Restore Employment Act of 2010, certain U.S. Holders are required to report information relating to our ordinary shares, subject to
certain exceptions (including an exception for ordinary shares held in accounts maintained by certain financial institutions), by attaching
a complete Internal Revenue Service Form 8938, Statement of Specified Foreign Financial Assets, with their tax return for each year in
which they hold ordinary shares.
F. Dividends and Paying Agents
Not applicable.
G. Statement by Experts
Not applicable.
H. Documents on Display
The Company is subject to
the informational requirements of the Securities Exchange Act of 1934, as amended, and will file reports, registration statements and
other information with the SEC. The Company’s reports, registration statements and other information can be inspected on the SEC’s
website at www.sec.gov and such information can also be inspected and copies ordered at the public reference facilities maintained by
the SEC at the following location: 100 F Street NE, Washington, D.C. 20549. You may also visit us at http://www.fjxfl.com. However, information
contained on our website does not constitute a part of this annual report.
I. Subsidiary Information
Not applicable.
ITEM 11. QUANTITATIVE AND QUALITATIVE DISCLOSURES
ABOUT MARKET RISK
Interest Rate Risk
We deposit surplus funds with
Chinese banks earning daily interest. We do not invest in any instruments for trading purposes. Most of our outstanding debt instruments
carry loan prime rates plus basis points of interest. Our operations generally are not directly sensitive to fluctuations in interest
rates and we currently do not have any long-term debt outstanding. Management monitors the banks’ prime rates in conjunction with
our cash requirements to determine the appropriate level of debt balances relative to other sources of funds. We have not entered into
any hedging transactions in an effort to reduce our exposure to interest rate risk.
Foreign Exchange Risk
While
our reporting currency is the U.S. dollar, substantially all of our consolidated revenues and consolidated costs and expenses are denominated
in RMB. Substantially all of our assets are denominated in RMB. As a result, we are exposed to foreign exchange risk as our revenues and
results of operations may be affected by fluctuations in the exchange rate between the U.S. dollar and the RMB. If the RMB depreciates
against the U.S. dollar, the value of our RMB revenues, earnings and assets as expressed in our U.S. dollar financial statements will
decline. Assets and liabilities are translated at exchange rates at the balance sheet dates and revenue and expenses are translated at
the average exchange rates and equity is translated at historical exchange rates. Any resulting translation adjustments are not included
in determining net income but are included in determining other comprehensive income, a component of equity. An average appreciation of
the RMB against the U.S. dollar of 5.7% decreased our comprehensive loss to $0.09 million based on our outstanding revenues,
costs and expenses, assets and liabilities denominated in RMB as
of March 31, 2022. As of March 31, 2022. We have not entered into any hedging transactions in an effort to reduce our exposure to foreign
exchange risk.
The value of RMB against the
U.S. dollar and other currencies is affected by, among other things, changes in China’s political and economic conditions. Since
July 2005, RMB has not been pegged to the U.S. dollar. Although the People’s Bank of China regularly intervenes in the foreign exchange
market to prevent significant short-term fluctuations in the exchange rate, RMB may appreciate or depreciate significantly in value against
the U.S. dollar in the medium to long term. Moreover, it is possible that in the future, PRC authorities may lift restrictions on fluctuations
in RMB exchange rate and lessen intervention in the foreign exchange market.
Inflation
Inflationary factors such
as increases in the cost of our product and overhead costs may adversely affect our operating results. Although we do not believe that
inflation has had a material impact on our financial position or results of operations to date, a high rate of inflation in the future
may have an adverse effect on our ability to maintain current levels of gross margin and selling, general and administrative expenses
as a percentage of net revenues if the selling prices of our products do not increase with these increased costs.
ITEM 12. DESCRIPTION OF SECURITIES OTHER THAN
EQUITY SECURITIES
Not applicable.
The accompanying notes are an integral part of these consolidated
financial statements.
The accompanying notes are an integral
part of these consolidated financial statements.
The accompanying notes are an integral part of
these consolidated financial statements.
The accompanying notes are an integral
part of these consolidated financial statements.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
NOTE 1 – ORGANIZATION AND NATURE OF OPERATIONS
Happiness Development Group Limited (“Happiness Development”)
is a holding company. It was incorporated on February 13, 2018 under the laws of the Cayman Islands and named Happiness Biotech Group
Limited. On November 5, 2021, the Company changed its name to Happiness Development Group Limited under the special resolution dated October
21, 2021. The Company has no substantive operations other than holding all of the outstanding share capital of Happiness Biology Technology
Group Limited (“Happiness Hong Kong”). Happiness Hong Kong is a holding company of all of the equity or ownership of Happiness
(Nanping) Biotech Co., Limited (“Happiness Nanping”).
Happiness Nanping is a holding company of all
of the equity or ownership of Fujian Happiness Biotech Co., Limited (“Fujian Happiness”), Fuzhou Happiness Enterprise
Management Consulting Co., Ltd. (“Fujian Consulting”), Happy Buy (Fujian) Network Technology Co., Ltd. (“Happy Buy”),
Taochejun (Fujian) Automobile Sales Co., Ltd. (“Fujian Taochejun”), Hangzhou Happiness Youche Automobile Partnership (Limited
partnership) (“Happiness Youche”) and Haiwushuo (Fujian) Food Co., Ltd. (“Haiwushuo Food”).
Reorganization
A Reorganization of the legal structure was completed
in August 2018. The Reorganization involved the incorporation of Happiness Development Group Limited, a Cayman Islands holding company;
Happiness Biology Technology Group Limited, a holding company established in Hong Kong, PRC; Happiness (Nanping) Biotech Co., Limited,
a holding company established in Fujian, PRC; and the transfer of 100% ownership of Fujian Happiness from the former shareholders to Happiness
Nanping. Happiness Development, Happiness Hong Kong and Happiness Nanping are all holding companies and had not commenced operation until
August 21, 2018.
Prior to the reorganization, Mr. Wang Xuezhu,
Chief Executive Officer owns 47.7% ownership of Fujian Happiness. On August 21, 2018, Mr. Wang Xuezhu and other shareholders of Fujian
Happiness transferred their 100% ownership interests in Fujian Happiness to Happiness Nanping, which is 100% owned by Happiness Hong Kong.
After the reorganization, Happiness Development owns 100% equity interests of Fujian Happiness. Mr. Wang Xuezhu, who owns 52.37% ownership
of Happiness Development, became the ultimate controlling shareholder (“the Controlling Shareholder”) of the Company.
Since the Company is effectively controlled by
the same Controlling Shareholder before and after the reorganization, it is considered under common control. Therefore, the above-mentioned
transactions were accounted for as a recapitalization. The reorganization has been accounted for at historical cost and prepared on the
basis as if the aforementioned transactions had become effective as of the beginning of the first period presented in the accompanying
financial statements of the Company.
On March 4, 2019, the Company subdivided its 50,000
ordinary shares into 90,000,000 Ordinary shares and 10,000,000 Preferred shares. The authorized ordinary shares became 100,000,000 shares
and the par value was changed from $1 to $0.0005. On the same day, the Company cancelled 77,223,100 ordinary shares and sold additional
223,100 ordinary shares. As of March 31, 2019, the Company has 23,000,000 ordinary shares issued and outstanding. The Company has retrospectively
reflected the stock subdivision and cancellation in all periods presented in these financial statements.
Initial Public Offering
On October 25, 2019, the Company announced the
closing of its initial public offering of 2,000,000 ordinary shares, US$0.0005 par value per share (“Ordinary Shares”) at
an offering price of $5.50 per share for a total of $11,000,000 in gross proceeds. The Company raised total net proceeds of $9,342,339
after deducting underwriting discounts and commissions and offering expenses. In addition, the Company granted to its underwriters, Univest
Securities, LLC as the Underwriter Representative, an option for a period of 45 days after the closing of the initial public offering
to purchase up to 15% of the total number of the Company’s Ordinary Shares to be offered by the Company pursuant to the initial
public offering (excluding shares subject to this option), solely for the purpose of covering overallotments, at the initial public offering
price less the underwriting discount.
During the reporting periods, the Company has
several subsidiaries in PRC. Details of the Company and its operating subsidiaries are set out below:
| Name of Entity |
|
Date of Incorporation |
|
Place of Incorporation |
|
Registered
Capital |
|
% of
Ownership |
|
Principal Activities |
| |
|
|
|
|
|
|
|
|
|
|
| Happiness (Nanping) Biotech Co., Ltd. (“Nanping Happiness”) |
|
June 1, 2018 |
|
PRC |
|
US$ 36,100,000 |
|
|
|
Investment |
| Fujian Happiness Biotech Co., Ltd (“Fujian Happiness”) |
|
November 19, 2004 |
|
PRC |
|
RMB 100,000,000 |
|
100% by Nanping Happiness |
|
Research, development, production and selling of nutraceutical and dietary supplements |
| Fujian Happiness comes Medical Equipment Manufacturing Co., Ltd. |
|
April 15, 2020 |
|
PRC |
|
RMB 10,000,000 |
|
51% by Fujian Happiness |
|
Selling of medical equipment |
| Shunchang Happiness comes Health Products Co., Ltd. |
|
May 19, 1998 |
|
PRC |
|
RMB 2,000,000 |
|
100% by Fujian Happiness |
|
Research, development, production and selling of edible fungi |
| Fujian Shennongjiagu Development Co., Ltd.(“Shennong”) |
|
December 10, 2012 |
|
PRC |
|
RMB 51,110,000 |
|
70% by Fujian Happiness |
|
Advertising service, online sales, food sales, data service, information consulting service |
| Fuzhou Hekangyuan Trading Co., Ltd. (“Hekangyuan”) |
|
October 13, 2017 |
|
PRC |
|
RMB 10,000,000 |
|
100% by Fujian Happiness |
|
Advertising service, online sales, food sales, commodity sales, information consulting service |
| Fuzhou Happiness Enterprise Management Consulting Co., Ltd. |
|
December 15, 2020 |
|
PRC |
|
RMB 1,000,000 |
|
100% by Nanping Happiness |
|
Management and consulting service |
| Happy Buy (Fujian) Network Technology Co., Ltd. (“Happy Buy”) |
|
July 16, 2020 |
|
PRC |
|
RMB 30,000,000 |
|
100% by Nanping Happiness |
|
Advertising service, online sales |
| Fujian Happy Studio Network Technology Co. LTD |
|
August 10, 2020 |
|
PRC |
|
RMB 10,000,000 |
|
51% by Happy Buy |
|
Advertising service |
| Hangzhou C’est la vie Interactive Technology Co., Ltd. (“Hangzhou C’est la vie”) |
|
August 26, 2020 |
|
PRC |
|
RMB 10,000,000 |
|
51% by Happy Buy |
|
Online sales |
| Fujian Lever Media Co., Ltd. (“Fujian Lever”) |
|
March 1, 2021 |
|
PRC |
|
RMB 10,000,000 |
|
51% by Hangzhou C’est la vie |
|
Online sales |
| Shunchang Baolong Electronic Commerce Co., Ltd. |
|
December 3, 2020 |
|
PRC |
|
RMB 100,000 |
|
100% by Fujian Lever |
|
Online sales |
| Shunchang Shihong Electronic Commerce Co., Ltd. |
|
December 3, 2020 |
|
PRC |
|
RMB 100,000 |
|
100% by Fujian Lever |
|
Online sales |
| Happiness Youdao (Hangzhou) Electronic Commerce Co., Ltd. |
|
August 21, 2017 |
|
PRC |
|
RMB 10,000,000 |
|
70% by Hangzhou C’est la vie |
|
Online sales |
| Putian City Hanjiang District Luochen Network Technology Co., Ltd. (“Putian Luochen”) |
|
February 8, 2021 |
|
PRC |
|
RMB 100,000 |
|
100% by Hangzhou C’est la vie |
|
Online sales |
| Putian City Hanjiang District Qiyao Trading Co., Ltd. |
|
February 9, 2021 |
|
PRC |
|
RMB 100,000 |
|
100% by Putian Luochen |
|
Online sales |
| Putian City Hanjiang District Zhiran Trading Co., Ltd. |
|
February 8, 2021 |
|
PRC |
|
RMB 100,000 |
|
100% by Putian Luochen |
|
Online sales |
| Fujian Seravi Electronic Commerce Co., Ltd. (“Fujian Seravi”) |
|
November 30, 2020 |
|
PRC |
|
RMB 10,000,000 |
|
100% by Hangzhou C’est la vie |
|
Online sales |
| Shunchang Qida Electronic Commerce Co., Ltd. |
|
December 3, 2020 |
|
PRC |
|
RMB 30,000 |
|
100% by Fujian Seravi |
|
Online sales |
| Shunchang Penghong Electronic Commerce Co., Ltd. |
|
December 2, 2020 |
|
PRC |
|
RMB 30,000 |
|
100% by Fujian Seravi |
|
Online sales |
| Fujian Daji Media Co., Ltd. (“Daji”) |
|
February 1, 2021 |
|
PRC |
|
RMB 10,000,000 |
|
51% by Happy Buy |
|
Live streaming service |
| Happy Buy (Nanping) Automobile Sales Co., Ltd. |
|
December 15, 2020 |
|
PRC |
|
RMB 5,000,000 |
|
100% by Happy Buy Automobile |
|
Automobile sales |
| Happy Optimal (Fujian) Network Technology Co., Ltd. (“Happy Optimal”) |
|
December 29, 2020 |
|
PRC |
|
RMB 10,000,000 |
|
51% by Happy Buy |
|
Advertising service |
| Shunchang Haiwushuo Brand Management Co., Ltd. (“Shunchang Haiwushuo”) |
|
September 2, 2021 |
|
PRC |
|
RMB 1,000,000 |
|
51% by Happy Buy |
|
Advertising service, online sales |
| Shunchang Salt Sweet Network Technology Co., Ltd. |
|
July 9, 2021 |
|
PRC |
|
RMB 500,000 |
|
100% by Shunchang Haiwushuo |
|
Online Sales |
| Haiwushuo (Hangzhou) Media Technology Co., Ltd. |
|
October 29, 2021 |
|
PRC |
|
RMB 1,000,000 |
|
100% by Shunchang Haiwushuo |
|
Advertising service, online sales |
| Shunchang County Partners Supply Chain Management Co., Ltd. |
|
June 11, 2021 |
|
PRC |
|
RMB 2,000,000 |
|
51% by Hangzhou C’est la vie |
|
Online Sales, Advertising |
| Shunchang Youxi e-commerce Co., Ltd. |
|
May 18, 2021 |
|
PRC |
|
RMB 200,000 |
|
100% by Fujian Seravi |
|
Online Sales |
| Haiwushuo (Fujian) Food Co., Ltd. |
|
March 9, 2022 |
|
PRC |
|
RMB 10,000,000 |
|
51% by Nanping Happiness |
|
Advertising service, online sales |
| Happy Unicorn (Hangzhou) Network Technology Co., Ltd. (“Happy Unicorn”) |
|
June 1, 2021 |
|
PRC |
|
RMB 10,000,000 |
|
51% by Happy Buy |
|
Advertising service, online sales, automobile sales, Internet technology service |
| Ganzhou Youjia New Energy Automobile Sales Co., Ltd. |
|
May 10, 2021 |
|
PRC |
|
RMB 10,000,000 |
|
100% by Fujian Taochejun |
|
Automobile sales |
| Happy car source (Ningbo) Automobile Service Co., Ltd. |
|
May 14, 2021 |
|
PRC |
|
RMB 10,000,000 |
|
100% by Fujian Taochejun |
|
Automobile sales |
| Wuhan Xingfu Youxuan Automobile Sales Co., Ltd. |
|
May 12, 2021 |
|
PRC |
|
RMB 10,000,000 |
|
100% by Fujian Taochejun |
|
Automobile sales |
| Taochejun (Hangzhou) New Energy Technology Co., Ltd. (“Hangzhou Taochejun”) |
|
July 12, 2021 |
|
PRC |
|
RMB 10,000,000 |
|
100% by Fujian Taochejun |
|
Technology service, automobile sales |
| Zhejiang Yiche Chuxing Technology Co., Ltd. |
|
May 26, 2020 |
|
PRC |
|
RMB 10,000,000 |
|
100% by Hangzhou Taochejun |
|
Technology service, automobile sales |
| Happy Travel Technology (Fujian) Co., Ltd. |
|
October 27, 2020 |
|
PRC |
|
RMB 50,000,000 |
|
100% by Fujian Taochejun |
|
Technology service, automobile sales |
| Sichuan Taochejun New Energy Technology Co., Ltd. |
|
July 13, 2021 |
|
PRC |
|
RMB 10,000,000 |
|
100% by Fujian Taochejun |
|
Automobile sales. |
| Taochejun (Xi’an) Car Rental Co., Ltd. |
|
August 20, 2021 |
|
PRC |
|
RMB 10,000,000 |
|
100% by Fujian Taochejun |
|
Automobile sales, online sales, car rental service |
| Taochejun (Fuzhou) Automotive Technology Co., Ltd. |
|
December 27, 2019 |
|
PRC |
|
RMB 30,000,000 |
|
60% by Fujian Taochejun |
|
Automobile sales, online sales |
| Fuzhou Taochejun Culture Media Co., Ltd. |
|
July 12, 2021 |
|
PRC |
|
RMB 1,000,000 |
|
100% by Fujian Taochejun |
|
Advertising service, information consulting service, |
| Taochejun (Hainan) New Energy Technology Co., Ltd. |
|
June 15, 2021 |
|
PRC |
|
RMB 10,000,000 |
|
100% by Fujian Taochejun |
|
Automobile sales, online sales, car rental service |
| Hunan Xingfu Vehicle Source Technology Co., Ltd. |
|
May 28, 2021 |
|
PRC |
|
RMB 10,000,000 |
|
100% by Fujian Taochejun |
|
NEV charging technology service, advertising service, automobile sales, automobile parts sales |
| Happy Automobile Service (Nanping) Co., Ltd. |
|
December 4, 2020 |
|
PRC |
|
RMB 30,000,000 |
|
70% by Fujian Taochejun |
|
Automobile sales, online sales |
| Hangzhou Happiness Youche Automobile Partnership (Limited partnership) |
|
December 29, 2021 |
|
PRC |
|
RMB 3,000,000 |
|
60% by Nanping Happiness |
|
automobile parts sales |
| Shunchang Bangren Electronic Commerce Co., Ltd. (a) |
|
December 3, 2020 |
|
PRC |
|
RMB 1,000,000 |
|
100% by Fujian Lever |
|
Online sales |
| Shunchang Shenzhou Electronic Commerce Co., Ltd. (a) |
|
December 2, 2020 |
|
PRC |
|
RMB 1,000,000 |
|
100% by Fujian Seravi |
|
Online sales |
| Shunchang Tongyuan Electronic Commerce Co., Ltd. (a) |
|
December 2, 2020 |
|
PRC |
|
RMB 200,000 |
|
100% by Fujian Seravi |
|
Online sales |
| Shunchang Guangxiang Electronic Commerce Co., Ltd. (a) |
|
December 2, 2020 |
|
PRC |
|
RMB 200,000 |
|
100% by Fujian Seravi |
|
Online sales |
| Shunchang Lishijin Electronic Commerce Co., Ltd. (a) |
|
December 2, 2020 |
|
PRC |
|
RMB 200,000 |
|
100% by Fujian Seravi |
|
Online sales |
| Shunchang Wangfu Electronic Commerce Co., Ltd. (a) |
|
December 2, 2020 |
|
PRC |
|
RMB 100,000 |
|
100% by Fujian Seravi |
|
Online sales |
| Shunchang Yibo Electronic Commerce Co., Ltd. (a) |
|
December 1, 2020 |
|
PRC |
|
RMB 100,000 |
|
100% by Fujian Seravi |
|
Online sales |
| Shunchang Runhao Electronic Commerce Co., Ltd. (a) |
|
December 2, 2020 |
|
PRC |
|
RMB 200,000 |
|
100% by Fujian Seravi |
|
Online sales |
| Shunchang fanyanfull Electronic Commerce Co., Ltd. (a) |
|
May 8, 2021 |
|
PRC |
|
RMB 200,000 |
|
100% by Fujian Seravi |
|
Online sales |
| Shunchang Fanquguan Electronic Commerce Co., Ltd. (a) |
|
April 23, 2021 |
|
PRC |
|
RMB 200,000 |
|
100% by Fujian Seravi |
|
Online sales |
| Shunchang Youqiangdiao Electronic Commerce Co., Ltd. (a) |
|
April 16, 2021 |
|
PRC |
|
RMB 200,000 |
|
100% by Fujian Seravi |
|
Online sales |
| Shunchang Shangyoupin Electronic Commerce Co., Ltd. (a) |
|
April 15, 2021 |
|
PRC |
|
RMB 200,000 |
|
100% by Fujian Seravi |
|
Online sales |
| Fuzhou baodeng Trading Co., Ltd (“Fuzhou Baodeng”) (b) |
|
April 1, 2021 |
|
PRC |
|
RMB 4,000,000 |
|
51% by Happy Unicorn |
|
Online sales |
| Fuzhou Dachen e-commerce Co., Ltd (b) |
|
April 1, 2021 |
|
PRC |
|
RMB 1,000,000 |
|
100% by Fujian Baodeng |
|
Online sales |
| Fuzhou Nanen Trading Co., Ltd (b) |
|
April 1, 2021 |
|
PRC |
|
RMB 1,000,000 |
|
100% by Fujian Baodeng |
|
Online sales |
| Fuzhou Dechen Trading Co., Ltd (b) |
|
April 1, 2021 |
|
PRC |
|
RMB 1,000,000 |
|
100% by Fujian Baodeng |
|
Online sales |
| Fuzhou lehuang Trading Co., Ltd (b) |
|
June 11, 2021 |
|
PRC |
|
RMB 1,000,000 |
|
100% by Fujian Baodeng |
|
Online sales |
| Happy Doddo (Fujian) Network Technology Co. , Ltd. (“Happy Doddo”) (c) |
|
June 28, 2021 |
|
PRC |
|
RMB 10,000,000 |
|
51% by Happy Unicorn |
|
Online sales |
| Shunchang Shenghui Electronic Commerce Co., Ltd. (c) |
|
December 3, 2020 |
|
PRC |
|
RMB 200,000 |
|
100% by Happy Doddo |
|
Online sales |
| Shunchang Wansheng Electronic Commerce Co., Ltd. (c) |
|
December 2, 2020 |
|
PRC |
|
RMB 30,000 |
|
100% by Happy Doddo |
|
Online sales |
| Shunchang Jiefei Electronic Commerce Co., Ltd. (c) |
|
December 2, 2020 |
|
PRC |
|
RMB 30,000 |
|
100% by Happy Doddo |
|
Online sales |
| Shunchang Zhibo Electronic Commerce Co., Ltd. (c) |
|
December 3, 2020 |
|
PRC |
|
RMB 1,000,000 |
|
100% by Happy Doddo |
|
Online sales |
| Shunchang Herui Electronic Commerce Co., Ltd. (c) |
|
December 1, 2020 |
|
PRC |
|
RMB 100,000 |
|
100% by Happy Doddo |
|
Online sales |
| Shunchang Xiaocongcong Electronic Commerce Co., Ltd. (d) |
|
December 3, 2020 |
|
PRC |
|
RMB 1,000,000 |
|
100% by Fujian Baodeng |
|
Online sales |
| Shunchang Xianghong Electronic Commerce Co., Ltd. (e) |
|
December 2, 2020 |
|
PRC |
|
RMB 200,000 |
|
100% by Happy Optimal |
|
Online sales |
| Shunchang Happy Cat Electronic Commerce Co., Ltd. (f) |
|
December 3, 2020 |
|
PRC |
|
RMB 200,000 |
|
100% by Happy Optimal |
|
Online sales |
| Shunchang Subobo E-commerce Co. , Ltd. (f) |
|
July 9, 2021 |
|
PRC |
|
RMB 500,000 |
|
100% by Happy Optimal |
|
Online sales |
| Happy Feiyue (Fujian) Network Technology Co., Ltd. (“Happy Feiyue”) (g) |
|
March 19, 2021 |
|
PRC |
|
RMB 10,000,000 |
|
51% by Happy Unicorn |
|
Online sales |
| HAPPINESS (HK) TECHNOLOGY LIMITED (g) |
|
April 8, 2021 |
|
PRC |
|
HK$ 10,000 |
|
100% by Happy Feiyue |
|
Online sales |
| (a) | During the year ended March 31, 2022, the Company closed 12 subsidiaries to optimize the Company’s
structure on online store business. |
| (b) | Fuzhou Baodeng and its subsidiaries were focus on the online store operation. In March 2022, the Company
disposed Fuzhou Baodeng and its subsidiaries to a third party. |
| (c) | Happy Doddo and its subsidiaries were focus on the online store operation. In February 2022, the Company
disposed Happy Doddo and its subsidiaries to a third party. |
| (d) | Shunchang Xiaocongcong Electronic Commerce Co., Ltd. was a company with no operation. The Company closed
it in October 2021. |
| (e) | Shunchang Xianghong Electronic Commerce Co., Ltd. was closed in October 2021 due to the business optimization. |
| (f) | Shunchang Happy Cat Electronic Commerce Co., Ltd. and Shunchang Subobo E-commerce Co., Ltd. were disposed
in November 2021 due to the business optimization. |
| (g) | Happy Feiyue and its subsidiary were focus on the online store operation. In January 2022, the Company
disposed Happy Feiyue and its subsidiary to a third party. |
NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation and Principles of Consolidation
The accompanying consolidated financial statements
have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”)
and have been consistently applied. The accompanying consolidated financial statements include the financial statements of Happiness Development
and its subsidiaries (collectively, the “Company”). All inter-company balances and transactions have been eliminated upon
consolidation.
Non-controlling interests
For the Company’s non-wholly owned subsidiaries,
a non-controlling interest is recognized to reflect the portion of equity that is not attributable, directly or indirectly, to the Company.
Non-controlling interests are classified as a separate line item in the equity section of the Company’s consolidated balance sheets
and have been separately disclosed in the Company’s consolidated statements of comprehensive (loss)/income to distinguish the interests
from that of the Company. Cash flows related to transactions with non-controlling interests are presented under financing activities in
the consolidated statements of cash flows.
Use of Estimates
In preparing the consolidated financial statements in conformity with
US GAAP, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent
assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting
period. These estimates are based on information as of the date of the consolidated financial statements. Significant estimates required
to be made by management include, but are not limited to, the valuation of accounts receivable and related allowance for doubtful
accounts, useful lives of property and equipment and intangible assets, the recoverability of long-lived assets, inventory reserve, allowance
for credit losses, goodwill impairment, income taxes related to realization of deferred tax assets and uncertain tax position, provisions
necessary for contingent liabilities and purchase price allocation in connection with the business combination. The current
economic environment has increased the degrees of uncertainty inherent in those estimates and assumptions, actual results could differ
from those estimates.
Business combination
Business combinations are recorded using the acquisition
method of accounting. The assets acquired, the liabilities assumed, and any non-controlling interests of the acquiree at the acquisition
date, if any, are measured at their fair values as of the acquisition date. Goodwill is recognized and measured as the excess of the total
consideration transferred plus the fair value of any non-controlling interest of the acquiree and fair value of previously held equity
interest in the acquiree, if any, at the acquisition date over the fair values of the identifiable net assets acquired. Common forms of
the consideration made in acquisitions include cash and common equity instruments. Consideration transferred in a business acquisition
is measured at the fair value as of the date of acquisition. Acquisition-related expenses and restructuring costs are expensed as incurred.
Accounting Standards Codification (“ASC”) 805 establishes
a measurement period to provide the Company with a reasonable amount of time to obtain the information necessary to identify and measure
various items in a business combination and cannot extend beyond one year from the acquisition date.
Cash and Cash Equivalents
The Company considers all highly liquid investment
instruments with an original maturity of three months or less from the date of purchase to be cash equivalents. The Company maintains
all bank accounts in the PRC. Cash balances in bank accounts in PRC are not insured by the Federal Deposit Insurance Corporation or other
programs.
Accounts Receivable and Allowance for Doubtful
Accounts
Accounts receivable are recognized and carried
at original invoiced amount less an estimated allowance for uncollectible accounts. The Company determines the adequacy of reserves for
doubtful accounts based on individual account analysis and historical collection trends. The Company establishes a provision for doubtful
receivables when there is objective evidence that the Company may not be able to collect amounts due. The allowance is based on management’s
best estimates of specific losses on individual exposures, as well as a provision on historical trends of collections. Based on management
of customers’ credit and ongoing relationship, management makes conclusions whether any balances outstanding at the end of the period
will be deemed uncollectible on an individual basis and on aging analysis basis. The provision is recorded against accounts receivables
balances, with a corresponding charge recorded in the consolidated statements of income and comprehensive income. Delinquent account balances
are written-off against the allowance for doubtful accounts after management has determined that the likelihood of collection is not probable.
Inventories
Inventories are stated at the lower of cost or
net realizable value. Cost of inventories is determined using the weighted-average method. In addition to cost of raw materials, work
in progress and finished goods include direct labor costs and overheads. The Company periodically assesses the recoverability of all inventories
to determine whether adjustments are required to record inventories at the lower of cost or market value. Inventories that the Company
determines to be obsolete or in excess of forecasted usage are reduced to its estimated realizable value based on assumptions about future
demand and market conditions. If actual demand is lower than the forecasted demand, additional inventory write-downs may be required.
Goodwill
Goodwill represents the excess of the purchase
price over the fair value of the identifiable assets and liabilities acquired in a business combination.
Goodwill is not depreciated or amortized but
is tested for impairment on an annual basis as of March 31, and in between annual tests when an event occurs or circumstances change
that could indicate that the asset might be impaired. In accordance with the FASB ASC 350 guidance on “Testing of Goodwill for
Impairment”, a company first has the option to assess qualitative factors to determine whether it is more likely than not that
the fair value of a reporting unit is less than its carrying amount. If the company decides, as a result of its qualitative assessment,
that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, the quantitative impairment
test is mandatory. Otherwise, no further testing is required. The quantitative impairment test consists of a comparison of the fair value
of each reporting unit with its carrying amount, including goodwill. If the carrying amount of each reporting unit exceeds its fair value,
an impairment loss equal to the difference between the fair value of the reporting unit and the carrying amount will be recorded. Application
of a goodwill impairment test requires significant management judgment, including the identification of reporting units, assigning assets
and liabilities to reporting units, assigning goodwill to reporting units, and determining the fair value of each reporting unit. The
judgment in estimating the fair value of reporting units includes estimating future cash flows, determining appropriate discount rates
and making other assumptions. Changes in these estimates and assumptions could materially affect the determination of fair value for
each reporting unit.
As of March 31, 2022, goodwill resulting from business acquisitions
have been allocated into three reporting units, including Shennong, Hekangyuan and Daji. The Company evaluates if goodwill impairment
may be indicated on quarterly basis and performs the annual goodwill impairment assessment as of March 31. As of March 31, 2022, the Company
qualitatively assessed relevant events and circumstances, including macroeconomics conditions, industry and market considerations, its
overall financial performance, and concluded by weighing all these factors in their entirety that it was more likely than not the fair
value of the Company’s reporting unit was lower than its respective carrying value.
Property, Plant and Equipment
Property, plant and equipment are stated at cost. The
straight-line depreciation method is used to compute depreciation over the estimated useful lives of the assets, as follows:
| |
|
Useful Lives |
| Buildings |
|
20 years |
| Machinery |
|
10 years |
| Furniture, fixture and electronic equipment |
|
3-10 years |
| Vehicles |
|
4 years |
Expenditures for maintenance and repairs, which
do not materially extend the useful lives of the assets, are charged to expense as incurred. Expenditures for major renewals and betterment
which substantially extend the useful life of assets are capitalized. The cost and related accumulated depreciation of assets retired
or sold are removed from the respective accounts, and any gain or loss is recognized in the consolidated statements of income and other
comprehensive income in other income or expenses.
Intangible Assets
Intangible assets with definite lives are initially
recorded at cost. Amortization of definite-lived intangible assets is computed using the straight-line method over the estimated average
useful lives. Intangible assets with indefinite lives should not be amortized but should be tested for impairment at least annually or
when event occurs or circumstances that could indicate that the asset might be impaired.
The estimated useful lives of intangible assets are as follows:
| |
|
Useful life |
| Land use right |
|
50 years |
| Licensed software |
|
5-10 years |
| Trademark |
|
10 years |
| Customer relationship |
|
5 years |
Impairment of Long-lived Assets other than goodwill
The Company reviews long-lived assets, including
definite-lived intangible assets, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset
may not be recoverable. If the estimated cash flows from the use of the asset and its eventual disposition are below the asset’s
carrying value, then the asset is deemed to be impaired and written down to its fair value. There were no impairments of these assets
as of March 31, 2022 and 2021.
Fair Value of Financial Instruments
The Financial Accounting Standards Board (“FASB”)
Accounting Standards Codification 820, Fair Value Measurement and Disclosures, requires certain disclosures regarding the fair
value of financial instruments. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability
in an orderly transaction between market participants at the measurement date. A three-level fair value hierarchy prioritizes the inputs
used to measure fair value. The hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable
inputs. The three levels of inputs used to measure fair value are as follows:
|
● |
Level 1 - Quoted prices in active markets for identical assets and liabilities. |
|
● |
Level 2 - Quoted prices in active markets for similar assets and liabilities, or other inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument. |
|
● |
Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets and liabilities. This includes certain pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs. |
The Company considers the recorded value of its
financial assets and liabilities, which consist primarily of cash and cash equivalents, accounts receivable, other receivable, accounts
payable, short-term borrowings, accounts payable, income tax assets and liabilities and income taxes payable and to approximate the fair
value of the respective assets and liabilities at March 31, 2022 and 2021 based upon the short-term nature of the assets and liabilities.
Warrants
The Company accounts for the
warrants pursuant to share exchange agreements in accordance with the guidance contained in ASC 815, under which the warrants do not meet
the criteria for equity classification and must be recorded as liabilities. All such warrant agreements contain fixed strike prices and
number of shares that may be issued at the fixed strike price, and do not contain exercise contingencies that adjust the strike price
or number of shares issuable upon settlement of the warrants. All such warrant agreements are exercisable at the option of the holder
and settled in shares of the Company. The warrants are qualified as equity-linked instrument embedded in a host instrument whereby do
not meet definition of derivative, therefore it’s not required to separate the embedded component from its host.
The Company
treats a modification of the terms or conditions of an equity award in accordance with ASC Topic 718-20-35-3, by treating the modification
as an exchange of the original award for a new award. In substance, the entity repurchases the original instrument by issuing a new instrument
of equal or greater value, incurring additional compensation cost for any incremental value. Incremental compensation cost is measured
as the excess, if any, of the fair value of the modified award determined in accordance with the provisions of ASC Topic 718-20-35-3
over the fair value of the original award immediately before its terms are modified, measured based on the share price and other pertinent
factors at that date. There is no modification of the terms or conditions of the warrant issued by the Company.
Deconsolidation
The Company accounts for the deconsolidation of
a subsidiary by recognizing a gain or loss in net income/loss attributable to the parent, measured as the difference between:
| a. | The aggregate of all of the following: |
1. The fair value of any consideration received;
2. The fair value of any retained noncontrolling
investment in the former subsidiary at the date the subsidiary is deconsolidated;
3.The carrying amount of any noncontrolling interest
in the former subsidiary (including any accumulated other comprehensive income attributable to the noncontrolling interest) at the date
the subsidiary is deconsolidated.
| b. | The carrying amount of the former subsidiary’s assets and liabilities. |
If the deconsolidation transactions were transacted
with related parties under common control, the Group should not recognize gain on sales of the subsidiaries and losses should be recognized
by the Company only when an impairment in value is indicated.
The Company has continued to operate the online store business through
the other subsidiaries. Since the deconsolidated subsidiaries’ operating revenue was less than 1% of the Company’s consolidated
revenue and the disposal did not constitute a strategic shift that would have a major effect on the Company’s operations and financial
results. The results of operations for these subsidiaries were not reported as discontinued operations in the consolidated financial statements.
Revenue Recognition
The Company generates its revenue mainly from
sales of healthcare products, automobiles, online store sales and internet information and advertising services.
The Company allows its customers to return products
within some range. The range was limited to 3% of the customer’s yearly payment amount for the year for online store
business. The transportation fee is borne by the customers in the condition of products return. For the year ended March
31, 2022, products return of all product sales amounted to $66,646, which is within the range.
The Company adopted the new guidance of ASC Topic
606, Revenue from Contracts with Customers (“Topic 606”), which supersedes the revenue recognition requirements in ASC Topic
605, Revenue Recognition on April 1, 2019.
The core principle of the guidance is that an entity should recognize
revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity
expects to be entitled in exchange for those goods or services. Revenue is the transaction price the Company expects to be entitled to
in exchange for the promised services in a contract in the ordinary course of the Company’s activities and is recorded net of value-added
tax (“VAT”). To achieve that core principle, the Company applies the following steps:
Step 1: Identify the contract (s) with a customer
Step 2: Identify the performance obligations in the contract
Step 3: Determine the transaction price
Step 4: Allocate the transaction price to the performance
obligations in the contract
Step 5: Recognize revenue when (or as) the entity satisfies a performance
obligation
Company generates revenues from providing transportation
services and warehouse storage and management services. No practical expedients were used when adoption ASC 606. Revenue recognition
policies for each type of revenue stream are as follow:
Healthcare products
The Company sells nutraceutical and dietary supplements to third-party
distributors and experience stores. Experience stores are owned by third parties, which are located in tourist
sites where the sales consultants gave in-depth presentation of the origin, tradition and history of the Company’s products. Tourists
are guided to enjoy a presentation of traditional Chinese herb culture offered by the distributors in the experience store and be presented
with the Company’s healthcare products. The Company is a principal for the healthcare product sales as i) the Company produce or
obtain control of the specified goods before transferring to the customers; ii) the Company has the right to determine the sales price;
iii) the Company bears the risk of inventories and collection of consideration. For all sales, the Company requires a signed contract
and sales order, which specifies pricing, quantity and product specifications. Under ASC 606, the Company recognizes revenue upon the
satisfaction of its performance obligation, which is to transfer the control of the promised products to customers in an amount that reflects
the consideration to which the Company expects to be entitled to in exchange for those products, excluding amounts collected on behalf
of third parties (e.g., value-added taxes). The transfer of control of the products is satisfied at a point in time, which is the delivery
of the products to distributors’ or the experience stores’ premises and evidenced by signed acknowledgment. The selling price,
which is specified in the signed sales orders, is fixed. The Company has unconditional right to receive full payment of the sales price,
upon the delivery of the products to distributors or experience stores and the signing of their acknowledgment. Distributors and experience
stores are required to pay under the customary payment terms, which is generally less than six months. According to the sales agreement,
the healthcare product sold cannot be returned after the acknowledgement.
Automobile
The Company sells automobiles in fiscal year 2022.
For all sales, the Company requires a signed contract and sales order, which specifies pricing, quantity and product specifications. The
Company is a principal for the automobiles sales as i) the Company produce or obtain control of the specified goods before transferring
to the customers; ii) the Company has the right to determine the sales price; iii) the Company bears the risk of inventories and collection
of consideration. Under ASC 606, the Company recognizes revenue upon the satisfaction of its performance obligation, which is to transfer
the control of the promised products to customers in an amount that reflects the consideration to which the Company expects to be entitled
to in exchange for those products, excluding amounts collected on behalf of third parties (e.g., value-added taxes). The transfer of control
of the products is satisfied at a point in time, which is the delivery of the products to customers’ premises and evidenced by signed
customer acknowledgment. According to the contract, the automobile sold cannot be returned after the customer acknowledgement. The selling
price, which is specified in the signed sales orders, is fixed. The Company has unconditional right to receive full payment of the sales
price, upon the delivery of the products to customers and the signing of the customer acknowledgment, which is within 3 months after sales.
Online store
The Company sells various goods through its online store business in
fiscal year 2022. For all sales, the Company requires a sales order generated by the online store platform, which specifies pricing, quantity
and product specifications. The Company is a principal for the online store sales as i) the Company produce or obtain control of the specified
goods before transferring to the customers; ii) the Company has the right to determine the sales price; iii) the Company bears the risk
of inventories and collection of consideration. Under ASC 606, the Company recognizes revenue upon the satisfaction of its performance
obligation, which is to transfer the control of the promised products to customers in an amount that reflects the consideration to which
the Company expects to be entitled to in exchange for those products, excluding amounts collected on behalf of third parties (e.g., value-added
taxes). The transfer of control of the products is satisfied at a point in time, which is the delivery of the products to customers’
premises and evidenced by signed customer acknowledgment. The selling price, which is specified in the signed sales orders, is fixed.
The Company has unconditional right to receive full payment of the sales price, upon the delivery of the products to customers and the
signing of the customer acknowledgment unless the customers require sales return within 7 days after the acknowledgement. Customers are
required to pay to the third-party platform before the goods were send out and the Company will receive the amount from the third-party
platform after the customer sign off the acceptance form on the platform.
Internet information and advertising service
The Company provides internet information and advertising service online.
For all sales, the Company requires a signed contract and sales order, which specifies the price and service range. The Company is a principal
for the services as i) the Company has the right to determine the sales price; ii) the Company bears the collection risks; iii) the Company
is responsible to the service provided. Under ASC 606, the Company recognizes revenue upon the satisfaction of its performance obligation,
which is to provide specified information and advertising service to customers in an amount that reflects the consideration to which the
Company expects to be entitled to in exchange for those services, excluding amounts collected on behalf of third parties (e.g., value-added
taxes). The information and advertising service provided is satisfied at a point in time, which is the time when the information and advertising
service is performed. No sales return is permitted after the service performed according to the contract signed. The selling price per
click, which is specified in the signed sales orders, is fixed. The Company has unconditional right to receive full payment of the sales
price, upon the completion of the service. Customers are required to pay to the Company in advance according to the contract.
The Company adopted ASC 606 as of April 1, 2019
using the modified retrospective transition method, the Company recognizes the cumulative effect of initially applying the new revenue
standard as an adjustment to the opening balance of retained earnings; however, no adjustment was required as a result of adopting the
new revenue standard. Results for reporting periods beginning after April 1, 2019 are presented under the new standard. The
comparative information has not been restated and continues to be reported under the historic accounting standards in effect for those
periods. The Company does not expect any impact to its net income from the adoption of ASU 2014-09 on an ongoing basis.
All of the Company’s revenues from
contracts with customers represent products transferred at a point in time as control is transferred to the customer and are generated
in PRC. All of the Company’s revenues are recognized on a gross basis and presented as revenue on the consolidated statements of
operations and comprehensive income/(loss).
The following table presents an overview of our
sales from our product lines for the years ended March 31, 2022, 2021 and 2020:
| | |
For the years ended March 31, | |
| | |
2022 | | |
2021 | | |
2020 | |
| Healthcare products | |
$ | 30,323,831 | | |
$ | 45,389,702 | | |
$ | 65,061,953 | |
| Online store | |
| 28,014,109 | | |
| 13,473,626 | | |
| - | |
| Internet information and advertising | |
| 10,538,943 | | |
| 9,245,019 | | |
| - | |
| Automobile | |
| 20,611,775 | | |
| 3,376,356 | | |
| - | |
| Revenue | |
$ | 89,488,658 | | |
$ | 71,484,703 | | |
$ | 65,061,953 | |
Cost of Revenues
Healthcare products
Cost of revenue of healthcare product is mainly composed of the cost
of product sales, employees, depreciation expenses and other manufacturing overhead expenses that are directly attributable to the business.
Automobile
Cost of revenue of automobile is mainly composed of the cost of automobile
and other miscellaneous expenses that are directly attributable to the business.
Online store
Cost of revenue of online store is mainly composed of the cost of goods
sales and other miscellaneous expenses that are directly attributable to the business.
Internet information and advertising service
Cost of revenue of automobile is mainly composed of the cost of service
provide and other miscellaneous expenses that are directly attributable to the business.
Government Grant
Government grants are recognized when received
and all the conditions for their receipt have been met. Government grants as compensation for the Company’s research and development
efforts. For the years ended March 31, 2022, 2021 and 2020, the Company recognized government grants of $11,893, $63,520 and $162,268,
respectively, for the government support of the Company’s research and development activities and patent applications. The government
grants were recorded as other income.
Research and Development Costs
Research and development activities are directed
toward the development of new products as well as improvements in existing processes. These costs, which primarily include salaries, contract
services, raw materials, and supplies, are expensed as incurred.
Shipping and Handling Costs
Shipping and handling costs are expensed when
incurred as selling and marketing expense. Shipping and handling costs were $291,170, $1,104,120 and $1,869,505 for the years ended March
31, 2022, 2021 and 2020, respectively.
Advertising Costs
Advertising costs expensed as economic
benefits are consumed in accordance with ASC 720-35, “Other Expenses-Advertising Costs”. Advertising costs
were $26,210,291, $5,720,458 and $3,856,921for the years ended March 31, 2022, 2021 and 2020, respectively.
Stock-Based Compensation
The Company accounts for stock-based compensation
to employees in accordance with ASC 718, “Compensation-Stock Compensation”. ASC 718 requires companies to measure the cost
of employee services received in exchange for an award of equity instruments, including the equity incentive plan, based on the grant
date fair value of the award and to recognize it as compensation expense over the period the employee is required to provide service in
exchange for the award, usually the vesting period. Stock option forfeitures are recognized at the date of employee termination. Effective
April 1, 2019, the Company adopted ASU 2018-07 for the accounting of share-based payments granted to non-employees for goods and services
and no material impacts to the Financial Statements.
Option
The fair value of options issued pursuant to the Company’s option
plans at the grant date was estimated using the Black-Scholes option pricing model. This model was developed for use in estimating the
fair value of traded options that have no vesting restrictions and are fully transferable. In addition, option-pricing models require
the input of highly subjective assumptions, including the expected term of the options, the estimated forfeiture rates and the expected
stock price volatility. The expected term of options granted represents the period of time that options granted are expected to be outstanding.
The Group uses projected volatility rates based upon the Group’s historical volatility rates. These assumptions are inherently uncertain.
Different assumptions and judgments would affect the Company’s calculation of the fair value of the underlying ordinary shares for
the options granted, and the valuation results and the amount of option would also vary accordingly.
Income Taxes
The Company accounts for current income taxes
in accordance with the laws of the relevant tax authorities. Deferred income taxes are recognized when temporary differences exist between
the tax bases of assets and liabilities and their reported amounts in the consolidated financial statements. Deferred tax assets and liabilities
are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected
to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the
period including the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount
expected to be realized.
The provisions of ASC 740-10, “Accounting
for Uncertainty in Income Taxes”, prescribe a more-likely-than-not threshold for consolidated financial statement recognition and
measurement of a tax position taken (or expected to be taken) in a tax return. This interpretation also provides guidance on the recognition
of income tax assets and liabilities, classification of current and deferred income tax assets and liabilities, accounting for interest
and penalties associated with tax positions, and related disclosures. The Company does not believe that there was any uncertain tax position
at March 31, 2022 and 2021.
To the extent applicable, the Company records
interest and penalties as a general and administrative expense. All of the tax returns of the Company and its subsidiaries remain subject
to examination by PRC tax authorities for five years from the date of filing.
The Company is subject to Chinese tax laws. We
are not subject to U.S. tax laws and local state tax laws. Our income and our related entities must be computed in accordance with Chinese
and foreign tax laws, as applicable, and we are subject to Chinese tax laws, all of which may be changed in a manner that could adversely
affect the amount of distributions to shareholders. There can be no assurance that Income Tax Laws of China will not be changed in a manner
that adversely affects shareholders. In particular, any such change could increase the amount of tax payable by us, reducing the amount
available to pay dividends to the holders of our ordinary shares.
We are a holding company with no material operations
of our own. We conduct our operations through our subsidiaries in China. As a result, our ability to pay dividends and to finance any
debt we may incur depends upon dividends paid by our subsidiaries. Under applicable PRC regulations, foreign-invested enterprises in China
may pay dividends only out of their accumulated profits, if any, determined in accordance with PRC accounting standards and regulations.
In addition, a foreign-invested enterprise in China is required to set aside at least 10% of its after-tax profit based on PRC accounting
standards each year to its general reserves until the accumulative amount of such reserves reaches 50% of its registered capital. These
reserves are not distributable as cash dividends.
As of March 31, 2022, our PRC subsidiaries had an aggregate retained
earnings of approximately RMB 195.2 million (US$26.04 million) under PRC GAAP. With respect to retained earnings accrued after
such date, our Board of Directors may declare dividends after taking into account our operations, earnings, financial condition, cash
requirements and availability and other factors as it may deem relevant at such time. Any declaration and payment, as well as the amount,
of dividends will be subject to our By-Laws, charter and applicable Chinese and U.S. state and federal laws and regulations, including
the approval from the shareholders of each subsidiary which intends to declare such dividends, if applicable.
Value-added Tax
Value-added taxes (“VAT”) collected
from customers relating to product sales and remitted to governmental authorities are presented on a net basis. VAT collected from customers
is excluded from revenue. The Company is generally subject to the VAT for merchandise sales and services
performed. Before May 1, 2018, the applicable VAT rate was 17%, while after May 1, 2018 and before April 1, 2019, the Company is subject
to a VAT rate of 16%. After April 1, 2019, the Company is subject to a VAT rate of 13% based on the new Chinese tax law.
Earnings/ Loss per Share
Basic earnings/loss per share is computed by dividing
net profit/loss attributable to holders of ordinary shares by the weighted average number of ordinary shares outstanding during the year
using the two-class method. Using the two class method, net profit/loss is allocated between Class A ordinary shares, Class B ordinary
shares and other participating securities (i.e. preferred shares) based on their participating rights.
The Company computes earnings per share (“EPS”)
in accordance with ASC 260, “Earnings per Share”. ASC 260 requires companies with complex capital structures to present basic
and diluted EPS. Basic EPS is measured as Net profit divided by the weighted average common shares outstanding for the period. Diluted
earnings/loss per share is calculated by dividing net profit/loss attributable to ordinary shareholders as adjusted for the effect of
dilutive ordinary equivalent shares, if any, by the weighted average number of ordinary and dilutive ordinary equivalents shares outstanding
during the year/period. Dilutive equivalent shares are excluded from the computation of diluted earnings/loss per share if their effects
would be anti-dilutive. Ordinary share equivalents consist of the ordinary shares issuable in connection with the Group’s convertible
redeemable preferred shares using the if-converted method, and ordinary shares issuable upon the conversion of the stock options, using
the treasury stock method. Except for voting rights, the Class A and Class B ordinary shares have all the same rights and therefore the
earning/loss per share for both classes of shares are identical. The earning/loss per share amounts are the same for Class A and Class
B ordinary shares because the holders of each class are entitled to equal per share dividends or distributions in liquidation.
Foreign Currency Translation
The Company and its subsidiaries’ principal
country of operations is the PRC. The Company maintained its financial record using the United States dollar (“US dollar”)
as the functional currency, while the subsidiaries of the Company in Hong Kong and mainland China maintained their financial records using
RMB as the functional currencies. The consolidated statements of income and comprehensive income and cash flows denominated in foreign
currency are translated at the average rate of exchange during the reporting period. Assets and liabilities denominated in foreign currencies
at the balance sheet date are translated at the applicable rates of exchange in effect at that date. The equity denominated in the functional
currency is translated at the historical rate of exchange at the time of capital contribution. Because cash flows are translated based
on the average rate of exchange, amounts related to assets and liabilities reported on the consolidated statements of cash flows will
not necessarily agree with changes in the corresponding balances on the consolidated balance sheets. Translation adjustments arising from
the use of different exchange rates from period to period are included as a separate component of accumulated other comprehensive income
(loss) included in consolidated statements of changes in shareholders’ equity. Gains and losses from foreign currency transactions
are included in the consolidated statement of income and comprehensive income.
The value of RMB against US$ and other currencies
may fluctuate and is affected by, among other things, changes in the PRC’s political and economic conditions. Any significant revaluation
of RMB may materially affect the Company’s financial condition in terms of US$ reporting. The following table outlines the currency
exchange rates that were used in creating the consolidated financial statements in this report:
| |
|
March 31, 2022 |
|
March 31,
2021 |
|
March 31,
2020 |
| Period-end spot rate |
|
US$1=RMB 6.3482 |
|
US$1=RMB 6.5713 |
|
US$1=RMB 7.0851 |
| Average rate |
|
US$1=RMB 6.4083 |
|
US$1=RMB 6.7960 |
|
US$1=RMB 6.965 |
Comprehensive Income
Comprehensive income includes net income and foreign
currency translation adjustments and is reported in the consolidated statements of income and comprehensive income.
Segment Reporting
The Company uses the “management approach”
in determining reportable operating segments. The management approach considers the internal organization and reporting used by the Company’s
chief operating decision maker (“CODM”) for making operating decisions and assessing performance as the source for determining
the Company’s reportable segments. The Company’s CODM has been identified as the chief executive officer of the Company who
reviews financial information of separate operating segments based on U.S. GAAP. In the year ended March 31, 2022, the CODM reviews financial
information analyzed by customer, which only presented at the gross profit level with no allocation of operating expenses.
Thus, the Company determined that it operates in four operating segments: (1) Healthcare products; (2) Automobile; (3) Online
store; and (4) Internet information and advertising service. The Company’s reportable segments are strategic business units that
offer different products and services. They are managed separately because each business requires different marketing strategies.
As the Company’s long-lived assets are substantially all located
in the PRC and all of the Company’s revenue and expense are derived from within the PRC, no geographical segments are presented.
Concentration of Risks
Exchange Rate Risks
The Company operates in China, which may give
rise to significant foreign currency risks from fluctuations and the degree of volatility of foreign exchange rates between the US$ and
the RMB. As of March 31, 2022 and 2021, cash and cash equivalents of $19,571,668 (RMB 124,244,865) and $36,203,665 (RMB 237,905,147),
respectively, is denominated in RMB and is held in PRC.
Currency Convertibility Risks
Substantially all of the Company’s operating
activities are transacted in RMB, which is not freely convertible into foreign currencies. All foreign exchange transactions take place
either through the People’s Bank of China or other banks authorized to buy and sell foreign currencies at the exchange rates quoted
by the People’s Bank of China. Approval of foreign currency payments by the People’s Bank of China or other regulatory institutions
requires submitting a payment application form together with other information such as suppliers’ invoices, shipping documents and
signed contracts.
Concentration of Credit Risks
Financial instruments that potentially subject
the Company to concentration of credit risks consist primarily of cash and cash equivalents and accounts receivable, the balances of which
are stated on the consolidated balance sheets which represent the Company’s maximum exposure. The Company places its cash and cash
equivalents in good credit quality financial institutions in China. Concentration of credit risks with respect to accounts receivables
is linked to the concentration of revenue. To manage credit risk, the Company performs ongoing credit evaluations of customers’
financial condition.
Interest Rate Risks
The Company is subject to interest rate risk.
Bank interest bearing loans are charged at variable interest rates within the reporting period. The Company is subject to the risk of
adverse changes in the interest rates charged by the banks when these loans are refinanced.
Risks and Uncertainties
The operations of the Company are located in the
PRC. Accordingly, the Company’s business, financial condition, and results of operations may be influenced by political, economic,
and legal environments in the PRC, as well as by the general state of the PRC economy. The Company’s results may be adversely affected
by changes in the political, regulatory and social conditions in the PRC. Although the Company has not experienced losses from these situations
and believes that it is in compliance with existing laws and regulations including its organization and structure disclosed in Note 1,
this may not be indicative of future results.
COVID-19 Pandemic
The outbreak of COVID-19 began in January 2020
and was quickly declared as a Public Health Emergency of International Concern and subsequently a pandemic by the World Health Organization.
A series of prevention and control measures including quarantines, travel restrictions, and the temporary closure of facilities were implemented
across the country.
The Company was impacted by the COVID-19 pandemic
in many ways, including the plump of closures of experience stores, diving sales by distribution channels, and shut down or partly shut
down of production facilities for several months.
Despite the fact that China has largely brought
the pandemic under control, there is still a high degree of uncertainty as to how the pandemic will evolve going forward. A new outbreak
in China could cause new disruptions of our production, distribution and sales, and have an adverse impact on our business, financial
condition and results of operations for the remainder of the fiscal year ending March 31, 2022, which cannot be reasonably estimated at
the current stage. The Company will regularly assess its business conditions and adopt measures to mitigate any new impact of the ongoing
pandemic.
Related Parties
The Company accounts for related party transactions
in accordance with ASC 850 (“Related Party Disclosures”). A party is considered to be related to the Company if the party
directly or indirectly or through one or more intermediaries, controls, is controlled by, or is under common control with the Company.
Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of
the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence
the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing
its own separate interests. A party which can significantly influence the management or operating policies of the transacting parties
or if it has an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or
more of the transacting parties might be prevented from fully pursuing its own separate interests is also a related party. There were no related party transactions as of March 31, 2022.
Recent Accounting Pronouncements
The Company considers the applicability and impact
of all accounting standards updates (“ASUs”). Management periodically reviews new accounting standards that are issued.
The Company is an “emerging growth company” (“EGC”)
as defined in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). Under the JOBS Act, EGC can delay adopting
new or revised accounting standards issued subsequent to the enactment of the JOBS Act until such time as those standards apply to private
companies.
Recently Issued Accounting Pronouncements
In February 2016, the FASB issued ASU 2016-02,
“Leases (Topic 842),” which increases lease transparency and comparability among organizations. Under the new standard, lessees
will be required to recognize all assets and liabilities arising from leases on the balance sheet, with the exception of leases with a
term of 12 months or less, which permits a lessee to make an accounting policy election by class of underlying asset not to recognize
lease assets and liabilities. ASU 2016-02 is effective for fiscal years beginning after December 15, 2018, including interim periods within
those fiscal years, and early adoption is permitted. In March 2018, the FASB approved an alternative transition method to the modified
retrospective approach, which eliminates the requirement to restate prior period financial statements and requires the cumulative effect
of the retrospective allocation to be recorded as an adjustment to the opening balance of retained earnings at the date of adoption. In
May 2020, the FASB issued ASC 2020-05 to defer the effective date for non-issuer entities that have not yet issued their financial statements
reflecting the adoption of leases; the amended effective date for non-issuer entities is for fiscal years beginning after December 15,
2021.
The Company as an “emerging growth company”
has elected to adopt the new lease standard as of the effective date applicable to non-issuers and will adopt the new lease standard on
April 1, 2022 using the modified retrospective method. The modified retrospective approach would not require any transition accounting
for leases that expired before the earliest comparative period presented. The Company does not expect this update will have a material
impact on the Company’s consolidated financial position, results of operations and cash flow.
In January 2017, the FASB issued ASU 2017-04,
Simplifying the Test for Goodwill Impairment, which simplifies the accounting for goodwill impairment by eliminating Step two from the
goodwill impairment test. If the carrying amount of a reporting unit exceeds its fair value, an impairment loss shall be recognized in
an amount equal to that excess, versus determining an implied fair value in Step two to measure the impairment loss. The guidance is effective
for annual and interim impairment tests performed in periods beginning after December 15, 2022. The guidance should be applied on a prospective
basis, and is not expected to have a material impact on the Company’s consolidated financial statements.
The Company adopted ASU No. 2018-13, Fair Value
Measurement (Topic 820): Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement on January 1, 2021
and the adoption of this standard did not have any material impact on the Company’s consolidated financial statements.
NOTE 3 – ACCOUNTS RECEIVABLE
Accounts receivable consisted of the following as of March 31, 2022
and 2021:
| | |
As of March 31, | | |
As of March 31, | |
| | |
2022 | | |
2021 | |
| Accounts receivable, gross | |
$ | 27,911,421 | | |
$ | 34,563,743 | |
| Less: allowance for doubtful accounts | |
| 463,514 | | |
| - | |
| Accounts receivable | |
$ | 27,447,907 | | |
$ | 34,563,743 | |
The Company recorded net of allowance for doubtful
accounts of $463,514 as of March 31, 2022 due to uncollectible balances from three overseas companies. The Company gives its customers
credit period of 180 days and continually assesses the recoverability of uncollected accounts receivable. As of March 31, 2022, the balance
of the Company’s accounts receivable was all due within 2 years. As of March 31, 2021, the balance of the Company’s accounts
receivable was all due within 1 year. The Company believes the balances of its accounts receivable are fully recoverable as of March 31,
2022.
NOTE 4 – INVENTORIES
All the inventories are located in China. Inventories consisted
of the following as of March 31, 2022 and 2021:
| | |
As of March 31, | | |
As of March 31, | |
| | |
2022 | | |
2021 | |
| Raw materials | |
$ | 786,082 | | |
$ | 1,422,941 | |
| Work in process | |
| - | | |
| 34,717 | |
| Finished goods | |
| 603,479 | | |
| 327,721 | |
| Total | |
$ | 1,389,561 | | |
$ | 1,785,379 | |
No lower of cost or net realizable value adjustment
was recorded as of March 31, 2022 and 2021, respectively.
No inventory provision or write-downs for the
years ended March 31, 2022 and 2021.
NOTE 5 – PREPAID EXPENSES AND OTHER CURRENT ASSETS
Prepaid expenses and other current assets consisted of the following
as of March 31, 2022 and 2021:
| | |
As of
March 31, | | |
As of
March 31, | |
| | |
2022 | | |
2021 | |
| Prepayments to suppliers | |
$ | 4,177,537 | | |
$ | 9,334,225 | |
| Loans receivables (a) | |
| 727,765 | | |
| - | |
| Deposit | |
| 691,070 | | |
| 12,174 | |
| Prepayments to technical provider | |
| 669,481 | | |
| 646,752 | |
| VAT-in | |
| 560,155 | | |
| - | |
| Prepayment to Weilan (b) | |
| 448,946 | | |
| - | |
| Receivable from disposal of subsidiaries | |
| 408,106 | | |
| - | |
| Deposit for the acquisition of Shennong (Note 14) | |
| - | | |
| 9,130,613 | |
| Other current assets | |
| 226,173 | | |
| 3,065,980 | |
| Total | |
$ | 7,909,233 | | |
$ | 22,189,744 | |
| (a) | Loans receivables to third parties mainly represent loan agreements
entered with certain third-party companies to support their daily operation or bridge loan of mortgage with maturity from six to nine
months and the interest rate from 0.03% to 0.5% per day. |
| (b) |
In the year ended March 31, 2022, the Company signed a cooperation agreement with a third party to invest in Hangzhou Weilan Automobile Co., Ltd. (“Weilan”) and paid $448,946 to the shareholders of Weilan. In June 2022, both parties agreed to terminate the cooperation agreement and the Company collected the full prepayment. |
NOTE 6 – PROPERTY, PLANT AND EQUIPMENT, NET
Property, plant and equipment consisted of the following as of March
31, 2022 and 2021:
| | |
As of March 31, | | |
As of March 31, | |
| | |
2022 | | |
2021 | |
| Buildings | |
$ | 15,345,997 | | |
$ | 12,813,510 | |
| Machinery | |
| 1,918,918 | | |
| 2,867,046 | |
| Furniture, fixture and electronic equipment | |
| 179,667 | | |
| 231,929 | |
| Vehicles | |
| 176,606 | | |
| 147,132 | |
| Total property plant and equipment, at cost | |
| 17,621,188 | | |
| 16,059,617 | |
| Less: accumulated depreciation | |
| (6,374,373 | ) | |
| (5,545,586 | ) |
| Property, plant and equipment, net | |
$ | 11,246,815 | | |
$ | 10,514,031 | |
As of March 31, 2022 and 2021, the Company pledged
its building with a carrying value of approximately $2.1 million and $5.1 million, respectively, as the collateral for short-term bank
loans (see Note 10).
Depreciation expense was $1,553,399, $849,454
and $674,247 for the years ended March 31, 2022, 2021 and 2020, respectively. Depreciation allocated as manufacturing overhead to inventories
was $621,654, $589,610 and $555,636 for the years ended March 31, 2022, 2021 and 2020, respectively.
The carrying amount of disposed property, plant
and equipment recognized for the year ended March 31, 2022 and 2021 were amounted to $505,969 and $0, respectively.
NOTE 7 – INTANGIBLE ASSETS, NET
| | |
As of March 31, | | |
As of March 31, | |
| | |
2022 | | |
2021 | |
| Land use right, cost | |
$ | 910,808 | | |
$ | 879,886 | |
| Customer relationship (Note 14) | |
| 8,822,973 | | |
| - | |
| Trademark | |
| 11,027 | | |
| - | |
| Software, cost | |
| 1,127,710 | | |
| 1,084,858 | |
| Total | |
| 10,872,518 | | |
| 1,964,744 | |
| Less: accumulated amortization | |
| (771,113 | ) | |
| (132,645 | ) |
| Intangible assets, net | |
$ | 10,101,405 | | |
$ | 1,832,099 | |
As of March 31, 2022 and 2021, the Company pledged
its land use right on its land with a carrying value of $93,140 (12,120 square meters) and $758,504 (29,720 square meters), respectively,
as the collateral for a short-term bank loan (see Note 10).
Amortization expense was $633,807, $31,425 and
$16,502 for the years ended March 31, 2022, 2021 and 2020, respectively.
Estimated future amortization expense is as follows
as of March 31, 2022:
| Years ending March 31, | |
Amortization
expense | |
| 2023 | |
$ | 1,897,000 | |
| 2024 | |
| 1,897,000 | |
| 2025 | |
| 1,897,000 | |
| 2026 | |
| 1,897,000 | |
| 2027 | |
| 1,897,000 | |
| Thereafter | |
| 616,405 | |
| | |
$ | 10,101,405 | |
NOTE 8 – GOODWILL
Goodwill consisted of the following as of March 31, 2022 and 2021:
| | |
As of
March 31, | | |
As of
March 31, | |
| | |
2022 | | |
2021 | |
| Shennong | |
$ | 6,288,219 | | |
$ | - | |
| Hekangyuan | |
| 3,627,427 | | |
| - | |
| Daji | |
| 168,555 | | |
| 162,832 | |
| Total | |
$ | 10,084,201 | | |
$ | 162,832 | |
The changes in the carrying amount of goodwill for the years ended
March 31, 2022 and 2021 were as follow:
| | |
As of
March 31, | | |
As of
March 31, | |
| | |
2022 | | |
2021 | |
| Balance as of March 31 | |
$ | 162,832 | | |
$ | - | |
| Acquisitions (Note 14) | |
| 20,237,015 | | |
| 162,832 | |
| Impairment | |
| (10,309,745 | ) | |
| - | |
| Exchange gain and loss | |
| (5,901 | ) | |
| - | |
| Goodwill, net | |
$ | 10,084,201 | | |
$ | 162,832 | |
The goodwill generated from the expected synergies from the output
capacity of the transaction and service scenario of the multi-industry, full-link and full-closed-loop of Shennong, and cooperation of
developing the health commodities business stably, combining the production and supply, jointly build a perfect supply chain system with
Hekangyuan.
Due to the continually influence of the COVID-19 pandemic, Shennong
and Hekangyuan’s operating result decreased significantly. The Company assessed qualitative factors and performed the quantitative
impairment test. As of March 31, 2022 and 2021, the Company recognized impairment amounted to $10,309,745 (including $5,844,804 to Shennong
and $4,464,941 to Hekangyuan) and nil, respectively.
NOTE 9 – PREPAID ASSETS
Prepaid assets consisted of the following as of March 31, 2022 and
2021:
| | |
As of March 31, | | |
As of March 31, | |
| | |
2022 | | |
2021 | |
| Prepayments for advertising or marketing | |
$ | 5,485,325 | | |
$ | 4,909,840 | |
| Prepayment of celebrity endorsement fee | |
| 141,774 | | |
| 228,265 | |
| Total | |
$ | 5,627,099 | | |
$ | 5,138,105 | |
Since October 1, 2018, the Company entered into
agreements with exclusive distributors to provide subsidy of $152,177 to $913,062 (RMB 1.0 million to 6.0 million) to each exclusive distributor
for advertising and marketing in the next 3 years when they open new stores. The Company provided $7.09 million and $2.95 million subsidy
in the year ended March 31, 2022 and 2021. In November 2019, the Company also entered into a business development cooperation agreement
with a service company located in the U.S, who provides market channel and advertisement supports to the Company, for a total of $1,600,000
over 3-year.
In October 2018, the Company paid a celebrity
endorsement fee of $445,533 (RMB 3.0 million). The celebrity endorsement contract is for a period of 5 years.
NOTE 10 – SHORT-TERM BANK BORROWINGS
Short-term bank borrowings consisted of the following as of March 31,
2022 and 2021:
| | |
As of March 31, | | |
As of March 31, | |
| | |
2022 | | |
2021 | |
| Industrial Bank Co., Ltd | |
$ | 1,102,675 | | |
$ | 1,065,238 | |
| Postal Saving Bank of China | |
| 1,165,685 | | |
| 1,171,762 | |
| Total | |
$ | 2,268,360 | | |
$ | 2,237,000 | |
On May 4, 2018, the Company entered into a bank loan agreement with
Industrial Bank Co., Ltd to borrow $1,039,578 (RMB 7.0 million) as working capital for one year with due date on April 21, 2019 and it
was renewed in 2019 for another year. The loan bears a fixed interest rate of 1-year Loan Prime Rate (“LPR”) +2.19% on the
date of drawing per annum. The loan facility agreement is personally guaranteed by Mr. Xuezhu Wang, Mr. Xianfu Wang, and Mrs. Yanying
Lin. Based on guarantee contract the maximum guaranteed amount was RMB 7.0 million. The Company also pledged its building and land use
rights as collaterals. Based on the pledge agreement, the maximum pledged amount was RMB 17.4 million. There were no loan guarantee fees
paid to the personal guarantors. In April 2020, Fujian Happiness renewed the loan agreement with Industrial Bank Co. Ltd for $1,065,238
(RMB 7.0 million) bearing interest rate at LPR plus 1.45% per annum, payable monthly. The loan was expired and paid off in April 2021.
In addition, the Company entered into a loan agreement of $1,065,238 (RMB 7.0 million) bearing interest rate at LPR plus 0.75% on June
9, 2021 and repaid it on June 5, 2022.
On June 24, 2019, the Company entered into a loan
facility framework agreement with Postal Saving Bank of China. The agreement allows the Company to access a total borrowing of approximately
$3.4 million (RMB 24.4 million) for short-term loans. The loan facility agreement is valid until June 23, 2025 and subject to renewal.
The loan facility agreement is personally guaranteed by Mr. Xuezhu Wang and Happiness Nanping. The Company also pledged its building and
land use right as collaterals. Pursuant to the loan facility agreement with Postal Saving Bank of China, which is valid from June 24,
2019 to June 23, 2025. On January 12, 2022 and January 13, 2022, the Company entered into a loan agreement of $846,848 (RMB 6.0 million)
and $197,597 (RMB 1.4 million) short-term loans bearing fixed interest rate of 4.25%, which was due on January 10, 2023 and February 12,
2023, respectively. In addition, on April 7, 2020 and January 15, 2021, the Company entered into a loan agreement of RMB 1.7 million and
RMB 6.0 million with Postal Saving Bank of China as working capital for one year, respectively. The loans bear a fixed interest rate of
LPR+20 BP. The Company repaid RMB 1.7 million on April 6, 2021 and April 8, 2021, and repaid RMB 6.0 million on January 12, 2022.
The carrying values of the Company’s pledged
assets to secure short-term borrowings by the Company are as follows:
| | |
As of March 31, | | |
As of March 31, | |
| | |
2022 | | |
2021 | |
| Buildings, net | |
$ | 2,076,215 | | |
$ | 5,062,724 | |
| Land use rights, net | |
| 93,140 | | |
| 758,504 | |
| Total | |
$ | 2,169,355 | | |
$ | 5,821,228 | |
For the years ended March 31, 2022, 2021 and 2020,
interest expense on all short-term bank loans amounted to $85,993, $111,790 and $98,086, respectively.
NOTE 11 – SHARE BASED COMPENSATION
2020 Equity incentive plan
In February 2021, the Company adopted the 2020 Equity incentive plan
which allows the Company to offer incentive awards to employee, directors and consultants (collectively, “the Participants”). Under the
2020 Equity incentive plan, the Company may issue incentive awards to the Participants to purchase no more than 3,500,000 ordinary shares
with no restrictive legend affixed.
Share-based compensation expense of $1,086,231 and $778,423 was immediately
recognized in general and administrative expenses for the year ended March 31, 2022 and 2021 with no vesting conditions.
The fair values of share units are determined based on the fair value
of the grant date of the Company’s ordinary shares.
NOTE 12 – SHAREHOLDERS’ EQUITY
Ordinary shares
Happiness Development was incorporated under the
laws of the Cayman Islands on February 9, 2018. The Company issued 50,000 ordinary shares with par value of $1 to exchange for the ownership
in Fujian Happiness from the former shareholders to Happiness Nanping.
A Reorganization of the legal structure was completed
in August 2018. The Reorganization involved the incorporation of Happiness Development Group Limited, a Cayman Islands holding company;
Happiness Biology Technology Group Limited, a holding company established in Hong Kong, PRC; Happiness (Nanping) Biotech Co., Ltd, a holding
company established in Fujian, PRC; and the transfer of 100% ownership of Fujian Happiness from the former shareholders to Happiness Nanping.
In May 2018, the Company received $627,628 (RMB
4.0 million) from two investors into Fujian Happiness.
On March 4, 2019, the Company subdivided its 50,000
ordinary shares into 90,000,000 Ordinary shares and 10,000,000 Preferred shares. The authorized ordinary shares became 100,000,000 shares
and the par value changed from $1 to $0.0005. On the same day, the Company cancelled 77,223,100 ordinary shares and sold additional 223,100
ordinary shares. The Company has retrospectively reflected the stock subdivision and cancellation in all periods presented in these financial
statements.
On October 25, 2019, the Company announced the
closing of its initial public offering of 2,000,000 ordinary shares, US$0.0005 par value per share (“Ordinary Shares”) at
an offering price of $5.50 per share for a total of $11,000,000 in gross proceeds. The Company raised total net proceeds of $9,342,339
after deducting underwriting discounts and commissions and offering expenses.
The Company entered several Securities Purchase
Agreement from September 2020 through March 2021. Pursuant to which, the Company issued 5,100,000 ordinary shares to the purchasers with
a total consideration amounted $10,965,703. The Company collected total net proceeds of $10,725,700 after deducting commissions and offering
expenses.
On March 15, 2021, the Company issued 381,580
ordinary shares to its management and employees for their service. The Company recorded compensation cost $778,423 according to the fair
value of the shares issued.
On June 21, 2021, the Company issued an aggregate
of 231,445 Class A ordinary shares of the Company to certain employees and a director for their services. The total compensation cost
was $351,796.
On June 25, 2021, the Company entered several
Securities Purchase Agreement with non-US investors. Pursuant to which, the Company issued 1,240,000 Class A ordinary shares to the purchasers
with a total consideration amounted $2,157,600. The Company collected total net proceeds of $2,157,600 after deducting commissions and
offering expenses.
On October 14, 2021, the Company issued an aggregate
of 113,458 Class A ordinary shares of the Company to certain employees and a director for their services. The total compensation cost
was $99,843.
On October 20, 2021, the Company entered
into a certain equity agreement with Shennong for the purchase of 70% of the equity interest of Shennong at a consideration of RMB
103.0 million (approximately $16.1 million). The total consideration paid for the Equity Interests are RMB 48.0 million (approximately
$7.5 million) in cash and 4,200,000 Class A ordinary shares of the Company. The Company issued an aggregate of 4,200,000 ordinary
shares of the Company to certain transaction on November 12, 2021. The total compensation cost was $3,736,320.
On October 21, 2021, the Company held its annual
meeting of shareholders for its fiscal year ending March 31, 2021. The Company approved as a special resolution an alteration to the share
capital of the Company by: a: the conversion of each issued paid up Ordinary Share with a par value of $0.0005 each into stock (the “Stock”);
b: the alteration of the authorized issued share capital of the Company from (i) US$50,000 divided into 90,000,000 Ordinary Shares with
a par value of US$0.0005 each and 10,000,000 Preferred Shares with a par value of US$0.0005 each; to (ii) 70,000,000 Class A Ordinary
Shares with a par value of $0.0005 each, 20,000,000 Class B Ordinary Shares with a par value of US$0.0005 each and 10,000,000 Preferred
Shares with a par value of US$0.0005 each. Class A Ordinary Shares was entitled to one vote per share and to receive notice of, attend
at and vote as a member at any general meeting of the Company; and be entitled to such dividends as the Board may from time to time declare;
and generally be entitled to enjoy all of the rights attaching to shares. Class B Ordinary Shares was entitled to twenty (20) votes per
share and to receive notice of, attend at and vote as a member at any general meeting of the Company; be entitled to such dividends as
the Board may from time to time declare; and generally be entitled to enjoy all of the rights attaching to shares.
On January 12, 2022, the Company issued an aggregate
of 1,133,200 Class A ordinary shares of the Company to certain employees for their services. The total compensation cost was $634,592.
On January 20, 2022, the Company entered several
Securities Purchase Agreement with non-US persons. Pursuant to which, the Company issued 12,500,000 Class A ordinary shares to the purchasers
with a total consideration amounted $10,000,000. The Company collected total net proceeds of $10,000,000 after deducting commissions and
offering expenses.
On March 4, 2022, the Company entered into a certain equity transfer
agreement with Hekangyuan for the purchase of 100% of the equity interest of Hekangyuan at a consideration of $12.0 million. The total
consideration paid for the Equity Interests are $8.0 million in cash and 10,000,000 Class A ordinary shares of the Company. The Company
issued an aggregate of 10,000,000 ordinary shares of the Company to certain transaction on March 7, 2022. The total compensation cost
was $3,560,000.
On March 10, 2022, the Company entered several
Securities Purchase Agreement with non-US investors. Pursuant to which, the Company issued 19,200,000 Class A ordinary shares to the purchasers
with a total consideration amounted $6,720,000. The Company collected total net proceeds of $6,720,000 after deducting commissions and
offering expenses.
Non-controlling Interest
Non-controlling interests represent the interest of non-controlling
shareholders in Happiness Development Group Limited based on their proportionate interests in the equity of that company adjusted for
their proportionate share, which is 30% to 49% of the particular subsidiaries, of income or losses from operations. See Note 1
for details of the Company and its operating subsidiaries ownership.
Statutory reserve
The Company is required to make appropriations
to certain reserve funds, comprising the statutory surplus reserve and the discretionary surplus reserve, based on after-tax net income
determined in accordance with generally accepted accounting principles of the PRC (“PRC GAAP”). Appropriations to the statutory
surplus reserve are required to be at least 10% of the after-tax net income determined in accordance with PRC GAAP until the reserve is
equal to 50% of the entity’s registered capital. Appropriations to the discretionary surplus reserve are made at the discretion
of the Board of Directors. In 2019, $56,077 was appropriated by Fujian Happiness to the statutory surplus reserve and the statutory reserve
reached 50% of its registered capital. In 2020, no statutory surplus was appropriated. In 2021, $5,558,669 was appropriated by Fujian
Happiness to the statutory surplus reserve. The reserved amounts as determined pursuant to PRC statutory laws amounted $7,622,765 and
$7,622,765 as of March 31, 2022 and 2021.
Under PRC laws and regulations, statutory surplus
reserves are restricted to set-off against losses, expansion of production and operation and increasing registered capital of the respective
company, and are not distributable other than upon liquidation. The reserves are not allowed to be transferred to the Company in terms
of cash dividends, loans or advances, nor allowed for distribution except under liquidation. Amounts restricted include paid-in capital,
additional paid-in capital and statutory surplus reserves of the Company in PRC amounted $19,978,449 and $18,978,449 as of March 31, 2022
and 2021, respectively.
As of March 31, 2022, our PRC subsidiaries had an aggregate retained
earnings of approximately RMB195.2 million (US$26.04 million) under PRC GAAP. With respect to retained earnings accrued after
such date, our Board of Directors may declare dividends after taking into account our operations, earnings, financial condition, cash
requirements and availability and other factors as it may deem relevant at such time.
Options
In October 2019, the Company granted its underwriters
an option for a period of 45 days after the closing of the initial public offering to purchase up to 15% of the total number of the Company’s
Ordinary Shares to be offered by the Company pursuant to the offering (excluding shares subject to this option), solely for the purpose
of covering overallotments, at the initial public offering price less the underwriting discount. These options expired and unexercised
in 2020.
| | |
Number Outstanding | | |
Weighted Average Exercise Price | | |
Contractual Life in Days | | |
Intrinsic Value | |
| Options Outstanding as of March 31, 2020 | |
| - | | |
$ | - | | |
| - | | |
$ | - | |
| Options Exercisable as of March 31, 2020 | |
| - | | |
$ | - | | |
| - | | |
| | |
| Options granted | |
| 300,000 | | |
| 5.12 | | |
| 45 | | |
| - | |
| Options forfeited | |
| - | | |
| - | | |
| - | | |
| - | |
| Options expired | |
| (300,000 | ) | |
| 5.12 | | |
| 45 | | |
| - | |
| | |
| | | |
| | | |
| | | |
| | |
| Options Outstanding as of March 31, 2022 and 2021 | |
| - | | |
$ | - | | |
| - | | |
$ | - | |
| Options Exercisable as of March 31, 2022 and 2021 | |
| - | | |
$ | - | | |
| - | | |
$ | - | |
Warrants
In October 2019, the Company granted to the underwriters
warrants to purchase up to a total of 184,000 ordinary shares (equal to 8% of the aggregate number of ordinary shares sold in the
offering, if over-allotment shares are placed by the underwriters. Without over-allotment share issuance, a total of 160,000 warrants
will be granted). The warrants will be exercisable at an exercise price equal to one hundred twenty percent (120%) of the offering price,
in whole or in parts, at any time from issuance and expire five (5) years from the effective date of the offering.
The Company’s outstanding and exercisable
warrants as of March 31, 2022 are presented below:
| | |
Number Outstanding | | |
Weighted Average Exercise Price | | |
Contractual Life in Years | | |
Intrinsic Value | |
| Warrants Outstanding as of March 31, 2020 | |
| 160,000 | | |
$ | 6.60 | | |
| 4.6 | | |
$ | - | |
| Warrants granted | |
| - | | |
$ | - | | |
| - | | |
| - | |
| Warrants forfeited | |
| - | | |
| - | | |
| - | | |
| - | |
| Warrants exercised | |
| - | | |
$ | - | | |
| - | | |
| - | |
| Warrants Outstanding as of March 31, 2021 | |
| 160,000 | | |
$ | 6.60 | | |
| 3.6 | | |
$ | - | |
| Warrants Outstanding as of March 31, 2022 | |
| 160,000 | | |
$ | 6.60 | | |
| 2.6 | | |
$ | - | |
NOTE 13 – TAXES
(a) Corporate Income Taxes (“CIT”)
The Company was incorporated in the Cayman Islands
and is not subject to tax on income or capital gain under the laws of the Cayman Islands.
Happiness Hong Kong was incorporated in Hong Kong
and is subject to a statutory income tax rate of 16.5%.
Under the Law of the People’s Republic of
China on Enterprise Income Tax (“New EIT Law”), which was effective from January 1, 2008, both domestically-owned enterprises
and foreign-invested enterprises are subject to a uniform tax rate of 25% while preferential tax rates, tax holidays and even tax exemption
may be granted on case-by-case basis. EIT grants preferential tax treatment to High and New Technology Enterprises (“HNTEs”).
Under this preferential tax treatment, HNTEs are entitled to an income tax rate of 15%, subject to a requirement that they re-apply for
HNTE status every three years. Fujian Happiness, the Company’s main operating entity in PRC, was approved as HNTEs and is entitled
to a reduced income tax rate of 15% from December 2019 to December 2022.
The Company evaluates each uncertain tax position
(including the potential application of interest and penalties) based on the technical merits, and measure the unrecognized benefits associated
with the tax positions. As of March 31, 2022 and 2021, the Company did not have any significant unrecognized uncertain tax positions.
The Company did not incur any interest and penalties related to potential underpaid income tax expenses for the years ended March 31,
2022 and 2021, respectively, and also did not anticipate any significant increases or decreases in unrecognized tax benefits in the next
12 months from March 31, 2022.
The following table reconciles the statutory rate
to the Company’s effective tax rate:
| | |
For the years ended March 31, | |
| | |
2022 | | |
2021 | | |
2020 | |
| PRC statutory income tax rate | |
| 25.0 | % | |
| 25.0 | % | |
| 25.0 | % |
| Effect of PRC preferential tax rate | |
| (10.0 | )% | |
| (10.0 | )% | |
| (10.0 | )% |
| Effect of other deductible expenses | |
| 2.7 | % | |
| 7.4 | % | |
| (3.3 | )% |
| Total | |
| 17.7 | % | |
| 22.4 | % | |
| 18.3 | % |
The provision for income tax consisted of the
following:
| | |
For the years ended March 31, | |
| | |
2022 | | |
2021 | | |
2020 | |
| Current income tax provision | |
$ | 195,678 | | |
$ | 959,384 | | |
$ | 2,844,087 | |
| Deferred income tax provision | |
| (3,921,905 | ) | |
| - | | |
| - | |
| Total | |
$ | (3,726,227 | ) | |
$ | 959,384 | | |
$ | 2,844,087 | |
The deferred income tax assets and liabilities as below:
| | |
For the years ended March 31, | |
| | |
2022 | | |
2021 | | |
2020 | |
| Net accumulated loss-carry forward | |
$ | 4,402,633 | | |
$ | - | | |
$ | - | |
| Less: valuation allowance | |
| (606,141 | ) | |
| - | | |
| - | |
| Net deferred tax assets | |
$ | 3,796,492 | | |
$ | - | | |
$ | - | |
| | |
For the years ended March 31, | |
| | |
2022 | | |
2021 | | |
2020 | |
| Beginning balance | |
$ | | | |
$ | - | | |
$ | - | |
| Write-off | |
| | | |
| | | |
| | |
| Change of valuation allowance | |
| 4,402,633 | | |
| - | | |
| - | |
| Ending balance | |
$ | 4,402,633 | | |
$ | - | | |
$ | - | |
| | |
For the years ended March 31, | |
| | |
2022 | | |
2021 | | |
2020 | |
| Intangible assets arising from acquisition | |
$ | (2,079,986 | ) | |
$ | - | | |
$ | - | |
| Total deferred tax liabilities | |
$ | (2,079,986 | ) | |
$ | - | | |
$ | - | |
Deferred income taxes reflect the net effects
of temporary difference between the carrying amounts of assets and liabilities for financial statement purposes and the amounts used for
income tax purposes. The Company recorded deferred tax assets of $3,796,492 and deferred tax liabilities of $2,079,986 as of March 31,
2022. The Company recorded no deferred tax assets and liabilities as of March 31, 2021, as there was no material temporary difference
between the carrying amounts of assets and liabilities.
(b) Taxes Payable
The Company’s taxes payable as of March 31, 2022 and 2021 consisted
of the following:
| | |
As of March 31, | | |
As of March 31, | |
| | |
2022 | | |
2021 | |
| Income tax payable | |
$ | 15,078 | | |
$ | 377,025 | |
| VAT payable | |
| 2,189 | | |
| (53,035 | ) |
| Other tax payables | |
| 19,958 | | |
| 10,533 | |
| Total | |
$ | 37,225 | | |
$ | 334,523 | |
NOTE 14 – BUSINESS COMBINATION
Acquisition of Daji
On February 1, 2021, the Company acquired 51%
equity interest of DAJI with total cash consideration of $75,044 (RMB510,000). DAJI is a company incorporated in Nanjing, the PRC and
engages in providing live show service. The results of DAJI have been included in the consolidated financial statements of the Company
since the acquisition date of February 1, 2021.
On the acquisition date, the purchase price was
allocated to the assets acquired and liabilities assumed based on their fair values was as follows. Fair value of the non-controlling
interests was estimated based on the equity value of DAJI derived by the discounted cash flow method after considering a discount for
lack of control:
| Net liabilities acquired | |
$ | (11,544 | ) |
| | |
| | |
| Goodwill | |
| 162,832 | |
| Non-controlling interests | |
| (76,244 | ) |
| Total | |
| 75,044 | |
| | |
| | |
| Purchase price – cash consideration | |
$ | 75,044 | |
The accompanying unaudited pro forma combined
statements of operations presents the accounts of the Company and DAJI for the years ended March 31, 2021 and 2020, respectively, assuming
the acquisition occurred on April 1, 2019.
| 2021 Summary Statement of Operations | |
HAPPINESS BIOTECH GROUP LIMITED | | |
DAJI | | |
Combined | |
| | |
| | |
| | |
| |
| Revenue | |
$ | 71,433,130 | | |
$ | 175,425 | | |
$ | 71,608,555 | |
| | |
| | | |
| | | |
| | |
| Net Income (Loss) | |
$ | 683,926 | | |
$ | (2,333 | ) | |
$ | 681,593 | |
| | |
| | | |
| | | |
| | |
Net Income (Loss) per ordinary share - basic and diluted | |
$ | 0.03 | | |
| | | |
$ | 0.03 | |
| | |
| | | |
| | | |
| | |
Weighted average ordinary shares - basic and diluted | |
| 26,160,270 | | |
| | | |
| 26,160,270 | |
| 2020 Summary Statement of Operations | |
HAPPINESS BIOTECH GROUP LIMITED | | |
DAJI | | |
Combined | |
| | |
| | |
| | |
| |
| Revenue | |
$ | 65,061,953 | | |
$ | 7,429 | | |
$ | 65,069,382 | |
| | |
| | | |
| | | |
| | |
| Net Income (Loss) | |
$ | 12,688,035 | | |
$ | (21 | ) | |
$ | 12,688,014 | |
| | |
| | | |
| | | |
| | |
Net Income (Loss) per ordinary share - basic and diluted | |
$ | 0.53 | | |
| | | |
$ | 0.53 | |
| | |
| | | |
| | | |
| | |
Weighted average ordinary shares - basic and diluted | |
| 23,843,836 | | |
| | | |
| 23,843,836 | |
Acquisition of Shennong
On November 12, 2021, the Company acquired 70%
equity interest of Shennong with total cash consideration of $7.5 million (RMB 48.0 million) and 4,200,000 Class A ordinary shares of
the Company. The Class A Ordinary Shares were registered on November 12, 2021, valued at $0.8896 per share. Shennong is a company incorporated
in Fujian, the PRC and focus on agriculture products, electronic products and hardware products. Acquisition of Shennong has strengthen
the supply-chain as well as the industrial integration of online store. According to the share transfer agreement signed with the transferer,
the Company owns the right to require the transferer purchasing back all the equity interests in cash of RMB72.1million if the target
company doesn’t meet the profit target. In the year ended March 31, 2021, the Company has paid $9.1 million (RMB 60.0 million) to
the transferer as a deposit of this acquisition. And the overpaid RMB 12.0 million (approximately $1.9 million with $0.3 million exchange
gain) has been collected back in the year ended March 31, 2022. The results of Shennong have been included in the consolidated financial
statements of the Company since the acquisition date of November 12, 2021.
The balance sheet as of March 31, 2022 and the statement of income
and comprehensive income for the period from the acquisition date to March 31, 2022 has been consolidated into the Company’s consolidated
financial statements. The net revenue and net income of Shennong since the acquisition date and that were included in the Company’s
consolidated statements of operations and comprehensive income/(loss) for year ended March 31, 2022 are $4,444,960 and $354,722, respectively.
The Company engaged an independent valuation firm
to assist management in valuing assets acquired, liabilities assumed, intangible assets identified, contingent consideration and non-controlling
interests as of the acquisition day.
The identifiable intangible assets acquired upon
acquisition were customer relationships with definite useful life. All other current assets and current liabilities carrying value approximated
fair value at the time of acquisition. The fair value of the consideration was based on closing market price of the Company’s common
share on the acquisition date.
According to the independent valuation report, the purchase price was
allocated to the assets acquired and liabilities assumed based on their fair values. Fair value of the non-controlling interests was evaluated
based on the equity value of Shennong derived by the discounted cash flow method after considering a discount for lack of control:
| Fair value of total consideration transferred: | |
| |
| Equity instrument (4.2 million Class A Ordinary Shares issued) | |
$ | 3,736,320 | |
| Cash consideration | |
| 7,492,391 | |
| Subtotal | |
$ | 11,228,711 | |
| | |
| | |
| Recognized amounts of identifiable assets acquired and liability assumed: | |
| | |
| Cash | |
$ | 59,091 | |
| Current assets other than cash | |
| 13,591,825 | |
| Intangible asset – customer relationships | |
| 4,214,470 | |
| Current liabilities | |
| (13,650,246 | ) |
| Deferred tax liabilities | |
| (1,053,617 | ) |
| Total identifiable net assets | |
$ | 3,161,523 | |
| Fair value of non-controlling interests* | |
| 4,010,254 | |
| Goodwill* | |
$ | 12,077,442 | |
| * | The goodwill generated from the expected synergies from the output
capacity of the transaction and service scenario of the multi-industry, full-link and full-closed-loop of Shennong. |
Non-controlling interest was recognized and measured at fair value
on the acquisition date by the Company.
Acquisition of Hekangyuan
On March 4, 2022, the Company acquired 100% equity
interest of Hekangyuan with total cash consideration of $8 million and 10,000,000 Class A Ordinary Shares of the Company. The Class A
Ordinary Shares were registered on March 4, 202, valued at $0.365 per share. Hekangyuan is a company incorporated in Fujian, the PRC and
focus on the sales of healthcare products and optical glasses. The acquisition has further strengthened the distribution network of the
Company. According to the share transfer agreement signed with the transferer, the Company owns the right to require the transferer purchasing
back all the equity interests in cash of $12.0 million if the target company doesn’t meet the profit target. The results of Hekangyuan
have been included in the consolidated financial statements of the Company since the acquisition date of March 4, 2022.
The balance sheet as of March 31, 2022 and the statement of income
and comprehensive income for the period from the acquisition date to March 31, 2022 has been consolidated into the Company’s consolidated
financial statements.The net revenue and net income of Hekangyuan since the acquisition date and that were included in the Company’s
consolidated statements of operations and comprehensive income/(loss) for year ended March 31, 2022 are $917,787 and $38,178, respectively.
The Company engaged an independent valuation firm to assist management
in valuing assets acquired, liabilities assumed, intangible assets identified and contingent consideration as of the acquisition day.
The identifiable intangible assets acquired upon acquisition were customer
relationships with definite useful life. All other current assets and current liabilities carrying value approximated fair value at the
time of acquisition. The fair value of the consideration was based on closing market price of the Company’s common share on the
acquisition date.
According to the independent valuation report, the purchase price was
allocated to the assets acquired and liabilities assumed based on their fair values was as follows:
| Fair value of total consideration transferred: | |
| |
Equity instrument (10 million Class A Ordinary Shares issued) | |
$ | 3,650,000 | |
| Cash consideration | |
| 8,000,000 | |
| | |
| | |
| Subtotal | |
$ | 11,650,000 | |
| | |
| | |
| Recognized amounts of identifiable assets acquired and liability assumed: | |
| | |
| Cash | |
$ | 1,164 | |
| Current assets other than cash | |
| 1,882,139 | |
| Property, plant and equipment, net | |
| 187 | |
| Intangible asset – customer relationships | |
| 4,582,227 | |
| Current liabilities | |
| (1,829,733 | ) |
| Deferred tax liabilities | |
| (1,145,557 | ) |
| Total identifiable net assets | |
$ | 3,490,427 | |
| Fair value of non-controlling interests | |
| - | |
| Goodwill* | |
$ | 8,159,573 | |
| * | The goodwill generated from the expected synergies from the
cooperation of developing the health commodities business stably, combining the production and supply, jointly build a perfect supply
chain system with Hekangyuan. |
The business combination accounting is provisionally
complete for all assets and liabilities acquired on the acquisition date and the Company will continue to evaluate the asset values within
the 1-year timeframe according to ASC 805.
NOTE 15 – DECONSOLIDATION
During the year, the Company has disposed several
subsidiaries supporting the online store business to optimize the Company’s structure and recognized loss resulting from the deconsolidation
amounted to $95,932 and $0, for the year ended March 31, 2022 and 2021, respectively.
NOTE 16 – COMMITMENTS AND CONTINGENCIES
As of March 31, 2022 and 2021, Company has no
significant leases or unused letters of credit.
From time to time, the Company is involved in
various legal proceedings, claims and other disputes arising from commercial operations, employees, and other matters which, in general,
are subject to uncertainties and in which the outcomes are not predictable. The Company determines whether an estimated loss from a contingency
should be accrued by assessing whether a loss is deemed probable and can be reasonably estimated. Although the Company can give no assurances
about the resolution of pending claims, litigation or other disputes and the effect such outcomes may have on the Company, the Company
believes that any ultimate liability resulting from the outcome of such proceedings, to the extent not otherwise provided or covered by
insurance, will not have a material adverse effect on our consolidated financial position or results of operations or liquidity. As of
March 31, 2022 and 2021, Company has no pending legal proceedings.
NOTE 17 – SEGMENT REPORTING
Before March 31, 2021, the Company’s CODM, chief executive officer,
measures the performance of the Company based on metrics of revenue only and doesn’t focus on any profit of the business. Starting
from April 1, 2021, the Company’s CODM, chief executive officer, measures the performance of each segment based on metrics of revenue
and gross profit and uses these results to evaluate the performance of, and to allocate resources to each of the segments. As most of
the Company’s long-lived assets are located in the PRC and most of the Company’s revenues are derived from the PRC, no geographical
information is presented. The Company does not allocate assets and operating expenses to its segments as the CODM does not evaluate the
performance of segments using asset and operating expenses information.
For the year ended March 31, 2022, the Company has determined that
it operates in four operating segments: (1) Healthcare products; (2) Automobile; (3) Online store; and (4) Internet information
and advertising service. The Company’s reportable segments are strategic business units that offer different products and services.
They are managed separately because each business requires different marketing strategies.
The following tables present the summary of each reportable segment’s
revenue and gross profit, which is considered as a segment operating performance measure, for the fiscal year ended March 31, 2022:
| Fiscal year ended March 31, 2022 |
|
|
| |
|
Healthcare products |
|
|
Automobile |
|
|
Online store |
|
|
Internet information and advertising service |
|
|
Consolidated |
|
| Revenues |
|
$ |
30,323,831 |
|
|
$ |
20,611,775 |
|
|
$ |
28,014,109 |
|
|
$ |
10,538,943 |
|
|
$ |
89,488,658 |
|
| Cost |
|
$ |
(30,538,282 |
) |
|
$ |
(20,380,773 |
) |
|
$ |
(25,844,918 |
) |
|
$ |
(9,013,219 |
) |
|
$ |
(85,777,192 |
) |
| Segment gross profit |
|
$ |
(214,451 |
) |
|
$ |
231,002 |
|
|
$ |
2,169,191 |
|
|
$ |
1,525,724 |
|
|
$ |
3,711,466 |
|
| Segment gross profit margin |
|
|
(0.7 |
)% |
|
|
1.1 |
% |
|
|
7.7 |
% |
|
|
14.5 |
% |
|
|
4.1 |
% |
NOTE 18 – CUSTOMER AND SUPPLIER CONCENTRATION
Significant customers and suppliers are those
that account for greater than 10% of the Company’s revenues and purchases.
The Company’s sales are made to customers
that are located primarily in China. For the years ended March 31, 2022 and 2021, no individual customer accounted for more than 10% of
the Company’s total revenues.
For the year ended March 31, 2022, Guanxian Chunjiang Ganoderma professional
cooperative community and Fuzhou Chenyao Industrial Co., Ltd. contributed approximately 13.4% and 12.5% of total purchases of the Company,
respectively, which amounted to $14.7 million and $13.7 million respectively. The accounts payable of Guanxian Chunjiang Ganoderma professional
cooperative community and Fuzhou Chenyao Industrial Co., Ltd. amounted to $4.3 million and nil as of March 31, 2022. For the years ended
March 31, 2021 and 2020, the Company purchased a substantial portion of raw materials from one third-party supplier (16.84% of total raw
materials purchase for the year ended March 31, 2021 and 16.67% of total raw materials purchases for the year ended March 31, 2020). As
of March 31, 2021, the amounts due to this vendor was $645,635. As of March 31, 2020, the amounts due to this vendor was $-0-
NOTE 19 – SUBSEQUENT EVENTS
On April 21, 2022, 150,000 Class A Ordinary Shares
owned by Xuezhu Wang were reconverted into Class B Ordinary Shares.
On June 1, 2022, the Company repaid $1,065,238
(RMB 7.0 million) under the above Max Pledge Amount Agreement from Industrial Bank Co., Ltd. On the same day, the Company borrowed $1,065,238
(RMB 7.0 million) bearing interest rate at LPR plus 0.9%. The loan facility agreement is personally guaranteed by Mr. Xuezhu Wang, Mr.
Xianfu Wang, and Mrs. Yanying Lin. The Company also pledged its building and land use rights as collaterals. There were no loan guarantee
fees paid to the personal guarantors.
On June 24, 2022, Ganzhou Youjia New Energy Automobile Sales Co., Ltd.
was dissolved.
The Company evaluated all events and transactions that occurred
after March 31, 2022 through the date of the issuance of the consolidated financial statements on August 15, 2022 and noted that there
were no other material subsequent events.
F-33
353001
0.03
0.53
1.22
23843836
40485912
40485912
In the year ended March 31, 2022, the Company signed a cooperation agreement with a third party to invest in Hangzhou Weilan Automobile Co., Ltd. (“Weilan”) and paid $448,946 to the shareholders of Weilan. In June 2022, both parties agreed to terminate the cooperation agreement and the Company collected the full prepayment.
Loans receivables to third parties mainly represent loan agreements entered with certain third-party companies to support their daily operation or bridge loan of mortgage with maturity from six to nine months and the interest rate from 0.03% to 0.5% per day.
0.03
0.03
26160270
26160270
0.53
0.53
23843836
23843836
10.0
false
N/A
FY
00000
0001751876
0001751876
2021-04-01
2022-03-31
0001751876
dei:BusinessContactMember
2021-04-01
2022-03-31
0001751876
us-gaap:CommonClassAMember
2022-08-15
0001751876
us-gaap:CommonClassBMember
2022-08-15
0001751876
2022-03-31
0001751876
2021-03-31
0001751876
us-gaap:CommonClassBMember
2022-03-31
0001751876
us-gaap:CommonClassBMember
2021-03-31
0001751876
us-gaap:CommonClassAMember
2022-03-31
0001751876
us-gaap:CommonClassAMember
2021-03-31
0001751876
2020-04-01
2021-03-31
0001751876
2019-04-01
2020-03-31
0001751876
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2019-03-31
0001751876
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2019-03-31
0001751876
us-gaap:AdditionalPaidInCapitalMember
2019-03-31
0001751876
happ:StatutorySurplusReserveMember
2019-03-31
0001751876
us-gaap:RetainedEarningsMember
2019-03-31
0001751876
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2019-03-31
0001751876
us-gaap:ParentMember
2019-03-31
0001751876
2019-03-31
0001751876
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2019-04-01
2020-03-31
0001751876
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2019-04-01
2020-03-31
0001751876
us-gaap:AdditionalPaidInCapitalMember
2019-04-01
2020-03-31
0001751876
us-gaap:ParentMember
2019-04-01
2020-03-31
0001751876
us-gaap:RetainedEarningsMember
2019-04-01
2020-03-31
0001751876
happ:StatutorySurplusReserveMember
2019-04-01
2020-03-31
0001751876
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2019-04-01
2020-03-31
0001751876
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2020-03-31
0001751876
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2020-03-31
0001751876
us-gaap:AdditionalPaidInCapitalMember
2020-03-31
0001751876
happ:StatutorySurplusReserveMember
2020-03-31
0001751876
us-gaap:RetainedEarningsMember
2020-03-31
0001751876
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2020-03-31
0001751876
us-gaap:ParentMember
2020-03-31
0001751876
us-gaap:NoncontrollingInterestMember
2020-03-31
0001751876
2020-03-31
0001751876
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2020-04-01
2021-03-31
0001751876
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2020-04-01
2021-03-31
0001751876
us-gaap:AdditionalPaidInCapitalMember
2020-04-01
2021-03-31
0001751876
happ:StatutorySurplusReserveMember
2020-04-01
2021-03-31
0001751876
us-gaap:RetainedEarningsMember
2020-04-01
2021-03-31
0001751876
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2020-04-01
2021-03-31
0001751876
us-gaap:ParentMember
2020-04-01
2021-03-31
0001751876
us-gaap:NoncontrollingInterestMember
2020-04-01
2021-03-31
0001751876
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2021-03-31
0001751876
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2021-03-31
0001751876
us-gaap:AdditionalPaidInCapitalMember
2021-03-31
0001751876
happ:StatutorySurplusReserveMember
2021-03-31
0001751876
us-gaap:RetainedEarningsMember
2021-03-31
0001751876
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2021-03-31
0001751876
us-gaap:ParentMember
2021-03-31
0001751876
us-gaap:NoncontrollingInterestMember
2021-03-31
0001751876
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2021-04-01
2022-03-31
0001751876
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2021-04-01
2022-03-31
0001751876
us-gaap:AdditionalPaidInCapitalMember
2021-04-01
2022-03-31
0001751876
happ:StatutorySurplusReserveMember
2021-04-01
2022-03-31
0001751876
us-gaap:RetainedEarningsMember
2021-04-01
2022-03-31
0001751876
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2021-04-01
2022-03-31
0001751876
us-gaap:ParentMember
2021-04-01
2022-03-31
0001751876
us-gaap:NoncontrollingInterestMember
2021-04-01
2022-03-31
0001751876
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2022-03-31
0001751876
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2022-03-31
0001751876
us-gaap:AdditionalPaidInCapitalMember
2022-03-31
0001751876
happ:StatutorySurplusReserveMember
2022-03-31
0001751876
us-gaap:RetainedEarningsMember
2022-03-31
0001751876
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2022-03-31
0001751876
us-gaap:ParentMember
2022-03-31
0001751876
us-gaap:NoncontrollingInterestMember
2022-03-31
0001751876
happ:FujianHappinessMember
2018-08-31
0001751876
happ:MrWangXuezhuMember
2018-08-31
0001751876
2018-08-02
2018-08-21
0001751876
pf0:MinimumMember
2019-03-04
0001751876
pf0:MaximumMember
2019-03-04
0001751876
2019-03-04
0001751876
2019-02-28
2019-03-04
0001751876
us-gaap:CommonStockMember
2019-02-28
2019-03-04
0001751876
us-gaap:IPOMember
2019-10-25
0001751876
2019-10-25
0001751876
happ:HappinessNanpingBiologyTechnologyCoLtdNanpingHappinessMember
2021-04-01
2022-03-31
0001751876
happ:FujianHappinessBiotechCoLtdFujianHappinessMember
2021-04-01
2022-03-31
0001751876
happ:FujianHappinessComesMedicalEquipmentManufacturingCoLtdMember
2021-04-01
2022-03-31
0001751876
happ:ShunchangHappinessComesHealthProductsCoLtdMember
2021-04-01
2022-03-31
0001751876
happ:FujianShennongjiaguDevelopmentCoLtdShennongMember
2021-04-01
2022-03-31
0001751876
happ:FuzhouHekangyuanTradingCoLtdHekangyuanMember
2021-04-01
2022-03-31
0001751876
happ:FuzhouHappinessEnterpriseManagementConsultingCoLtdMember
2021-04-01
2022-03-31
0001751876
happ:HappyBuyFujianNetworkTechnologyCoLtdHappyBuyMember
2021-04-01
2022-03-31
0001751876
happ:FujianHappyStudioNetworkTechnologyCoLTDMember
2021-04-01
2022-03-31
0001751876
happ:HangzhouCestLaVieInteractiveTechnologyCoLtdHangzhouCestLaVieMember
2021-04-01
2022-03-31
0001751876
happ:FujianLeverMediaCoLtdFujianLeverMember
2021-04-01
2022-03-31
0001751876
happ:ShunchangBaolongElectronicCommerceCoLtdOneMember
2021-04-01
2022-03-31
0001751876
happ:ShunchangShihongElectronicCommerceCoLtdTwoMember
2021-04-01
2022-03-31
0001751876
happ:HappinessYoudaoHangzhouElectronicCommerceCoLtdMember
2021-04-01
2022-03-31
0001751876
happ:PutianCityHanjiangDistrictLuochenNetworkTechnologyCoLtdPutianLuochenMember
2021-04-01
2022-03-31
0001751876
happ:PutianCityHanjiangDistrictQiyaoTradingCoLtdMember
2021-04-01
2022-03-31
0001751876
happ:PutianCityHanjiangDistrictZhiranTradingCoLtdMember
2021-04-01
2022-03-31
0001751876
happ:FujianSeraviElectronicCommerceCoLtdFujianSeraviMember
2021-04-01
2022-03-31
0001751876
happ:ShunchangQidaElectronicCommerceCoLtdMember
2021-04-01
2022-03-31
0001751876
happ:ShunchangPenghongElectronicCommerceCoLtdMember
2021-04-01
2022-03-31
0001751876
happ:FujianDajiMediaCoLtdDajiMember
2021-04-01
2022-03-31
0001751876
happ:HappyBuyNanpingAutomobileSalesCoLtdMember
2021-04-01
2022-03-31
0001751876
happ:HappyOptimalFujianNetworkTechnologyCoLtdHappyOptimalMember
2021-04-01
2022-03-31
0001751876
happ:ShunchangHaiwushuoBrandManagementCoLtdShunchangHaiwushuoMember
2021-04-01
2022-03-31
0001751876
happ:ShunchangSaltSweetNetworkTechnologyCoLtdMember
2021-04-01
2022-03-31
0001751876
happ:HaiwushuoHangzhouMediaTechnologyCoLtdMember
2021-04-01
2022-03-31
0001751876
happ:ShunchangCountyPartnersSupplyChainManagementCoLtdMember
2021-04-01
2022-03-31
0001751876
happ:ShunchangYouxiEcommerceCoLtdMember
2021-04-01
2022-03-31
0001751876
happ:HaiwushuoFujianFoodCoLtdMember
2021-04-01
2022-03-31
0001751876
happ:HappyUnicornHangzhouNetworkTechnologyCoLtdHappyUnicornMember
2021-04-01
2022-03-31
0001751876
happ:GanzhouYoujiaNewEnergyAutomobileSalesCoLtdMember
2021-04-01
2022-03-31
0001751876
happ:HappyCarSourceNingboAutomobileServiceCoLtdMember
2021-04-01
2022-03-31
0001751876
happ:WuhanXingfuYouxuanAutomobileSalesCoLtdMember
2021-04-01
2022-03-31
0001751876
happ:TaochejunHangzhouNewEnergyTechnologyCoLtdHangzhouTaochejunMember
2021-04-01
2022-03-31
0001751876
happ:ZhejiangYicheChuxingTechnologyCoLtdMember
2021-04-01
2022-03-31
0001751876
happ:HappyTravelTechnologyFujianCoLtdMember
2021-04-01
2022-03-31
0001751876
happ:SichuanTaochejunNewEnergyTechnologyCoLtdMember
2021-04-01
2022-03-31
0001751876
happ:TaochejunXianCarRentalCoLtdMember
2021-04-01
2022-03-31
0001751876
happ:TaochejunFuzhouAutomotiveTechnologyCoLtdMember
2021-04-01
2022-03-31
0001751876
happ:FuzhouTaochejunCultureMediaCoLtdMember
2021-04-01
2022-03-31
0001751876
happ:TaochejunHainanNewEnergyTechnologyCoLtdMember
2021-04-01
2022-03-31
0001751876
happ:HunanXingfuVehicleSourceTechnologyCoLtdMember
2021-04-01
2022-03-31
0001751876
happ:HappyAutomobileServiceNanpingCoLtdMember
2021-04-01
2022-03-31
0001751876
happ:HangzhouHappinessYoucheAutomobilePartnershipLimitedPartnershipMember
2021-04-01
2022-03-31
0001751876
happ:ShunchangBangrenElectronicCommerceCoLtdMember
2021-04-01
2022-03-31
0001751876
happ:ShunchangShenzhouElectronicCommerceCoLtdMember
2021-04-01
2022-03-31
0001751876
happ:ShunchangTongyuanElectronicCommerceCoLtdMember
2021-04-01
2022-03-31
0001751876
happ:ShunchangGuangxiangElectronicCommerceCoLtdMember
2021-04-01
2022-03-31
0001751876
happ:ShunchangLishijinElectronicCommerceCoLtdMember
2021-04-01
2022-03-31
0001751876
happ:ShunchangWangfuElectronicCommerceCoLtdMember
2021-04-01
2022-03-31
0001751876
happ:ShunchangYiboElectronicCommerceCoLtdMember
2021-04-01
2022-03-31
0001751876
happ:ShunchangRunhaoElectronicCommerceCoLtdMember
2021-04-01
2022-03-31
0001751876
happ:ShunchangFanyanfullElectronicCommerceCoLtdMember
2021-04-01
2022-03-31
0001751876
happ:ShunchangFanquguanElectronicCommerceCoLtdMember
2021-04-01
2022-03-31
0001751876
happ:ShunchangYouqiangdiaoElectronicCommerceCoLtdMember
2021-04-01
2022-03-31
0001751876
happ:ShunchangShangyoupinElectronicCommerceCoLtdMember
2021-04-01
2022-03-31
0001751876
happ:FuzhouBaodengTradingCoLtdFuzhouBaodengMember
2021-04-01
2022-03-31
0001751876
happ:FuzhouDachenEcommerceCoLtdMember
2021-04-01
2022-03-31
0001751876
happ:FuzhouNanenTradingCoLtdMember
2021-04-01
2022-03-31
0001751876
happ:FuzhouDechenTradingCoLtdMember
2021-04-01
2022-03-31
0001751876
happ:FuzhouLehuangTradingCoLtdMember
2021-04-01
2022-03-31
0001751876
happ:HappyDoddoFujianNetworkTechnologyCoLtdHappyDoddoMember
2021-04-01
2022-03-31
0001751876
happ:ShunchangShenghuiElectronicCommerceCoLtdMember
2021-04-01
2022-03-31
0001751876
happ:ShunchangWanshengElectronicCommerceCoLtdMember
2021-04-01
2022-03-31
0001751876
happ:ShunchangJiefeiElectronicCommerceCoLtdMember
2021-04-01
2022-03-31
0001751876
happ:ShunchangZhiboElectronicCommerceCoLtdMember
2021-04-01
2022-03-31
0001751876
happ:ShunchangHeruiElectronicCommerceCoLtdMember
2021-04-01
2022-03-31
0001751876
happ:ShunchangXiaocongcongElectronicCommerceCoLtdMember
2021-04-01
2022-03-31
0001751876
happ:ShunchangXianghongElectronicCommerceCoLtdMember
2021-04-01
2022-03-31
0001751876
happ:ShunchangHappyCatElectronicCommerceCoLtdMember
2021-04-01
2022-03-31
0001751876
happ:ShunchangSuboboEcommerceCoLtdMember
2021-04-01
2022-03-31
0001751876
happ:HappyFeiyueFujianNetworkTechnologyCoLtdHappyFeiyueMember
2021-04-01
2022-03-31
0001751876
happ:HAPPINESSHKTECHNOLOGYLIMITEDMember
2021-04-01
2022-03-31
0001751876
us-gaap:CashEquivalentsMember
2022-03-31
0001751876
us-gaap:CashEquivalentsMember
2021-03-31
0001751876
us-gaap:BuildingMember
2021-04-01
2022-03-31
0001751876
us-gaap:MachineryAndEquipmentMember
2021-04-01
2022-03-31
0001751876
pf0:MinimumMember
happ:FurnitureFixtureAndElectronicEquipmentMember
2021-04-01
2022-03-31
0001751876
pf0:MaximumMember
happ:FurnitureFixtureAndElectronicEquipmentMember
2021-04-01
2022-03-31
0001751876
us-gaap:VehiclesMember
2021-04-01
2022-03-31
0001751876
us-gaap:LandMember
2021-04-01
2022-03-31
0001751876
pf0:MinimumMember
us-gaap:SoftwareLicenseArrangementMember
2021-04-01
2022-03-31
0001751876
pf0:MaximumMember
us-gaap:SoftwareLicenseArrangementMember
2021-04-01
2022-03-31
0001751876
us-gaap:TrademarksMember
2021-04-01
2022-03-31
0001751876
us-gaap:CustomerRelationshipsMember
2021-04-01
2022-03-31
0001751876
happ:HealthcareProductsMember
2021-04-01
2022-03-31
0001751876
happ:HealthcareProductsMember
2020-04-01
2021-03-31
0001751876
happ:HealthcareProductsMember
2019-04-01
2020-03-31
0001751876
happ:OnlineStoreMember
2021-04-01
2022-03-31
0001751876
happ:OnlineStoreMember
2020-04-01
2021-03-31
0001751876
happ:InternetInformationAndAdvertisingMember
2021-04-01
2022-03-31
0001751876
happ:InternetInformationAndAdvertisingMember
2020-04-01
2021-03-31
0001751876
happ:AutomobileMember
2021-04-01
2022-03-31
0001751876
happ:AutomobileMember
2020-04-01
2021-03-31
0001751876
happ:PeriodEndSpotRateMember
2021-04-01
2022-03-31
0001751876
happ:PeriodEndSpotRateMember
2020-04-01
2021-03-31
0001751876
happ:PeriodEndSpotRateMember
2019-04-01
2020-03-31
0001751876
happ:AverageRateMember
2021-04-01
2022-03-31
0001751876
happ:AverageRateMember
2020-04-01
2021-03-31
0001751876
happ:AverageRateMember
2019-04-01
2020-03-31
0001751876
pf0:MinimumMember
2022-03-31
0001751876
pf0:MaximumMember
2022-03-31
0001751876
us-gaap:BuildingMember
2022-03-31
0001751876
us-gaap:BuildingMember
2021-03-31
0001751876
us-gaap:MachineryAndEquipmentMember
2022-03-31
0001751876
us-gaap:MachineryAndEquipmentMember
2021-03-31
0001751876
us-gaap:FurnitureAndFixturesMember
2022-03-31
0001751876
us-gaap:FurnitureAndFixturesMember
2021-03-31
0001751876
us-gaap:VehiclesMember
2022-03-31
0001751876
us-gaap:VehiclesMember
2021-03-31
0001751876
happ:ShennongMember
2021-04-01
2022-03-31
0001751876
happ:HekangyuanMember
2021-04-01
2022-03-31
0001751876
happ:ShennongMember
2022-03-31
0001751876
happ:HekangyuanMember
2022-03-31
0001751876
happ:DajiMember
2022-03-31
0001751876
happ:DajiMember
2021-03-31
0001751876
pf0:MinimumMember
2021-04-01
2022-03-31
0001751876
pf0:MaximumMember
2021-04-01
2022-03-31
0001751876
2019-11-01
2019-11-30
0001751876
2018-10-01
2018-10-31
0001751876
happ:IndustrialBankCoLtdMember
2018-05-04
0001751876
happ:IndustrialBankCoLtdMember
2018-04-28
2018-05-04
0001751876
happ:IndustrialBankCoLtdMember
2022-03-31
0001751876
happ:IndustrialBankCoLtdMember
2020-04-01
2020-04-30
0001751876
happ:IndustrialBankCoLtdMember
2020-04-30
0001751876
happ:PostalSavingBankOfChinaMember
2019-06-24
0001751876
happ:PostalSavingBankOfChinaMember
2022-01-12
0001751876
happ:PostalSavingBankOfChinaMember
2022-01-13
0001751876
happ:PostalSavingBankOfChinaMember
2020-04-07
0001751876
happ:PostalSavingBankOfChinaMember
2021-01-15
0001751876
happ:PostalSavingBankOfChinaMember
2021-04-01
2021-04-06
0001751876
happ:PostalSavingBankOfChinaMember
2021-04-01
2021-04-08
0001751876
happ:IndustrialBankCoLtdMember
2021-03-31
0001751876
happ:PostalSavingBankOfChinaMember
2022-03-31
0001751876
happ:PostalSavingBankOfChinaMember
2021-03-31
0001751876
us-gaap:LandMember
2022-03-31
0001751876
us-gaap:LandMember
2021-03-31
0001751876
happ:EquityIncentivePlanMember
2021-02-01
2021-02-28
0001751876
us-gaap:CommonStockMember
2018-02-09
0001751876
happ:TwoInvestorMember
2018-05-01
2018-05-31
0001751876
us-gaap:CommonStockMember
2019-03-04
0001751876
2020-09-01
2021-03-31
0001751876
2021-03-15
0001751876
us-gaap:CommonClassAMember
2021-06-21
0001751876
2021-06-01
2021-06-21
0001751876
us-gaap:CommonClassAMember
2021-06-25
0001751876
2021-06-01
2021-06-25
0001751876
us-gaap:CommonClassAMember
2021-10-01
2021-10-14
0001751876
2021-10-01
2021-10-14
0001751876
2021-10-01
2021-10-20
0001751876
us-gaap:CommonClassAMember
2021-10-20
0001751876
2021-11-01
2021-11-12
0001751876
2021-11-12
0001751876
2021-10-21
0001751876
us-gaap:CommonStockMember
2021-10-21
0001751876
us-gaap:PreferredStockMember
2021-10-21
0001751876
us-gaap:CommonClassAMember
2021-10-21
0001751876
us-gaap:CommonClassBMember
2021-10-21
0001751876
us-gaap:CommonClassAMember
2022-01-12
0001751876
2022-01-12
0001751876
us-gaap:CommonClassAMember
2022-01-20
0001751876
us-gaap:CommonClassAMember
2022-01-01
2022-01-20
0001751876
2022-01-01
2022-01-20
0001751876
happ:HekangyuanMember
2022-03-01
2022-03-04
0001751876
2022-03-01
2022-03-04
0001751876
2022-03-04
0001751876
us-gaap:CommonClassAMember
2022-03-10
0001751876
2022-03-01
2022-03-10
0001751876
2022-03-10
0001751876
happ:PRCMember
2022-03-31
0001751876
us-gaap:IPOMember
2019-10-01
2019-10-31
0001751876
us-gaap:WarrantMember
2019-10-01
2019-10-31
0001751876
happ:HongKongMember
2021-04-01
2022-03-31
0001751876
happ:AcquisitionOfDajiMember
2021-02-02
0001751876
2021-02-02
2021-02-02
0001751876
us-gaap:CommonClassAMember
2021-11-01
2021-11-12
0001751876
happ:ShennongMember
2021-11-01
2021-11-12
0001751876
happ:ShennongMember
2021-04-01
2022-03-31
0001751876
happ:ShennongMember
2020-04-01
2021-03-31
0001751876
happ:AcquisitionOfHekangyuanMember
2022-03-01
2022-03-04
0001751876
us-gaap:CommonClassAMember
2022-03-01
2022-03-04
0001751876
happ:HekangyuanMember
2021-04-01
2022-03-31
0001751876
happ:HekangyuanMember
2020-04-01
2021-03-31
0001751876
happ:HappinessBiotechGroupLimitedMember
us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember
2020-04-01
2021-03-31
0001751876
happ:DajiMember
us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember
2020-04-01
2021-03-31
0001751876
us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember
2020-04-01
2021-03-31
0001751876
happ:HappinessBiotechGroupLimitedMember
us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember
2019-04-01
2020-03-31
0001751876
happ:DajiMember
us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember
2019-04-01
2020-03-31
0001751876
us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember
2019-04-01
2020-03-31
0001751876
happ:ShennongMember
2021-04-01
2022-03-31
0001751876
happ:ShennongMember
2022-03-31
0001751876
happ:HekangyuanMember
2021-04-01
2022-03-31
0001751876
happ:HekangyuanMember
2022-03-31
0001751876
us-gaap:HealthcareSectorMember
2021-04-01
2022-03-31
0001751876
happ:AutomobileMember
2021-04-01
2022-03-31
0001751876
happ:OnlineStoreMember
2021-04-01
2022-03-31
0001751876
happ:InternetInformationAndAdvertisingServiceMember
2021-04-01
2022-03-31
0001751876
us-gaap:ConsolidatedEntitiesMember
2021-04-01
2022-03-31
0001751876
happ:GuanxianChunjiangGanodermaProfessionalCooperativeCommunityMember
2021-04-01
2022-03-31
0001751876
happ:FuzhouChenyaoIndustrialCoLtdMember
2021-04-01
2022-03-31
0001751876
happ:XuezhuWangMember
us-gaap:CommonClassAMember
us-gaap:SubsequentEventMember
2022-04-21
0001751876
us-gaap:SubsequentEventMember
2022-06-01
0001751876
us-gaap:SubsequentEventMember
2022-06-01
2022-06-01
xbrli:shares
iso4217:USD
iso4217:USD
xbrli:shares
xbrli:pure
iso4217:CNY